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Abstract 
Metabolomics is an exciting area of research obtaining the chemical and metabolic signals from 
biosamples. Food consumption is strongly linked to metabolism making the metabolome an ideal 
phenotype for identifying biomarkers and helping refine and explore diet-disease associations. 
However, the metabolome is highly complex and influenced by many factors, such as age, disease, 
genetics and gut microbiota. Discordant monozygotic twins may provide a strong model for 
confirming association findings as they are matched for age, sex and the baseline genetic 
sequence.  
 
In this thesis, I explored the potential and applicability of the metabolome in nutritional research in 
two main areas: for identifying biomarkers of food exposure and further investigating the 
relationship of food intake with indicators of health. Firstly, I examined metabolomics profiles 
associated with self-reported food intakes and dietary patterns and confirmed these associations 
using the co-twin control method. I then identified top metabolite markers of food group intakes, and 
created and tested metabolite scores using multiple-methods. I searched for markers of gut 
microbiome diversity, an emerging indicator of health, by examining the association of alpha-
diversity with blood metabolomics profiles and the relationship with diet and the metabolic 
syndrome. In the final chapter, I created a dietary score predictive of visceral fat mass, a strong risk 
factor for cardio-metabolic disease, and examined the degree to which the relationship between diet 
and visceral fat mass is mediated by associated metabolites and microbiome taxa. Throughout 
each chapter I used discordant monozygotic twins to validate top results. Overall, my findings show 
that metabolomics is a highly versatile tool for advancing nutrition research from biomarker 
identification through to untangling the impact of dietary exposures on indicators of metabolic health 
and the gut microbiome.   
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Chapter 1 Introduction 
 
In this chapter I discuss twin studies that have examined the heritability of reported food and 
nutrient intakes and dietary patterns. I then introduce the usage of monozygotic (MZ) twins for 
recent nutriomics studies including specifically the metabolome and gut microbiome. Finally, I briefly 
introduce the usage of twins combined with nutriomic methods for the exploration of the effect of 
diet on metabolic disease.  
Part of this work has been published as a literature review in Nutrition Research Reviews (Pallister 
et al., 2014). 
 
Early nutrition studies on twins and multi-foetal pregnancies focused on the side effects of the 
pregnancy, achieving adequate maternal nutrition during gestation, and on the implications for the 
health of the growing foetuses (Brown and Carlson, 2000). The womb, however, is a solitary 
internal environment, where nutritional parameters can be measured with more ease. Once twins 
enter the world, where myriad of external environmental influences on different phenotypes can be 
assessed, twins provide us with the unique ability to accurately determine heritability of certain 
complex traits, such as dietary phenotypes. In this context, dietary phenotypes broadly refer to the 
observable and measurable foods, and their constituents, consumed by individuals or groups. 
Indeed, twin studies have proven that genetic makeup plays a significant role in dietary intakes 
(Rankinen and Bouchard, 2006). Moreover, twins have the advantage of limiting inter-individual 
variability as they are raised in a similar environment and have matched age, genes and sex (for 
monozygotic [MZ] pairs). They therefore represent a natural matched case-control experiment.  
Omics technologies allow for a systems approach to nutrition research, that encompasses 
the primary level of DNA sequence (genomics), gene expression (transcriptomics) and epigenome, 
to the intermediate phenotypes (proteome, metabolome, and microbiome), finally to clinical 
endpoints (Kussmann et al., 2006). Food constituents may influence each of these areas, but their 
effect is difficult to ascertain due to imprecise dietary assessment methods. Omics techniques may 
help ameliorate this issue through food intake biomarker discovery within the intermediate 
phenotypes, primarily the metabolome (Zivkovic and German, 2009). Once biomarkers of intake 
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have been validated, in conjunction with currently utilized intake and known biomarker measures, 
reliable associations between genomic and transcriptomic data can be made. This can allow for 
identification of groups at risk for poor dietary patterns, gene-diet interactions, and diet-disease 
associations, which combined could conjure an accurate depiction of a “healthy” phenotype 
(Kussmann et al., 2006), although this is limited by currently used methods of dietary assessment. 
Presently, epidemiological studies rely mainly on subjective reporting to obtain dietary 
information. These include prospective methods such as weighted and estimated food records, and 
retrospective methods, including 24-hour recalls and food frequency questionnaires (FFQs). Each 
of these methods carry their own strengths and weaknesses, which have been reviewed by Shim et 
al. (2014). Weighted records and estimated food records carry a higher participant burden, and use 
more time and costs, though they provide more accurate data as they do not rely on participant 
memory (i.e. recall bias). 24 hour recalls commonly require an interviewer (though computer-based 
methods are becoming more common-place), they are limited by possible recall bias and 
interviewer bias and are expensive and time-consuming. Both food records and 24 hour recalls 
require multiple days of evaluation to assess usual food intake. FFQs are the most commonly used 
dietary assessment method for population-based studies as they have a lower participant burden 
and resources and indicate habitual food consumption, though are limited to a set list of foods and 
have low accuracy due to recall bias. With these limitations in mind, identifying novel dietary 
biomarkers using multi-omics will be challenging and require confirmation and evaluation by dietary 
intervention studies.  
In this introduction, I first discuss the usage of twins for generating heritability estimates of 
food intake phenotypes, including energy and macronutrient intakes, dietary patterns and specific 
food group intakes. I then highlight the value of discordant MZ pairs, for furthering nutrition research 
through discovery and validation of biomarkers of intake and health status in conjunction with 
cutting-edge omics technologies, with metabolomics being the focal point.   
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1.1 Heritability of food intake phenotypes: The usage of twins 
for heritability estimates of intakes 
The classic twin design allows for a natural experiment that exploits the difference in genetic 
relatedness between MZ and dizygotic (DZ) twins to estimate the degree to which phenotypic 
variability, such as food or nutrient intake, is explained by genetic and environmental factors. 
Heritability is defined as the degree of total phenotypic variance due to genetic variation and is 
relevant only to groups or populations and not at the individual level (Visscher et al., 2008).  
1.1.1 Heritability of energy and macronutrient intakes  
Accurate assessments of the genetic influence on energy intakes is crucial as these provide a 
baseline assessment for which genes influence total food intakes (de Castro, 1993a) and therefore 
justify genotype-specific dietary intervention strategies. Furthermore, the degree to which 
macronutrient intakes are genetically determined may have significant implications for the role of 
elevated intakes of energy dense foods (i.e. those containing high concentrations of fat and refined 
carbohydrates) to the obesity epidemic (Guyenet and Schwartz, 2012). Therefore, multiple twin 
studies have evaluated these components through various dietary assessment methods (Figure 1-
1a; Appendix A Table 1).  
Studies of different size and quality have estimated heritability of different energy and 
macronutrient intakes to lie between 8% and 70% (Liu et al., 2013, Pimpin et al., 2013, de Castro, 
1993a, Heller et al., 1988, Wade et al., 1981, Hasselbalch et al., 2008, Aden et al., 1979, Hur et al., 
1998). Beginning from a young age, infant twins have showed that the genetic component provides 
a small, albeit significant, effect on energy and macronutrient intakes (8% to 12%) (Pimpin et al., 
2013
)
. As children age and they become less dependent on their parents, the genetic effect on 
energy and macronutrient intakes appears to intensify, as suggested by findings in 11-13 year-old 
US twins (31% to 48%) (Liu et al., 2013). This pattern is similar to other health-related phenotypes, 
including BMI (Dubois et al., 2012), which has been recently confirmed through a more complex 
longitudinal genome-wide complex trait analysis for determining DNA-based heritability (Llewellyn et 
al., 2014). Heritability of dietary energy and macronutrients in adults has been found to vary widely: 
for energy (32% to 65%), for fats (35% to 53%), carbohydrates (25% to 67%), and proteins (28% to 
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70%) (Hasselbalch et al., 2008, Hur et al., 1998, de Castro, 1993a, Wade et al., 1981). An 
extensive study of adult Danish twins showed inheritance of energy and energy-adjusted 
macronutrient intakes to range from 28% to 55% (Hasselbalch et al., 2008). Although, genetic 
effects on macronutrient intakes were more substantial in men (49% to 55%) than women (28% to 
36%), they were not different between macronutrients. In support of this, two other twin studies 
suggested the same genetic mechanisms governing energy intakes (Guyenet and Schwartz, 2012) 
influence macronutrient intakes (de Castro, 1993b, Faith et al., 1999).   
The lack of evidence to date for independent sets of genes influencing macronutrient intakes 
from those genes governing energy intakes has focussed attention on whether dietary energy 
density (kilocalories per gram of food) is genetically determined, with one study suggesting 
substantial genetic influence (de Castro, 2006), and another not (Hasselbalch et al., 2008). Despite 
this, in the latter Danish study, factors related to dietary energy density, including fibre, glycaemic 
index and the glycaemic load, were found to be significantly heritable both in women (49%, 36% 
and 33%, respectively) and men (41%, 30%, and 25%, respectively). The dependence of these 
phenotypes on the constituents of the whole diet suggests genetic effects on these phenotypes may 
be reflective of variable dietary patterns.   
1.1.2 Heritability of dietary patterns 
Dietary patterns are identified by two primary methods: empirically-derived or a priori (Hu, 2002). 
Empirically-derived dietary patterns employ statistical methods to identify natural groupings of 
intakes of food items (e.g., principal component analysis or cluster analysis (Hu, 2002)). A priori 
dietary patterns are generated based on adherence to diet parameters previously associated with 
health outcomes or physiological states, such as the Mediterranean diet score. A key advantage to 
using dietary patterns is the translatable results that encompass the degree to which genetics 
influence the global diet. 
Two twin studies on children using empirically-derived dietary patterns generated highly 
inconsistent heritability estimates despite reasonable sample size (Appendix A Table 2) (Breen et 
al., 2006, Faith et al., 2008). In a study of US 7 year olds (n=792) heritability estimates of food 
pattern intakes obtained by 24-hour recalls were stronger in boys than girls, ranging from 12% to 
79% and 20% to 56%, respectively (Faith et al., 2008). In another study of 4 to 5 (SD: 0.3) year-old 
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UK twin-pairs (n=214) heritability of food preference was measured through the use of a modified 
95-item “liking” food frequency questionnaire (FFQ) administered to parents (Breen et al., 2006). 
Heritability ranged from 20% (desserts) to 78% (meat and fish) on food liking-disliking groups. It is 
difficult to make valid comparisons between these two studies as the dietary assessment methods 
used measure different outcomes (i.e. intakes versus liking), although it has been found that 
exposures to foods generally encourages liking and intakes in children (Wardle et al., 2001). This 
suggests environmental influences may override genetic predispositions to food pattern intakes in 
children, which has implications for combating food neophobia, a highly heritable and perhaps 
evolutionarily important trait (Cooke et al., 2007).  
Contrary to studies in children, studies in adults have generated relatively stable heritability 
estimates for food pattern intakes across patterns and genders. “Healthy” dietary patterns, 
characterised by high intake of vegetables, fruits and whole grains and low intake of fatty foods of 
animal origin and simple carbohydrates, have heritability estimates ranging from 33% to 54%, while 
“unhealthy” patterns ranged from 33% to 50% (Appendix A Table 2) (van den Berg et al., 2013, 
Keskitalo et al., 2008, Teucher et al., 2007, Gunderson et al., 2006, van den Bree et al., 1999). 
Furthermore, a study which utilized a twins of mistaken zygosity approach (a useful method to 
control for potential equal environmental assumption bias (Scarr, 1968)) in US female twins 
(n=700), found additive genetic effects to account for 50% of the variability in healthy pattern 
intakes, while an unhealthy diet pattern was not significantly heritable (Gunderson et al., 2006). A 
healthy diet is more phenotypically similar to diets humans have consumed through millennia and 
evolved with, it is only very recently that high energy dense and processed foods have been readily 
available, as such it makes sense the variation in this diet may be more genetically influenced in 
some groups (Breslin, 2013). One study conducted on an older age group (≥ 50 years) determined 
additive genetic effects to account for 33% of the variability of consumption frequency for both 
healthy and unhealthy patterns (van den Bree et al., 1999). A pattern of increased dietary variety in 
modern societies may contribute to the obesity epidemic through ready availability of highly 
processed, calorific foods compared to healthier, natural choices such as fruits and vegetables 
(McCrory et al., 1999). In middle age to elderly twins from the “Virginia 30,000” twin study 
(N = 5,543) dietary variety seeking was up to 30% heritable, supporting the notion that our 
environment is an important driver of dietary variety (Scheibehenne et al., 2014).  































Figure 1-1.  Estimated heritability of nutrients (a), food (b) and beverage (c) intakes from twin studies 
Intake heritabilities presented are significant findings from previous twin studies. Heritability histograms are color coded according to study. 
From clockwise, histograms are grouped according to age; the first line below the histogram denotes this: light grey, children; dark grey, 
adults. Within each age group, histograms were grouped according to accuracy of the dietary assessment method used, from most accurate 
(e.g. 2 day buffet style meal intervention) to least accurate (e.g. 67-item FFQ). The second line below the histograms indicates gender:  pink, 
female; blue, male; yellow, combined. Modified from Pallister et al.(Pallister et al., 2014) 
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1.1.3 Individual foods and food group heritabilities 
A number of recent studies have estimated the genetic effect of food and beverage intakes in 
humans (Figures 1-1b and 1-1c; Appendix A Tables 3 and 4) generating wide-ranging heritability 
estimates across food groups, particularly for children (Pimpin et al., 2013, Fildes et al., 2014). 
Findings from the UK Gemini cohort of infants and children aged 21 months to 3 years have shown 
age effects on heritability of food group intakes are evident even in the early years (Fildes et al., 
2014, Pimpin et al., 2013). Intakes for 21 month-old children were minimally heritable for food 
groups ranging from 9% (potatoes) to 17% (dairy). Whereas preference for food groups were highly 
heritable in 3 year-old children, ranging from 27% (dairy) to 54% (vegetables). It should be noted 
that heritability estimates in the older children were calculated from age- and sex-adjusted 
residuals, an approach which may have prevented inflation of shared environmental effects (McGue 
and Bouchard, 1984). The study on infants did not use this approach, perhaps resulting in an 
underestimation of the genetic effects on food group intakes.   
Recent studies in adults have also confirmed there is a genetic component to many food 
type intakes. Danish twins showed a large degree of variation in calculated heritabilities overall 
ranging from 17% (fish) to 68% (potato) in men, and 20% (whole grain cereal) to 61% (fish) in 
women (Hasselbalch et al., 2008). Similar results were seen in UK female twins where heritabilities 
ranged from 8% (refined grains) to 46% (garlic) (Teucher et al., 2007). Furthermore, the grouping of 
fruit and vegetable sources generated the highest heritability estimate in this cohort (49%). These 
authors proposed taste perception may be a key driver of the predicted genetic influence as foods 
characterised by strong tastes are the cornerstone of these groups. This observation extends to 
consistently substantial heritabilities for coffee as well as alcohol intakes, ranging from 29% to 73% 
and 28% to 82%, respectively (Hasselbalch et al., 2008, Teucher et al., 2007, Hur et al., 1998, de 
Castro, 1993b). Although, the pharmacological properties of both must be considered as alcohol 
dependence, as well as caffeine consumption-related traits, are both highly heritable (30% to 70%, 
and 36% to 58%, respectively) (Agrawal and Lynskey, 2008, Yang et al., 2010a) and may drive 
intakes up in a way independent of taste preference or a biological requirement for these items. 
Taste is the strongest determinant of food choices (Feeney et al., 2011), and a recent twin 
study showed multiple chemosensory facets of numerous food compounds to be highly heritable 
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and associated with particular gene variants (Knaapila et al., 2012). Future heritability studies of 
food intakes may shift the focus to food groupings characterized by specific tastes.   
1.1.4 Nutritional phenotype heritability conclusion 
In summary, twin studies have shown food and macronutrient intakes to be genetically determined. 
However, heritability estimates are often inconsistent between studies for multiple reasons. First, 
heritability is only specific to the population studied, which can vary greatly, due to the vast country 
specific food environments. Indeed, if a food is not readily available in a population there is no 
capacity for intakes to be genetically determined. Second, important evidence is available for 
familial and community influence on food intake (such as parenting styles, food exposures, 
socioeconomic status) which have an important place for battling current issues, such as childhood 
obesity (Berge, 2009) and food neophobia (Anzman-Frasca et al., 2012), and diabetes (Pollard et 
al., 2014). Finally, methods for determining heritability are not standardised, for instance the 
inclusion/exclusion of variables from the model (e.g. age, country), the segregation/aggregation of 
sexes, and the different methods for obtaining and analysing dietary data tend to be unique for each 
study. The same genetic mechanisms governing energy intakes are suspected to influence 
macronutrient intakes. However, recent studies have assessed the impact of gene variants 
encoding proteins related to the complex energy intake regulatory systems under central nervous 
system control (Guyenet and Schwartz, 2012) on preference for macronutrient types. These studies 
are few on twins (Hasselbalch et al., 2010, Bouchard-Mercier et al., 2012). Heritability estimates are 
more limited for macronutrient subtype intakes (e.g. the fatty acid profile (Hur et al., 1998, Heller et 
al., 1988)), different age groups or changing physiological states (e.g. pregnancy), and socially 
driven diets (e.g. veganism). Macronutrient profiles do not account entirely for food pattern 
preferences that may be more determined by genetic makeup. Variation in diet patterns of adults 
are to a relatively high degree attributable to genetics (van den Berg et al., 2013, Keskitalo et al., 
2008, Teucher et al., 2007, Gunderson et al., 2006, van den Bree et al., 1999). Furthermore, 
specific food type intakes that characterise a healthy diet pattern tend to be highly heritable in 
adults and in turn consist of foods that elicit distinctive taste responses (e.g. garlic, fruit and 
vegetables) (Teucher et al., 2007).  
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The substantial heritability of multiple dietary phenotypes supports the concept of 
personalised dietary recommendations, the generation of which has so far primarily relied on the 
exploration of an individual’s genetic makeup. However, on a molecular level, the search for 
genotypes predisposing individuals to particular dietary intakes is very much in its infancy. 
Nonetheless, the evidence generated by twin heritability studies can lead scientists to dietary 
phenotypes that are consistently highly heritable and demand further exploration through GWAS 
and candidate gene studies, following which twins can aid the determination of the heritable 
contribution of specific singly nucleotide polymorphisms (SNPs) to the dietary phenotype (as used 
previously for human height (Yang et al., 2010b)).   
A key issue which has long plagued nutrigenetic research arises from the inaccuracies of 
self-reported diet intake and food preference data and as a result, the hunt for dietary biomarkers, 
objective measures of dietary intakes and nutritional status, has been hastened. These may allow 
for more accurate heritability calculations for food and nutrient intakes as has recently been shown 
for salt intakes using urinary sodium excretion, an established, valid biomarker of salt intake (Kho et 
al., 2013), and could potentially be used in genetic association studies. However, the usage of 
biomarkers is not confined to genetic studies. It is becoming increasingly clear that for the 
establishment and refinement of personalised nutrition, in combination with genetic information, a 
whole organism, multi-systems approach must be undertaken, where the usage of biomarkers of 
food intakes and nutritional status will be essential. Nutrition research is now embarking on a 
nutriomics era, where emerging high-throughput omics technologies will substantially aid biomarker 
discovery and “healthy phenotype” definition. As will be explored next, twin studies are 
progressively taking steps to make a contribution in this way.   
1.2 The importance of twins for emerging nutriomic research 
This next section will explore emerging dietary studies on twins used in collaboration with high-
throughput omics to capture metabolism (metabolomics) and the gut microbiota (microbiome). 
Integrating these technologies to determine a “healthy” phenotype is the long-term goal of 
personalised nutrition (van Ommen and Stierum, 2002). A reoccurring issue with this type of 
analysis is the high degree of inter-individual variation, making associations often inconsistent 
(Kussmann et al., 2006). As such, the usage of identical twins discordant for dietary factors or 
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objective measures of nutrition status, matched entirely for age, sex, genetics and partially for early 
environmental influences, will provide an enhanced method of assessing diet and biological 
relationships.   
Obesity, the greatest and fastest growing health concern in the world at this time, is a highly 
genetic disorder, influenced by myriad complex factors (Despres et al., 1992). However, rare obese 
discordant identical twin pairs, provide a unique opportunity to disentangle lifestyle and 
environmental factors on the human system derangements induced by energy imbalance 
independently of genetics.  
1.2.1 Nutrimetabolomics 
Nutritional metabolomics involves the extensive chemical profiling of various tissues completed in a 
global manner through targeted and non-targeted methods used as a complement to diet- and 
health-related complex systems approaches. The metabolome gives unique information into the 
metabolic status of an individual by providing a snapshot of the metabolic processes undertaken in 
a bodily system, specific organ, tissue or cell, which cannot be identified through measuring gene 
expression or the proteome. Targeted methods measure a panel or group of chemically defined 
metabolites. Whereas non-targeted methods aim to detect all measureable chemicals in a sample 
and therefore have more coverage. Moreover, non-targeted metabolomics has the potential to 
detect previously unknown metabolites in a sample, increasing the possibility for identifying novel 
findings. Although, it may be difficult to draw conclusions from such findings. Targeted 
metabolomics has increased sensitivity over non-targeted methods measuring absolute 
concentrations as opposed to relative methods used for non-targeted methods. Moreover, targeted 
methods typically measure metabolites which are biologically well-defined (Patti et al., 2012).  
The two primary technologies used to analyse sample metabolomes are mass spectrometry 
(MS) and nuclear magnetic resonance (NMR) spectroscopy. NMR spectroscopy is a quantitative 
technique that determines information on the solution-state molecular structures in a sample 
through atom-based nuclear interactions (Marion, 2013). MS-based methods typically separate 
metabolites first in a sample using chromatography (examples include gas or liquid-based 
chromatography, and capillary electrophoresis), then metabolites are identified with a mass 
spectrometer (Feng et al., 2008). Although, some MS methods do not require the initial sample 
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separation step and metabolites can be quantified directly. Gas or liquid chromatography separate 
metabolites by time, providing detailed chemical information, though this may require complex 
chemical preparation that can destroy metabolites (Sellick et al., 2010). Moreover, often techniques 
(such as GC–MS and LC-MS) are combined as different techniques detect different types of 
metabolites.    
 Veenstra (2012) previously summarized the advantages and disadvantages of both 
methods. The key advantage of MS metabolomics is the sensitivity or the ability to measure very 
small analytes (within the femtomolar to attomolar range) with accuracy. Although the main 
disadvantage of MS is less precise quantification due to the MS signal intensity being influenced by 
the method of sample preparation (Veenstra, 2012), with complex sample preparation also being a 
disadvantage. Conversely, NMR spectroscopy is highly precise due to the peak area of a 




C) (Veenstra, 2012). Moreover, NMR techniques require minimal sample preparation, are non-
destructive, and provide rapid results with high reproducibility at a low cost (Markley et al., 2016). 
The primary disadvantage of NMR-based methods is their lack of sensitivity (Veenstra, 2012), it is 
also non-discriminatory (Markley et al., 2016). 
Nutrition and the metabolome are intimately linked in that nutrients and non-nutrient food 
constituents supply metabolites, however these contributions make the dietary influence on the 
metabolome all the more difficult to ascertain (Gibney et al., 2005). Despite this, dietary pattern and 
food intakes generated through self-reported intake data have identified novel biomarkers within the 
metabolome (O'Sullivan et al., 2011, Altmaier et al., 2011, Guertin et al., 2014b, Zheng et al., 2014), 
validating this approach for use in epidemiological studies. However, the genetic influence on 
metabolite levels is wide-ranging (Suhre et al., 2011), therefore novel usage of the twin model 
provides an ideal method for determining the dietary impact on metabolites, through segregating 
the non-genetic component. One nutri-metabolomic study conducted on twins further confirmed 
self-reported intake associations with metabolites (Menni et al., 2013c). Female UK twins completed 
131-item FFQs that generated dietary constituents and intake patterns found to associate with 42 
metabolite levels in the larger twin population. Monozygotic twins discordant for dietary intakes were 
then identified and utilized to replicate results, confirming the utility of this method (Zivkovic and 
German, 2009).   
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Lipidomics, a branch of metabolomics, has been used to characterize environmental and 
lifestyle-induced changes to the global serum lipid profile in 14 healthy, young MZ obesity-
discordant twin pairs (Pietilainen et al., 2007). Levels of lysophosphatidylcholines, lipids associated 
with inflammation (Yang et al., 2005) and atherogenesis (Glass and Witztum, 2001) were found to 
be elevated in obese co-twins, with concommitant decreases in antioxidant (Wallner and Schmitz, 
2011) ether phospholipids. Moreover, despite the young ages of the obese co-twins (24 to 27 
years), these lipid profile changes were associated with insulin resistance.   
The metabolome is highly complex and inter-individual variation is high for a multitude of 
reasons (Zulyniak and Mutch, 2011), including age (Menni et al., 2013b), sex (Krumsiek et al., 
2015), genetics (Shin et al., 2014), ethnicity (Wikoff et al., 2013) and the gut microbiome (Wikoff et 
al., 2009), thus factoring solely nutritional intake into nutrimetabolomic studies is problematic and 
the relative importance of blood and urine levels is unclear. For example, previous analysis on the 
non-targeted metabolomics TwinsUK dataset showed 22 metabolites to account for 59% of the 
variance in age (Menni et al., 2013b). In another study conducted on the TwinsUK dataset the 
heritability of blood metabolite levels ranged from 10-81%, while only 30% of the blood metabolites 
were not significantly influenced by genetics (Shin et al., 2014). Finally, sex has shown to influence 
one-third of metabolites, while a network analysis showed certain metabolic pathways to be sex-
specific (Krumsiek et al., 2015). 
An area of increasing interest for its potential influence on metabolic processes is the gut 
microbiome. In rodents, the gut microbiota were found to account for 10% of the variability in the 
plasma metabolome (Wikoff et al., 2009). Although estimates for humans are unknown at this time, 
regional variation in human metabolomic profiles has been attributed in part to gut microbes 
(Nicholson et al., 2012). In turn, the gut microbiota carry out processes in the digestion and 
handling of nutrients, some of which are essential for optimal nutrition, prior to entering the host 
metabolome (Nicholson et al., 2012). Emerging methods for direct measurement of the intestinal 
metabolome will help to unravel the microbiome effects on host metabolome (Ursell et al., 2014). 
1.2.2 Microbiome 
The human gut microbiome is estimated to contain hundreds of bacterial species, with upwards of 
536,000 bacterial genes among them (Qin et al., 2010). For years, dietary constituents, such as 
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pre- and pro-biotics, have been consumed for their proposed health benefits postulated to be 
through modulation of the gut microbial population (Collins and Gibson, 1999). Population-based 
studies suggest dietary patterns appear to strongly drive gut microbiome composition. Differences 
have been observed between Americans and Malawians and Amerindians (Yatsunenko et al., 
2012), and consumers of meat- versus plant-based diets (Matijasic et al., 2013, Wu et al., 2011a), 
findings that are being confirmed by dietary intervention studies (David et al., 2014, O'Keefe et al., 
2015). Although the potential for the gut microbiota to drive eating behaviours has also been 
proposed through modifying cravings and inducing dysphoria (Alcock et al., 2014), for instance 
individuals showing a desire for chocolate have a distinctive urinary microbial metabolite profile than 
subjects who were chocolate indifferent, although they consumed identical diets (Rezzi et al., 
2007), studies in this area are limited. Twins discordant for obesity have shown significantly 
different gut microbial species composition (Tims et al., 2013). Lower BMI was associated with 
increased primary fibre degraders, while higher BMI subjects displayed an abundant network of 
butyrate producers, as such it was suggested that a shift in fermentation patterns near the end of 
the colon may be influencing energy homeostasis, although this study did not investigate the dietary 
impact on the microbial species population.   
An analysis on Finnish MZ twin pairs concordant (n=9) and discordant (n=11) for BMI 
revealed dietary energy intakes and constituents to be more influential on microbial populations 
than BMI group (Simoes et al., 2013). Specifically, stool bacterial counts were significantly 
influenced by intakes of energy, monounsaturated and n-3 and n-6 polyunsaturated fatty acids, and 
soluble fibre intakes. Furthermore, profiles of Bacteroides spp. were very similar in co-twins 
consuming the same amount of energy or saturated fats than twins discordant for intakes. These 
findings suggest that the obesity status per se is less influential on microbial species population and 
rather, it is the content of the diet (i.e. high energy and fat) mediating important changes, 
highlighting the essential need to incorporate dietary variables into obesity research. The role of 
host genetics on the microbiome composition is still unclear, though our group has recently shown 
that gut microbiome phenotypes ranged from 0% to 39% heritable (Goodrich et al., 2014a), further 
studies (which are ongoing) are needed to provide clarity.  
Recent findings suggest that the microbial species signature has the potential to promote and 
aggravate an obesity phenotype and may interact synergistically through diet-by-microbiota 
                                                                              29 
interactions. In a unique study, transplantation of fecal samples from US female lean and obese co-
twins (3 DZ; 1 MZ) into germ-free mice revealed the obese compared to lean co-twin’s microbiota 
significantly increased adiposity and metabolic derangements in mice (Ridaura et al., 2013). When 
co-housed with lean mice, obese mice adiposity and metabolic effects were reduced, suspected to 
be a result of Bacteroidetes translocation from lean to obese mice. When fed a diet based on the 
lower tertile of saturated fats and upper tertile of fruits and vegetables of the US National Health 
and Nutrition Examination Survey (NHANES), obese mice adiposity was sustained, but relieved 
when co-housed with lean. Moreover, when compared to co-housing with normal chow, the 
healthier diet aided the success of lean to obese mice bacterial invasion. When supplied with an 
unhealthy diet containing the upper tertile of saturated fats with the lower tertile of fruits and 
vegetables from the NHANES survey, both lean and obese mice presented with significantly 
increased adiposity, mitigating transmissible effects. These results show the potentially causal role 
of the microbiome composition and potential for its manipulation. 
1.3 Applying omics to untangle the effects of diet on metabolic 
disease in twins 
Obesity elevates risk of cardiometabolic diseases such as the metabolic syndrome and CVD. The 
metabolic syndrome is a cluster of metabolic abnormalities characterised by at least three of the five 
symptoms: high blood pressure, an unfavourable lipid profile specifically elevated triglycerides and 
reduced high density lipoprotein cholesterol, elevated waist circumference, and elevated fasting 
blood glucose. One of the primary risk factors for cardiometabolic disease is elevated visceral fat 
mass (St-Pierre et al., 2002, Naukkarinen et al., 2014), which is metabolically active fat that covers 
the internal abdominal organs.  
In the previous sections I have discussed the independent applications of metabolomics 
and the microbiome to examining diet, primarily through studies on body weight discordant MZ 
twins. However the link between diet and metabolic outcomes such as the metabolic syndrome and 
related factors could potentially be further elucidated through collaborative applications of omics 
technologies. In one recent twin study (Bogl et al., 2016), using metabolomics in combination with 
waist circumference (an indicator of visceral fat mass) a strong genetic overlap between waist 
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circumference and a number of metabolites, most notably positive correlations between 
phenylalanine (rg = 0.40), glycoprotein (rg = 0.37), serum triglycerides (rg = 0.36) and BCAAs 
(rg = 0.30–0.40), and negative correlations between HDL particle diameter (rg = − 0.33) and HDL 
cholesterol (rg = − 0.30), supporting the usage of the MZ discordant twin model.  
A single study employed multi-omic methods to examine the time-dependent impact of a 
Big Mac challenge (Bondia-Pons et al., 2014) on 394 serum metabolites and faecal microbiota in 16 
MZ twin pairs discordant for BMI and 9 concordant non-obese MZ pairs (Bondia-Pons et al., 2014). 
Overall, intra-pair changes in metabolite levels were minimal following the Big Mac challenge. Intra-
pair differences at baseline for two branched chain amino acid (BCAAs) were found to converge 
after 120 minutes following the Big Mac challenge, with lower BCAAs in the high weight co-twin 
compared to the low weight co-twin at baseline. Secondary bile acids glycocholic acid and 
glycolithocholic acid were significantly different at 120 min following the Big Mac challenge, with 
higher levels in lean co-twins compared to higher weight co-twins. An examination into Bacteroides 
spp. diversity did not find significant differences between weight-discordant twins, though overall 
Bacteroides spp. diversity was positively associated with postprandial changes in sugar- and 
microbiota-derived organic acids. Links to other clinical indicators of metabolic health were also 
assessed, in particular postprandial changes in glycine-conjugated ursodeoxycholic acid were 
negatively associated with liver fat content as well as MI, a marker of insulin sensitivity. This study 
showed overall that within-pair similarity was the primary determinant of the metabolic response to a 
dietary challenge, highlighting the important role of genetics and early life factors in metabolism.  
 
1.4 Conclusion 
The interconnectedness between each omic presented here is evident. A systems biological 
approach that incorporates multiple omics methods for phenotype definition for use in nutriomic 
studies is much needed (Norheim et al., 2012). The principal central to this approach is that the 
whole organism will provide a more accurate view than the sum of its parts, or rather, the entire 
system has definitive characteristics which will not be replicated by simply adding the effects 
(MacLellan et al., 2012). However, a primary setback for amalgamating these methods is the 
inability to define what is “normal” due to the significant inter-individual variability underlying 
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metabolic processes (Kussmann et al., 2006). Furthermore, it has been suggested that many omics 
vary relatively little over time within individuals but significantly between individuals compounded by 
factors such as age, BMI and gender (Eady et al., 2005). To aid in discerning these effects, 
longitudinal phenotypic information from twin registries will be a critical resource for molecular 
dietary studies of the future (van Dongen et al., 2012). The studies presented here fall short of this 
view of an integrated technology-driven approach and focus rather on omics in isolation as this is 
where the current research stands. To move forward twin cohorts need to make a collaborative 
effort, collecting extensive dietary data in conjunction with multiple omics, undertaking complex 
statistical analyses, while contributing findings to international proposed databases such as the 
Nutritional Phenotype database (van Ommen et al., 2010).  
Identifying individuals susceptible to poor dietary habits and defining an (un)healthy 
phenotype are the overarching aims of nutrigenetic and nutrigenomic research. Twins have 
provided valuable evidence that many dietary intakes are influenced by genetics, validating further 
nutrigenetic research and future dietary counselling which targets this domain. Early studies of twins 
for nutriomic studies have primarily been for unhealthy phenotype definition and single omic, while 
being less inclusive of diet. However, future studies need to begin to incorporate dietary factors to 
fill a void in this research area. Although accurate dietary assessment methods are problematic 
(Tucker et al., 2013). As twins have shown, metabolites are significantly correlated with dietary 
constituents, and could in the future be used as surrogates, as well as other techniques (e.g. 
microbiome) (Lloyd et al., 2013, Vernocchi et al., 2012). Twin studies will remain an important and 
integral part of nutritional research now and in the future.   
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Chapter 2 Hypothesis, aims and tasks of the thesis 
2.1 Hypothesis 
Metabolites have the potential to act as useful surrogates of dietary intakes. Identification of 
metabolites in tissues that consistently associate with reported intakes through validation by the co-
twin control method can be used to better establish and explore diet-disease relationships. 
2.2 Aims 
i) To identify and characterise metabolite associates of self-reported intakes of foods and 
dietary patterns.  
ii) To create, validate and test the utility of food group metabolite scores as novel biomarkers 
of food group intakes.  
iii) To identify metabolite marker(s) of gut microbiome diversity that are modulated by food 
intake, identify the gut microbiome profile of those markers and their relationship to 
metabolic disease.  
iv) To create a visceral fat mass dietary risk score and characterise the score using a multi-
omic approach.   
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Chapter 3 Materials and methods 
 
In this chapter I provide an overview of the study population used, I briefly describe the food 
frequency questionnaire used to evaluate food intakes, the metabolomics and genotyping datasets 
and clinical measures used throughout the thesis. Moreover I introduce the statistical method for 
calculating heritability.  
 
3.1 Subjects and phenotypes 
3.1.1 Subjects 
Subjects included in all analyses were twins enrolled on the TwinsUK registry, a sample of 
extensively phenotyped, mainly female, adult MZ and DZ twins from the UK (Moayyeri et al., 2013, 
Spector and Williams, 2006). Healthy Caucasian twins were recruited nation-wide primarily through 
media campaigns. Twin zygosity was determined by a validated questionnaire or through multiplex 
DNA fingerprinting (PE Applied Biosystems, Foster City, CA). Ethical approval has been obtained 
from St. Thomas’ Hospital Research Ethics committee and all subjects have undergone informed 
consent. Specifically, my thesis included female and male twins, aged 18 to 80 years, who had 
completed at least one FFQ between 1994 and 2001 (Appendix B Document 1), in 2007, and in 
2014 and 2015 (Appendix B Document 2).  
3.1.2 Food frequency questionnaire 
Twins completed a 131-item FFQ that was developed and validated against pre-established nutrient 
biomarkers for the European Prospective Investigation into Diet and Cancer (EPIC) Norfolk 
(Appendix B Documents 1 and 2) (Bingham et al., 2001, Bingham et al., 1997). Processing of the 
FFQ, including subject exclusion and determination of nutrient intakes was completed by 
nutritionists from the University of East Anglia. Intake frequency of an average serving of listed 
foods was determined from a 9-point scale ranging from “Never or less than once/month” to “6+ per 
day”. The questionnaire was intended to capture average intakes in the past year. Nutrient intakes 
were determined via consultation with McCance and Widdowson's The Composition of Foods 6
th
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edition (McCance et al., 1991), this resource includes nutritional information (including fat, sodium, 
fibre, and carbohydrates, vitamins and minerals) for over 1,200 commonly consumed foods derived from 
the UK Nutrient Databank. 
3.1.2.1 Exclusion criteria 
Submitted FFQs were excluded if greater than 10 food items were left unanswered, or if the total 
energy intake estimate derived from FFQ as a ratio of the subject’s estimated basal metabolic rate 
(determined by the Harris-Benedict equation (Frankenfield et al., 1998)) was more than two 
standard deviations outside the mean of this ratio (< 0.52 or > 2.58). Overall, this included 828 twins 
(9.4%) and 284 twins (6.5%) who completed FFQs between 1994 and 2007 (n=8785) and between 
2014 and 2015 (n=4400), respectively. 
3.1.2.2 Residual energy adjustment 
Differences in reported intakes as a product of physiological requirements (due to differences in 
body size, physical activity, and metabolic efficiency) may mask true diet-outcome associations. To 
account for this, food and nutrient intakes were energy adjusted using the residual method prior to 
analysis (Willett and Stampfer, 1986), unless otherwise specified. This involved regressing each 
food item or nutrient on the estimated total kilocalorie intake. The residual was then added to a 
constant, in this case, predicted food or nutrient intake for the mean estimated total kilocalorie 
intake. 
3.1.3 Anthropometry 
Anthropometric measures including body height (metres) and weight (kilograms) were taken at 
clinical visits by a trained research assistant. Body mass index (BMI) was calculated as body weight 
in kilograms divided by the square of height in metres. 
3.1.4 Samples 
3.1.4.1 Blood samples 
Fasted blood samples were collected by a trained research nurse at the twin’s annual visit at St. 
Thomas’ Hospital. Twins were instructed to fast for 8 hours prior to their clinical visit. Visits occurred 
in the morning (9:00 or 10:00) or afternoon (13:00 or 14:00). Time of collection was not recorded 
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therefore diurnal variation may have influenced the results. Following collection samples were 
stored at -80°C until further processing. 
3.1.4.2 Faecal samples 
Faecal samples were collected by the twins at home. Following collection, samples were stored in 
the refrigerator for 2 days or less prior to their annual clinical visit at St. Thomas’ Hospital. Once the 
samples arrived with the clinical team they were stored at −80°C until further processing. 
3.1.5 Clinical measures 
3.1.5.1 Blood pressure 
Systolic and diastolic blood pressure (SBP and DBP, respectively) were carried out by an 
experienced nurse using the Marshall mb02 or the Omron Mx3 Digital Blood Pressure Monitors. An 
average of three readings (separated by one minute) was used for analysis.   
3.1.5.2 Blood lipid profiling and glucose 
Three devices (Cobas Fara; Roche Diagnostics, Lewes, UK; Kodak Ektachem dry chemistry 
analysers [Johnson and Johnson Vitros Ektachem machine, Beckman LX20 analysers, Roche 
P800 modular system]) were used to measure serum levels of total cholesterol, high density 
lipoprotein (HDL) cholesterol and triglycerides (TG) on fasted blood samples using enzymatic 
colorimetric assays. Using an enzymatic colorimetric slide assay fasting blood glucose was 
measured on an Ektachem 700 multichannel analyser (Johnson and Johnson Clinical Diagnostic 
Systems, Amersham, UK).  
3.1.6 Metabolomics 
3.1.6.1 Non-targeted metabolomics 
Metabolites were detected and quantified in fasted serum and plasma samples by the 
metabolomics platform Metabolon, Inc. (Durham, NC), which uses a non-targeted mass 
spectrometry based-approach as has been previously described (Menni et al., 2013b) and 
described in greater detail below. Metabolomics was completed cross-sectionally in three batches, 
one in serum and two in plasma. Quality control of the non-targeted metabolomics dataset was 
undertaken by Metabolon Inc. and Dr Cristina Menni. Raw data were median-normalised by dividing 
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metabolite concentrations by the day median of that metabolite. As the metabolite concentrations 
were not normally distributed, all metabolites underwent a rank-based inverse normal 
transformation (INT). The rank-based INT method used back transformation of the sample quantile 
to estimate the expected normal scores (Beasley et al., 2009). Overall there were 456 metabolites, 
including 292 chemically identified (‘known’) and 164 for which the identity is currently unknown 
(‘unknown’). In 2016 non-targeted metabolomics profiling was also completed on blood samples at 
3 time points on 2069 twins, the same quality control procedures were undertaken, the details of 
this dataset are not included as only one metabolite was used for analysis in Chapter 6. 
3.1.6.1.1 Metabolon metabolomics detailed methods 
Methanol was added to samples for protein precipitation and isolation of a range of metabolites, 
samples were shaken vigorously for 2 minutes, centrifuged, and the resultant extract divided into 
four portions: one to be analysed by ultra-high performance liquid chromatography-tandem mass 
spectrometry (UPLC-MS/MS; positive mode), one to be analysed by UPLC-MS/MS (negative 
mode), one to be analysed by gas chromatography–mass spectrometry (GC-MS), and one sample 
saved in case of incident. Three different controls were used in conjunction with sample analysis, 
these included: human plasma samples that have been analysed considerably by Metabolon, Inc. 
for replication; water samples for process blanks; and multiple standard solutions spiked into all 
experimental samples to assess equipment performance. Randomisation of samples and controls 
was ensured across runs. 
 The UPLC-MS/MS platform used a Waters Acquity UPLC and a ThermoFisher LTQ mass 
spectrometer, the latter comprised of an electrospray ionization source and a linear ion-trap mass 
analyser. The instrument had scanning set at 99-1000 m/z and to fluctuate between MS and 
MS/MS. Positive and negative ions were identified in acidic and basic extracts, respectively by 
separate injections.  Columns (Waters UPLC BEH C18-2.1 × 100 mm, 1.7 μm) had sample extracts 
loaded and then gradient-eluted with water and 95% methanol with 0.1% formic acid or 6.5 mM 
ammonium bicarbonate for acidic and basic extracts, respectively. Following each injection, 
columns were washed.  
 Analysis of samples by GC-MS were first vacuum dried for 18 h minimum before 
derivitization using bistimethyl-silyl trifluoroacetamide under nitrogen. Following derivitization, 
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separation of samples occurred on a 5% phenyldimethyl silicone column. The column used helium 
as the carrier gas at a temperature rise from 60° to 340° C for a run time of 17 minutes. Sample 
analysis was conducted on a Thermo-Finnigan Trace DSQ MS set at unit mass resolving power 
with electron impact ionization and an atomic mass unit scan range from 50-750. 
 Software developed at Metabolon was used for metabolite identification, which compared 
ion features (retention time, molecular weight (m/z), preferred adducts, MS spectra, etc.) in the 
experimental samples to a reference library (Dehaven et al., 2010). Known metabolites were 
identified by comparison to a mass spectroscopy library containing >2,400 purified standards. 
Approximately 5,300 unknown, but commonly reoccurring biochemicals have been added to this 
library for identification in the experimental samples. Peaks were quantified by area under the curve 
and therefore use relative measures and hence have no units.  
 
3.1.6.2 Targeted metabolomics 
A targeted metabolomic assay using the Biocrates Absolute IDQTM-kit p150 (BIOCRATES Life 
Sciences, AG, Innsbruck, Austria) was conducted on serum samples (by Biocrates employees) from 
1030 twins who also had non-targeted metabolomics profiling from the same visit the details have 
been previously described (Illig et al., 2010, Römisch-Margl et al., 2012). In short, the flow injection 
analysis (FIA) tandem mass spectrometry (MS/MS) method quantifies 163 small molecule 
metabolites at once through multiple reaction monitoring. Metabolite quantification is completed by 
reference to the applicable internal standards. Concentrations of targeted metabolites are reported 
in μM. 
The Biocrates platform analyses acylcarnitines (Cx:y), hydroxylacylcarnitines [C(OH)x:y] and 
dicarboxylacylcarnitines (Cx:y-DC); amino acids; sphingomyelins (SMx:y) and sphingomyelin-
derivatives [SM(OH)x:y]; and glycerophospholipids (PC) in absolute metabolite values (mM). The 
metabolite concentrations were right-skewed and therefore log transformation was undertaken. 
There were 18 metabolites measured both by the Biocrates and Metabolon platforms, therefore for 
analyses including both platforms only 145 metabolites were considered from the Biocrates 
platform. Table 3-1 shows the Pearson’s correlation between metabolites measured on both 
platforms.  
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Table 3-1. Pearson's correlation between metabolites measured by the targeted and non-
targeted platforms (n=1030) 






















Genotyping for TwinsUK samples has been outlined recently (Metrustry et al., 2014). Quality control 
of the genotyping data was undertaken by Dr Massimo Mangino. Multiple Illumina arrays were used 
for genotyping: Human-Hap300 (Richards et al., 2008), HumanHap610Q, 1M-Duo and 1.2M-Duo 
1M. First, normalized intensity data from each of the arrays were pooled independently (1M-Duo 
and 1.2M-Duo 1 M pooled together), then genotypes assigned for each dataset by the Illuminus 
calling algorithm (Teo et al., 2007). Had an individual’s expected genotype been called with lower 
than a posterior probability cutoff of 0.95, no calls were assigned. Pooling was validated by a visual 
inspection for observable batch effects of 100 random, shared SNPs. SNPs were excluded in a 
similar manner from each of the three datasets by visually inspecting intensity cluster plots of 
significant SNPs for no calling bias due to overdispersion, and/or false assignment of genotype. 
Samples and SNPs were further excluded for the reasons outlined in Table 3-2 (columns A and B, 
respectively). Each of the three datasets had alleles aligned to HapMap2 or HapMap3 forward 
strand alleles. A pair-wise comparison was then conducted between the three datasets that allowed 
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for additional sample and SNP exclusion for subsequent avoidance of false genotyping, as outlined 
in Table 3-2 (column C). Finally, the three datasets were merged, reserving data from the array that 
had typed the largest number of SNPs when two different arrays were used for one individual.  
 
Table 3-2. Exclusion criteria for samples, SNPs and following pair-wise comparison 
A. Samples  B. SNPs  C. Pair-wise comparison 
1. Sample call rate <98%  1. Hardy-Weinberg p-value 
<10
-6
 (determined in a sample 
of unrelated subjects) 
 1. Similarity at corresponding 
samples <1% 
2. Heterozygosity across all SNPs 
≥ 2 
SD from the sample mean 
 2. MAF <1% (determined in a 
sample of unrelated subjects) 
 2. Similarity at corresponding 
SNPs <1% 
3. Identification of non-European 
ancestry by comparison of the 
PCA with HapMap3 populations. 
 3. SNP call rate < 97% for 
SNPs with MAF ≥ 5%, 
or <99% for 1% ≤ MAF < 5% 
 3. All pair-wise dataset 
comparisons inspected for 
logistic regression by visual 
investigation of QQ plots 
4. Pair-wise IBD probabilities 
imply sample misidentification 
   4. Hardy-Weinberg p-value <10
-6
 
(determined in a sample of 
unrelated subjects) 
5. Misidentified MZ and DZ twins 
were amended in accordance 
with IBD probabilities 
   5. Pair-wise IBD probabilities 
imply sample misidentification 
Abbreviations: SNPs, single nucleotide polymorphisms; SD, standard deviation; PCA, Principal Components 
Analysis; IBD, identity-by-descendant; MZ, monozygotic; DZ, dizygotic; MAF, minor allele frequency; Quintile-
Quintile, QQ. 
 
3.2 Statistical analysis 
3.2.1 Heritability 
Heritabilities of dietary phenotypes were determined using linear structural equation modeling in Mx 
(Neale et al., 2003, Neale et al., 1992). The variance of the phenotype is decomposed into 3 
different effect components: A, additive genetic; C, common environmental; E, non-shared 
environmental. This is termed univariate ACE modelling. If MZ twins are significantly more alike in a 
trait than DZ twins, it is indicated that additive genetic effects are high. The common environmental 
component indicates the effect of the family environment on a trait. In the model the effect of the 
family is assumed to be equal in both MZ and DZ twin pairs (Kyvik, 2000). The effects that are 
unique to each individual and also the measurement error are captured by the non-shared 
environmental component. Heritability (h
2
) is the proportion of the variance in a trait due to genetic 
factors and is demonstrated by the equation, h
2
 = (A)/(A + C + E). Each of the four models: ACE, 
AE, CE, and E were tested and evaluated by the Akaike’s information criterion (AIC); the lowest AIC 
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indicated the best fitting model reflecting a good balance between goodness of fit and parsimony 
(Neale et al., 1992). Prior to modelling, the phenotypes were adjusted for age and sex using linear 
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Chapter 4 Metabolomic associations of self reported food group 
intakes and food patterns 
 
In this chapter I have undertaken a discovery approach, examining all metabolite associations with 
food intakes and dietary patterns in the TwinsUK population with the primary aim of identifying 
candidate food intake biomarkers. I applied the discordant MZ twin model as a novel method of 
replicating significant findings from the discovery analysis.  
Part of this work has been published in PLoS One (Pallister et al., 2016). 
 
4.1 Introduction 
For decades epidemiological studies have depended on self-reported accounts of food intake to 
evaluate dietary intakes. Using these approaches, however it is difficult to precisely capture food 
intakes and portion sizes and consequently the findings of diet-disease association studies have 
been called into question. Using objective biomarkers of food intake (such as essential fatty acids in 
blood to estimate fatty fish intake), there is potential to improve upon this issue, but not many 
biomarkers have so far been identified and have scarcely been utilized in epidemiological settings.  
 The high-throughput profiling of metabolites completed through targeted and non-targeted 
means in tissues and biological fluids used in collaboration with dietary studies is deemed 
nutritional metabolomics. Diet and the chemicals within our bodies (metabolites) are intimately 
linked, as the food we consume provides the basic chemical inputs which our bodies use to 
produce metabolic products downstream, in addition to the energy required to complete these 
mechanisms that are essential to life.  
 Recently, metabolomics studies using non-targeted approaches have identified novel 
biomarkers of food intake in large population settings. Among those, subjects from the Prostate, 
Lung, Colorectal, and Ovarian Cancer Screening Trial were used to identify 39 candidate dietary 
biomarkers for multiple food groups (Guertin et al., 2014b). In two separate studies of subjects from 
the African Americans in the Atherosclerosis Risk in Communities Study 39 metabolites were found 
to associate with alcohol intake (Zheng et al., 2014) and 48 to reported food intakes (Zheng et al., 
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2014). Studies that have applied targeted metabolomics methods have also been successful in 
identifying significant associations between self-reported dietary intake patterns and serum 
metabolites (O'Sullivan et al., 2011, Altmaier et al., 2011, Floegel et al., 2013b).  
A primary issue to be addressed is how candidate biomarkers of a healthy diet can be most 
effectively identified in collaboration with currently utilised methods of dietary assessment. 
Emerging research on dietary patterns is showing promising results within classic nutritional 
epidemiological studies (Hu, 2002). Empirically-derived dietary patterns are particularly relevant as 
they represent real trends in population reporting. Conversely, an advantage of using a priori over 
data-driven methods to detect metabolite biomarkers is that these patterns can be replicated in 
other populations. Due to its emerging importance for ameliorating derangements in metabolism 
associated with the metabolic syndrome (Kastorini et al., 2011), and the tendency of subjects in this 
group to underreport intakes (Kastorini et al., 2011), objective biomarkers of the Mediterranean diet 
would be particularly useful for clinicians and nutritionists. 
Genetic factors have a strong impact on metabolism and may influence up to 81% of the 
variation in blood levels (Shin et al., 2014). As shown by classic examples of gene mutations 
causing inborn errors of metabolism that need dietary adjustments (e.g. phenylketonuria, maple 
syrup urine disease), complicated interactions exist between genes, metabolism and diet. However, 
recent studies suggest variation at a multiple loci with less exaggerated independent effects on 
metabolism are likely primarily responsible for the interplay between diet and its link to complex 
diseases (Kettunen et al., 2012). The effect of lipid metabolism genes (e.g. hepatic lipase gene, 
cholesteryl ester transfer protein) on the variation in blood cholesterol levels has been shown to 
depend on dietary fat content in recent intervention studies (Qi et al., 2015, Xu et al., 2015), 
however effects were minimal. Using more than 400 blood metabolites in the TwinsUK and the 
Cooperative health research in the Region of Augsburg (KORA) datasets (Wichmann et al., 2005, 
Shin et al., 2014), 145 metabolic loci were shown to associate with blood metabolites. The identified 
loci from these studies may pinpoint areas where metabolism, diet and genetics interact.  
It may be challenging to replicate findings between populations due to the large inter-
individual variability in metabolite levels (Sampson et al., 2013), to factors such as age (Menni et al., 
2013b) and genetics (Shin et al., 2014). Identical (monozygotic, MZ) twins who are matched for 
age, sex and the baseline genetic sequence, may aid reproducibility issues by acting as “co-twin 
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controls”. The TwinsUK group has used this method previously in one dietary metabolomics study 
(Menni et al., 2013c), where FFQ-derived principal component dietary patterns were found to 
correlated with 42 metabolites in the greater twin population with top findings replicated in MZ twins 
discordant for the dietary patterns.  
 
Using blood samples profiled by both targeted and non-targeted metabolomic platforms, my aims 
for this chapter were to:  
i) To identify novel associations with blood metabolites with reported food intakes and dietary 
patterns. 
ii) To replicate these associations using MZ twins discordant for food intakes.  
iii) To identify potential genotypes influencing food intakes from SNPs previously shown to be 
associated with metabolite levels on the TwinsUK and KORA cohorts (Shin et al., 2014). 




4.2 Materials and methods 
I included 3559 female twins, who completed a 131-item validated FFQ between 1995 and 
2007, and had Metabolon metabolomics and BMI data available within and including (+/-) 5 
years of FFQ completion. I also analysed a subset of this sample who had Biocrates targeted 
metabolomics data (n=858).  
The characteristics of the study population can be found in Appendix C Table 1. 
4.2.1 Food items 
Previously, intake frequencies were adjusted for total energy intake using the residual method 
(Willett and Stampfer, 1986) and I summed these into 71 food groups based on nutrient content, 
taste and usage (Appendix C Table 2). 
4.2.2 Dietary patterns 
4.2.2.1 Principal components 
The principal components analysis (PCA) had been completed and the steps outlined 
previously (Teucher et al., 2007). The PCA was undertaken by nutritionists at the University of 
East Anglia. Briefly, the 131 food items were combined a priori into 54 groups based on nutrient 
content and culinary use. Intake frequencies of these groups were the sum of the servings per 
week for the original questionnaire items they were derived from. The residual energy adjusted 
food group intake frequencies (servings/week) were standardised to z scores and then used in 
the PCA. Bootstrapping is a resampling approach used to approximate properties of an 
estimator by evaluating those properties when sampling from an approximating distribution. It 
was used to test if family relatedness influenced the results. Briefly, the sampling distribution of 
the components was estimated in unrelated individuals. 10,000 bootstrap replications of the 
PCA were undertaken on subsamples containing one randomly selected twin. The full dataset 
PCA loadings were assessed against a 95% confidence interval determined from the 2.5% and 
97.5% percentiles of this distribution. It was determined that family relatedness had no 
significant effect. The top 20 components were examined on a scree plot (Appendix C Figure 
1), elbows were shown after components 1 and 5, however, components 2 to 5 were 
reasonable dietary patterns therefore the first 5 components were used. These 5 components, 




(Table 4-1) as follows: ‘Fruit and vegetable’; ‘High alcohol’; ‘Traditional English’; ‘Dieting’; and 
‘Low meat’. Consult Appendix C Table 3 for their complete factor loadings.  
 
Table 4-1. Principal component derived dietary patterns, with percentage of variance 











8.2% Fruit, allium and cruciferous 
vegetables  
Fried potatoes  
High 
alcohol 
3.9% Beer, wine and allium 
vegetables  




3.6% Fried fish and potatoes, meats, 
savoury pies and cruciferous 
vegetables  
 
Dieting 3.3% Low-fat dairy products, low-
sugar soda  
Butter and sweet baked products  
Low meat 3.2% Baked beans, pizza and soy 
foods  
Meat, other fish and seafood, and 
poultry  
1
Food frequency questionnaire items with factor loadings ≥0.20.  
2
Food frequency questionnaire items with factor loadings ≤-0.20.  
 
4.2.2.2 Mediterranean diet score 
I calculated Mediterranean diet adherence using the modified Mediterranean diet score (MDS) 
method, as outlined by Trichopoulou (Trichopoulou et al., 2005). Nine food/nutrient categories 
were included to generate a Mediterranean diet score (MDS) of 0 to 9 (“least” to “most” 
Mediterranean). The two nutrient intake categories included alcohol and fatty acid ratio 
(monounsaturated+polyunsaturated/saturated fatty acid intakes), both in grams per day and 
residual energy adjusted. Seven food group intakes were generated including: fruits (including 
nuts), vegetables, meats, fish, dairy, cereals, and legumes. To form groups, I first multiplied 
intake frequencies for assigned foods by the amount in grams per serving (Appendix C Table 
4) and then divided by 7 to determine intake of that food in grams per day (raw data are per 
week). Next, the amount in grams of these foods was added to make the final category total.  
Categories in grams were then adjusted using the residual method (consult Section 3.1.2.2).   
I then generated the scores. For all frequency categories as well as the fatty acid intake 
ratio, I determined median intakes of each category using all eligible twin data for FFQs 1 and 2 
combined. I assigned a score of 0 (no MDS) or 1 (MDS) for each category depending on 
whether the twin was above or below the median intake, specific to the category (refer to Table 
4-2). For alcohol intakes, a range was used for score assignment: twins between 5 and 25 g/d 




Finally, the MDS was then generated by summation of each category score to generate a score 
of 0 to 9.  
Table 4-2. Criteria for a score assignment of 1 on the Mediterranean diet 
Above median  Below median  Moderate 
Fruit & nuts  Meat  Alcohol: 5 – 25 grams/d 
Vegetables  Dairy   
Legumes     
Fish     
Cereals     
Unsaturated : saturated fatty acid     
 
4.2.3 Replication population 
One metabolite was particularly strongly associated with low fat milk intake in the TwinsUK 
sample, I therefore obtained data on milk intake from the Cooperative Health Research in the 
Region of Augsburg (KORA) study to replicate this association. The KORA study includes 
individuals from the region of Augsburg, Germany who are unrelated (Holle et al., 2005). As part 
of the fourth survey (S4) between 1999-2001 4261 persons aged 25-74 years were examined. 
For the replication analysis, 1593 individuals with serum metabolite levels of the top milk-
associated metabolite in the TwinsUK sample were used. Dietary intake in the KORA study was 
determined by a validated FFQ on the same day as blood sampling (Winkler and Doring, 1998) 
The questionnaire included 24 food items and asked subjects to recall their “average 
intake” out of the six frequency categories: almost daily, several times per week, about once a 
week, several times per month, once a month or less, never. For the replication analysis I used 
the item “milk intake including buttermilk”. Prior to analysis, I recoded the milk intake variable so 
interpretation of the result was easier therefore the least frequency (“never”) was coded as 1 
and the highest frequency (“almost daily”) was coded as 6, and I changed the rest of the 
categories as follows: once a month or less, 2; several times per month, 3; about once a week, 
4; and several times per week, 5.   
4.2.4 Statistical analysis 
Statistical analysis was carried out using Stata version 12. 
For each metabolite, I ran a random intercept linear regression analysis using each food group 
as the predictor in the discovery sample, excluding discordant MZ twin pairs (pairs ≥ 1 SD apart 
in intake by food group). I adjusted for age, metabolite batch effects, BMI and family 




where Yi is the metabolite and Xij is the food group intake of twin j from pair i, and ζj is the family-
specific error component that captures the unobserved heterogeneity or family characteristics.  
I used the Bonferroni correction to adjust for multiple testing which allowed a significant 
threshold of 1.08x10
-6
 (0.05/[77 diet phenotypes x 601 detected metabolites]). For associations 
that passed the significance threshold in the discovery sample, I repeated/replicated them using 
the same model in the MZ discordant twins sample. Associations were considered replicated in 
the MZ discordant sample if they (i) passed the 5% level of significance threshold and (ii) had 
the same effect direction as the discovery group (I used only this second criteria for the targeted 
platform). Lastly, using an inverse variance fixed effects meta-analysis I combined the results of 
both analyses, these are the results that I report here. To test if dietary patterns associated to a 
unique metabolomic signature not captured by investigating single food groups I repeated the 
analysis for each of the six diet patterns (five principal components and the MDS). The beta 
coefficients (β) I present for the significant associations represent the reported food amount in 
servings per week or dietary pattern score that corresponds to a 1 SD change in the metabolite 
level.  
4.2.5 Diet pattern association with metabolite mediated by reported food intake 
For each metabolite associated with both diet patterns and food group intakes first the 
proportion of the variance of metabolite was determined for each relevant diet pattern after 
taking into account all covariates (age, BMI, batch effects, family relatedness). This quantity is 
indicated as r
2
x. The proportion of the variance for the metabolite explained by the applicable 
diet pattern was then calculated after taking into account the same covariates as above but also 
including intakes of all associated foods (r
2
xy). The percentage of the diet pattern association 
mediated by the food group intake (r
2
y) was calculated as the proportion of the variance of 




x).     
4.2.6 Genotype associations 
I have outlined the genotyping protocols that have been undertaken in the TwinsUK population 
in Section 3.1.7. A genome-wide association study (GWAS) was previously undertaken on the 
Metabolon metabolomics datasets conducted for TwinsUK and the Cooperative health research 
in the Region of Augsburg (KORA) cohorts (Wichmann et al., 2005, Shin et al., 2014). Based on 
the results of this study, I undertook diet-genotype associations on gene variants (56 SNPs) that 




associations, I used additive genotype as a predictor of the appropriate energy-adjusted food 
group intake or dietary pattern, including age and family relatedness as covariates. I defined 
statistical significance using a Bonferroni correction of 2.94x10
-4





4.3.1 Food group-metabolite associations 
I found 178 significant associations with 39 food groups after meta-analysing the discovery and 
MZ discordant twin groups, consisting of 105 unique metabolites (Appendix C Tables 5, 6, and 
7). From these 105 unique metabolites, 73 have been identified (Figure 4-1) and 32 are 
unknown at this time. Those 73 identified metabolites belong to six biochemical groups: 38 
lipids, 16 amino acids, 14 xenobiotics, 3 carbohydrates, 1 cofactor/vitamin, and 1 peptide 
(Figure 4-2a and b). To my knowledge, 72 of the food associations with identified metabolites 
have not been previously identified in nutritional metabolomics using similar methods 
(Appendix C Table 7).  
 
Figure 4-1. Associations between food group intakes and known metabolites 
Associations between food group intakes and known blood metabolites are represented by the 
circular histogram plot. Associations are clustered according to general food groups, which are 
represented by the colored lines below the histogram bars. The histogram bars represent the –
log10 of the p-value result from the fixed effects meta-analysis and the color of the bars 




Figure 4-2 shows a stacked histogram of the number of associated metabolites representing each superpathway (a) and subpathway (b) 
by general food group intake. Pathways were determined by Metabolon based on Kyoto Encyclopedia of Genes and Genomes (KEGG) 
pathways. Superpathways are assigned by chemical classes corresponding to the top-level KEGG pathways. Subpathways are assigned 
by the metabolic role of the metabolite. 




I found reported intakes of alcoholic beverages to be associated with the most 
metabolites, including 41 associations overall (38 wine,1 spirits/liquors) with 15 associations (of 
the known metabolites) I believe to be novel; the top association was between wine and scyllo-
inositol (meta-analysis result: Beta[SE]: 0.052[0.003]; P=1.47x10
-49
). Reported intakes of teas 
and coffee included 27 associations (8 novel of the known metabolites) overall including: 12 
coffee, 9 black tea, and 6 herbal tea. Notably, for both coffee and tea, 6 metabolites belonging 
to the xenobiotics pathway, i.e. metabolites foreign to the human body, were identified. These 
likely originated from gut bacterial metabolism of caffeine (e.g. catechol sulfate, 1-
methylxanthine). The top association was between coffee and the unknown metabolite X-14473 
(0.038[0.001]; P=6.12x10
-187
). There were 26 associations (4 novel) with reported seafood 
consumption, including: 15 oily fish and 11 with other seafood. A number of the metabolites 
associated with reported seafood consumption were essential fatty acid metabolites; the top 
association was between docosahexaenoate (DHA; 22:6n3) and oily fish (0.177[0.013]; 
P=2.09x10
-44
). I found 8 associations (5 novel) with meat products, specifically: 3 meat, 2 
poultry, 2 processed meat and 1 beef burgers. The associations were primarily with amino 
acids, the top association being a novel associations between meat and trans-4-hydroxyproline 
(0.075[0.009]; P=1.08x10
-17
). I found 14 metabolites (5 novel) were associated with reported 
dairy product intake, including: 9 butter, 3 cream and 2 low-fat milk. Primarily associations with 
dairy products included lipids, the top association was reported between low fat milk intake and 
the recently named metabolite trimethyl-N-aminovalerate (X-21365: 0.076[0.007]; P=9.36x10
-
27
). There were 10 associations (3 novel) with grain-rich foods, including: 5 high fibre breakfast 
cereals, 2 refined bread and grains, 2 porridge and 1 wholemeal bread and grains. The top 
association was between porridge and the unknown metabolite X-09789 (0.094[0.008]; 
P=4.96x10
-33
). There were 13 associations (4 novel) with reported fruit intakes consumption, 
including: 6 apple and pears, 3 citrus fruits, 1 bananas, 1 berries, 1 peaches and 1 fruit juices. 
The top association within the fruit category was between fruit juice and stachydrine 
(0.058[0.005]; P=3.26x10
-37
). I identified 16 associations (8 novel) with reported vegetable 
intakes, including: 6 green leafy, 5 avocado, 3 allium, 1 tomatoes and 1 mushrooms. The 
strongest association within the vegetables group was between reporeted mushroom 
consumption and ergothioneine (0.181 [0.019]; P=5.93x10
-22
). I found 17 associations (9 novel) 
with reported sweet and savoury discretionary food intakes, including: 5 sweet baked products, 




discretionary foods group, the strongest association was between reported savoury snack 
intake and the unknown metabolite X-11372 (0.051[0.007]; P=3.88x10
-14
). Other notable 
associations included 2 metabolites with reported chocolate intake (1 novel; top association with 
theobromine: 0.024[0.003]; P=1.34x10
-11
), a novel association between reported soymilk intake 
and 4-ethylphenylsulfate (0.239[0.033]; P=6.05x10
-13
) and also an association between an 
unknown metabolite and reported intake of soyfoods (X-11381: -0.108[0.020]; P=5.80x10
-8
) and 
nuts (X-11315: 0.054[0.005]; P=3.75x10
-25
).  
A number of metabolites were associated to more than one food item, many of these 
are listed in Tables 4-3 and 4-4. Notably, the essential fatty acids eicosapentaenoate (EPA) and 
docosahexaenoate (DHA), their downstream metabolite 1-docosahexaenoylglycerophospho-
choline and 3-carboxy-4-methyl-5-propyl-2-furanpropanoate were all positively associated with 
oily fish and other fish/seafood intakes, and all but DHA with avocado. These multiple 
associations may be due to correlated food intakes, though each source may be contributing 
independently. Higher levels of EPA and DHA were also associated with lower intakes of sweet 
baked products. The metabolite 3-phenylpropionate was associated positively to intakes of 
apples/pears and negatively with fried fish and savoury pies. The latter associations may be due 
to systematic under reporting rather than biological in origin as is discussed later. A further 
example of this observation are the metabolites quinate, cyclo(leu-pro), 3-methyl catechol 
sulfate 1 and 3-hydroxypyridine sulfate, which were positively associated with coffee intake and 
negatively with tea intake. 
4.3.1.1 Milk association replication 
I replicated the association between the previously unknown metabolite trimethyl-N-
aminovalerate (X-21365) and milk intake in the KORA population (0.008[0.002]; P=6.88x10
-6
), 
establishing the quality of the data.  
4.3.2 Dietary pattern results 
4.3.2.1 Nutrient profile of the Mediterranean diet  
Energy-adjusted nutrient intakes are represented as percentages of the recommended intakes 
by tertile of the Mediterranean Diet Score (MDS) are presented in Figure 4-3 with significance 
level for trend. Nutrient profiles of the FFQ PCs have been described previously (Teucher et al., 




suggesting that individuals who scored higher on the MDS reported consuming more nutrient-
dense diets, high in fibre and lower in total, saturated fat and sucrose content. Despite the 
monounsaturated fat content being lower in those who scored in the top versus bottom tertile of 
the MDS, an important characteristic of the Mediterranean diet derived from olive oil intake, a 
logistic regression analysis of olive oil intake (yes or no) was strongly predicted by the MDS 
(OR= 1.15, SE= 0.02, P=1.19x10
-13
). 
4.3.2.2 Heritability of the MDS 
The best fitting model for MDS was the AE model, with heritability estimates of 0.41[95% CI = 
0.36; 0.46] and 0.59[0.54;0.64] respectively.  
4.3.2.1 Dietary pattern-metabolite associations 
I identified 108 significant dietary pattern-metabolite associations that passed the Bonferroni 
level of significance (P<1.08x10
-6
) in the discovery twin population and following meta-analysis 
(Appendix C Tables 8, 9). The MDS (Figure 4-4a) was associated with 18 metabolites (2 
amino acids, 5 lipids, 2 xenobiotics and 9 unknown metabolites). Of the known metabolites, 
MDS was most strongly associated with DHA (meta-analysis result: 0.097[0.009]; P=2.45x10
-
27
). The F&V diet pattern (Figure 4-4b) was associated with 33 metabolites (6 amino acids, 3 
carbohydrates, 1 cofactor/vitamin, 7 lipids, 1 peptides, 3 xenobiotics and 12 unnamed 
metabolites), a number of which were also associated with the MDS. A high F&V pattern was 
most strongly associated with glycerate (0.094[0.009]; P=1.97x10
-27
), a carbohydrate involved in 
glycolysis, gluconeogenesis, and pyruvate metabolism. The high alcohol pattern (Figure 4-4c) 
was associated with 23 metabolites (3 amino acids, 1 cofactor/vitamin, 4 lipids, 3 xenobiotics, 
and 12 unnamed metabolites). The strongest known metabolite association with a high alcohol 
diet pattern was with the amino acid involved in valine, leucine and isoleucine metabolism, α-
hydroxyisovalerate (0.158[0.013]; P=3.20x10
-35
). The traditional English diet pattern (Figure 4-
4d) was associated with 6 metabolites (2 amino acids, 1 xenobiotic, and 3 unnamed 
metabolites). A negative association was the strongest observed between the traditional English 
pattern and stachydrine (-0.094[0.012]; P=9.94x10
-16
), an amino acid involved in urea cycle and 
arginine, proline metabolism. The dieting pattern (Figure 4-4e) was associated with 5 
metabolites (2 xenobiotics, and 3 unnamed metabolites). Dieting was most strongly, negatively 
associated with quinate (-0.095[0.015]; P=1.40x10
-10
), a xenobiotic derived from benzoate 




acids, 7 lipids, and 8 unnamed metabolites). Most prominent, was a strong negative association 












Average intakes by tertile (1, black; 2, yellow; 3, red) were assessed for percentage of recommended intakes. P* is the significance value for the 









































Figure 4-4. Significant diet phenotype and metabolite associations 
 
Associations are significant at the Bonferroni level: 1.08x10
-6
 for discovery and meta-analysis. Significance level for discordant twin replication set 





4.3.2.2 Metabolites uniquely associated with food intakes or dietary patterns and 
those associated to both 
Overall 126 metabolites (43 unknown) were associated to at least one dietary phenotype 
(Figure 4-5). Fifty-five metabolites were associated with single food intakes but not the dietary 
patterns (Figure 4-5a). This may suggest these metabolites are less important for dietary 
intakes of the whole population. Twenty-one metabolites were not associated to single foods 
(Figure 4-5b) but were associated with the dietary patterns. In this case the combined food 
intakes may have an effect on these metabolites not occurring by the food intake alone or the 
associations may originate from food intakes not explicitly measured by the FFQ or behaviours 
correlated to a dietary pattern. Fifty metabolites were associated to at least one pattern and one 
food (Figure 4-5c), there are likely the most important metabolites related to food intake in our 
dataset. 
4.3.2.3 Dietary pattern-metabolite associations mediated by food intakes 
To confirm if the 50 metabolites associated with dietary patterns and at least one food group 
were driven by the reported food intakes and not other factors, I analysed the degree to which 
the variance in dietary pattern-metabolite associations was mediated by the metabolites 
association with single food intakes. I found that between <0% and 100% of the variance in the 
association between the metabolites and the dietary pattern scores were mediated by the 
metabolites association with food intake (Tables 4-3 and 4-4). The MDS and fruit and vegetable 
diet pattern associations with essential fatty acid metabolites (eicosapentaenoate, 1-
docosahexaenoylglycerophosphocholine*, CMPF and docosahexaenoate) were strongly 
accounted for by food intakes (range: 86.2% to 99.7%). This was also the case for the low meat 
pattern association with pyroglutamine* which was strongly accounted for by meat intakes 
(93.2%), the dieting pattern with quinate which was accounted for by coffee and tea intakes 
(97.9%), the high alcohol pattern with 4-androsten-3beta, 17beta-diol disulfate 1*, 5alpha-
androstan-3beta,17beta-diol disulfate and scyllo-inositol accounted for by wine or spirit intake 
(98.3%, 92.4% and 99.5%, respectively). 
4.3.2.4 Gene-variants SNP associations 
A GWAS study was previously performed on the TwinsUK dataset to identify SNPs associated 




dietary-associated metabolites, 48 contributed to 62 metabolite-SNP associations including 56 
unique SNPs in 39 genes (Appendix C Table 10). I undertook this analysis to identify potential 
SNPs which may be influencing dietary intakes. I did not find any SNP-diet associations with 
these variants at the Bonferroni level of statistical significance (P<2.94x10
-4
 = 0.05/170 tests). I 
found 19 SNP-diet associations at the nominal level (P<0.05; Appendix C Table 11). The fact 
that I did not identify any significant associations between diet and metabolite-related SNPs 
suggests that these SNPs do not have such a strong effect as to influence eating behaviour, 
although it could also be due to the limited power due to the low sample size or the lack of 




Figure 4-5. Metabolites significantly associated with only reported intakes of foods (a) and dietary patters (b), and to both (c) 
   Associations are significant at the Bonferroni level: 1.08x10
-6
 for discovery and meta-analysis. Significance level for discordant twin replication set: 




Table 4-3. List of known metabolites associated with food intakes and dietary patterns 





























eicosapentaenoate  6 ↑ Avocado, High fat salad 
dressing, Oily fish, Other 
fish/seafood, Wine 
↓ Sweet baked products 
0.08 ↑ MDS 0.026 0.001 95.1 
↑ F & V 0.047 0.004 90.9 





4 ↑ Avocado, Green leafy 
vegetables, Oily fish, Other 
fish/seafood 
0.04 ↑ F & V 0.023 0.002 93.2 




4 ↑ Avocado, Green leafy 
vegetables, Oily fish, Other 
fish/seafood 
0.10 ↑ F & V 0.029 0.000 99.7 
↑ MDS 0.028 0.001 97.5 
↓ Low Meat 0.036 0.015 59.2 
docosahexaenoate 
(DHA; 22:6n3) 
4 ↑ Oily fish, Other 
fish/seafood, Wine 
↓ Sweet baked products 
0.11 ↑ F & V 0.043 0.003 93.4 
↑ MDS 0.035 0.003 91.1 
↓ Low Meat 0.027 0.004 85.0 
3-phenylpropionate 
(hydrocinnamate) 
3 ↑ Apples/pears 
↓ Fried fish, Savoury pies 




0.015 0.006 62.0 
glycerate 3 ↑ Citrus fruit, Tomatoes 
Confectionary/jam 
0.03 ↑ F & V 0.037 0.009 75.8 
pyroglutamine* 3 ↓ Meat, Other fish/seafood, 
Poultry 
0.04 ↑ Low Meat 0.022 0.002 93.2 
scyllo-inositol 3 ↑ Wine 
↓ Fried fish, Sweet baked 
products 
 
0.13 ↑ High 
Alcohol 
0.043 0.000 99.5 
↑ F & V 0.035 0.010 71.3 




2 ↑ Spirits/liquor, Wine 0.09 ↑ High 
Alcohol 
0.035 0.001 98.3 
creatine 2 ↑ Meat, Poultry 0.03 ↑ 
Traditional 
English 
0.014 0.001 89.9 
↓ Low Meat 0.015 0.002 87.9 
ergothioneine 2 ↑ Mushrooms 
↓ Savoury pies 
0.12 ↑ F & V 0.048 0.006 88.4 
↑ MDS 0.025 0.007 71.1 
↑ High 
Alcohol 
0.041 0.022 47.0 
indolepropionate 2 ↑ Apples/pears, Bananas 0.03 ↑ F & V 0.029 0.012 58.2 
↑ MDS 0.021 0.011 50.5 
pipecolate 2 ↑ Wine 
↓ Confectionary/jam, 
0.03 ↑ F & V 0.016 0.007 58.5 
quinate 2 ↑ Coffee 
↓ Black tea 
0.20 ↓ Dieting 0.014 0.000 97.9 
stachydrine 2 ↑ Citrus fruit, Fruit juice 0.11 ↓ 
Traditional 
English 
0.019 0.010 45.5 
1,5-anhydroglucitol 
(1,5-AG) 
1 ↓ Other fish/seafood 0.01 ↓ F & V 0.022 0.013 41.6 
10-undecenoate 
(11:1n1) 
1 ↑ Butter 0.02 ↑ High 
Alcohol 




1 ↑ Butter 0.03 ↓ Low Meat 0.016 0.009 46.0 
2-aminobutyrate 1 ↑ Wine 0.02 ↑ High 
Alcohol 
0.017 0.003 83.1 
↓ Low Meat 0.018 0.008 57.4 
2-hydroxybutyrate 
(AHB) 
1 ↑ Wine 0.02 ↓ Low Meat 0.011 0.004 60.2 




1 ↑ Wine 0.06 ↑ High 
Alcohol 
0.029 0.002 92.4 
alpha-
hydroxyisovalerate 
1 ↑ Wine 0.07 ↓ Low Meat 0.014 0.001 91.5 
↑ High 
Alcohol 




Table 4-3. List of known metabolites associated with food intakes and dietary patterns 





























catechol sulfate 1 ↑ Coffee 0.03 ↑ F & V 0.014 0.015 -3.5 
myo-inositol 1 ↑ Wine 0.02 ↑ F & V 0.012 0.008 34.7 
Octenoylcarnitine 1 ↑ White/brown bread & 
refined grains 
0.03 ↓ F & V 0.038 0.019 50.3 
Phosphatidylcholine 
diacyl C36:5 
1 ↑ Wine 0.05 ↓ Low Meat 0.062 0.033 46.6 
Phosphatidylcholine 
diacyl C38:6 
1 ↑ Oily fish 0.04 ↑ F & V 0.031 0.008 73.4 
↓ Low Meat 0.036 0.027 25.8 
piperine 1 ↑ Wine 0.03 ↑ High 
Alcohol 
0.031 0.009 71.2 
↑ MDS 0.011 0.009 16.5 
threitol 1 ↑ Apples/pears 0.03 ↑ F & V 0.016 0.005 71.2 
tryptophan betaine 1 ↑ Allium vegetables 0.03 ↑ F & V 0.026 0.007 74.6 
↑ High 
Alcohol 
0.028 0.011 62.0 
↑ MDS 0.024 0.010 57.3 
F & V, fruit and vegetable pattern; MDS, Mediterranean diet score 
(1) The proportion of the variance in the diet pattern explained by the metabolite after 
taking into account all covariates (age, BMI, batch effects and family relatedness). 
(2) The proportion of the variance in the diet pattern explained by the metabolite after 








Table 4-4. List of unknown metabolites associated with both food intakes and dietary 
patterns and the degree to which their association with each pattern is mediated by 
reported food intakes 
Metabolite RT Mass 
No. 





























X-11315 1.19 130.2 13 ↑ Apples/pears, Berries, 
Citrus fruit, Green leafy 
vegetables, High fibre 
breakfast cereals, Nuts, 
Oily fish, Peaches 
↓ Confectionary/jam, 
Fried fish, Savoury pies, 
Sweet baked products, 
White/brown bread & 
refined grains 
0.13 ↑ F & V 0.088 0.001 98.4 
  ↑ MDS 0.042 0.002 94.6 
  ↓ Traditional 
English 
0.019 0.004 79.3 
X-02269 1.55 255.1 6 ↑ Allium vegetables, 
Avocado, Green leafy 
vegetables, High fibre 
breakfast cereals, Oily 
fish, Other fish/seafood 
0.11 ↑ F & V 0.051 0.002 96.5 
  ↑ MDS 0.039 0.002 94.8 
  ↓ Low Meat 0.020 0.005 75.9 
X-09789 2.62 153.1 5 ↑ Apples/pears, High 
fibre breakfast cereals, 
Porridge, Wholemeal 
bread/grains 
0.09 ↑ F & V 0.016 0.001 98.2 
  ↓ High 
Alcohol 
0.026 0.004 90.1 
X-11372 NA NA 5 ↑ Fried fish, Savoury 
pies, Savoury snacks 
↓ Apples/pears, Green 
leafy vegetables 
0.08 ↓ F & V 0.046 0.004 91.6 
  ↑ Traditional 
English 
0.015 0.005 65.1 
  ↑ Low Meat 0.016 0.014 14.4 
X-11469 3.82 239.1 5 ↑ Avocado, Green leafy 
vegetables, High fibre 
breakfast cereals, Oily 
fish, Other fish/seafood 
0.11 ↓ Low Meat 0.021 0.001 97.2 
  ↑ F & V 0.056 0.002 95.7 
  ↑ MDS 0.040 0.002 94.8 
X-11381 1.11 186.2 2 ↑ Processed meats 
↓ Soy foods 
0.03 ↑ Traditional 
English 
0.011 0.003 76.6 
  ↓ MDS 0.017 0.011 36.4 
  ↓ High 
Alcohol 
0.012 0.013 -9.2 
X-11799 1.58 226.0 2 ↑ Wine 
↓ Sweet baked products 
0.06 ↑ High 
Alcohol 
0.030 0.001 96.0 
X-12816 NA NA 2 ↑ Coffee 
↓ Black tea 
0.15 ↑ High 
Alcohol 
0.015 0.002 85.8 
X-14374 NA NA 2 ↑ Coffee 
↓ Black tea 
0.09 ↓ Dieting 0.010 0.000 98.0 
X-14473 3.27 211.2 2 ↑ Coffee 
↓ Black tea 
0.28 ↓ Dieting 0.033 0.001 97.0 
X-01911 4.26 464.1 1 ↑ Wine 0.03 ↑ High 
Alcohol 
0.030 0.007 77.6 
X-02249 4.03 267.2 1 ↑ Butter 0.02 ↑ Dieting 0.013 0.004 71.8 
  ↓ Low Meat 0.019 0.011 40.0 
X-04495 NA NA 1 ↑ Wine 0.02 ↑ High 
Alcohol 
0.016 0.001 93.8 
X-10395 9.94 156.0 1 ↑ Wine 0.03 ↑ High 
Alcohol 
0.017 0.001 91.7 
X-11795 NA NA 1 ↑ Wine 0.06 ↑ High 
Alcohol 
0.043 0.007 83.4 
X-11858 NA NA 1 ↑ Allium vegetables 0.03 ↑ F & V 0.026 0.006 77.1 
X-12038 5.82 245.3 1 ↑ Wine 0.01 ↑ High 
Alcohol 
0.008 0.001 88.6 
X-12798 1.84 240.1 1 ↑ Low fat mik 0.02 ↓ High 
Alcohol 
0.020 0.008 59.4 
  ↓ MDS 0.016 0.008 48.8 
X-21365
(3)
 NA NA 1 ↑ Low fat mik 0.04 ↓ High 
Alcohol 
0.017 0.005 73.7 
  ↓ MDS 0.019 0.009 54.1 
RT, retention time; F & V, fruit and vegetable pattern; MDS, Mediterranean diet score; NA, not 
available 
(1) The proportion of the variance in the diet pattern explained by the metabolite after 
taking into account all covariates (age, BMI, batch effects and family relatedness). 
(2) The proportion of the variance in the diet pattern explained by the metabolite after 
taking into account all covariates as in (1) and adjusting for all foods associated to the 
metabolite. 





Using one of the largest datasets of its kind, I identified and replicated using MZ discordant 
twins 73 novel associations between metabolites and specific food groups, providing further 
potential intake biomarkers for future research. Moreover, I found 108 significant metabolite 
associations with 5 different dietary patterns. Forty-eight metabolites contributed to 62 
metabolite-SNP associations in 56 unique SNPs that were identified from a previous 
metabolomics GWAS study (Shin et al., 2014), though I did not find these SNPs to be related to 
dietary intakes. 
4.4.1 Food items 
Alcohol consumption 
To my knowledge the associations between higher reported wine intake and increased 
branched-chain amino acids (BCAA; valine, leucine and isoleucine and their metabolites, 3-
methyl-2-oxobutyrate and 4-methyl-2-oxopentanoate) and medium-chain fatty acids (caprate 
and caprylate) are novel findings. BCAA, 3-methyl-2-oxobutyrate and 4-methyl-2-oxopentanoate 
have been found to be higher in twins with type 2 diabetes or impaired fasting glucose (3-
methyl-2-oxobutyrate being the strongest predictor) previously (Menni et al., 2013a) and 
associated with a higher BMI (Moore et al., 2014). Under impaired mitochondrial oxidation of 
lipids and glucose, levels of these BCAA catabolites increase, suggesting mitochondrial 
dysfunction. Insulin resistance has found to occur under binge drinking (Lindtner et al., 2013) 
though long-term effects are not known, these associations may highlight a novel pathway 
mediating this effect. 
I also confirmed a number of metabolite associations with reported alcohol intake from a 
previous metabolomics study (Zheng et al., 2014) including higher intakes of wine with 
increased alpha-hydroxyisovalerate, scyllo-inositol, a inositol metabolite, and steroids 
originating from dehydroepiandrosterone (DHEA; 5-alpha-androstan-3beta,17beta-diol disulfate, 
4-androsten-3beta,17beta-diol disulfate 1, 5-alpha-androstan-3beta,17beta-diol disulfate and 
epiandrosterone sulfate) (Zheng et al., 2014). Interestingly, a variant in the HAO2 gene 
(rs12141041) encoding long-chain L-2-hydroxy acid oxidase 2 associated to alpha-
hydroxyisovalerate. The HAO2 gene has been found to be related to blood pressure regulation 
in animal models (Barawkar et al., 2012). A variant in the SLC5A11 gene (rs4787294) is 




transporting sodium-dependent glucose transporter. The SLC5A11 gene has been implicated in 
systemic lupus erythematosus (SLE) risk. Two SNPs the SULT2A1 (rs2547231 and rs296396) 
gene which is involved in the sulfation of a number of steroids and bile acids, were associated 
to 4-androsten-3beta,17beta-diol disulfate 1 and 5-alpha-androstan-3beta,17beta-diol disulfate 
levels. Ethanol feeding in rats has recently shown significantly increased expression of 
SULT2A1 in the intestines and liver (Maiti and Chen, 2015), suggesting this gene may be 
directly involved in modulating this association.  
 
Seafood consumption  
I identified novel associations between increased reported fish and seafood intakes with 
reduced pro-inflammatory lysolipids (1-arachidonoylglycerophosphoethanolamine, 1-
eicosatrienoylglycerophosphocholine, 1-linoleoylglycerophosphoethanolamine, 1-
oleoylglycerophosphoethanolamine), originating from essential fatty acid (EFA) metabolism. 
Lysolipids are involved in the formation of the cellular lipid bilayer, though contribute to 
inflammatory processes forming free lysophosphatidylcholines when cleaved by lipoprotein-
associated phospholipase A2. Lysophosphatidylcholines potentially aggravate inflammatory 
artherosclerotic plaques (Goncalves et al., 2012). I replicated previous associations between 
increased reported intakes of oily fish and other seafood with higher 3-carboxy-4-methyl-5-
propyl-2-furanpropanoate (CMPF), a furan fatty acid, and docosahexaenoate (DHA), an EFA 
(Guertin et al., 2014b, Zheng et al., 2014). Variants in FADS1 (rs174538, rs174556, rs968567 
and rs174535), a gene encoding a delta-5 desaturase enzyme, were associated with EFA 
lysolipids and DHA (Yang et al., 2015). Recently, a meta-analysis confirmed two of these 
variants in FADS1 (rs174538 and rs174548) modulated gene-dietary-derived EFA associations 
(Smith et al., 2015).  
 
Meat consumption  
I found reported meat consumption to be associated with amino acids primarily, including 
creatine, trans-4-hydroxyproline and pyroglutamine. In particular, I found increased red meat 
intake to be associated with higher trans-4-hydroxyproline, a component of collagen previously 
shown to increase in blood following gelatin feeding (Ohara et al., 2007). Another novel 
association I identified was between increased reported red meat and poultry intakes and higher 




have been found in vegetarians (Delanghe et al., 1989). Lower blood creatine has been 
associated with increased insulin sensitivity (Gall et al., 2010) and in liver steatotic versus NASH 
patients (Kalhan et al., 2011), higher levels have been found in individuals with dilated 
cardiomyopathy (Alexander et al., 2011). A variant in carbamoyl-phosphate synthase 1 (CPS1; 
rs715) was found to associate with creatine. CPS1 is the first enzyme of the urea cycle, 
producing ammonia from urea. Expression of CPS1 is a candidate biomarker of NAFLD 
(Rodriguez-Suarez et al., 2012). Finally, higher intakes of seafood and meat correlated with 
lower levels of pyroglutamine, though little is known about this metabolite it is a cyclic derivative 
of glutamine, lower levels have previously been associated with chicken intake (Guertin et al., 
2014b). A variant in SLC6A13 (rs11613331), a gene that which encodes GAT2 a gamma-
aminobutyric acid and betaine transporter, was associated with pyroglutamine. Other SNPs in 
SLC6A13 have been related to renal function (Franceschini et al., 2014, Liu et al., 2011).  
 
Dairy consumption   
I identified novel associations between higher reported intakes of creams (double and clotted 
cream) with increased levels of lysoPhosphatidylcholine acyl C17:0 and C28:1 and 
hydroxysphingomyeline C14:1. A previous study on the EPIC-Potsdam cohort showed a diet 
pattern high in butter and high-fat dairy products and low margarine intake to be positively 
associated with lysoPhosphatidylcholine acyl C17:0 (Floegel et al., 2013b). Heptadecanoid acid 
(C17:0) has shown to be elevated following a dairy intervention trial, the lipid is formed by 
ruminal bacteria and therefore thought to be milk fat specific (Abdullah et al., 2015).  
 Reported butter consumption was uniquely associated with elevated levels of six lipids, 
including associations with increased butter intake and nonanoylcarnitine, an ester of carnitine 
with pelargonic acid (C9), 10-nonadecenoate (19:1n9), a monounsaturate of nonadecenoate 
(19:0), and myristate (14:0), a saturated fatty acid found most animal and vegetable fats. A 
variant in ACADL (rs3738934), a gene with important roles in lipid oxidation was associated with 
blood nonanoylcarnitine. Expression of ACADL has shown to be lower in mouse liver and 
adipocytes following high fat feeding, this effect also reduced overexpression of Il-15 (Sun and 
Liu, 2015). I also confirmed associations with butter intake and pentadecanoate (15:0), 10-
undecenoate (11:1n1) and 15-methylpalmitate from previous metabolomics studies (Guertin et 




 Low fat milk intake was strongly associated with a recently identified metabolite 
trimethyl-N-aminovalerate (X-21365). I replicated this association between general milk intake 
and trimethyl-N-animovalerate in the KORA population. The origin of this novel association is 
complicated to decipher as literature is limited on trimethyl-N-aminovalerate. Trimethyl-N-
aminovalerate is potentially a methylated product of 5-aminovalerate, a product of lysine or 
proline degradation by gut bacteria Escherichia coli (Li et al., 2016) and Pseudomonas putida 
(Revelles et al., 2005). Moreover, both molecules are structurally similar to carnitine. Further 
research will be needed to unravel the mechanism of this association. 
 
Grain-rich product intake 
I found higher reported intakes of high fibre breakfast cereals to be associated uniquely with 
increased levels of pyridoxate, a vitamin B6 metabolite. Pyridoxate has many essential roles 
including being a coenzyme in the synthesis of amino acids, sphingolipids, neurotransmitters 
(serotonin, norepinephrine) and aminolevulinic acid. Higher pyridoxate in bloods has been 
associated with increased reported consumption of vitamins/supplements and other fruits 
(including plums, apricots, peaches, prunes, raisins, grapes and pineapple), as well as 
increased scores on the Healthy Eating Index (Guertin et al., 2014b). As it is common practice 
for breakfast cereals to be fortified with B vitamins this may have contributed to higher levels. I 
also found increased porridge intake to be associated with higher levels of 2-aminophenol 
sulphate. Previously, higher urinary output of 2-aminophenol sulphate was found in subjects fed 
whole grain rye bread versus refined wheat bread in a cross-over intervention study (Bondia-
Pons et al., 2013). 2-aminophenol sulfate is a benzoxazinoid metabolite. Whole grains contain 
higher levels of benzoxazinoids which are readily absorbed from these products (Jensen et al., 
2015). Higher reported intakes of refined grain products were associated with increased 
octenoylcarnitine. Octenoylcarnitine is an acylcarnitine formed from mitochondrial beta-
oxidation. A previous metabolomics study undertaken on 33 coeliac disease patients showed 
those following a long-term gluten free diet had reduced octenoylcarnitine (Bene et al., 2005).  
 
Fruit consumption 
Higher reported intakes of apples and pears were associated uniquely with a sugar alcohol, 
threitol, and two amino acids formed from gut bacterial metabolism of phenolic compounds: 




2001) and 3-phenylpropionate (Smith and Macfarlane, 1996). Apple proanthocyanidins have 
shown to be directly catabolized to 3-phenylpropionate when incubated with human gut bacteria 
(Ou et al., 2014). A previous study showed higher reported intakes of eggs and red meat in a 
US population to associated with lower indolepropionate in blood (Guertin et al., 2014b). Their 
finding may suggest these subjects had lower intakes of fruit-derived proanthocyanidins or 
higher consumption of animal proteins, which have been shown to rapidly alter the gut 
microbiome composition (David et al., 2014), and hence may indirectly influence bacterial 
metabolism of proanthocyanidins through altering the intestinal environment. Previously, 
increased indolepropionate has been associated with insulin sensitivity (Gall et al., 2010), and 
lower levels associated with reduced muscle mass in elderly subjects (Lustgarten et al., 2014). 
For 3-phenylpropionate (ACSM5, rs11647589) and indolepropionate (ACSM2A, rs1394678) 
SNPs within medium-chain acyl-CoA synthetase (MACS) genes were associated with levels. 
The ligation of medium-chain fatty acids with CoA is catalysed by MACS genes, though MACS 
also conjugate glycine with benzoic acid derivatices (Kasuya et al., 1996). Similar to 3-
phenylpropionate and indolepropionate, benzoic acid is produced by gut microbial degradation 
of apple and cranberry phenolic compounds (Ou et al., 2014), the genotypic association with 3-
phenylpropionate and indolepropionate may be due to their correlation to products of this 
process. An association with metabolic syndrome phenotypes and a variant in the ACSM2 gene 
have been found previously; though this this association may be due mainly to the role of 
ACSM2 in lipid metabolism (Lindner et al., 2006). I confirmed a previous association between 
reported intakes of fruit juice with stachydrine (also proline betaine) (Guertin et al., 2014b, 
Zheng et al., 2014), a component found in citrus fruits. 
 
Vegetable consumption 
Reported mushroom intake was associated with ergothioneine, a novel finding. Ergothioneine is 
a thiol compound found in higher quantities in specialty mushrooms such as oyster and king 
bolete (Ey et al., 2007). Ergothioneine has also shown to prevent lipid peroxidation in vivo 
(Deiana et al., 2004) and recent data suggest that ergothioneine may prevent vascular 
dysfunction (Li et al., 2014). I found higher reported intakes of green/leafy vegetables and 
avocado to associated with higher levels of metabolites that are strongly associated with 
seafood consumption including CMPF (3-carboxy-4-methyl-5-propyl-2-furanpropanoate) and 1-




intakes, a problem encountered previously (Guertin et al., 2014a, Zheng et al., 2014, Ling et al., 
2014). 
 
Tea and coffee 
I identified higher reported intakes of herbal tea were associated with lower levels of long-chain 
phosphatidylcholine acyl-alkyls derived from hepatic lipid metabolism (Wittenbecher et al., 
2015). A dietary pattern characterised by a high intake of red meat and fish and lower intakes of 
whole grain bread and tea was previously shown to correlate with reduced levels of 
phosphatidylcholine diacyl (including phosphatidylcholine diacyl C42:4) in the EPIC Potsdam 
cohort (Floegel et al., 2013b). Also in the EPIC Potsdam cohort, levels of these 
phosphatidylcholines have associated with diabetes risk (Floegel et al., 2013a), though little is 
known currently about the origin of these associations.  
I also confirmed associations between increased reported coffee intake and higher 
levels of metabolites derived from caffeine and coffee (Guertin et al., 2014a, Zheng et al., 
2014). Interestingly, I also found a number of metabolites derived from coffee were associated 
inversely with reported black tea intake. This pattern is suggestive that individuals who reported 
having a higher tea intake had habitually lower coffee consumption. I identified higher levels of 
O-methyl catechol sulfate to be associated with higher reported coffee intake, which was a 
novel finding. One of the strongest metabolites associated to coffee intake was 1-
methylxanthine. 1-methylxanthine is derived from caffeine metabolism and was previously 
associated to a variant in NAT2 (rs4921914) which encodes a liver enzyme that acetylates 
caffeine metabolites (Butler et al., 1992). A SNP in NAT2 has found to modulate an association 
with black tea consumption and risk of SLE (Kiyohara et al., 2014). 
 
Sweet & savoury discretionary food intakes 
Multiple associations were identified between foods where reduced consumption is promoted 
(‘discretionary’; such as sweet baked products, sweets and jams, crisps, fried potatoes and fish 
and savoury pies) that seem to not be biologically sound and are also novel. This could suggest 
that these associations are showing habitual reduced intakes of other foods (i.e. vegetables, 
fruit, fish and wine) with increased reported intakes of discretionary foods. For instance, 
increased reported consumption of sweet baked products (including cookies, cakes, pies and 




EPA) and scyllo-inositol (strongly correlated with wine intake). Also, I found higher intakes of 
fried fish and savoury pies to be associated to lower levels of 3-phenylpropionate derived from 
gut microbial catabolism of fruit proanthocyanidins (Ou et al., 2014). Reporting of these foods 
may have been influenced by self-reporting biases (Westerterp and Goris, 2002), a limitation of 
this dataset. 
 
Other notable associations 
I identified a novel association with increased soymilk consumption and higher levels of 4-
ethylphenylsulfate, despite intakes being low in the sample; a previous study of US subjects 
found higher 4-ethylphenylsulfate to be correlated with increased tofu consumption (Guertin et 
al., 2014b). 4-ethylphenylsulfate is formed under gut bacteria metabolism. Elevated levels of 4-
ethylphenylsulfate have been found to correlate with anxiety-like traits in rats. Increased levels 
of 4-ethylphenylsulfate in blood are thought to be due to higher gut permeability (Hsiao et al., 
2013). This association may be derived from the high saponin content of soybeans, which have 
shown to increase intestinal cell permeability in vitro (Johnson et al., 1986) though also in 
Atlantic salmon (Knudsen et al., 2008). 
I found a novel association between higher reported chocolate intake and increased 7-
methylxanthine, a methylated purine, and I also confirmed an association with theobromine, a 
bitter alkaloid and recognised marker of cocoa intake (Rodriguez et al., 2015). 7-methylxanthine 
is derived from methylxanthine metabolism, methylxanthines include caffeine, theophylline and 
theobromine (Suzuki and Takahashi, 1975). 
 
Notable unknown metabolite associations 
The chemical identity of 31 metabolites associated to food intakes are currently unknown, 
though these may become important food intake biomarkers in the future. In particular I found 
an association between increased reported fried food intake (fried fish and savoury snacks 
[including potato crisps]) and higher levels of the metabolite X-11372. I also identified another 
metabolite associated positively with red and processed meat consumption, metabolite X-
11381. Metabolite X-11381 was previously associated with a SNP in a gene encoding a 
carnitine efflux transporter SLC16A9 (rs12356193) (Suhre et al., 2011). Variants in SLC16A9 
have previously been associated with serum uric acid levels (Lee and Song, 2012) and risk of 




associated positively with porridge intake. A variant in the SLC51A gene (also known as OST-
alpha; rs7642243) was found to be associated with X-09789. Interestingly, SLC51A encodes a 
component of the Ost-alpha/Ost-beta complex which functions in bile acid transport from 
intestinal enterocytes into portal blood (Ballatori et al., 2008). Oats are known to contain beta-
glucan, a soluble fibre found to reduce blood cholesterol levels (Charlton et al., 2012) by 
sequestering intestinal bile acids and effectively reducing the reabsorption of bile acids 
(Wolever et al., 2010). I also found the unknown metabolite X-11315 to be associated with 
reported consumption 13 foods (top association: apple and pears; negative associations with 
discretionary foods). Metabolite X-11315 was previously associated to a SNP in SLC6A20 
(rs4327428), which encodes a proline transporter, this suggests metabolite X-11315 is 
structurally like proline. Previous studies have identified polymorphisms in SLC6A20 to be 
associated with risk of Type 2 diabetes in white-European and Chinese populations (Ling et al., 
2014). 
 
4.4.2 Dietary patterns discussion 
Examining dietary patterns in conjunction with metabolomics, I identified a number of potential 
metabolite biomarkers of dietary intakes in the twin population and validated the results using 
the co-twin control method. The repetitive occurrence of a number of metabolites within 
opposing dietary patterns in this study (Table 4-5) further confirms the utility of metabolomics for 
the identification and exploration of diet and disease relationships. I also identified a number of 
metabolites unique to each diet pattern (Table 4-6). Many of the associations with dietary 
patterns were attributable to their association with food intakes, therefore I will not discuss these 
associations in detail. However, there were 11 known metabolites and 10 unknown metabolites 
identified by measuring dietary patterns that I did not find to associate with food intakes 
independently. The Traditional English and Dieting patterns did not appear to have a substantial 
metabolomic footprint and did not capture unique associations with metabolites, this may be 
due to underreporting.  
 
Fruit and vegetable pattern 
Twins scoring highly on the F&V pattern presented with an increase in metabolites relating to 




foods containing high phenolic compounds such as green and black teas (Van Dorsten et al., 
2006); threonate, a product of vitamin C metabolism; and the γ-glutamyl peptide, γ-
glutamylvaline and proline which both suggest reduced glutathione and collagen breakdown on 
this diet. Higher scores on the F&V diet pattern were also associated with increased 
phosphatidylcholine diacyl 38:6 and N-acetylornithine. N-acetylorthinine is an endogenously 
synthesized amino acid involved in urea metabolism. A genetic variant in N-acetyltransferase 8 
gene (NAT8) was found to contribute to N-acetylornithine levels which may play role in kidney 
function and CKD (Yu et al., 2014). Despite the MDS and F&V patterns characterised by similar 
foods the data-driven F&V score captured unique metabolite associations, suggesting that 
measuring a Mediterranean diet in a non-Mediterranean country such as the UK may be 
problematic, an issue which has been thoroughly discussed previously (Hoffman and Gerber, 
2013).  
 
Low meat dietary pattern 
Higher scores of the low meat dietary pattern were associated with lower levels of 
phosphatidylcholine acyl-alkyl 38:6 and higher levels of betaine and C-glycosyltryptophan. 
Betaine is an amino acid derived from choline. Choline is a nutrient that has an important role in 
methylation processes and reduction of homocysteine levels and subsequent risk of coronary 
heart disease (Zeisel and da Costa, 2009), the origin of this association requires further 
investigation. The low meat diet pattern was positively associated with C-glycoyltryptophan. 
Circulating levels of C-glycosyltryptophan have been associated with aging and age-related 
diseases in the TwinsUK population (Menni et al., 2013b), negatively associated with muscle 
mass in less mobile elderly subjects (Lustgarten et al., 2014), and a CpG site in the promoter of 
the WDR85 gene, which is required for protein synthesis (Menni et al., 2013b). This could 
suggest that individuals consuming a dietary pattern low in protein but high in starches and 
carbohydrates tend to be older or this type of dietary pattern may contribute to physical aging 
and reduced muscle mass.  
 
High alcohol dietary pattern 
A unique association was identified between the high alcohol diet and 4-vinylphenol sulphate, a 
product of benzoate metabolism and compound resulting from nut roasting (Walradt, 1971), and 




associated with nut consumption (Guertin et al., 2014b) and several CpG loci (Petersen et al., 
2014). The metabolic implications for this epigenetic association are unknown at this time, 
though it may suggest that individuals scoring highly on this pattern are more prone to cigarette 
smoking. Increased scores on the alcohol pattern were also associated with higher levels of 
gamma-tocopherol, Gamma-tocopherol is one form of vitamin E, a major dietary antioxidant. 
The relationship between alcohol intake and gamma-tocopherol is unclear, a previous study 
found higher intakes of vitamins and supplements, and scores on the US Healthy Eating Index 







Table 4-5. List of metabolites associated to multiple dietary patterns 







Amino acid Creatine metabolism 
 
Creatine    ↑ ↓ 
 Phenylalanine & tyrosine 
metabolism 
3-Phenylpropionate (hydrocinnamate)  ↑  ↓  
 Tryptophan metabolism Indolepropionate ↑ ↑  ↓  
 Valine, leucine and isoleucine 
metabolism 
α-Hydroxyisovalerate   ↑  ↓ 
Carbohydrate Glycolysis, gluconeogenesis, 
pyruvate metabolism 
1,5-Anhydroglucitol (1,5-AG)  ↓   ↑ 
  Glycerate ↑ ↑    
Lipid Essential fatty acid 
 
Docosahexaenoate (DHA; 22:6n3) ↑ ↑   ↓ 
  Eicosapentaenoate (EPA; 20:5n3) ↑ ↑   ↓ 
 Fatty acid, dicarboxylate 
 
3-Carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF) ↑ ↑   ↓ 
 Inositol metabolism  Scyllo-inositol ↑ ↑ ↑  ↓ 
 Lysolipid 1-Docosahexaenoylglycerophosphocholine ↑ ↑    
 Medium chain fatty acid 10-Undecenoate (11:1n1)   ↑  ↓ 





Table 4-6. List of metabolites associated to specific dietary phenotype 
Dietary phenotype Super-pathway Sub-pathway Metabolite Direction of association 
Fruit & vegetable Amino acid Lysine metabolism Pipecolate ↑ 
 Carbohydrate Nucleotide sugars, pentose 
metabolism 
Threitol ↑ 
 Cofactors and vitamins Ascorbate and aldarate metabolism Threonate ↑ 
 Peptide gamma-glutamyl γ-Glutamylvaline ↓ 
 Xenobiotics Benzoate metabolism Hippurate ↑ 
High alcohol Amino acid Butanoate metabolism 2-Aminobutyrate ↑ 
 Lipid  Inositol metabolism Myo-inositol ↑ 
  Medium chain fatty acid Caprate (10:0) ↑ 
  Medium chain fatty acid 10-Undecenoate (11:1n1) ↑ 
 Xenobiotics Food component/Plant Piperine ↑ 
Traditional English Amino acid Urea cycle; arginine-, proline-, 
metabolism 
Stachydrine ↓ 
  Urea cycle; arginine-, proline-, 
metabolism 
Trans-4-hydroxyproline (Hydroxyproline) ↑ 
Dieting Xenobiotics Benzoate metabolism 4-Ethylphenylsulfate ↑ 
  Food component/Plant Quinate ↓ 
Low meat Amino acid Glutamate metabolism Pyroglutamine ↑ 
  Glycine, serine and threonine 
metabolism 
Betaine ↑ 
  Tryptophan metabolism C-Glycosyltryptophan ↑ 
  Cysteine, methionine, SAM, taurine 
metabolism 




Strengths and Limitations 
Although I replicated many associations from previous diet-metabolomics studies, there were 
multiple limitations to my study. The population I used was only female and as such my findings 
may not apply to men. Replicating my top associations in an independent population would 
have strengthened my findings, although I used the twin model for validation, allowing me to 
use controls matched for age, sex and the baseline genetic sequence. I did however, confirm 
associations from similar studies (Guertin et al., 2014b, Zheng et al., 2014) which suggests the 
data used in the study were of decent quality. Due to the cross-sectional nature of this study 
design, the study does not allow me to indicate cause and effect. As I used only FFQ data as 
my source for dietary information, the accuracy of the data can be called into question due to 
the consequences of self-reporting (Westerterp and Goris, 2002). Despite this issue, many of 
the associations I identified are biologically plausible. Moreover, food frequency data only 
provides categorical information and therefore the precise effect cannot be quantified, though 
this is an area where future dietary intervention studies can aid findings. I do recognize I may 
have experienced a small number of associations due to type 1 errors potentially as a result of 
correlated intake reporting, this issue may have been encountered for foods which lower intakes 
are generally discouraged, including sweet and savoury discretionary foods (sweets and jams, 
sweet baked products, fried fish and savoury pies). Using very stringent multiple-testing cut-offs 
I am hopeful many of these spurious associations were minimized, although this likely caused 
false negatives. Moreover, I did not have longitudinal data on metabolite levels, which in future 
studies could provide useful information on metabolite stability over time and may improve the 
strength of associations with food intakes. The true blood concentration of the metabolites is not 
measured by the Metabolon platform, therefore accurate quantification could not be determined 
for these metabolites. Furthermore, the current study only provides a snapshot of associations 
in one type of tissue, at only one time point and therefore provides limited insight into the origin 
and directionality of associations and virtually no insight into mechanisms. Having genotypic 
profiling completed on a large sample of TwinsUK with results also replicated in KORA, this 
allowed me to supplement my discussion, though future studies would need to untangle these 
potential genotype-metabolite-disease relationships and whether they are modulated by dietary 
factors. Strengths of this chapter include the large sample size and number of metabolites that 
were assessed and I was also able to use MZ discordant twins who are matched for age, sex 





By using one of the largest and comprehensive datasets of its kind, I identified 178 self-reported 
food intake associations (72 novel) with blood metabolites. I also identified 108 associations 
with 6 dietary patterns, confirming dietary patterns are associated with a unique metabolomic 
signature not captured by assessing food intakes independently. Future studies should aim to 
undertake dietary interventions trials to confirm our findings, adequately determine mechanisms 
for associations and quantify the effect of food intake on metabolite levels. The findings of my 







Chapter 5 Creating metabolite scores based on reported food 
group intake and applying these to explore the impact of diet 
on the metabolic syndrome 
 
In this chapter I analyse 20 food groups for their association with metabolites from the non-
targeted (Metabolon) platform, I then use three methods to combine multiple metabolites 
associated with food group intakes and evaluate them in an independent testing dataset. 
Therefore the overall aim of this chapter is to assess combining metabolites as a means to 
strengthen the utility of food intake biomarkers. Finally, I use the top performing metabolite 
scores to evaluate their correlation with an example of a common disorder - metabolic 
syndrome risk.   
 
5.1 Introduction 
In the previous chapter I showed that reported food intakes are associated with a unique blood 
metabolomic fingerprint. In order to best categorise habitual food intake to improve disease risk 
prediction, the appropriate handling of identified biomarkers must first be evaluated.  
Used alone single biomarkers may be less precise as they can be influenced by a 
multitude of factors and non-specific to a particular disease state. For example, c-reactive 
protein is synthesised by the liver under inflammatory states and is therefore used as a general 
marker for inflammatory processes occurring in the body and not specific to one condition. 
Indeed it is one marker of the metabolic syndrome (Olza et al., 2015) and CVD risk (Berezin et 
al., 2015). Moreover, complex chronic diseases are characterised by clusters of symptoms that 
cannot be quantified by measuring a single biomarker. Biomarker risk scores have been 
evaluated and shown to improve accuracy over traditional methods for a multitude of conditions, 
such as CVD (Berezin et al., 2015, Richter et al., 2013, Hughes et al., 2012) and metabolic 
syndrome (Olza et al., 2015).  
Similarly, combining dietary information to create scores is currently performed, such as 
for creating dietary patterns a priori to measure adherence to dietary patterns associated with 
particular health outcomes or measuring diet quality, including the MDS (Trichopoulou et al., 




points previously associated to health outcomes or diet quality. Diet quality is indicated by 
scoring reported food intakes by how closely they adhere to established dietary guidelines and 
also the variety of healthy food choices within core food groups. Dietary adherence scores have 
been tested for their correlation with traditional biomarkers of nutrient intake (e.g. n-3 fatty acids 
and carotenoids) (Golley et al., 2015). A study from EPIC-Norfolk created a panel of traditional 
biomarkers of fruit and vegetable intakes by summing plasma vitamin C, beta-carotene and 
lutein and found the panel to be strongly inversely associated with incident type II diabetes 
(Cooper et al., 2015). Moreover, a multi-food intake biomarker approach applying summation 
and PCA methods was used to evaluate adherence to a healthy Nordic diet dietary intervention 
in patients with MetS (Marklund et al., 2014), both methods performed similarly. With emerging 
nutritional metabolomics studies measuring multiple biomarkers simultaneously these traditional 
biomarkers may soon be replaced by more precise food intake scores.  
In one nutritional metabolomics study biomarkers of alcohol consumption in African 
Americans were identified and combined to create an alcohol risk score to evaluate the effects 
of alcohol consumption on levels of white blood cells and incident CVD (Zheng et al., 2014) . 
Specifically, the authors created three composite scores by summing quartile-ranked 
metabolites belonging to the same alcohol-related metabolic sub-pathways, including 2-
hydroxybutyrate and related BCAAs, lysophosphatidylcholines, and γ-glutamyl dipeptides. 
However, combining this information may have been more useful as independently these 
pathways are affected by different health conditions. In another study, a metabolomics 
approach was used to identify a panel of metabolites related to sugar-sweetened beverage 
(SSB) consumption, where a panel of 4 metabolites (formate, citrulline, taurine, and isocitrate) 
were found to be discriminate consumers and non-consumers (Gibbons et al., 2015). 
 
Combined biomarker scores representing long-term intakes of frequently consumed foods may 
greatly improve our understanding of the health impacts of diet. Therefore, my aims for this 
chapter were to:  
i) Identify potential biomarkers of intakes of 20 commonly consumed food groups.  
ii) Form food metabolite scores using multiple methods and test their utility. 




5.2 Materials and methods 
Figure 5-1 shows the pipeline of the chapter.  
Figure 5-1. Study pipeline of the chapter 
 
 
5.2.1 Food groups 
I created and analysed twenty food groups of similar taste and nutrient content (shown in Table 
5-1) derived from FFQ against blood metabolites.  
Table 5-1. List of food items included in food groups 
Food group FFQ items 
Vegetables 



















Table 5-1. List of food items included in food groups 
Food group FFQ items 
Leeks 
Onions 
Green salad, lettuce, cucumber, celery 
Spinach 
Watercress 
Vegetable soups (bowl) 
Boiled, mashed, instant or one jacket potato 
Fruit 
 Strawberries, raspberries, other berries, kiwi fruit (one fruit or handful) 
Smoothies (cup) 
Pure fruit juice (100%) e.g. orange, apple juice (cup) 
Grapefruit (half) 
Oranges, satsumas, mandarins (1 fruit) 
Apples (1 fruit) 
Bananas (1fruit) 
Dried fruit, e.g. raisins, prunes (heaped tablespoon) 
Grapes (handful) 
Melon (1 slice) 
Peaches, plums, apricots (1 fruit) 
Pears (1 fruit) 
Tinned fruit (handful) 
Whole grains 
 High Fibre cereals e.g. Branflakes, All Bran, Fruit and Fibre 
Muesli 
Porridge, Readybreak, oats 
Brown rice 
Wholemeal & granary bread/rolls 
Wholemeal pasta 
Crispbread, e.g. Ryvita 
Refined grains 
 Breakfast cereal e.g.  Cornflakes, Rice Krispies 
Sugar topped cereals e.g. Frosties 
Naan, poppadoms, flour tortillas 
Brown bread/rolls 
White bread/rolls 
White or green pasta, e.g. spaghetti, macaroni, noodles 
White rice 
Nuts and legumes 
 Beansprouts 
Pulses e.g. lentils, beans, peas 
Green beans, broad beans, runner beans 
Peas 
Baked beans 
Salted nuts e.g. peanuts, cashews (handful) 
Unsalted nuts, e.g. brazil, walnuts (handful) 
Seeds e.g. Sunflower, pumpkin (tablespoon) 
Peanut butter (teaspoon) 
Meat substitutes e.g. tofu, soyameat, textured vegetable protein, vegeburger 
Seafood 
 Oily fish, fresh or canned, e.g. tuna, mackerel, kippers, salmon, sardines, herring 
Fish roe, taramasalata 
Shellfish, e.g. crab, prawns, mussels 
Other white fish, fresh or frozen, e.g. cod, plaice, sole, haddock, halibut 
White meat 
 Chicken or other poultry e.g. turkey 
Red meat and eggs 
 Beef: roast, steak, mince, stew or casserole 
Lamb: roast, chops or stew 
Pork: roast, chops or stew 
Beefburgers 
Bacon or gammon 
Corned Beef, Spam, luncheon meats 




Table 5-1. List of food items included in food groups 
Food group FFQ items 
Liver, liver pate, liver sausage 
Sausages 
Eggs as boiled, fried, scrambled, etc. (one) 
Fermented dairy 
 Low fat cheese e.g. reduced fat cheddar  (matchbox size) 
Cheese, e.g. cheddar, brie, edam  (matchbox size) 
Cottage cheese, low fat soft cheese  (2 tablespoons) 
Full fat or Greek yoghurt (small pot) 
Low fat yoghurt, fromage frais (small pot) 
Fried foods 
 Fish fingers, fish cakes & breaded fish 
Fried fish in batter, as in fish and chips 
Chips, retail, fried in vegetable oil 
Potato salad 
Old potatoes, roast in blended oil 
Savoury pies, e.g. meat pie, pork pie, pasties, steak & kidney pie, sausage rolls 
Cream crackers, savoury biscuits 
Crisps or other packet snacks, e.g. Wotsits (one packet) 
Pizza (one slice) 
Quiche (slice) 
Sweets and sweet baked products 
 Reduced fat biscuits e.g. Go Ahead, Highlights (one small packet or one small bar/biscuit) 
Sweet biscuits, chocolate, e.g. digestive (one) 
Sweet biscuits, plain, e.g. Nice, ginger (one) 
Buns, pastries e.g. scones, flapjacks, croissants, doughnuts, home baked 
Cakes e.g. fruit, sponge, home baked 
Cakes e.g. fruit, sponge, ready made 
Fruit pies, tarts, crumbles, home baked 
Fruit pies, tarts, crumbles, ready made 
Milk puddings e.g. rice, custard, trifle 
Sponge puddings, home baked 
Sponge puddings, ready made 
Dairy desserts (small pot) e.g. chocolate mousse, cream caramels 
Ice cream, choc ices 
Jam, marmalade, honey (teaspoon) 
Sugar added to tea, coffee, cereal (teaspoon) 
Sweets, toffees, mints (small packet) 
Chocolate 
 Dark chocolates, single or squares (one) 
White or milk chocolates, single or squares (one) 
Low fat hot chocolate (cup) 
Cocoa, hot chocolate (cup) 
Chocolate snack bars e.g. Mars, Crunchie (one) 
Butter and cream 
 Reduced fat butter (teaspoon) 
Butter (teaspoon) 
Double or clotted cream (tablespoon) 
Single or sour cream (tablespoon) 
Spreads and dressings 
 Low fat spread, e.g. Outline, Gold (teaspoon) 
Very low fat spread (teaspoon) e.g. Diet Flora 
Cholesterol lowering fat spreads e.g. Benecol (teaspoon) 
Olive oil spread (teaspoon) 
Block margarine, e.g. Stork, Krona (teaspoon) 
Other soft margarine, dairy spreads, e.g. Blue Band, Clover (teaspoon) 
Polyunsaturated margarine, e.g. Flora, sunflower (teaspoon) 
French dressing (tablespoon) 
Full fat salad cream, mayonnaise (tablespoon) 
Other salad dressing (tablespoon) 
Low calorie, low fat salad cream (tablespoon) 
Milk 
 Channel Islands milk 




Table 5-1. List of food items included in food groups 




Soya and other milk 
 Goats' milk 
 Rice milk  
 Soya milk 
Soda 
 Fizzy soft drinks, e.g. Coca Cola, lemonade (cup) 
Low calorie or diet fizzy soft drinks (cup) 
Tea 
 Tea (cup) 
Green tea (cup) 
Coffee 
 Coffee, instant or ground (cup) 
Coffee, decaffeinated (cup) 
Alcohol 
 Beer, lager or cider (half pint) 
Port, sherry, vermouth, liqueurs (pub measure) 
Spirits, e.g. gin, brandy, whisky, vodka (pub measure) 
Red wine (small glass) 
White wine (small glass) 
 
5.2.2 Metabolomics dataset 
Fasted blood metabolites derived from the Metabolon dataset were used (Section 3.1.6.1). I 
included in the analysis 329 metabolites that were present in both serum and plasma and had 
no missing values in 75% of the sample.  
5.2.3 Training and validation datasets 
Female twins with Metabolon data available within and including 5 years of FFQ completion 
were included in the total sample (n=3559). A subset of 1156 twins had food preference data 
available, I therefore randomly assigned 1779 twins (keeping co-twins together) of this subset 
(50% of the whole sample) to the validation group, while the remaining 50% of the sample 
(n=1780) were assigned to the training group. Table 5-2 shows the characteristics of the 
training and validation datasets.  
 
Table 5-2. Characteristics of the training and validation groups 










Phenotype n Mean (SD) 
 
n Mean (SD) 
 
n Mean (SD) 




1779 54.4 (11.6) 













Vegetables 1652 32.1 (16.2) 
 
128 40.4 (24.1) 
 
1779 34.2 (15.5) 
Fruit  1588 20.3 (12.7) 
 
192 26.2 (16.9) 
 
1779 21.8 (12.5) 
Whole grains  1582 9.7 (8.6) 
 
198 14.4 (11.2) 
 




Table 5-2. Characteristics of the training and validation groups 










Phenotype n Mean (SD) 
 
n Mean (SD) 
 
n Mean (SD) 
Refined grains 1588 10 (8.3) 
 
192 13.9 (11.2) 
 
1779 9.6 (8.2) 
Nuts and legumes 1598 6.5 (4.3) 
 
182 9.9 (6.1) 
 
1779 7.5 (5.3) 
Seafood 1590 2.1 (1.8) 
 
190 3.5 (2.7) 
 
1779 2.4 (1.9) 
White meat 1492 1.8 (1.3) 
 
288 2.2 (1.4) 
 
1779 2.0 (1.3) 
Red meat 1626 6.5 (3.7) 
 
154 8.5 (5.1) 
 
1779 6.7 (3.8) 
Fermented dairy 1618 5.5 (4.3) 
 
162 8.2 (7.2) 
 
1779 6.2 (4.8) 
Fried foods 1604 4.9 (3.6) 
 
176 7.3 (5.9) 
 
1779 4.5 (3.3) 
Sweets and sweet baked products 1618 17.4 (14.5) 
 
162 27.0 (22.6) 
 
1779 15.6 (14) 
Chocolate 1662 3.3 (5.0) 
 
118 7.8 (9.3) 
 
1779 4.0 (6.0) 
Butter and cream 1616 3.3 (5.7) 
 
164 8.6 (8.8) 
 
1779 4.1 (6.4) 
Spreads and dressings 1610 8.8 (8.5) 
 
170 14.9 (13.2) 
 
1779 8.6 (9.1) 
Milk 1592 3.7 (2.2) 
 
188 4.4 (3.1) 
 
1779 3.4 (2.2) 
Soya and other milk 1752 0.1 (0.6) 
 
28 2.0 (2.1) 
 
1779 0.2 (0.8) 
Soda 1672 2.3 (5.2) 
 
108 7.8 (8.3) 
 
1779 2.3 (5.5) 
Tea 1584 20.2 (13.8) 
 
196 19.7 (13.8) 
 
1779 19.0 (13.8) 
Coffee 1574 8.9 (10.8) 
 
206 15.9 (12.6) 
 
1779 8.9 (10.7) 
Alcohol 1682 4.9 (7.1) 
 
98 12.0 (11.7) 
 
1779 6.3 (7.8) 
1
Excluding twins discordant for food group intake.  
2
Variables are residual adjusted for energy intake.   
 
5.2.4 Classification of the metabolic syndrome 
During clinical visits undertaken on the twins estimates of waist circumference were determined 
by analysing DXA scans, fasted blood samples were taken and analysed to determine levels of 
total triglycerides (TG), high density lipoprotein (HDL)-cholesterol and glucose, and blood 
pressure (BP) was determined, consult Section 3.5.1 for details.  
I determined MetS status using the criteria outlined by the International Diabetes 
Federation and the American Heart Association/National Heart, Lung, and Blood Institute 
(Alberti et al., 2009). Twins who had at least three of any of the following factors were 
considered to have the metabolic syndrome: 




2. Increased triglycerides (TG): >1·7 mmol/L, or treatment for abnormality 
3. Lower HDL-cholesterol: men <1·03 mmol/L in men and women <1·29 mmol/L, or 
treatment for abnormality 
4. High blood pressure: ≥130/85 mm Hg, or treatment for hypertension 
5. Raised fasting plasma glucose (FBG): FBG ≥ 5·6 mmol/L. Most individuals with type 2 




I included 414 twins in the analysis who had metabolomics profiling and diet information 
and did not have MetS at this time. These twins also attended a clinical visit 5 years or more 
after metabolomics profiling where MetS status was confirmed.  
5.2.5 Statistical analysis 
Statistical analysis was carried out using Stata version 12.  
5.2.5.1 Discovery analysis in the training dataset 
For each metabolite, random intercept linear regression analysis was undertaken in the first 
sample (discovery sample) excluding MZ twin pairs discordant (MZ twins with measures one SD 
apart in food group intake) for each food group. Age, metabolite batch, BMI and family 
relatedness were included as covariates: 
Υ𝑖 = 𝛽0 + 𝛽𝑖Χ𝑖𝑗 + 𝛾𝑖𝑎𝑔𝑒𝑖𝑗 + 𝛿𝑖𝐵𝑀𝐼𝑖𝑗 +ζ𝑗 + 𝜀𝑖𝑗 
where Yi is the metabolite and Xij  the food group intake of twin j from pair i , ζj, is the family-
specific error component that captures the unobserved heterogeneity or family characteristics.  
I adjusted for multiple testing using Bonferroni correction thus giving a significant threshold of 
7.60x10
-6
 (0.05/(20 food groups x 329 eligible metabolites)). For each significant metabolite-
food group association from the discovery sample, I repeated the same linear regression 
analysis on the MZ discordant twin pair sample. The MZ discordant twin pairs were used to 
replicate the significant findings from the discovery group, associations in the same direction as 
the discovery group were considered replicated. Finally, we combined the results of both 
analyses using an inverse variance fixed effects meta-analysis that are the reported results. The 
beta coefficients (β) presented in the results of each linear regression analysis represent the 
amount of a food group consumed in servings per week that corresponds to a 1 SD change in 
the metabolite level.  
5.2.5.2 Data reduction 
Following identification of significant metabolites for each food I reduced the number of 
associations.  
Firstly, a number of metabolites were associated with multiple food groups, which may 
have been a result of correlations in intake reporting. I therefore conducted a backward 
stepwise linear regression using the 5% level of significance as the cut-off threshold for each 




metabolite accordingly. I considered associations to be significant if they passed the Bonferroni 
cut-off for multiple testing used for the discovery analysis (P<7.60x10
-6
).  
Secondly, a number of the food groups were associated with multiple potentially 
correlated metabolites. Although the hypothesis is that metabolite levels change with food 
intake, to determine which metabolites are correlated independently of one another with food 
intake I undertook a backwards stepwise linear regression (cut-off threshold: P<0.05), with food 
group intake as the dependent variable. I performed this on all the metabolite residuals 
identified following the discovery and first data reduction steps, to identify a potential panel of 
independent metabolites to use as food intake markers. 
5.2.5.3 Food-metabolite group generation  
Significant food group-metabolite associations were then converged into scores based on three 
different methods: 1) Similar to the method used by Zheng and colleagues (Zheng et al., 2014), 
I quartile ranked blood levels of significant metabolites and assigned the quartiles a score of 0 
to 3 according to the direction of the association (i.e. positive association: Q1=0, Q2=1, Q3=2, 
Q4=3; negative association: Q1=3, Q2=2, Q3=1, Q4=0) and summed these values; 2) Like the 
method used by Marklund and colleagues (Marklund et al., 2014), I created a continuous 
summed score by summing the relative levels of each significant metabolite. Negatively-
associated metabolites were multiplied by -1; 3) I created a weighted score by multiplying the 
relative levels by the beta-coefficients for each metabolite as a predictor of food intakes 
(standardized to have mean 0 and SD 1), adjusting for all other associated metabolites and 
summed the final scores. This method has been used by Dash and colleagues (Dash et al., 
2013) to examine the indicators of oxidative balance and incident, sporadic colorectal 
adenomas.  
5.2.5.4 ROC analysis by food intake 
To evaluate the utility of the food metabolite scores as potential markers of food intakes I 
conducted a binary classification test in the validation group. I classified twins in lower tertile of 
each food group as a negative outcome (0), and the top tertile of food group intake I considered 
a positive outcome (1). The ability of the metabolite scores to correctly classify twins consuming 
high intakes (sensitivity; true positive rate) and correctly classify twins consuming low intakes 
(specificity; true negative rate) of the model was predicted and the receiver operating 




rate at multiple threshold settings. I tested whether any scoring method had a consistent 
advantage over another method by testing the difference in the area under the ROC curve 
(AUC).  The AUC may be interpreted as follows:  AUC>0.9 has high accuracy, AUC>0.7–0.9 
has moderate accuracy, AUC>0.5–0.7 has low accuracy, and AUC=0.5 is a chance result 
(Fischer et al., 2003).  
 
Confirmation of Associations by Food Preference 
I used an alternative form of getting diet information from subjects by asking them their food 
preferences. I adapted the food preference questionnaire developed in the US by Dr Valerie 
Duffy (Duffy et al., 2007) for use in the UK twin cohort (details in Appendix D Document 1). To 
do this, in collaboration with other scientists, items were changed to suit the UK diet and I 
transformed the questionnaire into an online format, this work has been published (Pallister et 
al., 2015). Modifications to the questionnaire involved changing the terms for some items (e.g. 
‘French fries’ to ‘chips’, ‘breakfast sausage’ to ‘sausage’, and ‘unflavoured oatmeal’ to 
‘porridge’) and some items were removed as they are infrequently consumed in the UK (e.g. 
‘bologna’, ‘canned noodle soup’, ‘chocolate milk’, and ‘blackened hot dog’). I compared their 
preferences for foods (ranked on a scale from -100 to +100) against those food groups as a way 
to further validate the metabolite scores. Table 5-3 shows the foods which ratings were 
averaged to form the group. I ran a linear regression with the metabolite score as the response 
variable (adjusted for batch effects, BMI and age) and twin food group liking as the predictor 
variable adjusting for family relatedness. Those associations passing the cut-off for multiple 
testing (Bonferroni P<3.33x10
-3
) were considered validated.  
 
Table 5-3. List of food preference items by food group 
Food group Preference item 
Vegetables 

































Table 5-3. List of food preference items by food group 




































Tuna or salmon 
 


























Fried and fast foods 
 









Sweets and sweet baked products 
 




Jam and jelly 
 








Butter or margarine 
Spreads and dressings 
 



















Table 5-3. List of food preference items by food group 
Food group Preference item 
Soda 
 
Carbonated drinks & sweet drinks 
 








Coffee or tea with sugar 
 









Vokda, gin or scotch 
5.2.5.5 Usage of food metabolite scores to predict the metabolic syndrome 
To determine whether food metabolite scores were associated with risk of developing MetS, I 
used the food metabolite scores that performed the best (weighted scores if multiple 
metabolites and continuous variable for foods associated to single metabolites). I undertook a 
logistic regression in 414 twins using each food metabolite score (residual adjusted for age, BMI 
and batch at time of metabolomics) to predict future MetS status (0, no MetS [n=389]; 1, MetS 
[n=25]) adjusted for age, BMI and family relatedness. Statistical significance was defined as 
P<0.05. I performed the same logistic regression on reported food intake for metabolite scores 
significantly predictive of future MetS. I finally performed a logistic regression using each 





In the following paragraphs I will first present those metabolite associations used to create the 
food metabolite scores from the training dataset, followed by the validation results.  
5.3.1 Overall associations with food group intakes  
A summary of the results for the discovery and data reduction analysis can be found in Table 5-
4. Following the meta-analysis of the discovery and discordant twin groups, 112 significant 
associations were identified in the training dataset (Figure 5-2; Appendix D Table 1). 
Significant associations were identified for all food groups except chocolate and refined grain 
intake. Thirty-nine metabolites were associated only with one food group (unique associations; 
Table 5-5), whereas 26 metabolites were associated with multiple foods (73 associations 
overall) potentially as a result of correlated intakes. Following a multivariate backward stepwise 
linear regression using each associated food group as a predictor of the latter 26 metabolites 












 data reductions, 




























Vegetables   3 2 0 1 0.0094 
Fruit 10 2 4 4 0.1195 
Whole grains   7 4 0 3 0.0508 
Nuts and 
legumes 
  2 1 0 1 0.0384 
Seafood 18 3 8 7 0.1535 





  4 1 0 3 0.0403 
Fermented 
dairy 
  1 1 0 0 - 




12 8 0 4 0.0588 
Butter and 
cream  
  5 0 0 5 0.0754 
Spreads and 
dressings  
  3 0 1 2 0.0331 
Milk   5 2 0 3 0.0735 
Soy and other 
milks 
  1 1 0 0 - 
Soda   1 1 0 0 - 
Tea   7 2 0 5 0.2113 
Coffee 10 2 6 2 0.1963 
Alcohol 17 4 5 8 0.2493 
(1) Number of metabolites significantly associated to each food group in the discovery (Bonferroni; 
P<7.60x10
-6
) and the discordant MZ twin samples (P<0.05), and following fixed effects meta-
analysis of results from both groups (Bonferroni; P<7.60x10
-6
).  
(2) Metabolites with multiple associated foods were included in a backwards stepwise regression 
(cut-off threshold P<0.05), those associations not passing the significance threshold from the 
discovery analysis (P<7.60x10
-6
) were removed.  
(3) Food groups associated with multiple metabolites were included in a backwards stepwise 





Figure 5-2. Metabolites associated to food groups in the training dataset  
Figure 5-2 shows the metabolites significantly associated with intakes of each food group in the training 
dataset. Bars with a white centre represent the –log10 P-value from the discovery analysis. Solid bars 
indicate the –log10 P-value from the multivariate regression with the final metabolites included in the scores 
following data reduction. Green bars indicate a positive association and red bars indicate a negative 
association. Metabolites whose biochemical identity has not yet been identified are denoted by ‘X-’ 





Table 5-5. List of metabolites associated with a single food group following the discovery analysis 
Food group Metabolite Superpathway Subpathway 
Vegetables ↓ X-12063 Unknown   
Fruit ↑ stachydrine Xenobiotics Food component, Plant 
↑ threonate Cofactors and vitamins Ascorbate and aldarate metabolism 
↑ threitol  Carbohydrate Nucleotide sugars, pentose metabolism 
↓ proline Amino acid Urea cycle; arginine-, proline-, metabolism 
↑ hippurate Xenobiotics Benzoate metabolism 
Nuts and legumes ↑ tryptophan betaine Amino acid Tryptophan metabolism 
Seafood ↑ 3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF) Lipid Fatty acid, dicarboxylate 
↓ 1-arachidonoylglycerophosphoethanolamine* Lipid Lysolipid 
↓ 1-oleoylglycerophosphoethanolamine Lipid Lysolipid 
↓ 1-eicosatrienoylglycerophosphocholine* Lipid Lysolipid 
↓ 1-linoleoylglycerophosphoethanolamine* Lipid Lysolipid 
White meat ↑ 3-methylhistidine Amino acid Histidine metabolism 
Red, processed meat and eggs ↑ trans-4-hydroxyproline Amino acid Urea cycle; arginine-, proline-, metabolism 
↑ creatine Amino acid Creatine metabolism 
  ↑ C-glycosyltryptophan* Amino acid Tryptophan metabolism 
↓ piperine Xenobiotics Food component, Plant 
↑ X-12696 Unknown   
Butter and cream  ↑ nonanoylcarnitine* Lipid Carnitine metabolism 
↑ myristate (14:0) Lipid Long chain fatty acid 
↑ caprate (10:0) Lipid Medium chain fatty acid 
↑ X-02249 Unknown   
↑ X-10510 Unknown   
Spreads and dressings  ↑ X-11478 Unknown   
↑ X-11521 Unknown   




Table 5-5. List of metabolites associated with a single food group following the discovery analysis 
Food group Metabolite Superpathway Subpathway 
Milk ↑ X-21365 (trimethyl-N-aminovalerate) Unknown   
Tea ↑ N-acetylornithine Amino acid Urea cycle; arginine-, proline-, metabolism 
Coffee ↑ catechol sulfate Xenobiotics Benzoate metabolism 
↑ paraxanthine Xenobiotics Xanthine metabolism 
↑ theophylline Xenobiotics Xanthine metabolism 
↑ X-05426 Unknown   
↑ X-12217 Unknown   
Alcohol ↑ 4-androsten-3beta,17beta-diol disulfate 1* Lipid Sterol, Steroid 
↑ 2-oleoylglycerophosphocholine* Lipid Lysolipid 
↑ X-10395 Unknown   
↑ X-11204 Unknown   
↓ X-11444 Unknown   




5.3.2 Overall associations with food group intakes following data reduction 
Each food group was associated with more than one metabolite (73 associations overall) which 
were potentially correlated, therefore a backward stepwise linear regression was performed to 
remove these using a significance threshold of P<0.05. Table 5-4 summarises the results of this 
analysis, the detailed results can be found in Appendix D Table 3. For alcohol, seafood and 
coffee intakes, at least one metabolite was significant in the first model but in the opposite 
direction to the results of the fixed effects meta-analysis (Appendix D Table 3, metabolite name 
and result highlighted in red), therefore a second model was undertaken using only the 
significant metabolites that were in the same direction. The names and weightings 
(standardized betas) of the final metabolites used to produce the metabolite scores are 
highlighted in bold in Appendix D Table 3. The metabolites included in the final score are 
indicated by the solid bars in Figure 5-2 which represent the –log10 P-value from the 
multivariate regression including all final metabolites in the food score (the R
2 
for these 
regression models can be found in Table 5-4). 
 Complete results for each food group against each final metabolite score can be found 
in (Appendix D Table 4). The associations between the metabolite scores and food group 
intake were stronger than the top single metabolite association for all food groups in the training 
dataset. All top metabolites and score associations except for vegetables and spreads and 
dressings (continuous and weighted) passed the significance threshold for the discovery 
analysis (P<7.60x10
-6
) in the test group.  
5.3.3 ROC analysis of metabolite food scores in the test group 
Figure 5-3 shows the ROC curves for each of the metabolite scores ability to predict high and 
low consumers based on tertiles (intakes summarised in Appendix D Table 5). The results for 
the top metabolite and top performing metabolite score are presented in Table 5-6 (results for 
all scores can be found in Appendix D Table 6). Overall, all scores were above the line of no-
discrimination (AUC>0.5), indicating the metabolite scores performed better than a random 
guess at identifying low and high food group consumers. Metabolite scores for alcohol 
performed moderately (AUC>0.8) and metabolite scores for fruit, whole grains, seafood, fried 
foods, tea and coffee performed reasonably (AUC>0.7) at predicting high and low consumers. 
When comparing the combined metabolite scores against the top single metabolite from each 




seafood, red meat, sweet and sweet baked products, butter and cream and alcohol intakes. For 
the rest of the groups the scores did not significantly improve the prediction. For foods 
associated to only a single metabolite (fried foods, vegetables, nuts and legumes, and white 
meat), dividing the group into quartiles did not significantly change the predictive ability.  
5.3.4 Metabolite score associations with food preferences in the test group 
We previously showed that food preference patterns in our twin population are correlated to 
metabolite signatures in the blood, despite metabolomics profiles being measured seven years 
prior (Pallister et al., 2015). This finding suggests that food preference patterns are quite stable 
through time. Here I have used the food preference questionnaire to further validate the 
metabolite scores in the test group. All score associations passed the Bonferroni cut-off 
(P<3.33x10
-3
) except for spreads and dressings. The top results from this analysis can be found 
in Table 5-7. The full results are in Appendix D Table 7. For those foods only associated with 1 
metabolite, vegetables and white meat were not significantly associated with food liking, which 
supports our results from the ROC analysis. These results provide further evidence that food 
liking has a strong impact on food intakes.  
5.3.5 Metabolite scores results summary 
i) Summarising multiple metabolites into a score improved the strength of associations 
between food intakes and metabolite profiles. 
ii) Differences in the overall predictive performance of scoring methods were negligible for 
most food groups, though the weighted method generally performed the best.  
iii) Based on the results from the ROC analysis and associations with food preferences, 






Figure 5-3. ROC curves for each diet metabolite score 
Each food group metabolite scoring method (quartiles, continuous and weighted) and the top associated 
metabolite were each fitted into a logistic regression model (adjusted for age, BMI, batch and family 
relatedness) to classify the top (1, positive outcome) and bottom (0, negative outcome) tertiles of food 
group intake. The equality of the receiver operating characteristic area (AUC) is shown for each scoring 




Figure 5-3. Continued…ROC curves for each diet metabolite score 
Each food group metabolite scoring method (quartiles, continuous and weighted) and the top associated 
metabolite were each fitted into a logistic regression model (adjusted for age, BMI, batch and family 
relatedness) to classify the top (1, positive outcome) and bottom (0, negative outcome) tertiles of food 
group intake. The equality of the receiver operating characteristic area (AUC) is shown for each scoring 




Table 5-6. Results of ROC analysis 
(1) 
            Versus top metabolite 
Food group Score Sensitivity Specificity Correctly classified AUC χ² P 
Vegetables 
(2)
 Top: X-12063 59.74% 55.47% 57.60% 0.6136 [0.5802, 0.6470]     
Fruit 
Top: X-11315  65.59% 60.34% 62.98% 0.6783 [0.6479, 0.7087]     
Weighted 66.84% 67.24% 67.04% 0.7411 [0.7131, 0.7690] 29.77 <0.0001 
Whole grains 
Top: X-09789  65.25% 67.07% 66.15% 0.7134 [0.6841, 0.7428]     
Weighted 67.63% 65.81% 66.72% 0.7224 [0.6934, 0.7514] 1.37 0.2425 
Nuts and legumes
 (2)
 Top: tryptophan betaine 64.25% 60.70% 62.47% 0.6723 [0.6366, 0.7080]     
Seafood 
Top: DHA 64.79% 67.46% 66.13% 0.7230 [0.6943, 0.7516]     
Weighted 69.57% 70.68% 70.13% 0.7547 [0.7274, 0.7821] 11.88 0.0006 
White meat
 (2)
 Top: 3-methylhistidine 77.78% 32.44% 56.86% 0.5733 [0.5371, 0.6096]     
Red meat 
Top: trans-4-hydroxyproline 58.94% 65.37% 62.16% 0.6697 [0.6390, 0.7003]     
Weighted 63.61% 65.53% 64.57% 0.6963 [0.6666, 0.7260] 9.36 0.0022 
Fried foods 
(2)
 Top: X-11372 65.30% 66.32% 65.81% 0.7322 [0.7038, 0.7606]     
Sweets and sweet baked products 
Top: C-glycosyltryptophan*  58.67% 56.51% 57.59% 0.6002 [0.5679, 0.6325]     
Weighted 60.10% 58.97% 59.54% 0.6254 [0.5937, 0.6571] 5.07 0.0243 
Butter and cream 
Top: nonanoylcarnitine* 71.88% 39.55% 56.84% 0.5889 [0.5529, 0.6249]     
Weighted 59.15% 59.90% 59.52% 0.6385 [0.6036, 0.6734] 11.39 0.0007 
Spreads and dressings 
Top: X-11261 59.08% 57.48% 58.28% 0.6199 [0.5880, 0.6518]     
Quartiles 60.27% 60.10% 60.19% 0.6374 [0.6059, 0.6689] 5.42 0.0199 
Milk 
Top: X-21365 [trimethyl-N-aminovalerate] 60.17% 60.65% 60.41% 0.6409 [0.6096, 0.6723]     
Continuous 60.68% 61.33% 61.00% 0.6355 [0.6040, 0.6669] 0.22 0.6402 
Tea 
Top: X-14473  59.28% 73.51% 67.04% 0.7384 [0.7078, 0.7691]     
Quartiles 61.63% 64.63% 63.13% 0.7121 [0.6803, 0.7439] 2.68 0.1016 
Coffee 
Top: X-14473 78.21% 65.38% 72.42% 0.7779 [0.7483, 0.8074]     
Quartiles 72.06% 76.36% 74.21% 0.7917 [0.7627, 0.8208] 3.08 0.079 
Alcohol 
Top: scyllo-inositol 75.75% 63.32% 70.02% 0.7531 [0.7230, 0.7832]     
Weighted 74.70% 76.40% 75.55% 0.8351 [0.8104, 0.8598] 38.99 <0.0001 
ROC, receiver operating characteristic; AUC area under the receiver operating characteristic curve 
(1) Each food group metabolite scoring method (quartiles, continuous and weighted) and the top associated metabolite were each fitted into a logistic regression 
model (adjusted for age, BMI, batch and family relatedness) to classify the top (1, positive outcome) and bottom (0, negative outcome) tertiles of food group 
intake. The equality of the receiver operating characteristic area (AUC) for each scoring method was tested against the ROC area for the top associated 
metabolite.  





Table 5-7. Top and metabolite score associations with food preferences in the test group 
(1)
 
Food group Top metabolite Beta (SE) P Best scoring method Beta (SE) P 
Vegetables 
(2)
 X-12063 -0.062 (0.059) NS    
Fruit X-11315 0.203 (0.045) 7.40x10
-6
 Weighted 0.077 (0.017) 1.12x10
-5
 
Whole grains X-09789 0.287 (0.054) 1.37x10
-7
 Weighted 0.045 (0.012) 1.70x10
-4
 
Nuts and legumes 
(2)
 tryptophan betaine 0.271 (0.045) 3.04x10
-9
      
Seafood DHA 0.333 (0.035) 6.85x10
-20





 3-methylhistidine 0.083 (0.037) 2.45x10
-2
*    
Red meat trans-4-hydroxyproline 0.221 (0.046) 2.29x10
-6





 X-11372 0.344 (0.046) 2.69x10
-13
    
Sweets and sweet baked products C-glycosyltryptophan 0.004 (0.002) 1.09x10
-2
* Weighted 0.002 (0.000) 2.24x10
-7
 
Butter and creams nonanoylcarnitine 0.023 (0.033) 4.79x10
-1
* Weighted 0.022 (0.007) 2.61x10
-3
 
Spreads and dressings X-11261 0.105 (0.041) 1.15x10
-2
* Quartiles 0.207 (0.089) 2.06x10
-2
* 
Milk X-21365 [trimethyl-N-aminovalerate] 0.167 (0.041) 5.71x10
-5
 Continuous 0.352 (0.097) 3.15x10
-4
 
Tea X-14473 -0.217 (0.031) 7.83x10
-12
 Quartiles 0.624 (0.082) 8.88x10
-14
 
Coffee X-14473 0.241 (0.055) 1.36x10
-5
 Quartiles 0.689 (0.101) 1.98x10
-11
 
Alcohol scyllo-inositol 0.322 (0.042) 1.01x10
-13
 Weighted 0.197 (0.018) 4.08x10
-27
 
NS, not significant; *, not statistically significant (P<3.33x10
-3
) 
(1) The top metabolite associated with each food group and the best performing scoring method (if multiple metabolites associated) from the receiver operating 
characteristic curve analysis were using to predict preferences for food groups.  





5.3.6 Metabolite score associations with future incidence of MetS  
Metabolite scores for butter and creams (OR[SE]: 0.602[0.119]; P=0.010), seafood 
(0.513[0.115]; P=2.85x10
-3
), and whole grains (0.325[0.095]; P=1.15x10
-4
) were associated with 
reduced odds of future MetS. Reported intakes for the same food groups were not significantly 
predictive of MetS, though effect directions were the same, which is suggestive that the 
metabolite scores were able to capture an effect more strongly than the questionnaires. Each 
significant metabolite score was predictive of at least one feature of MetS. Lower metabolite 
scores were predictive of reduced HDL-cholesterol for all food groups (Table 5-8). Lower 
metabolite scores for whole grains were mildly predictive of elevated triglycerides. There were 
no associations between metabolite scores and elevated WC, high blood pressure or impaired 
fasting plasma glucose.  
 
Table 5-8. Metabolite score predictions of criteria categories of the metabolic syndrome 
NS, not significant (P<0.05); MetS, metabolic syndrome; HDL, high density lipoprotein cholesterol 
A logistic regression (0, no risk; 1, risk) was performed in 414 twins using each food metabolite score 
(residual adjusted for age, BMI and batch at time of metabolomics) to predict the 5 clinical MetS criteria 





Criteria Butter and creams Seafood Whole grains 
 OR[SE] P OR[SE] P OR[SE] P 
Elevated 
triglycerides 














The primary aims of this chapter were to identify markers of long-term reported intakes of 
general food groups, to create biomarker scores using multiple methods and evaluate them, 
including testing them on the future development of MetS. Through the work I completed in this 
chapter I came to the following conclusions: i) summarising multiple metabolites into a score 
improved the strength of associations between food intakes and metabolite profiles; ii) 
differences in the overall predictive performance of scoring methods were negligible for most 
food groups, though the weighted method generally performed the best; iii) based on the results 
from the ROC analysis and associations with food preferences, I would not use scores for 
vegetable, white meat and spreads and dressings for further analysis. Nearly all of the 
metabolite associations identified and confirmed in discordant MZ twins have been identified in 
Chapter 4 as markers of reported intakes of more specific food items, I have therefore not 
highlighted these in the discussion. Moreover, I found that lower biomarker scores, though not 
reported intakes, associated to consumption of butter and creams, seafood and whole grain 
products associated to a higher risk of MetS later in life.   
Few epidemiological studies and no twin studies to date have examined reported food 
intakes against metabolomics profiles to create biomarker scores and evaluated them. One 
study of African Americans examined the impact of alcohol consumption related metabolite sub-
pathways on white blood cell levels and incident CVD (Zheng et al., 2014). In this chapter I used 
their method of summing quartile ranked metabolites to create a score, though this method did 
not perform the best overall and appears to lose some information. Moreover, while the authors 
created scores for different sub-pathways they did not acknowledge that these pathways are not 
specific to alcohol intake, such as 2-hydroxybutyrate and related branched chain amino acids 
which are markers of insulin resistance and type 2 diabetes (Menni et al., 2013a), and therefore 
may not truly connect alcohol consumption to CVD directly. I also used the summation score 
method that has previously been used to assess adherence to a healthy Nordic diet (Marklund 
et al., 2014). I found this method simple, though for most food groups did not perform better 
than the weighted method. I used the weighted method as it has been used to study markers of 
oxidative stress and their influence on incident, sporadic colorectal adenomas (Dash et al., 
2013), though they did not directly test the difference in accuracy between the equal weight 




similarly. An issue with equally weighting scores is that they may be less biologically meaningful 
than weighting. However, the weights used here may not be applicable to other populations. 
Although through splitting our group into a training and test set I found the weighting method still 
tended to perform better. Single metabolites did not perform well compared with combining 
metabolites into scores, supporting the use of biomarker scores for future study. 
All scores performed better than a random guess at identifying low and high food group 
consumers. Generally, scores including more metabolites performed better. Scores that 
performed with moderate accuracy (AUC>0.7) included those for alcohol, fruit, whole grains, 
seafood, fried foods, tea and coffee. Suggesting that these metabolites should be investigated 
more thoroughly. Previous metabolomics studies have identified strong associations with 
reported coffee, fruit, alcohol and seafood intakes (Guertin et al., 2014b, Guertin et al., 2015, 
Zheng et al., 2014), many of which I confirmed in this and the previous chapter. It is interesting, 
though encouraging, that the marker for fried food intake performed reasonably well as 
reporting of fried food intake may be more prone to underreporting. It is difficult to draw 
conclusions for metabolite scores that did not perform as well (AUC<0.7). However, the 
potential markers may simply not be good markers, though it also should be taken into account 
that ranking of the intakes for some foods may not be precise. To help resolve these issues 
controlled feeding studies should be undertaken, moreover applying different or new 
metabolomics platforms with more metabolites may yield markers with greater potential.  
An important issue with creating scores is that many of the metabolites associated to 
food intakes appear to lack specificity to a particular food. Moreover, in our study many 
metabolites were associated to multiple foods that may also be a result of correlations in 
reporting and dietary patterns. I attempted to ameliorate this issue by running a multivariate 
linear regression including all foods associated to each applicable metabolite and used the 
stringent significance threshold from the discovery analysis. However, by doing this I may have 
eliminated important markers. Moreover, future studies may find that working with correlations in 
intakes and identifying markers of healthy versus unhealthy dietary patterns (which tend to 
cluster together) may be more useful for public health research (and easier for translation) than 
examining single foods alone.  
 I found that lower biomarker scores (though not reported intakes) for butter and creams, 
seafood and whole grains associated to a higher risk of MetS later in life. However, only 25 




drawn from this small sample size. It is interesting that metabolites associated to butter and 
cream intake were lower in individuals who later developed MetS, which seems conflicting. 
Moreover, higher scores on the butter and cream metabolite score were associated with higher 
levels of HDL-cholesterol. Although large population studies have supported these findings, a 
recent study on 15,105 Brazilian adults identified inverse associations between total dairy and 
high fat dairy consumption and later development of the MetS which appeared to be mediated 
by dairy saturated fat consumption (Drehmer et al., 2016). In a large population of adults from 2 
US cohorts (the Health Professionals Follow-Up Study: 51,529 men; the Nurses' Health Study: 
121,700 women), classic blood biomarkers of dairy fat consumption, trans palmitoleate, 
pentadecanoic and heptadecanoic acids were not associated with incidence of stroke (Yakoob 
et al., 2014). In another study of 659 adults from the triethnic multicenter Insulin Resistance 
Atherosclerosis Study, circulating pentadecanoic acid was inversely associated with incident 
type 2 diabetes, a clinical measure of insulin resistance and β-cell dysfunction (Santaren et al., 
2014). I also found that individuals with lower whole grain metabolite scores were more likely to 
develop MetS. All of the metabolites forming the whole grain score are unknown therefore not 
much information can be derived from them at this time. Though it has been found that whole 
grain consumption appears to have a protective effect on MetS (Sahyoun et al., 2006) and 
cardiometabolic traits (Giacco et al., 2010). Using a biomarker approach, increased plasma 
alkylresorcinols (AR) ratio C17:0/C21:0, a biomarker of whole grain rye intake, was associated 
with an improved blood lipid profile following the consumption of a healthy Nordic diet in 
subjects with MetS (which includes high intakes of rye bread) (Magnusdottir et al., 2014), 
however total AR which is more representative of total whole grain wheat and rye intake was 
not associated with an improved lipid profile. I identified a particularly strong association 
between having lower scores on the whole grain metabolite score and having lower HDL-
cholesterol, though a strong relationship between HDL-cholesterol and whole grain 
consumption has not been identified (Hollaender et al., 2015). Higher scores on the seafood 
biomarker score were also found to associate with a reduced MetS risk and higher HDL 
cholesterol. A systematic review of 7 studies found 4 studies (one follow-up, three cross-
sectional) to suggest increased fish intake is protective of MetS (Torris et al., 2014). The long 
chain omega-3 fatty acids found in fatty fish, and also included in the biomarker score I used, 
are thought to be protective through improving vascular function and reducing inflammatory 




4356 American young adults found that increasing reported intakes of non-fried fish and dietary 
long-chain omega-3 fatty acids were associated inversely with MetS at 25 years follow-up (Kim 
et al., 2016). Biomarker studies are scarce on the relationship between blood long-chain 
omega-3 PUFAs and MetS risk. One study of chronic kidney disease patients found a pattern of 
high n-3 PUFAs in serum were not consistently associated with MetS (Huang et al., 2014). In 
another study serum DHA was associated with reduced cardiometabolic risk (Song et al., 2014).   
 There are a number of limitations and factors that must be considered. The Metabolon 
method does not determine the true blood concentration of the metabolites therefore I could not 
identify accurate cut-off points for what constitutes high and low intakes or risk levels. For 
chocolate, refined grains, fermented dairy, soy and other milk, and soda intakes no metabolite 
biomarkers were identified or did not pass data reduction and could not be studied further. By 
evaluating the metabolite scores against FFQ data I likely did not capture the true discriminatory 
ability of the scores due to the nature of dietary self-reporting. Through using these methods I 
was able to compare the utility of different scoring methods. Future feeding studies will be better 
equipped to assess biomarker utilization more accurately. The classification of foods was done 
a priori based on foods derived from similar sources (e.g. plants, animals, processing), which 
confer similar health benefits (e.g. whole grain versus refined grain), food usage and cooking. I 
may have chosen foods to be in a group that are not well correlated to intakes of the rest of the 
foods, therefore one food may be more strongly related to a metabolite, whereas another food 
included in the group has no relationship. Future work should aim to unravel the precise 
mechanism for these associations in order to discern which foods contribute to the same 
metabolite associations. Only women were used for this study, therefore the results may not be 
applicable to men. Many markers are unidentified at this time therefore I could not confirm they 
may be biologically related to food intakes, however I used stringent cut-offs, discordant MZ 
twins and data reduction methods to identify the best metabolite markers possible in our 
population. Importantly, the metabolite scores were tested in a group independent from the 





Chapter 6 Metabolomic associates of microbial diversity, their 
modulation by diet and relationship to the metabolic syndrome 
 
In this chapter I analysed gut microbiome Shannon diversity (Shannon) for its association with 
blood metabolites from the Metabolon platform, I then examined whether these microbe-related 
metabolites were associated with reported food intakes and finally, I explored longitudinal 
changes of the top diversity-associated metabolite and its association with metabolic syndrome 




The microbiome refers to the collective genomes of the microorganisms within an environmental 
niche. Within the human gut, microbiota undertake important processes allowing for potential 
host-microbe interactions such as vitamin synthesis, hormone production, metabolism of food 
components and interactions with host innate immunity. The number of different organisms 
present within the human gut (referred to as ‘richness’ or ‘diversity’) is associated with the 
increased abundance of beneficial bacteria and is emerging as an important indicator of health.  
Richness represents the total gene count, while diversity additionally accounts for the rarity of 
those microbial genes present within the whole dataset. Reduced alpha-diversity (intra-
individual diversity) has been coupled with dysbiosis (microbial imbalance) in inflammatory 
bowel disease patients (Manichanh et al., 2006, Michail et al., 2012, Scher et al., 2015), though 
this has not been highlighted in studies of obesity (Turnbaugh et al., 2009) or metabolic health 
(Le Chatelier et al., 2013). Although mechanisms are unclear microbial imbalance occurs when 
beneficial bacterial growth is compromised and a few pathogenic taxa dominate and overtake 
the metabolic potential of the microbiome with possible deleterious effects. Recent studies have 
shown reduced diversity is present in disease states and metabolic conditions such as auto-
immune diseases, including inflammatory bowel disease (Michail et al., 2012, Ott et al., 2004, 
Manichanh et al., 2006) and in patients with psoriatic arthritis and inflammatory bowel disease 
(Scher et al., 2015), and metabolic derangements, including obesity (Turnbaugh et al., 2009) 
and MetS-related phenotypes (Le Chatelier et al., 2013). Diet has been shown to contribute to 




richness in humans (Tap et al., 2015) and this stability has recently been shown to be 
transferred to future generations in mice (Sonnenburg et al., 2016), highlighting the important 
potential of good nutrition in humans. 
Microbes play a distinct role in human metabolism by transforming food- and host-
derived metabolites, such as bile acids, polyphenols and fibre. These products may in turn 
influence disease development by interacting with human host physiology. Studies are now 
attempting to untangle these interactions through measuring the chemical profile (metabolome) 
in biofluids (urine and blood), faeces, tissues and organs in collaboration with microbiome 
analysis. Comparing conventional versus germ-free mice, conventional mice exhibited elevated 
blood levels of indole-containing compounds (e.g. indoxyl sulfate and indole-3-propionic acid), 
serotonin, sulfated compounds (e.g. phenyl and p-cresol sulfate), and glycine-conjugated 
compounds (hippuric acid, cinnamoylglycine and phenylpropionylglycine), showing the major 
contribution of the gut microbiome to metabolism (Wikoff et al., 2009). In another study, urinary 
excretion of hippuric acid, a metabolite derived from high polyphenol foods (Gonthier et al., 
2003, Walsh et al., 2007), has been found to discriminate well between obese and normal 
weight controls (Calvani et al., 2010). Many of the metabolites implicated are food-derived 
components. In the two previous chapters I found many food associations with microbial co-
metabolites, therefore merging microbiome and metabolomics approaches with dietary studies 
is the logical next step in improving our understanding of the interplay between diet, the 
microbiome and metabolic disease. 
Diet is thought to be the most important avenue for modulating the gut microbial 
composition and its metabolic outputs, despite this there are relatively few good human studies. 
It has been shown that daily consumption of 40 g of dark chocolate for 2 weeks altered urinary 
output of gut microbial metabolites, increasing hippurate and methylamines, and reducing p-
cresol sulfate (Martin et al., 2009). A recent randomized controlled pilot found consuming 30 g/d 
of heat-stabilized rice bran for 28 days increased abundance of 8 operational taxonomic units 
(OTUs) from the genera Methanobrevibacter, Paraprevotella, Ruminococcus, 
Dialister, Anaerostipes and Barnesiella, and 3 from Bifidobacterium and Ruminococcus, 
moreover elevated levels of secondary bile acids (deoxycholic and lithocholic) and metabolites 
derived from plants and microbial modifications of plant phenolics (benzoic, hydrocinnamic and 
phosphoric acids, and inositol monophosphate) were observed in the faecal metabolome 




fish and eggs, to trimethylamine  (TMA) and then oxidized in the liver to trimethylamine-N-oxide 
(TMAO) has been implicated in why some red-meat consumers develop atherosclerosis (Koeth 
et al., 2013, Wang et al., 2011). Specifically, TMAO has been suggested to encourage the 
upregulation of macrophage scavenger receptors and through this enhance forward cholesterol 
transport (Bremer, 1983). Though in mice with intact intestinal microbiota and also with higher 
TMA and TMAO blood concentrations, choline and L-carnitine feeding each suppressed reverse 
cholesterol transport (Koeth et al., 2013). Interestingly, suppression of the gut microbiota 
removed the effect. 
 
The metabolomic signature of gut microbial alpha-diversity has yet to be examined on a large 
scale, and could provide useful candidate markers of a metabolically fit microbiome. Therefore 
for the current chapter, I aimed to: 
i) Identify the blood metabolites correlated with gut microbiome diversity.  
ii) Examine the impact of food intake on these metabolites.  
iii) Examine if longitudinal changes in these metabolites are predictive of both future 




6.2 Materials and methods 
Data relevant to this chapter included the reported intakes of 20 food groups as described in the 
previous chapter (Section 5.3.1), microbiome data and blood metabolomics data (details 
Section 3.1.6.1). I used all 292 known metabolites measured by the Metabolon platform. Twins 
who completed FFQs collected between 1995 and 2001 and in 2007 were used in the discovery 
analysis (n=1529). New FFQ data were collected between 2014 and 2015, 484 additional twins 
had microbiome, metabolomics data and completed FFQs during this time, 420 of these twins 
who had no co-twin in the discovery sample were used as a validation sample. The remaining 
64 twins who had co-twins in the discovery sample were used for the subsequent microbiome 
and MetS analyses. 
Table 6.1 provides the study population characteristics and subject numbers.  
Table 6-1. Study population characteristics for the whole, discovery and validation 
samples 
 Whole  FFQ<2014 
(Discovery) 
 FFQ≥2014  
(including validation) 
 Mean (SD)  Mean (SD)  Mean (SD) 
N 2013  1529  484 
Age (y) 57.2 (10.6)  57.7 (10.6)  55.4 (10.4) 
BMI 26.0 (4.6)  26.1 (4.6)  25.9 (4.6) 





    
Food groups 
(servings/week) 
     
Vegetables 34.9 (16.5)  34.8 (15.4)  35.1 (19.6) 
Fruit  21.4 (12.7)  21.9 (12.4)  19.5 (13.5) 
Whole grains  10.3 (8.0)  10.7 (8.1)  9.2 (7.4) 
Refined grains 8.6 (7.6)  9.0 (7.9)  7.2 (6.3) 
Nuts and legumes 7.9 (5.8)  7.6 (5.2)  8.8 (7.2) 
Seafood 2.4 (2.0)  2.5 (2.0)  2.3 (2.1) 
White meat 1.9 (1.3)  1.9 (1.3)  1.9 (1.3) 
Red meat 6.9 (4.1)  6.8 (3.9)  7.4 (4.6) 
Fermented dairy 6.2 (5.1)  6.1 (4.7)  6.5 (6.2) 
Fried foods 4.5 (3.5)  4.5 (3.3)  4.8 (4.1) 
Sweets and sweet 
baked products 
15.2 (13.9)  15.5 (14.0)  14.1 (13.4) 
Chocolate 4.0 (5.9)  4.0 (5.8)  3.9 (6.3) 
Butter and cream 4.4 (6.5)  4.2 (6.4)  5.0 (6.8) 
Spreads and 
dressings 
8.2 (9.0)  8.5 (9.1)  7.2 (8.6) 
Milk 3.2 (2.3)  3.4 (2.3)  2.8 (2.2) 
Soya and other milk 0.2 (0.8)  0.2 (0.9)  0.2 (0.8) 
Soda 1.7 (4.2)  1.8 (4.3)  1.3 (3.5) 
Tea 19.3 (13.5)  19.2 (13.5)  19.4 (13.5) 
Coffee 9.0 (10.6)  9.1 (10.7)  8.8 (10.5) 





6.2.1 Faecal microbiome composition 
Faecal samples were collected at follow-up and the composition of the gut microbiome was 
determined by 16S rRNA gene sequencing carried out at Cornell as previously described 
(Goodrich et al., 2016). Firstly, the V4 region of the 16S rRNA gene was amplified and then 
sequenced on Illumina MiSeq. The reads were next compiled to operational taxonomic units 
(OTUs) (Ley et al., 2006). Quality control was undertaken by Matthew Jackson and Tiphaine 
Martin at KCL by sample, paired-ends with an overlap of less than 200nt were removed. 
Chimeric sequences were then removed by de novo chimera detection in USEARCH (Edgar et 
al., 2011). Using Sumaclust within QIIME 1.9.0 de novo OTU clustering was undertaken across 
all reads, reads with a 97% identity threshold were brought together (Jackson et al., 2016a, 
Caporaso et al., 2010). Log transformation was undertaken on OTU counts, prior to 
transformation zero counts were given an arbitrary value (1x10
-6
). OTU abundances were then 
adjusted for technical covariates including sequencing depth, sequencing run, sequencing 
technician and sample collection method using linear modelling and the residuals obtained. As 
the residuals were not normally distributed, I completed an inverse normalisation. To determine 
alpha diversity, the total OTU count table was rarefied to 10000 sequences for each sample 50 
times. Per sample, alpha diversity metrics were determined in each of the rarefied tables and 
the average score for all 50 was considered as the final diversity measure. The primary alpha 
diversity metric considered was the Shannon Index as this was considered the most robust and 
is a commonly used metric though findings were confirmed on other parameters including 
observed OTU counts and Chao1 (richness), and the Simpson diversity index. All alpha 
diversity indices were standardised to have mean 0 and SD 1. 
6.2.2 Classification of the metabolic syndrome 
I determined MetS status using the criteria outlined by the International Diabetes Federation 
and the American Heart Association/National Heart, Lung, and Blood Institute (Alberti et al., 
2009). Consult Section 5.2.4 for details.  







Table 6-2. Clinical characteristics of the twin subsample to investigate longitudinal 
hippurate, diversity, diet with the MetS phenotypes and its components 
 Londitudinal sample (n=1032) 
 Mean (SD) 
Age at MetS status (y) 64.2 (7.8) 
MetS status (0, no; 1, yes) 906:116 
Longitudinal metabolomics baseline to 
endpoint (y) 
10.6 (3.9) 
Sex (M:F) 27:1005 
BMI (kg/m2)  26.2 (4.5) 
Systolic blood pressure (mmHg) 129.0 (15.7) 
Diastolic blood pressure (mmHg) 75.5 (9.7) 
Glucose (mmol/L) 4.9 (0.6) 
Cholesterol (mmol/L) 5.6 (1.0) 
HDL-Cholesterol (mmol/L) 1.9 (0.5) 
Triglycerides (mmol/L) 1.1 (0.5) 
 
6.2.3 Statistical analysis 
Statistical analysis was carried out using Stata version 12. The statistical analysis was 
undertaken in two parts. First, a marker of microbiome diversity was identified, its relationship to 
food intake explored and associations with microbiome OTUs/collapsed taxonomies identified. 
In the second part, the relationship between longitudinal levels of the diversity metabolite 
marker, diet, diversity and associated OTUs/taxa with the risk of MetS and its components were 
explored.  
6.2.3.1 Part 1: Metabolite associations with diversity, relationship to food intake 
and associations with microbiome OTUs/taxa 
Figure 6-1 shows the analysis pipeline for part 1.  
6.2.3.1.1 Microbiome diversity-metabolite associations 
I ran a linear regression model with Shannon diversity as a predictor of the metabolite level (292 
metabolites, Metabolon platform) in a group of 1529 female twins, adjusted for age, batch, BMI 
and family relatedness (closest to blood sampling) and multiple testing (Bonferroni: 0.05/292 = 
1.71x10
-4
). Significant metabolites from the discovery sample were then evaluated against 
Shannon diversity using the same linear regression (additionally including sex as a covariate) in 
the male (n=113) and female validation sample (n=420), associations passing the 5% level of 




6.2.3.1.2 Food intakes associated with diversity-associated metabolites 
To identify if any validated diversity-associated metabolites were potentially related to food 
intake, in the discovery sample I used reported intakes of the 20 food groups to predict levels of 
the metabolites (Bonferroni: 0.05/[5 metabolites x 20 food groups] = 5.00x10
-4
), adjusted for the 
same covariates as above. In a subsample of individuals from the discovery group (n=788) 
longitudinal metabolomics data were available (n=705 3 time points, n=83 2 time points) as well 
as reported food group intake at the same time or 5 years before the first blood sample. 





I determined trajectories of change in the top diversity-associated metabolite (years after 
baseline: 2
nd
 time point: 7.4 [range: 2.3-12.8]; 3
rd
 time point: 13.9 [range: 8.3-17.9]) by empirical 
Bayes predictions (adjusted for age and BMI) which estimates the rate of change in standard 
deviations/year (Rabe-Hesketh and Skrondal, 2008). Using this method point estimates were 
calculated and a slope of change determined. Food group intake at baseline was then used to 
predict the metabolite trajectories (Bonferroni: 0.05/20 food groups = 0.0025). 
A predictive score was created from those significantly associated foods according to 
the direction of association (i.e. positive association: Q1=0, Q2=1, Q3=2, Q4=3; negative 
association: Q1=3, Q2=2, Q3=1, Q4=0) and summed. In the validation sample, I conducted a 
logistic regression model (adjusted for covariates, including sex) to test the ability of the top 
diversity-associated metabolite to identify twins in the top and bottom tertiles of Shannon 
diversity, as well as the utility of the diet score to identify the top and bottom tertiles of the 
metabolite in blood.  
6.2.3.1.3 Food-microbiome-metabolite axis 
To identify associations between the metabolite and the microbiome I combined the discovery 
and validation samples (n=2013). To establish the strong association between the metabolite 
and diet score with richness (observed OTUs) and additional diversity metrics (Simpson and 
Chao1), I ran these associations using the same linear regression as for the Shannon diversity 
discovery analysis in the pooled sample. I then evaluated associations within the microbiome by 
running a linear regression model using the OTUs and OTUs collapsed at each taxonomic level 
(phylum, class, order, family, genus) as predictors of the metabolite adjusted for covariates, 
Shannon diversity and multiple-testing (Bonferroni cut-off; Table 6-3 shows the significance 
threshold for the OTUs and each taxonomic level). To determine the total variance in both 
Shannon diversity and the metabolite accounted for by metabolite-associated OTUs, I included 
all associated OTUs in a backwards stepwise linear regression using P<0.05 as the threshold 
cut-off, I report the R
2 
for each model. Metabolite-associated OTUs/taxa were examined for their 
association with the diet score (predictor) adjusted for covariates, the metabolite and multiple 
testing (assigned at each taxonomic level; Table 6-3). To investigate if any of the foods forming 
the score were driving associations, I ran a multivariate regression model including all 









(1) Bonferroni correction was calculated within each level.  
(2) Variables significantly associated with hippurate were tested for their association against 
the hippurate diet score. 
 
6.2.3.1.4 Microbiome-metabolite-diet interactions 
I next tested if there was an interaction between the diet score and the microbiome 
OTU/collapsed taxa associated to both the metabolite and the diet score in the prediction of the 
blood metabolite levels. I first ran a continuous x continuous interaction model using each 
OTU/collapsed taxa adjusting for covariates (age, BMI, batch, sex and Shannon diversity). In 
the second analysis, to determine if total numbers of all associated bacteria were important, I 
first multiplied abundances of associated microbiome variables by the direction of association 
with the metabolite (-1, negative, 1, positive) and summed the variables. I then ran the same 
continuous x continuous interaction model as above using this variable.  
6.2.3.2 Part 2: The relationship between longitudinal levels of the diversity 
metabolite marker, diet, diversity and associated OTUs/taxa with the risk 
of MetS and its components 
Figure 6-2 shows the analysis pipeline for part 2.  
6.2.3.2.1 Relationship between microbiome diversity, longitudinal metabolite and the 
MetS score and its components 
Microbiome diversity has been reduced in metabolic diseases, therefore I hypothesized that 
reduced longitudinal changes in the top metabolite diversity marker would be associated with 
increased MetS risk. A subsample of 1032 individuals had longitudinal blood metabolite levels 
(n=533 with 2 time points, n=499 with 3 time points). The time for the longitudinal analysis 
ranged from 2.4-17.9 years. I evaluated whether the longitudinal levels of the top diversity 
 Hippurate  Hippurate diet 
(2)
 
Level Number of variables P  Number of variables P 
Phylum 34 1.47x10
-3
  1 0.05 
Class 72 6.94x10
-4
  2 0.025 
Order 137 3.65x10
-4
  3 0.017 
Family 194 2.58x10
-4
  3 0.017 
Genus 382 1.31x10
-4











metabolite predicted MetS status and scoring or any of its components. I ran a linear regression 
model using Shannon diversity, the metabolite trajectory, the diet score or metabolite/diet-
associated OTUs/taxa to predict MetS status (adjusting for age, sex, and family relatedness), 
and each component adjusting for age, BMI (except for BMI), sex, and family relatedness.  
6.2.3.2.2 Metabolite trajectory association with MetS (and components) mediated by 
Shannon diversity, the diet score and specific OTUs/taxa 
The aim of this analysis was to determine the degree to which the variance in MetS (and 
components) attributable to the metabolite trajectory was accounted for by the MetS (and 
components) association with Shannon diversity, the diet score or specific OTUs/taxa. The 
proportion of the variance of the MetS status and its components were determined for the 
metabolite trajectory after taking into account all covariates. This quantity is indicated as r
2
x. The 
proportion of the variance for the MetS status (and its components) explained by the metabolite 
trajectory was then calculated after taking into account the same covariates as above but also 
including, Shannon diversity, the diet score (if applicable) or associated OTUs/taxa (r
2
xy). The 
percentage of the longitudinal metabolite association mediated by Shannon diversity, the diet 
score and associated OTUS/taxa (r
2
y.) was calculated as the proportion of the variance of MetS 
status (and components) that is due to the longitudinal metabolite trajectory association with 





6.2.3.2.1 Confirmation of findings in twins discordant for Shannon diversity 
Fifty-five MZ twin pairs discordant (≥ 1 SD) for Shannon diversity were used to confirm 
associations with diversity associations with the top metabolite cross-sectionally and 














6.3 Part 1 results 
6.3.1 Microbiome diversity metabolomics associations 
Eight metabolites significantly correlated with Shannon diversity in the discovery sample and 
five were validated in the validation sample (Table 6-4). Among those, hippurate, a benzoate 
metabolite, associated significantly (P<5.00x10
-4
: 0.05/[5 metabolites x 20 food groups]) with 
intakes of fruit (0.012[0.002]; P=7.36x10
-8
) and whole grains (0.013[0.003]; P=2.05x10
-5
). 
Another benzoate metabolite 3-phenylpropionate was associated with fried foods (-
0.045[0.009]; P=5.63x10
-7
), whole grains (0.018[0.004]; P=2.71x10
-6
) and fruit (0.010[0.002]; 
P=2.45x10
-5
). Hippurate and 3-phenylpropionate were strongly correlated (r=0.51), although 
summing the two metabolites did not improve their association with Shannon diversity 
(hippurate R
2
: 0.0258; 3-phenylpropionate R
2
: 0.0122; and combined R
2
: 0.0236), therefore for 
the remainder of the analysis I focused on hippurate.
 
6.3.2 Food intakes predict longitudinal hippurate trajectories  
I next analysed longitudinal levels of hippurate (Figure 6-3 shows the data for 25 randomly 
selected twins). Higher intakes of whole grains, coffee and fruit significantly (P<0.0025) 
predicted increasing hippurate trajectories (Table 6-5). All associations remained significant in a 
multivariate linear regression (Table 6-5) and together accounted for 5.3% of the variance in the 
hippurate trajectory. The nutrient profile of the score formed from these foods is shown in Table 
6-6. I validated the hippurate diet score in the validation sample against hippurate (0.089[0.024]; 
P=3.21x10
-4
) and Shannon diversity (0.040[0.019]; P=0.035), independently of hippurate. The 
diet score was moderately (h
2
≥30%) heritable (A: 0.3782 [0.3024, 0.4485]; E: 0.6218 [0.5515, 




Figure 6-3. Blood hippurate levels at 3 visits 
Figure 6-3 shows blood hippurate levels at 3 different visits for 25 randomly selected twins. 





Table 6-4. Metabolites associated to Shannon diversity in the discovery sample, following backward stepwise linear regression and in the 
validation sample 
(1) 
*Statistically significant: P<0.05 
(1) A linear regression was performed using Shannon diversity to predict levels of 292 metabolites adjusting for age, BMI, batch effects (and sex in the 
validation) and family relatedness.  
(2) Statistically significant (P<1.71x10
-4
) associations from the discovery group were validated in the validation group.  
 
Table 6-5. Food intake and score predictions of longitudinal hippurate trajectories and following a backwards stepwise linear regression in a 
subsample of 788 twins 
(1) Intakes of 20 food groups at baseline were used to predict the hippurate trajectory adjusted for age, BMI and sex. Statistical significance was defined as 
P<0.0025 (0.05/20 food groups). The diet score was formed by summing quartile ranked intakes of food groups significantly associated with the hippurate 
trajectory. 
(2) Whole grain, coffee and fruit intake were included in a multivariate regression to predict the hippurate trajectory including age, BMI and sex as covariates. 








Sub-pathway beta (SE) P  beta (SE) P 
Hippurate Xenobiotics Benzoate metabolism 0.230 (0.040) 3.72x10
-8
  0.238 (0.072) 0.001* 
p-cresol sulfate Amino acid Phenylalanine & tyrosine metabolism 0.200 (0.040) 9.90x10
-8
  0.179 (0.063) 0.005* 
phenol sulfate Amino acid Phenylalanine & tyrosine metabolism -0.200 (0.040) 5.82x10
-7
  -0.121 (0.063) 0.055 
Phenylacetylglutamine Amino acid Phenylalanine & tyrosine metabolism 0.180 (0.040) 5.21x10
-6
  0.195 (0.062) 0.002* 
3-phenylpropionate (hydrocinnamate) Amino acid Phenylalanine & tyrosine metabolism 0.160 (0.040) 3.43x10
-5
  0.185 (0.084) 0.028* 
4-ethylphenylsulfate Xenobiotics Benzoate metabolism 0.190 (0.050) 5.12x10
-5
  0.062 (0.081) 0.441 
Hyodeoxycholate Lipid Bile acid metabolism -0.190 (0.050) 8.66x10
-5
  -0.215 (0.089) 0.016* 
Indolepropionate Amino acid Tryptophan metabolism 0.140 (0.040) 9.20x10
-5
  0.093 (0.083) 0.262 
 Independent regression
 (1)




Beta (SE) P 
 


















































Table 6-6. Nutrient profile and linear trends of the hippurate diet score according to 
tertiles of the hippurate diet score 
NS= not significant: P>0.05. FA: fatty acid, MUFAS: monounsaturated fatty acids, PUFAS: 
polyunsaturated fatty acids, NSP: non-starch polysaccharides                                                                 
Tertile 1: score 0-3; tertile 2: score 4-5; tertile 3: scores 6-9. Linear trend determined by using the tertile of 
the hippurate diet score as a predictor of the energy-adjusted nutrient intake.
 
 Tertile 1 Tertile 2 Tertile 3 Trend 
Nutrient Mean (SD) Mean (SD) Mean (SD) Beta (SE) P 
Energy (kcal) 2009.4 (562.8) 1847.1 (534.2) 1826.6 (498.7) -90.77 (14.75) 9.16x10-10 
Fat (g/d) 72.2 (12.5) 67.2 (10.4) 62.5 (9.9) -4.87 (0.3) 9.54x10-55 
   Saturated FAs (g/d) 26.8 (6.6) 23.7 (5.8) 21.2 (5.2) -2.76 (0.16) 8.00x10-61 
   MUFAs (g/d) 24.2 (4.6) 22.1 (3.8) 20.2 (3.7) -1.98 (0.11) 2.19x10-64 
   PUFAs (g/d) 15.6 (5.2) 15.8 (4.3) 15.7 (4) 0.04 (0.13) NS 
   trans-FAs (g/d) 1.8 (0.7) 1.5 (0.6) 1.3 (0.5) -0.22 (0.02) 2.47x10-37 
   Cholesterol (mg/d) 241.4 (92.2) 233.1 (78.5) 210.8 (70.7) -15.34 (2.24) 8.98x10-12 
Protein (g/d) 79.3 (13) 80.5 (12.7) 80.4 (11.5) 0.56 (0.34) NS 
Carbohydrate (g/d) 221.6 (39.3) 232.2 (32) 245.2 (29.8) 11.83 (0.93) 2.14x10-35 
   Starch (g/d) 112.3 (31.2) 108.8 (26.6) 111.2 (27) -0.54 (0.78) NS 
   Total sugars (g/d) 106.6 (30.6) 120.7 (28.2) 131.1 (26.2) 12.23 (0.78) 8.44x10-52 
   Glucose (g/d) 17.8 (7.8) 23.4 (9.1) 27.1 (7.9) 4.64 (0.23) 2.42x10-82 
   Fructose (g/d) 19.8 (9.1) 27.5 (11.2) 32.9 (9.8) 6.57 (0.28) 1.02x10-107 
   Sucrose (g/d) 44.3 (18.9) 44.2 (14.2) 45.5 (12.8) 0.58 (0.43) NS 
   Maltose (g/d) 3.4 (1.9) 3.1 (1.5) 3.3 (1.5) -0.03 (0.05) NS 
   Lactose (g/d) 18.2 (10.7) 17.7 (9.8) 17.3 (9.2) -0.45 (0.27) 9.79x10-2 
NSP (g/d) 16.8 (5) 20.4 (4.9) 23.4 (5.2) 3.29 (0.14) 9.35x10-110 
Alcohol (g/d) 10.6 (14.8) 9.6 (11.9) 8.6 (10.5) -0.95 (0.35) 5.77x10-3 
Water (g/d) 2395.3 (596.3) 2623.5 (575.6) 2817.4 (591.6) 210.9 (16.26) 5.21x10-37 
Sodium (mg/d) 2172.9 (487.6) 2263 (502.5) 2341.4 (468.7) 84.19 (13.47) 4.98x10-10 
Potassium (mg/d) 3526.7 (575.9) 3886 (576.2) 4174.1 (564.8) 323.4 (15.84) 2.50x10-84 
Chloride (mg/d) 3446.9 (750.3) 3603.9 (773) 3757.3 (712.8) 155.16 (20.65) 8.56x10-14 
Calcium (mg/d) 1015.3 (288) 1037.2 (276.3) 1037.9 (274.2) 11.17 (7.73) NS 
Magnesium (mg/d) 299.1 (48.6) 343.4 (48.3) 377.1 (50.4) 38.93 (1.36) 2.03x10-151 
Phosphorous (mg/d) 1388.4 (223.7) 1476.2 (213.8) 1528.9 (207.9) 70.11 (5.96) 5.50x10-31 
Iron (mg/d) 11.5 (2.5) 12.8 (2.7) 13.7 (3) 1.08 (0.08) 1.64x10-43 
Copper (mg/d) 1.5 (0.5) 1.6 (0.5) 1.6 (0.4) 0.08 (0.01) 5.57x10-9 
Zinc (mg/d) 9.8 (1.7) 10.2 (1.6) 10.3 (1.5) 0.27 (0.04) 2.00x10-9 
Manganese (mg/d) 3.7 (1.1) 4.1 (1.1) 4.5 (1.1) 0.41 (0.03) 2.02x10-39 
Iodine (ug/d) 199.3 (74.8) 205.7 (72.6) 206.1 (67.2) 3.35 (1.98) 9.12x10-2 
Retinol (ug/d) 610 (776.9) 500.6 (508.6) 439.2 (425.7) -85.14 (16.18) 1.58x10-7 
Carotene (ug/d) 4987.8 (3370.1) 5754.6 (3645.7) 5896.5 (3627.5) 451.48 (98.45) 4.80x10-6 
Vitamin D (ug/d) 2.3 (1) 2.5 (1) 2.5 (1.2) 0.1 (0.03) 5.47x10-4 
Vitamin E (mg/d) 10.1 (3.2) 11.2 (3.2) 11.7 (3.1) 0.78 (0.09) 9.48x10-19 
Thiamin (mg/d) 1.6 (0.4) 1.7 (0.4) 1.8 (0.4) 0.1 (0.01) 1.15x10-21 
Riboflavin (mg/d) 2.2 (0.7) 2.2 (0.7) 2.3 (0.6) 0.02 (0.02) NS 
Niacin (mg/d) 19.8 (4.9) 21.2 (4.7) 23 (4.6) 1.6 (0.13) 2.67x10-33 
Tryptophan (mg/d) 16.6 (2.7) 16.8 (2.6) 16.9 (2.3) 0.17 (0.07) 1.59x10-2 
Vitamin B6 (mg/d) 2.3 (0.6) 2.5 (0.6) 2.7 (0.5) 0.16 (0.02) 6.41x10-26 
Vitamin B12 (mg/d) 6.2 (3) 6.1 (2.4) 5.9 (2.2) -0.16 (0.07) 1.87x10-2 
Folate (ug/d) 358 (106.9) 388.7 (113.4) 416 (110.1) 28.97 (3.05) 6.00x10-21 
Pantothenate (mg/d) 5.7 (1.6) 6.2 (5.3) 6.2 (1.8) 0.24 (0.09) 1.11x10-2 
Biotin (ug/d) 40.9 (9.8) 45.4 (9.1) 49.4 (8.9) 4.25 (0.26) 4.40x10-58 




6.3.3 Utility of hippurate as a marker of diversity and the hippurate diet score as 
a marker of hippurate 
Overall hippurate measured at a single time point correctly classified 64.64% of individuals into 
the upper and lower tertiles of Shannon diversity (sensitivity: 68.57%; specificity: 60.71%). The 
AUC was 0.682 (0.620, 0.745) (Figure 6-4). The hippurate diet score correctly classified 
60.93% of individuals into the upper and lower tertiles of hippurate levels (sensitivity: 64.03%; 
specificity: 57.86%). The AUC was 0.649 (0.585, 0.713) (Figure 6-5). This suggests both 
models had low accuracy.  
Figure 6-4. Receiver operating characteristic curve for the 
ability of hippurate to predict the upper and lower tertiles of 




















Figure 6-5. Receiver operating characteristic curve for the 
ability of the hippurate diet score to predict the upper and 





6.3.4 Associations with hippurate and the hippurate diet score across diversity 
metrics 
I confirmed the same directional effects for other diversity metrics for hippurate and the diet 
score (Table 6-7).   
 
Table 6-7. Associations between hippurate and the hippurate diet score across diversity 
metrics in the whole sample 
 Hippurate 
(2)





 Beta(SE) P  Beta(SE) P 
Observed species  0.158 (0.024) 9.55x10
-11
  0.086 (0.023) 2.17x10
-4
 
Shannon 0.160 (0.025) 2.16x10
-10
  0.108 (0.023) 3.03x10
-6
 
Simpson 0.082 (0.026) 0.002  0.062 (0.021) 0.003 
Chao1 0.060 (0.023) 0.011  0.023 (0.023) NS 
NS= not significant: P>0.05. 
(1) Standardized to have mean 0, SD 1. 
(2) Hippurate associations with diversity metrics adjusted for sex, age, BMI, metabolite 
batch and family relatedness.  
(3) Hippurate diet score associations with diversity adjusted for sex, hippurate, age, BMI, 
metabolite batch and family relatedness. 
6.3.5 OTU and collapsed taxa associations with hippurate  
Thirty OTUs and sixteen collapsed taxa (Figure 6-6; Appendix E Tables 1 and 2) were 





At the phylum level, the Firmicutes were associated with reduced levels of hippurate in blood, 
suggesting reduced diversity. Within the Firmicutes phylum, 28 OTU associations were 
assigned to the order Clostridiales, though not all associations were in the same direction. 
Within the order Clostridiales, higher hippurate levels were associated with increased 
abundances of two OTUs assigned to the family Clostridiaceae and 10 OTUs assigned to the 
family Ruminococcacea (including 2 Oscillospira genus OTUs, 1 Ruminococcus genus OTU 
and 1 Faecalibacterium prausnitzii OTU).  
 Increased abundances of 14 OTUs assigned to the family Lachnospiraceae were 
associated with reduced hippurate levels. Associations within the Lachnospiraceae family 
remained strong and in the same direction within the collapsed taxonomies, including at the 
family level. In particular, within the Lachnospiraceae family there were associations with OTUs 
assigned to the genera Ruminococcus (2 OTUs), Blautia (4 OTUs), Dorea (2 OTUs) and 
Roseburia (1 OTU), these OTUs were likely driving associations within their respective 
collapsed genera.  
At the class level, lower hippurate levels were associated with increased abundance of 




Erysipelotrichales, Erysipelotrichaceae, and Eubacterium, respectively. Interestingly there were 
no OTUs associated to blood hippurate that were assigned to this class.  
Outside of the Firmicutes phyla, increased abundances of one OTU assigned to the 
genus Actinomyces was associated with increased blood hippurate levels, this association was 
likely driving associations within the family Actinomycetaceae and order Actinomycetales 
collapsed taxa. Increased levels of hippurate were also associated with increased abundances 
of an OTU belonging to the family Rikenellaceae of the Bacteroidetes phyla and reduced 
abundances of the collapsed genus Ralstonia of the Proteobacteria phyla. 
Following a backward stepwise linear regression using P<0.05 as the cut-off threshold, 
together the remaining OTUs accounted for 58.0% of the variance in Shannon diversity and 
7.1% of the variance in hippurate levels (adjusted for diversity).  
6.3.6 OTU and taxa associated with both hippurate and the hippurate diet score 
Five OTUs and five taxa were associated with hippurate were also associated with the diet 
score in the same direction (Table 6-8). Specifically, reduced abundances of one OTU assigned 
to the genus Actinomyces was associated with increased scores on the diet, similar to hippurate 
this trend was significant both the family and order levels. At the genus level, reduced 
abundances of Ruminococcus (including 2 OTUs) and Eubacterium were associated with 
increasing diet scores. Moreover, increased diet scores were associated to increased 
abundances of OTUs assigned to the species Faecalibacterium prausnitzii and the genus 
Clostridiales. Most associations appeared to be primarily driven by intakes of fruit and whole 
grains. Though higher abundances of one Clostridiales OTU were associated with increased 
coffee intake.  
 I did not identify any significant interactions between the diet score and hippurate/diet-
associated microbes independently, nor when abundances were summed, in the prediction of 












Associations between blood hippurate and microbiome variables are represented by the histogram bars on the right side of 
the plot. The histogram bars represent the –log10 of the P-value of the regression and the colour of the bars indicates the 





Table 6-8. List of taxa associated with hippurate, the hippurate diet score and foods 
(1)
 
    
Hippurate Diet score 
 
Order Family Genus species OTU ID
 (2)









 Fruit: -0.004(0.002) 
WG: -0.007(0.003) 




 Fruit: -0.004(0.002) 
WG: -0.007(0.003) 




 Fruit: -0.005(0.002) 
WG: -0.008(0.003) 




 Fruit: -0.005(0.002) 
WG: -0.009(0.003) 




 Coffee: 0.013(0.002)* 




 Fruit: -0.005(0.002) 
WG: -0.008(0.003) 




 Fruit: -0.006(0.002)* 
WG: -0.009(0.003) 




 Fruit: -0.006(0.002)* 
WG: -0.009(0.003) 




 WG: 0.007(0.003) 




 Fruit: -0.004(0.002) 
WG: -0.010(0.003)* 
*= statistically significant: P<0.0017; WG: whole grain products 
(1) Microbiome OTUs and collapsed taxa significantly associated with both hippurate and the hippurate diet score are shown. Associations were adjusted 
for covariates (age, Shannon Index, metabolite batch, BMI, sex and family relatedness) and multiple testing using Bonferroni correction. Hippurate diet 
score associations were also adjusted for hippurate. 
(2) OTU ID assignment is specific to the TwinsUK cohort.  
(3) All foods included in the hippurate diet score were fitted into a backwards stepwise linear regression using P<0.05 as the cut-off threshold with each 
taxa associated to both hippurate and the diet score. Results displayed are the betas with standard errors of foods at least nominally associated 




6.4 Part 2 results 
6.4.1 Relationship of diversity, the hippurate trajectory and diet to MetS and its 
components 
Longitudinal hippurate trajectories were significantly associated with Shannon diversity, 
independently of diet and covariates in a subsample of 1032 twins (15.736[1.96]; P=4.95x10
-15
), 
moreover the hippurate trajectory accounted for 6.5% of the variance in Shannon diversity.  
 Figure 6-7 shows the results of the analysis for associations between diversity, the 
hippurate trajectory and MetS (Appendix E Tables 3 and 4 contain the full results). Higher 
Shannon diversity (R
2
: 0.0105) and an increasing hippurate trajectory (R
2
: 0.0054) were 
associated with a reduced risk of having MetS (Figure 6-7a). The variance in MetS attributable 
to the hippurate trajectory was accounted for 61.1% by Shannon diversity. The variance in MetS 
attributable to the hippurate trajectory was accounted for from 3.7% (Eubacterium genus) to 
51.9% (Clostridiales OTU) for the five collapsed taxa and 3 of the OTUs that were associated to 
both hippurate and the diet (Figure 6-7b). 
 Increased Shannon diversity and the hippurate trajectory were significantly associated 
with a reduced BMI (diversity R
2
: 0.0288) and TG (diversity R
2
: 0.0213; Figure 6-7a). Increased 
Shannon diversity was also associated with higher HDL cholesterol (R
2
: 0.0126). Shannon 
diversity accounted for 57.6% of the variance in BMI (R
2
: 0.0288) attributable to the hippurate 
trajectory, the impact of specific OTUs/taxa ranged from 22.6% (Ruminococcus genus) to 
35.4% (Faecalibacterium prausnitzii). Shannon diversity accounted for 63.2% of the variance in 
TG (R
2
: 0.0087) attributable to the hippurate trajectory, the impact of specific OTUs/taxa ranged 
from 3.4% (Eubacterium genus) to 48.3% (Clostridiales OTU). 




Figure 6-7a shows the associations between MetS, BMI, triglycerides and HDL-cholesterol with 
Shannon diversity, the hippurate trajectory, the diet score and taxa significantly associated with both 
hippurate, the diet score and MetS represented as betas with SEs; all variables have been 
standardized. Figure 6-6b shows the percentage variance the MetS, BMI and triglycerides are 
attributable to the hippurate trajectory accounted for through each applicable variable.  
Abbreviations: MetS, metabolic syndrome; HDL, high density lipoprotein; BMI, body mass index.   
Figure 6-7. Associations between diversity, the hippurate trajectory, diet and OTUs and 





6.4.2 Confirmation of results in discordant twins 
I identified 55 MZ twin pairs who were discordant (≥1 SD apart) for Shannon diversity. 
Associations between Shannon diversity and hippurate cross-sectionally and the longitudinal 
trajectory were significant (P<0.05), associations with all other variables were in the same 
direction as in the whole group analysis (Table 6-9), except for HDL-cholesterol.   
 
Table 6-9. Associations between hippurate (discovery), the hippurate trajectory, MetS 
status and components in MZ twins discordant for diversity 
Variable Beta(SE) P R
2
 
Hippurate (discovery) 0.208 (0.081) 0.013 0.0607 
Hippurate trajectory 0.478 (0.078) 9.53x10
-8
 0.1768 
Hippurate diet score 0.149 (0.099) 0.137 0.0136 
MetS status* 1.046 (0.299) 0.875 0.0004 
BMI 0.021 (0.063) 0.737 0.0010 
HDL-cholesterol -0.035 (0.069) 0.612 0.0022 
TG -0.073 (0.060) 0.233 0.0118 
MetS, metabolic syndrome; HDL, high density lipoprotein; TG, triglycerides 
A linear regression was conducted using diversity to predict hippurate (discovery), the hippurate trajectory, 
and MetS status and components in the MZ discordant (1 SD apart in diversity) twin sample.   







In summary circulating levels of hippurate were significantly and positively associated with gut 
microbiome diversity in all twins and confirmed in MZ twins discordant for diversity. Blood 
hippurate levels longitudinally and cross-sectionally were also associated with food intakes, 
specifically self-reported intakes of fruit and whole grains. Longitudinal changes in blood 
hippurate (reflecting in part food polyphenol content) were also strongly associated with 
Shannon diversity, accounting for 17.7% of the variance in diversity in MZ discordant twins. 
Blood hippurate levels and reported intakes of associated foods were associated with 5 OTUs 
and 5 collapsed taxa independent of diversity. Both an increasing Shannon diversity and higher 
hippurate trajectory were associated with a lower risk of MetS, which was primarily accounted 
for by their relationship to BMI and TG, moreover the 5 collapsed taxa and 3 OTUs were 
associated with MetS.  
 
Metabolite associations with diversity 
I identified and validated in an independent sample of male and female twins 5 blood 
metabolites associated with gut microbiome diversity: hippurate, p-cresol sulfate, 
phenylacetylglutamine and 3-phenylpropionate which were associated positively; and negatively 
with hyodeoxycholate. All of these metabolites are derived from or modified by bacterial 
metabolism.  
P-cresol sulfate (also p-cresyl sulfate) and phenylacetylglutamine are potentially toxic 
uremic solutes formed from the putrefication by colonic bacteria of dietary proteins that have 
escaped digestion in the small intestine. Our group previously showed p-cresol sulfate and 
phenylacetylglutamine to be strongly associated with reduced estimated glomerular filtration 
rate, moreover 52 OTUs assigned to the genera Christensenellaceae, Ruminococcaceae and 
Lachnospiraceae were associated with phenylacetylglutamine and 3 OTUs assigned to the 
genera Ruminococcaceae and Lachnospiraceae with P-cresol sulfate (Barrios et al., 2015). 
Hyodeoxycholate is a secondary bile acid, produced from intestinal bacterial metabolism. In 
healthy individuals hyodeoxycholate is metabolised by glucuronidation in the human liver and 
kidneys, a pathway for toxin elimination (Perreault et al., 2013). In individuals with cholestatic 




urine (Sacquet et al., 1983), suggesting hyodeoxycholate may act as a marker of poor liver 
function. Which is an interesting observation considering the relationship between some 
metabolic diseases and poor liver function. 
Increased blood 3-phenylpropionate and hippurate were associated with increased 
diversity and also intakes of fruits and whole grains. Both 3-phenylpropionate and hippurate are 
derived from gut microbial metabolism of polyphenols to benzoates and are significantly 
correlated (r=0.51), though hippurate accounted for a greater degree of variance in diversity 
therefore I decided to focus on it. Hippurate is emerging as a key mammalian-microbial co-
metabolite. It is a glycine conjugate of benzoic acid formed in the mitochondria of the liver 
(Gatley and Sherratt, 1977) and kidneys (Temellini et al., 1993), through gut bacterial 
production of benzoic acid from dietary components, primarily polyphenols (Gonthier et al., 
2003). Supporting my findings, human feeding studies of foods with a high polyphenol content, 
such as teas, fruit and coffee, have shown to increase urinary output of hippurate (Gonthier et 
al., 2003, Walsh et al., 2007). It should be noted however that the ROC analysis showed 
hippurate was a poor marker of Shannon diversity, therefore future studies should aim to 
identify biomarkers with better predictive performance. 
 
Microbiome associations with hippurate but not associated with diet 
To date, the microbiome profile associated with blood hippurate levels has not been well 
characterised. Within the TwinsUK dataset I found overall higher hippurate levels were 
associated to both increased and reduced abundances of 30 OTUs and 16 collapsed taxa, 
independently of Shannon diversity. At the phylum level, increased levels of hippurate were 
associated with reduced abundances of Firmicutes. The Firmicutes, which primarily consist of 
gram-positive bacteria, are one of the dominating phyla of the adult microbiome. One of the first 
large-scale microbiome studies suggested that a high Firmicutes to Bacteroidetes ratio is 
characteristic of obesity (Ley et al., 2006), although I did not investigate this ratio. A handful of 
studies have found reduced Firmicutes levels with increasing BMI (Duncan et al., 2008, Tims et 
al., 2013, Escobar et al., 2014). Moreover, increased faecal SCFAs have been shown in obese 
compared to lean subjects which also correlated with a higher ratio of Firmicutes to 
Bacteroides/Prevotella (Fernandes et al., 2014). Interestingly, polyphenol (concord grape 
extract) feeding to mice has recently shown to prevent obesity induced by a high fat diet in part 




find a relationship between total Firmicutes and dietary factors, it is possible our dataset was not 
powerful enough to detect associations.  
Increased hippurate levels were associated to both increased and decreased 
abundances of bacteria within lower taxonomies of the Firmicutes phyla. Twenty-eight 
associations with hippurate were with OTUs/taxa belonging to the Clostridiales order which was 
negatively associated overall. The Clostridiales order belonging to the class Clostridia, are 
obligate anaerobes found primarily in soil. Directions within lower taxonomic levels of 
Clostridiales were not consistent with the collapsed order. For instance, increased abundances 
of two OTUs belonging to the Clostridiales order and 2 OTUs within the Clostridiaceae family 
were associated with increased blood hippurate levels. OTUs within the Clostridiales order were 
related to diet and MetS and will be discussed in more detail below. 
Notably, the direction of associations between hippurate and OTUs/taxa within the 
Ruminococcaceae (10 associations) and Lachnospiraceae (14 associations) families of the 
order Clostridiales, were consistently increased and decreased, respectively. Both 
Lachnospiraceae and Ruminococcaceae are involved in butyrate production (Vital et al., 2014). 
In a previous study conducted on the TwinsUK dataset, higher abundances of multiple OTUs 
assigned to Lachnospiraceae were associated with increased eGFR and reduced levels of 
blood phenylacetylglutamine (Barrios et al., 2015), a metabolite that was also related to 
diversity. Another study found that higher abundances of Ruminococcaceae and 
Lachnospiraceae were associated with increased levels of urinary 3-indoxyl-sulfate and better 
outcomes in patients at risk of developing gastrointestinal (GI) graft-versus-host-disease (Weber 
et al., 2015). Moreover, lower abundances of both families are associated with inflammatory 
bowel disease (Kostic et al., 2014). I did not identify associations with hippurate or other 
polyphenol-related metabolites in the literature. It is interesting and perhaps noteworthy that I 
identified clear opposing directions between hippurate levels and these families.  
Higher levels of hippurate were associated with reduced abundances of the class 
Erysipelotrichi, and associations were consistent at the order, family and genus levels with 
Erysipelotrichales, Erysipelotrichaceae, and Eubacterium, respectively. Elevated levels of 
Clostridium ramosum, a member of Erysipelotrichi, have shown in mice fed a high-fat, 
obesogenic diet, which the authors suspected was due to increasing nutrient absorption (Woting 




was found that faecal levels of of Erysipelotrichi and Gammaproteobacteria were related to 
changes in liver fat (Spencer et al., 2011).  
Outside of the Firmicutes phyla, lower abundances of Actinobacteria were observed 
with increasing hippurate, these bacteria were further found to be associated with diet and MetS 
as discussed below. These results provide a microbiome profile associated with hippurate levels 
although, the complex metabolic relationships require further investigation. As I found diet to be 
significantly associated with food intakes, I investigated the relationship between these 
hippurate-associated OTUs and collapsed taxa. 
 
Microbiome associations with hippurate and the hippurate diet 
Three of the OTUs and 5 collapsed taxonomies associated to both hippurate and the hippurate 
diet (independently of diversity), moreover the variance in MetS attributable to the hippurate 
trajectory that was accounted for by these OTUs and taxa was between 3.7% and 51.9% (Table 
6-10). These included the increased abundances of the Actinomycetaceae family, Eubacterium 
and Ruminococcus being associated with an increased risk (and reduced blood hippurate and 
diet score) and OTUs within the order Clostridiales and of the species Faecalibacterium 
prausnitzii associated with a reduced MetS risk (and increased blood hippurate and diet score). 
A detailed discussion of each observation is given below.  
 
Table 6-10. Direction of associations between OTUs/collapsed taxa and hippurate, food 
intakes, MetS and its components.   
Microbiome Hippurate Fruit WG Coffee MetS BMI TG HDL 
Actinomycetales         
Actinomycetaceae         
Actinomyces         
Eubacterium         
Ruminococcus         
Ruminococcus (OTU)        
Clostridiales (OTU)         
Faecalibacterium 
prausnitzii (OTU) 
        
Abbreviations: WG, whole grain; MetS, metabolic syndrome; BMI, body mass index; TG, triglycerides; 
HDL, high density lipoprotein cholesterol.  
 
An increasing hippurate trajectory associated with a lower MetS risk 
Overall, increased Shannon diversity and the hippurate trajectory were associated with a 
reduced risk of having MetS. Supporting this, previous studies have shown reduced gut 




al., 2011), obesity (Turnbaugh et al., 2009) and with phenotypes characteristic of the metabolic 
syndrome (Le Chatelier et al., 2013). Interestingly, most of the variance in MetS that was 
attributable to the hippurate trajectory was accounted for by Shannon diversity (61.1%). An 
increasing hippurate trajectory (accounting for BMI) was similarly associated with a lower BMI 
and TG (variance 57.6% and 63.2% by Shannon diversity, respectively) at endpoint.   
Previous studies that examined urinary excretion or serum levels of hippurate have 
shown reduced urinary hippuric acid excretion in obesity (Shearer et al., 2008, Waldram et al., 
2009, Calvani et al., 2010), though mainly in animal models. To my knowledge, no human 
studies to date have investigated specifically the relationship between the MetS and markers of 
dietary polyphenol consumption, such as hippurate. Though the diet score was not associated 
with MetS, it was associated with a lower BMI for which the hippurate trajectory (60.4%) and 
Shannon diversity (45.3%) contributed particularly strongly (Appendix E Table 5), suggesting 
that these factors were important mediators between of the effect of diet on obesity and 
consequential metabolic risk. 
 
Increased abundances of the Actinomycetaceae family, and Eubacterium and 
Ruminococcus genera associate with MetS risk 
The Actinomycetaceae family are typical commensals within the oral cavity. Elevated levels of 
Actinomycetaceae within the gut have been implicated in conditions where stomach acid 
production has been compromised, such as with proton pump inhibitor use (Imhann et al., 
2016). The metabolic implications of increased abundance of Actinomycetaceae in the gut are 
not clear at this time, though higher levels within the oral cavity contribute to periodontitis and 
correlate with reduced insulin sensitivity (Demmer et al., 2015). In rare cases an Actinomyces 
overgrowth contribute to an infection within the gut (abdominal actinomycosis) through forming 
filamentous branches that grow through damaged mucosal tissue penetrating the gut barrier, 
forming abscesses and fistula (Bonnefond et al., 2016). As mucosal inflammation and bacterial 
translocation are emerging as important factors in the aggravation of MetS, Actinomyces should 
be explored further. The relationship between Actinomycetaceae and the foods forming the 
hippurate score is not entirely clear, though these findings suggest a healthy diet may prevent 
the proliferation of Actinomycetaceae.  
Increased abundance of the genus Eubacterium was significantly associated with both 




The Eubacterium genus is within the family Eubacteriaceae of the Firmicutes phyla. Effects at 
the Eubacterium genus level have not been clarified, though different species belonging to the 
same genus may have different metabolic capacities and therefore be enriched by varying 
dietary exposures. Contrary to my findings others have shown feeding of whole grains (Martinez 
et al., 2013) and switching from a Western to plant-based diet (David et al., 2014) have shown 
to enrich abundances of Eubacterium rectale. More studies are needed to outline effects at the 
Eubacterium genus level or with other species.   
Higher abundances of the genus Ruminococcus (one OTU and collapsed taxonomy) 
were associated with MetS risk and in particular higher levels of both HDL and TG. 
Ruminococcus are most abundant in one of the 3 major, though controversial (Jeffery et al., 
2012) enterotypes (Arumugam et al., 2011). Functional analyses have shown the 
Ruminococcus enterotype to be enriched for genes that produce membrane sugar transporters 
(Arumugam et al., 2011), which may predispose to weight gain. Ruminococcus are also able to 
ferment complex carbohydrates (Walker et al., 2011) and produce alcohol (Christopherson et 
al., 2014). Previous studies have not found the Ruminococcus enterotype to be consistently 
modified by diet (Wu et al., 2011a, Claesson et al., 2012). I found increased Ruminococcus 
abundances were shown to be associated with a lower fruit intake. Following 12 weeks feeding 
of schisandra chinensis fruit, high in flavonoids, to obese women was previously been shown to 
reduce Ruminococcus abundances (Song et al., 2015). Increased abundances of 
Ruminococcus were also associated significantly with increased severity of NAFLD lesions 
(Boursier et al., 2016). Supporting the strong association between TG and Ruminococcus, 
uncultured phylotypes of the Ruminococcus gnavus-group correlated positively with 
polyunsaturated serum TGs of dietary origin (Lahti et al., 2013). The Ruminococcus genus 
contains species with differential effects on metabolism, moreover dietary effects are likely quite 
complex, for instance increased consumption of foods of animal origin increase abundances of 
Ruminococcus gnavus, but decrease Ruminococcus bromii and Ruminococcus callidus (David 
et al., 2014).  
 
Increased abundances of OTUs belonging to the order Clostridiales and 
Faecalibacterium prausnitzii associate with protection from MetS 
Increased abundances of OTUs within the order Clostridiales and species Faecalibacterium 




Clostridiales OTU was particularly strongly associated to coffee intake and TG. The gut 
microbiota play an important role in the metabolism of chlorogenic acids found in high 
concentrations in coffee. Significantly elevated levels of the Clostridium coccoides-Eubacterium 
rectale group have been shown following the incubation of human faecal microbiota with coffee 
samples (Mills et al., 2015). Due to the high polyphenol content coffee intake has been thought 
to have beneficial effects on metabolic health. In a large observational study including 93,179 
individuals high coffee intake was associated with a low risk of obesity, MetS and type 2 
diabetes, though this was not supported by Mendellian Randomization using five genetic 
variants associated with coffee intake (Nordestgaard et al., 2015).  
Increased abundances of the Faecalibacterium prausnitzii OTU were strongly inversely 
associated with BMI and mildly with higher whole grain intake. Faecalibacterium prausnitzii is an 
important gut commensal accounting for 5% of the total faecal microbiota (Arumugam et al., 
2011) that ferments dietary fibre to short-chain fatty acids (including butyrate). In our sample 
Faecalibacterium prausnitzii was strongly associated with Shannon diversity (Beta[SE]: 
0.250[0.015]; P=5.09x10
-59
) and most strongly related to BMI of all microbes related to hippurate 
and the diet. This clear effect reflects previous findings where Faecalibacterium prausnitzii was 
shown to correlate with microbiome gene count and predict weight loss over time (Le Chatelier 
et al., 2013). Faecalibacterium prausnitzii has previously shown to be depleted in 239 MetS 
subjects, an effect shown to be partially restored following a long-term (2 years) Mediterranean 
diet intervention (Haro et al., 2016). Whole grain intake and increased fibre intake as a result 
allows Faecalibacterium prausnitzii to flourish (Benus et al., 2010) and encourages the anti-
inflammatory properties of Faecalibacterium prausnitzii (Sokol et al., 2008), which may further 
protect against MetS.  
 
Limitations 
There were a number of potential limitations to this study. There were a small number of male 
subjects in the sample, therefore these results may be applicable only to women. A de novo 
method was used to classify the OTUs into taxonomies. The de novo method involves creating 
a reference panel that is sample specific, therefore replicating our results in independent 
populations may be difficult to achieve. But this is true of all OTU studies. As the FFQ relies on 
subject reporting, the accuracy of this data have been called into question. Though in the 




with hippurate, coffee, fruit and whole grains, associate with biologically plausible metabolites. If 
misclassification had occurred it would likely have obscured real findings and not strengthened 
them. Furthermore, we replicate findings from feeding studies that have shown hippurate 
urinary excretion to be increased following the consumption of these foods. 
There were a number of advantages to this study. I had a large number of unique 
subjects with metabolomics profiling, dietary information and microbiome profiling. I also had 
access to a unique longitudinal metabolomics data in order to evaluate the influence of changes 
in hippurate levels on MetS risk.  
 
Conclusion 
In conclusion, hippurate, is associated with gut microbiome diversity and foods high in 
polyphenols. Subjects whose hippurate trajectory increased showed a reduced risk of MetS and 
related risk factors, largely accounted for by Shannon diversity. Microbiome OTUs/taxa related 
to blood hippurate and related food intakes, including increased abundances of 
Actinomycetaceae, Eubacterium and Ruminococcus and reduced OTUs within the order 
Clostridiales and the species Faecalibacterium prausnitzii associated with an increased MetS 
risk. These findings support the gut microbiome as an important mediator in the relationship 
between diet, in particular high polyphenol foods, and metabolic disease. The potential of 
hippurate as a marker of alpha-diversity and the interplay between high polyphenol foods, gut 
microbes and hippurate production should now be established in mechanistic studies ideally 




Chapter 7 Untangling the Relationship Between Diet and 
Visceral Fat Mass Through Blood Metabolomics and Gut 
Microbiome Profiling 
 
In this chapter I created a visceral fat mass diet (VFM) score using the intakes of top foods 
associated with VFM. I then examined the blood metabolomics and gut microbiome profiles 
associated with the diet score with the aim of identifying potential biological intermediates 
linking diet with VFM development.  
The work from this chapter has been formatted as a manuscript and submitted to the 
International Journal of Obesity.  
 
7.1 Introduction 
Increased visceral fat (VF) is a primary risk factor for cardio-metabolic diseases. Observational 
studies examining the impact of habitual food consumption on VFM or waist circumference 
(WC) have found that increased intakes of fruit (Romaguera et al., 2011), dairy products 
(Romaguera et al., 2011) and related nutrients (Fischer et al., 2015), and whole grains (Caron-
Jobin et al., 2011) and fibre (Hairston et al., 2012, Fischer et al., 2015) are associated with 
lower risk, whereas higher intakes of fried foods and fat (Mollard et al., 2014, Romaguera et al., 
2011), alcohol, red and processed meats (Romaguera et al., 2011) and related nutrients 
(Fischer et al., 2015), sugar-sweetened beverages (Ma et al., 2014, Mollard et al., 2014, 
Odegaard et al., 2012, Romaguera et al., 2011), refined grains (Caron-Jobin et al., 2011, 
Romaguera et al., 2011) and high glycaemic index foods (Dal Molin Netto et al., 2014, 
Romaguera et al., 2010) are associated with higher risk of VF.  
Within the past decade, the effects of an unhealthy dietary pattern have been 
increasingly explored. For instance, Nettleton and colleagues created a diet protective health 
score using self-reported intakes of whole grains, fish, fruits, vegetables, nuts/seeds (favorable) 
and red/processed meats, sweets, sugar-sweetened beverages and fried potatoes 
(unfavorable). They were then able to show that the score was a powerful means to examine 
gene X diet interactions in obesity in 68,317 subjects of European ancestry (Nettleton et al., 




combining the intake frequencies for all foods associated with changed in WC over a 5.5 year 
median in 48,631 men and women. However, dietary pattern scores have not yet been applied 
against high-throughput omic datasets.  
Metabolomics is being increasingly used in dietary studies in order to further explore the 
mechanisms of diet on metabolic disease development as extensively shown in this thesis. A 
recent study from our group showed that some of the metabolites associated with VF mass 
relate also to type 2 diabetes, insulin resistance and blood pressure (Menni et al., 2016). 
Moreover, we have found that self-reported reported food intakes are associated with 106 
unique metabolites (Pallister et al., 2016), which confirmed the strong role of food intake on 
metabolic traits (see Chapter 4). At this time, the characteristic metabolomics profile of a 
metabolically unhealthy diet has yet to be established, nor have those primary metabolites that 
connect diet to VFM development been defined.  
Recent studies are alluding to a role of the gut microbiota in VF development by 
interacting with food compounds and as a result, supplying metabolites to our bodies (Shoaie et 
al., 2015), this is supported by in Chapters 4 and 5 where I showed food intakes to be 
correlated with microbially-derived metabolites. Moreover, I found microbiome alpha diversity 
and hippurate (a microbial co-metabolite) to be associated with a reduced risk of MetS 
supporting the interplay of diet, the microbiome and the metabolome in metabolic disease 
development. These interactions may also intensify the health effects of a calorific, low nutrient 
dense Western Diet. Through feeding rodents high-fat or high-fat/high-sugar diets, early studies 
have shown HF feeding increases Firmicutes and reduces Bacteriodetes (Taira et al., 2015) 
abundances,  reduces the abundance of the class Clostridia which was additionally linked to 
higher visceral adipose tissue (Etxeberria et al., 2015), and increases abundances of 
sulfidogenic bactera which was associated with higher intestinal inflammation (Shen et al., 
2014). Under high fat feeding of animals, cranberry (Anhe et al., 2015) and pomegranate 
(Neyrinck et al., 2013) polyphenols, resveratrol from red wine (Neyrinck et al., 2013) and gluco-
oligosaccharide (Serino et al., 2012) have been found to be protective of obesity and associated 
inflammation in by changing the gut microbiome profiles. Also, conjugated linoleic acid, a 
constituent of dairy fats has been shown to encourage fat loss, which may be due to increasing 





Previous studies have not undertaken a multi-omic approach to decipher the influence of an 
unhealthy diet on VFM, as such the aims of this chapter were: 
i) To identify foods most strongly associated with VFM from these develop and validate a 
predictive dietary VFM-risk score. 
ii) To characterise the blood metabolomics profile of the VFM-risk score.  





7.2 Materials and methods 
Figure 7-1 shows the summary of the study protocol.  
For the analysis I used FFQs completed between 1995 and 2001, in 2007 and 2014 to 2015. I 
used the 20 food groups as defined in Section 5.2.1.  
7.2.1 Visceral Fat Mass 
During clinical visits a train research nurse or assistant determined visceral fat mass (VFM; g) in 
3457 twins using Dual-Energy X-ray Absorptiometry  (DXA; Hologic QDR; Hologic, Inc., 
Waltham, MA, USA) whole-body scanning in the supine position. To analyse the scans, the 
QDR System Software Version 12.6 was used. VFM was estimated at one cross-section of the 
whole body (L4-L5), this is the usual area of a computed tomography slice. If VFM was 4 SD 
above or below the mean VFM, twins were excluded from the analysis. I normalized the VFM 
data using a rank-based inverse-normalization as it did not follow a normal distribution.  
7.2.2 Metabolomic profiling 
For this chapter, I used 292 chemically identified metabolites analyzed by the non-targeted 
Metabolon platform. Quality control of the metabolomics dataset has been described in Section 
3.1.6.1. For the analysis I included 2218 twins (99.8% female) with metabolomics profiling, BMI 
and VFM data within ± 5 years of FFQ completion. 
7.2.3 Gut microbiome profiles 
16S rRNA gene sequencing was used to determine the faecal bacterial profiles. For a previous 
study (Goodrich et al., 2014b) microbial DNA was extracted, amplified, sequenced and 
processed by the Cornell technical team, since this earlier study an additional ∼1000 samples 
were collected and processed using the same protocols. Quality control of the microbiome data 
were undertaken by Tiphaine Martin, Matthew Jackson and Dr Michelle Beaumont. At 97% 
sequence similarity, sequencing reads were condensed as operational taxonomic units (OTUs). 
To do this, UCLUST open-reference clustering was used against Greengenes v13_5 reference 
within QIIME 1.7.0. Of the total sequences, 6.2% did not cluster to the reference and were 










OTUs that were found in fewer than 25% of individuals were removed from the analysis. 
Using this threshold and after removing singletons, of 9,840 OTUs only 2,118 OTUs (16%) 
remained for the final analysis. All OTU counts, including those OTUs present in less than 25% 
of individuals, were collapsed into taxonomies at the family (124 taxa), genus (283 taxa) and 
species (153 taxa) levels. For the analysis I only considered taxa fully classified within each 
taxonomic level. Following rarefaction of the complete OTU table to 10000 reads per sample, 
alpha-diversity was determined by Shannon’s phylogenetic diversity (Faith, 1992) using QIIME. 
Using linear regression, OTUs were adjusted for technical covariates which included 
sequencing run and sequence number per sample. I normalized the data using rank-based 
inverse normalization. I analyzed a subsample (n=889) of twins from the FFQ, VFM and 
metabolomics dataset that additionally had fecal microbiome profiling. 
7.2.4 Muther expression data  
Gene expression of abdominal fat samples in 825 individuals were analysed with the Illumina 
Human HT-12 V3 for the Muther study, as described previously (Grundberg et al., 2012). Using 
random intercept linear regression, 586 individuals were analyzed for AT expression 
associations with the top metabolite adjusting for age, BMI, metabolite and expression batches, 
and family relatedness. This analysis was conducted by Dr Cristina Menni. 
7.2.5 Statistical analysis 
I conducted all statistical analysis using Stata version 12. 
7.2.5.1 Food group associations with VFM and diet score formation and 
heritability 
First, I randomly allocated twins to two independent groups: the test (n=1109) and replication 
(n=1109) groups. I ensured that twin pairs were assigned to the same group. To identify food 
group associations with VFM, in the test group I ran a linear regression for each of the 20 food 
groups as predictors of VFM (residual adjusted for BMI), I adjusted for covariates including total 
fat mass, age, sex, height
2
, family relatedness and DXA batch. The cut-off for statistical 
significance was defined using Bonferroni correction (P<2.50x10
-3 
= [0.05/20 food groups]). I 
included food groups that were significantly associated with VFM in the risk score. I calculated 
the score, first I quartile ranked the consumption frequencies of associated foods and then 




Q3=2, Q4=3; negative association: Q1=3, Q2=2, Q3=1, Q4=0). Next I summed each food group 
score to create the final risk score that ranged from 0 to 15. I used linear structural equation 
modelling in Mx (Neale et al., 1992, Neale et al., 2003) to determine the heritability of the VFM 
diet score (consult Section 3.2.1 for analysis details).  
7.2.5.2 Binary classification test 
I next tested the VFM risk score in the replication group by first fitting a logistic regression model 
with the diet score predicting low and high VFM. I defined the lower tertile of VFM as a negative 
outcome (0; n=369) and the upper tertile of VFM as a positive outcome (1; n=370). In the model 
I adjusted for covariates including total fat mass, age, sex, height
2
, family relatedness, DXA 
batch, and BMI category (1: <18.5 kg/m
2
; 2: ≥18.5-24.9 kg/m
2
; 3: ≥25-29.9 kg/m
2
; 4: ≥30 kg/m
2
). 
To assess the predictive ability of the VFM diet score, I conducted a binary classification test. 
The ability of the VFM diet score to identify twins with high VFM accurately (sensitivity; true 
positive rate) and identify twins with low VFM accurately (specificity; true negative rate) was 
predicted. The receiver operating characteristic curve (ROC) was then generated by plotting the 
true positive rate against the false positive rate at a number of threshold settings.  
7.2.5.3 VFM diet score and metabolomics and microbiome 
For each metabolite or microbiome taxon, I ran a random intercept linear regression analysis for 
each metabolite or microbiome OTU/taxa adjusting for age, BMI, sex and metabolite batch (for 
metabolomics) or Shannon Index (for microbiome), and family relatedness: 
𝛶𝑖 = 𝛽0 + 𝜷𝒊𝜲𝒊𝒋 + 𝛿1𝑖𝑎𝑔𝑒𝑖𝑗 + 𝛿2𝑖𝐵𝑀𝐼𝑖𝑗 + 𝛿3𝑖𝑆𝑒𝑥𝑖𝑗 + 𝛾1𝑖𝑍𝑖𝑗 + 𝜁𝑗 + 𝜀𝑖𝑗 
where Yi is the metabolite/microbiome OTU/taxa, Xij is the VFM diet score of twin j from pair i, Zij 
is the metabolite batch or Shannon Index and ζj, is the family-specific error component that 
captures the unobserved heterogeneity or family characteristics. I also used Bonferroni 
correction to account for multiple testing giving a significance threshold for metabolites of 
1.71x10
-4
 (0.05/(292 known metabolites)). For the microbiome analysis I defined statistical 
significance within each taxonomic level, Table 7-1 shows the thresholds by level. 
A large number of potentially correlated metabolites were associated with the VFM diet, 
therefore I next undertook a backwards stepwise linear regression including all associated 






Table 7-1. Statistical significance thresholds for microbiome analysis using Bonferroni 
correction 
 VFM diet score  VFM 
Level 
(1)





  2 0.025 
Genus 283 1.77x10
-4
  2 0.025 
Species 153 3.27x10
-4
  2 0.025 
OTU 2118 2.36x10
-5
  8 6.25x10
-3
 
(1) Bonferroni correction was calculated within each level.  
(2) Variables significantly associated with the VFM diet score were tested for their 
association against VFM. 
 
7.2.5.4 VFM and metabolomics and microbiome 
To determine if the remaining metabolites, and OTUs/taxa (both residual-adjusted for BMI) 
associated with the VFM diet score were also associated with VFM, I used each of these 
variables as predictors of VFM (residual-adjusted for BMI at scan) in a linear regression 
including the covariates scan age, sex, total fat mass, height
2
, scan batch and metabolite batch 
(for metabolomics) or Shannon Index (for microbiome), family relatedness and for the VFM diet 
score. 
𝑉𝐹𝑀𝑖 = 𝛽0 +  𝜷𝟏𝒊𝒀𝒊 + 𝛽2𝑖𝛸𝑖𝑗 + 𝛿1𝑖𝑎𝑔𝑒𝑖𝑗 + 𝛿3𝑖𝑆𝑒𝑥𝑖𝑗 + 𝛿4𝑖𝑇𝑜𝑡𝑎𝑙_𝑓𝑎𝑡_𝑚𝑎𝑠𝑠𝑖𝑗 + 𝛿5𝑖𝐻𝑒𝑖𝑔ℎ𝑡_𝑠𝑞𝑢𝑎𝑟𝑒𝑑𝑖𝑗
+ 𝛿6𝑖𝑆𝑐𝑎𝑛_𝑏𝑎𝑡𝑐ℎ𝑖𝑗 +  𝛾1𝑖𝑍𝑖𝑗 + 𝜁𝑗 + 𝜀𝑖𝑗 
where Yi is the metabolite/taxon, Xij is the VFM diet score of twin j from pair i, Zij is the 
metabolite batch for metabolomics data or Shannon Index for microbiome data and ζj, is the 
family-specific error component that captures the unobserved heterogeneity or family 
characteristics. Associations which passed the Bonferroni cut-off were considered significant. 
For metabolites the threshold was 5.56x10
-3
 (0.05/9 metabolites). The assignment for statistical 
significance for the microbiome analysis is shown in Table 7-1.  
 I identified MZ twins who were discordant (1 SD apart) for VFM, this included 80 pairs in 
the metabolomics dataset and 27 pairs in the microbiome subsample. In this group, I ran a 
linear regression to validate top associations between diet, metabolites and the microbiome and 
VFM.  
7.2.5.5 Top microbiome and metabolite associations with food groups  
To confirm the associations between the metabolites/microbiome and the VFM diet score were 
not due to intakes of other foods, I ran a backward stepwise linear regression model including 
the VFM diet score and food groups not forming the score to predict the associated metabolite 




I then assessed whether the foods contributing to the VFM diet score were independently 
driving the association between the VFM diet score and taxa/metabolites. I fitted all 20 food 
groups into a backward stepwise linear regression model using cut-off thresholds of P<0.01 for 
metabolites and P<0.05 for microbiome.  
7.2.5.6 VFM diet score association with VFM mediated by metabolite and 
microbiome 
I first determined the proportion of the variance of VFM attributable to the VFM diet score after 
accounting for all covariates (age, sex, BMI, total fat, height
2
, family relatedness, metabolite 
batch, Shannon Index and scan batch). This quantity was represented by r
2
x. I next determined 
the proportion of the variance in VFM explained by the VFM diet score by adjusted for the same 
covariates as above but additionally including the metabolite or OTU/taxon (r
2
xy). To calculate 
the percentage of the VFM diet score association that was mediated by the metabolite or 
OTU/taxa (r
2
y), I determined the proportion of the variance of VFM that is due to the VFM diet 




x).     
7.2.5.7 Microbiome association with VFM mediated by metabolite 
I determined the proportion of the variance of VFM attributable to the taxon after taking into 
account all covariates as above in addition to the VFM diet score (r
2
x). I next determined the 
proportion of the variance in VFM explained by the taxon after adjusting for the same covariates 
as above but additionally adjusting for the metabolite (r
2
xy). To calculate the percentage of the 
taxon association that was mediated by the metabolite (r
2
y), I determined the proportion of the 









7.3.1 VFM food group associations 
The characteristics of the sample as well as the training and validation groups are shown in 
Table 7-2. 
Table 7-2. Study population characteristics
 
  No significant differences between the training and validation sets. 
 
I found 5 food groups were significantly associated with VFM in the training dataset (Table 7-3). 
Higher intakes of fruit, whole grain and fermented dairy products were associated with reduced 
VFM, whereas increased intakes of fried and fast foods and red, processed meat and eggs 









Mean (SD) Mean (SD) Mean (SD) 
Age (years) 58.3 (10.9) 58.1 (11.1) 58.4 (10.8) 
BMI (kg/m
2
) 26.2 (4.8) 26.1 (4.8) 26.4 (4.8) 
Total fat (grams) 6827 (2180) 6779 (2178) 6911 (2258) 
Visceral fat (grams) 562.7 (293.7) 553.9 (293.8) 572.7 (295.5) 
Height (m) 1.61 (0.06) 1.62 (0.06) 1.62 (0.06) 
Sex (M:F) 4:2214 0:1109 4:1105 
Food intakes (servings/week)    
Vegetables 34.3 (15.4) 33.8 (15.0) 34.8 (15.8) 
Fruit and fruit juices 22.4 (13.3) 22.7 (13.8) 22.1 (12.8) 
Nuts and legumes 7.9 (5.5) 7.8 (5.6) 8.0 (5.4) 
Whole grains 10.2 (7.9) 10.2 (7.7) 10.2 (8.1) 
Refined grains 8.4 (7.4) 8.4 (7.4) 8.5 (7.4) 
Fermented dairy 6.3 (4.8) 6.4 (4.7) 6.3 (4.8) 
White meat 1.9 (1.3) 1.9 (1.3) 2.0 (1.3) 
Seafood 2.4 (2.1) 2.4 (1.9) 2.5 (2.2) 
Red, processed meat and eggs 6.9 (4.0) 6.9 (3.9) 6.9 (4.0) 
Fried and fast foods 4.5 (3.4) 4.5 (3.4) 4.6 (3.4) 
Sweets and sweet baked products 15.7 (13.6) 16.2 (13.3) 15.2 (13.8) 
Chocolate 4.0 (5.8) 4.1 (6.0) 3.9 (5.7) 
Butter and cream 4.4 (6.6) 4.7 (6.8) 4.1 (6.4) 
Spreads and dressings 8.3 (8.4) 8.4 (8.8) 8.2 (8.1) 
Soy and other milks 0.2 (0.8) 0.2 (0.8) 0.2 (0.8) 
Milk 3.9 (4.2) 3.8 (4.1) 4.0 (4.3) 
Soda 2.0 (5.2) 1.9 (5.5) 2.1 (4.9) 
Coffee 8.7 (10.4) 8.8 (10.5) 8.6 (10.4) 
Tea 19.3 (13.7) 19.5 (13.8) 19.1 (13.6) 




Table 7-3. List of food groups significantly associated with VFM and the VFM diet score 
association with VFM in the training group 
(1)
 
(1) 20 food groups were tested for their association with VFM in the training group adjusting for 
covariates (scan batch, age, BMI, total fat, height
2
, sex and family relatedness) and multiple 
testing (P<0.0025).  
(2) The VFM diet score was formed from quartile ranking the VFM-associated food groups, scoring 
them according to the direction of association and summing the scores.  
 
Based on the direction of the food group association with VFM in the training dataset, I created 
the VFM diet score and tested it in the validation sample. I found 93.21% of the subjects were 
accurately classified into low and high VFM by the diet score. Moreover, the sensitivity (true 
positive rate) and specificity (true negative rate) of the VFM diet score were 93.72% and 
92.70%, respectively. The ROC curve is displayed in Figure 7-2. The area under the receiver 
operating curve (AUC) was 0.9841 (95% CI: 0.9772; 0.9911). Notably, I found the association 
between the diet score and VFM to be significant in the VFM-discordant MZ twin sample 













Food group Beta SE  P 
Fruits -0.005 0.001 1.95x10
-5
 
Red, processed meat and eggs 0.016 0.005 3.94x10
-4
 
Fermented dairy products -0.011 0.004 1.14x10
-3
 
Fried and fast foods 0.015 0.005 1.18x10
-3
 
Whole grains -0.008 0.002 1.27x10
-3
 
VFM diet score 
(2)
  0.033 0.006 7.38x10
-9
 
Figure 7-2. Receiver operating characteristic curve for the VFM diet 





The best-fitting model for the heritability analysis of the VFM diet score was the AE model, with 
a heritability estimate of 44% (95% CI: 37%, 50%) (Table 7-4 shows details of heritability 
analysis). 
 
Table 7-4. Results of the structural equation modelling for heritability of the visceral fat 
mass diet score 
















(0.37, 0.50) - 
0.56  





(0.62, 0.73) 9090 23.40 0.000 5514 
E - - 
1.00  
(1.00, 1.00) 9192 124.70 0.000 5613 
*Best fitting model; Abbreviations: A, additive; C, common; E, environmental; df, degrees of freedom; AIC, 
Akaike’s information criterion; Incalc, incalculable.  
Structural equation modeling was performed on the visceral fat mass diet score. The best-fitting model is 
indicated by the lowest AIC.  
 
Figure 7-3 displays the nutrient profile of the VFM diet score (consult Appendix F 
Table 1 for details). Individuals scoring highly on the VFM diet score had significantly 
increased intakes of fat (notably monounsaturated fatty acids) and reduced carbohydrate 






Figure 7-3. Nutrient profile of the VFM diet score presented as percentages of the UK 
dietary reference values by tertile of the VFM diet score 
 
Average nutrient intakes by increasing tertile of the VFM diet score from clockwise (lightest to 
darkest) were assessed for percentage of the recommended intakes for 55-year-old women 
(according to the UK Dietary Reference Values (Health., 1991)). Using VFM diet score by 
tertile as the predictor of the residual energy adjusted nutrient intakes in a linear regression 
statistically significant trends (P<0.001) were observed for all nutrients, except 
polyunsaturated fatty acids, protein, zinc and vitamin D. Carotene and retinol are represented 
as percentage of the recommended intake for total retinol equivalents. There is no UK DRV 
for vitamin D therefore 10 ug/d was used. Abbreviations: SFAs, saturated fatty acids; MUFAs, 
monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; Trans, trans fatty acids; 
CHO, carbohydrates; NSP, non-starch polysaccharides; vit, vitamin. 
 
7.3.2 VFM diet score metabolomics associations  
Thirty metabolites were significantly associated (P<1.71x10
-4
) with the VFM diet, shown in 
Table 7-5. Overall, these metabolites belonged to 21 unique sub-pathways, specifically, there 
were associations with 12 lipids, 5 amino acids, 5 vitamins and cofactors, 3 carbohydrates, 3 




After I adjusted for other food group intakes (Table 7-5) all associations between the 
VFM diet score and metabolites remained (P<0.01) however 6 associations did not pass 
adjustment for multiple testing (primarily lysolipids). 
7.3.3 Metabolites associated with the VFM diet score and food groups 
independently 
Following the backward stepwise regression including all food groups, I found that 18 
metabolites were significantly (P<3.33x10
-4
 (0.05/[5 food groups x 30 metabolites])) associated 
with the food groups forming the VFM diet score (Table 7-5). Fruit intakes were associated with 
11 metabolites, suggesting it was an important influence on associations between the VFM diet 
score and metabolites. Moreover, 5 metabolites were significantly associated with whole grain 
intake, 3 metabolites with red, processed meat, and eggs, and 2 metabolites with fried and fast 
food intakes. I found associations between the food groups forming the VFM diet score and the 











VFM Score adjusted 
foods 
(2)
 Foods associated 
(3)
 
Metabolite Sub-pathway Beta (SE) P Beta (SE) P P<0.01 P<3.33x10
-4
 


























 FF (-0.023(0.007)) WG (0.013(0.003)) 




 WG (0.010(0.003)) Fruit (0.008(0.002)) 






 RM (-0.019(0.006)) Fruit (0.014(0.002)) 






 Fruit (0.006(0.002)) WG (0.014(0.003)) 
FF (-0.028(0.007)) 




  Fruit (0.010(0.002)) 
WG (0.011(0.002)) 




 WG (0.008(0.003)) Fruit (0.008(0.002)) 







  Fruit (0.010(0.002)) 






  Fruit (0.007(0.002)) 
WG (0.011(0.002)) 






  Fruit (0.011(0.002)) 





  0.039(0.007) 9.09x10
-9
  RM (0.020(0.005)) 




  0.027(0.006) 4.48x10
-5
  RM (0.022(0.005)) 
1-Arachidonoylglycerophospho-
ethanolamine* 
Lysolipid  0.038(0.007) 2.09x10
-7
  0.030(0.007) 3.43x10
-5
 WG (-0.011(0.003)) 
FD (-0.013(0.005)) 
 






  Fruit (0.007(0.002)) 





  0.026(0.007) 3.46x10
-4
  Fruit (-0.008(0.002)) 







 WG (0.008(0.003))  






















VFM Score adjusted 
foods 
(2)
 Foods associated 
(3)
 
Metabolite Sub-pathway Beta (SE) P Beta (SE) P P<0.01 P<3.33x10
-4
 






  FF (-0.020(0.006)) 
1-Oleoylglycerophosphoethanolamine Lysolipid  0.032(0.007) 9.21x10
-6
  0.023(0.007) 1.35x10
-3
 WG (-0.008(0.003))  
1-Arachidonoylglycerophosphocholine* Lysolipid  0.032(0.007) 1.76x10
-5
  0.024(0.007) 1.26x10
-3
 WG (-0.010(0.003))  






 None  
4-Androsten-3beta,17beta-diol disulfate 
1* 
Sterol, Steroid  0.032(0.008) 4.67x10
-5
  0.019(0.007) 7.86x10
-3
 None  




  0.027(0.007) 7.01x10
-5
 WG (-0.009(0.002)) 
FD (-0.015(0.005)) 
 




  0.031(0.007) 7.13x10
-6
 FD (-0.013(0.005)) RM (0.028(0.006)) 
Glycoursodeoxycholate Bile acid metabolism  0.032(0.008) 1.00x10
-4
  0.028(0.008) 5.70x10
-4
 None  
gamma-Glutamylvaline gamma-glutamyl  0.023(0.006) 1.11x10
-4
  0.023(0.006) 1.38x10
-4
 FD (-0.014(0.004)) Fruit (-0.005(0.001)) 
1-Eicosatrienoylglycerophosphocholine* Lysolipid  0.028(0.007) 1.32x10
-4
  0.020(0.007) 4.40x10
-3
 WG (-0.009(0.003))  




  0.028(0.007) 1.45x10
-4
 FF (0.015(0.006)) Fruit (-0.008(0.002)) 
FD: Fermented dairy; FF: Fried and fast foods; RM: Red meat; WG: Whole grain products
 




(2) The VFM diet score and 15 food groups not forming the score were fitted into a backward stepwise linear regression model to predict each 
significant metabolite using P<0.01 as the cut off threshold.  
(3) All 20 food groups were fitted into a backward stepwise linear regression model to predict each significant metabolite using P<0.01 as the cut 
off threshold. Significant results shown only for foods forming the VFM diet score. Associations passing the Bonferonni cut-off were considered 
statistically significant: P<3.33x10
-4








7.3.4 Metabolites associated to both the VFM diet and VFM 
I included all 30 metabolites in a backward stepwise linear regression and found 9 metabolites 
were significantly and independently associated with the VFM diet score (Table 7-6), these 
metabolites accounted for 14% of the variance in the VFM diet score. Notably, four of these 
metabolites also passed the cut-off four multiple testing (P<5.56x10
-3
). I also found 6 out of the 
9 metabolites were nominally associated (P<0.05) with both the VFM diet and VFM. The 
remaining 3 metabolites were associated only with the VFM diet and not VFM.  
I found higher scores on the VFM diet score and high VFM (independently of diet and 
total body fat) were associated with lower hippurate and bilirubin (Z,Z), and higher alpha-
hydroxyisovalerate and butyrylcarnitine (Table 7-6). Notably, in the VFM-discordant MZ twins, 
associations between VFM and butyrylcarnitine (0.199[0.087]; P=0.023) and hippurate (-
0.297[0.095]; P=0.002) were significant (Figure 7-4; Appendix G Table 2). On average, these 
four metabolites accounted for 18.5% (range: 13.5% [alpha-hydroxyisovalerate]-28.9% 





Table 7-6. List of metabolites independently associated with the VFM diet score (P<0.01 in backward linear regression), their association with 




NS= not significant: P>0.05 
(1) Thirty metabolites significantly associated with the VFM diet score (Table 7-5) were adjusted for covariates (batch effects, age, BMI and sex) 
and fitted into a backward stepwise linear regression to predict the VFM diet score using P<0.01 as the threshold cut-off.  
(2) Nine metabolites independently associated with the VFM diet score were tested for their association with VFM adjusted for covariates (age, 
batch effects, BMI, total fat, sex, height
2




(3) the proportion of the variance in VFM explained by the VFM diet score after taking into account all covariates (age, sex, BMI, height
2
, and batch 
effects). 
(4) the proportion of the variance in VFM explained by the VFM diet score after taking into account all covariates as in (1) and adjusting for the 
metabolite. 
 

























 0.0312 0.0222 28.8% 
alpha-Hydroxyisovalerate  0.38(0.10) 9.60x10
-5
  0.050(0.013) 1.65x10
-4
  0.0270 13.5% 
Butyrylcarnitine   0.33(0.10) 8.54x10
-4
  0.072(0.013) 5.86x10
-8
  0.0267 14.4% 




  0.0258 17.3% 









  0.031(0.012) 1.07x10
-2
    
Eicosapentaenoate (EPA; 20:5n3) -0.75(0.10) 1.13x10
-13
  0.020(0.012) NS    
Threonate  -0.32(0.11) 2.59x10
-3
 -0.016(0.012) NS    
X-11793--Oxidized bilirubin*  0.33(0.11) 2.63x10
-3





Figure 7-4. Comparisons of the VFM diet score, alpha diversity and top microbiome 
and metabolite associations in the low and high MZ VFM-discordant twins 
 
All variables were standardized to have mean=0, SD=1. A linear regression was conducted 
using the VFM diet score, alpha diversity (Shannon Index) and top microbiome and 
metabolite associations to predict VFM in the MZ discordant (1 SD apart in VFM) twin 
sample.  Significantly (P<0.05) higher VFM diet scores and butyrylcarnitine, and lower 
hippurate were observed with increasing VFM (*). 
 
7.3.5 VFM diet score microbiome associations 
In a subsample of 889 twins I found higher scores on the VFM diet were associated with lower 
gut microbiome diversity (Shannon Index; -0.025[0.009], P=6.26x10
-3
), after I adjusted for VFM 
this association was reduced but remained significant (-0.020[0.010], P=0.035).  
I found the VFM diet score was associated significantly with 8 OTUs (Table 7-7) and 6 
taxa (Table 7-8). However, after I adjusted for intakes of other food groups, the associations 
became nominally significant (P<0.05) (Table 7-8). 
7.3.6 Microbiome taxa associated to both the VFM diet and VFM 
I found higher abundances of the species species Eubacterium dolichum (0.057[0.019], 
P=2.73x10
-3
) was associated significantly with increased VFM and a Bifidobacterium OTU (OTU 
ID: 4426298; -0.046[0.016], P=0.005) with reduced VFM (adjusting for the VFM diet score). I 
found that 16.4% of the effect of the VFM diet score on VFM (r
2
x= 0.0238) was mediated by E. 
dolichum (r
2




7.3.7 Eubacterium dolichum and hippurate associated with both VFM and VFM 
diet 
I tested associations between those 4 metabolites significantly associated to both VFM and the 
VFM diet to determine if E. dolichum and the Bifidobacterium OTU may be related to the 
metabolomics profile. I found that higher abundances of E. dolichum were associated with lower 
levels of hippurate at the nominal level (P<0.05) after adjusting for VFM, the VFM diet score, 
Shannon Index and covariates (-0.075[0.032], P=0.021). Moreover, I found that 36.9% of the 
effect of Eubacterium dolichum on VFM (r
2
x= 0.0065) was mediated by hippurate (r
2
xy= 0.0041) 
independently of diet and covariates.  
7.3.8 Hippurate association with adipose tissue transcriptome 
Adipose tissue gene expression levels in the greater twin population, in order to provide 
potential mechanisms of the effect of hippurate on fat mass development. Higher levels of 
hippurate were associated with increased expression of neuroglobin (0.016[0.004], P=9.82x10
-
6




Table 7-7. List of OTUs associated with the VFM diet score (unadjusted and adjusted for other food intakes), their association with foods 
forming the VFM diet score and their independent association with the VFM diet score (P<0.05 in backward linear regression) 
*= statistically significant: P<0.0025; FD: fermented dairy; FF: fried and fast foods; RM: red meat; WG: whole grain products
 
(1) OTU associations with the VFM diet score were adjusted for covariates (age, Shannon Index, BMI and sex) and multiple testing (P<2.36x10
-5 
[Bonferroni: 0.05/2118 OTUs]). 
(2) The VFM diet score and 15 food groups not forming the score were fitted into a backward stepwise linear regression model to predict each 
significant OTU using P<0.05 as the cut off threshold.  
(3) All 20 food groups were fitted into a backward stepwise linear regression model to predict each significant OTU using P<0.05 as the cut off 
threshold. Significant results shown only for foods forming the VFM diet score.  
(4) OTU 4426298 is the only taxon associated with VFM independently of the VFM diet score (Beta[SE]: (-0.046[0.016]; P=0.005).
  VFM score 
(1)
 VFM score adjusted foods 
(2)
 Foods associated 
(3)
 
OTU ID Assigned Taxonomy Beta(SE) P Beta(SE) P P<0.05 
4426298 
(4)
 k__Bacteria; p__Actinobacteria; 
c__Actinobacteria; o__Bifidobacteriales; 





 FD (0.029(0.008))* 
FF (-0.022(0.010)) 
183686 k__Bacteria; p__Firmicutes; c__Clostridia; 





 RM (0.018(0.009)) 
WG (-0.016(0.004))* 







 RM (0.027(0.009))* 
 
2368865 k__Bacteria; p__Firmicutes; c__Clostridia; 





 FD (0.031(0.006))* 
509709 k__Bacteria; p__Firmicutes; c__Clostridia; 









k__Bacteria; p__Bacteroidetes; c__Bacteroidia; 





 WG (-0.011(0.004)) 







 Fruit (0.006(0.002)) 
2407149 k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Lachnospiraceae; g__; s__ 
-0.043(0.010) 2.24x10
-5




 Table 7-8. List of taxa associated with the VFM diet score (unadjusted and adjusted for other food intakes), their association with foods 
forming the VFM diet score and their independent association with the VFM diet score (P<0.05 in backward linear regression) 
*= statistically significant: P<0.0025: FF: Fried and fast foods; RM: Red meat; WG: Whole grain products
 
(1) Taxa associations with the VFM diet score were adjusted for covariates (age, Shannon Index, BMI and sex) and multiple testing.  
(2) The VFM diet score and 15 food groups not forming the score were fitted into a backward stepwise linear regression model to predict each 
significant taxon using P<0.05 as the cut off threshold.  
(3) All 20 food groups were fitted into a backward stepwise linear regression model to predict each significant taxon using P<0.05 as the cut off 
threshold. Significant results shown only for foods forming the VFM diet score.  







 VFM Score adjusted foods 
(2)
 Foods associated 
(3)
 
Taxon Level beta(SE) P beta(SE) P P<0.05 
Actinomyces genus  0.052(0.011) 9.77x10
-7
  0.052(0.011) 9.77x10
-7
 FF (0.028(0.009))* 
RM (0.027(0.008))* 




 Fruit (0.006(0.002)) 
Actinomycetaceae family  0.043(0.011) 5.47x10
-5
  0.043(0.011) 5.47x10
-5




 species  0.042(0.011) 8.47x10
-5
  0.043(0.011) 6.19x10
-5
 WG (-0.010(0.004)) 















In this chapter, I developed a dietary VFM risk score and evaluated it against blood 
metabolomics and faecal microbiome profiles. I characterised the metabolomics profile of the 
VFM dietary pattern and additionally found a specific gut bacterial species to associate with this 
pattern and VFM independently of confounders such as age, BMI and total fat mass. In 
particular, using this novel dataset I found the species E. dolichum in the gut and hippurate in 
blood may connect an unhealthy diet to VFM. 
The score I created was strongly predictive of VFM in the TwinsUK cohort, and it was 
replicated VFM-discordant MZ twins. This allowed me to further explore the potential effects of 
diet on VFM development through metabolomics and microbiome methods. Overall, I found 4 
metabolites were significantly associated with both the VFM diet score and VFM (after adjusting 
for diet). These metabolites also accounted for some portion of the variance in the association 
between the VFM diet score and VFM. Specifically lower levels of hippurate and bilirubin (Z,Z), 
and higher levels of alpha-hydroxyisovalerate and butyrylcarnitine were associated with higher 
VFM diet scores and VFM. Both alpha-hydroxyisovalerate and butyrylcarnitine are metabolites 
involved in BCAA catabolism and fatty acid metabolism, both have previously been shown to be 
higher in obese children (Butte et al., 2015) and adults (Moore et al., 2014). In particular, alpha-
hydroxyisovalerate has been found to predict insulin resistance and glucose intolerance well 
(Gall et al., 2010, Varvel et al., 2014). Higher levels of both alpha-hydroxyisovalerate and 
butyrylcarnitine were associated with increased intakes of red and processed meats and eggs. 
Although animal sources of fats and protein have yet to be connected to deranged BCAA 
metabolism in humans, a previous study has shown through feeding mice a HF diet the addition 
of BCAA (which are primarily sourced from animal-derived proteins) aggravates insulin 
resistance by activating the mTOR kinase pathway (Newgard et al., 2009).  
Bilirubin is an endogenous anti-oxidant that also has roles in haemoglobin and 
porphyrin metabolism. Similar to my findings, reduced levels of serum bilirubin have been 
associated with increased abdominal adiposity and metabolic derangements (Wu et al., 2011b, 
Kwon et al., 2011, Jenko-Praznikar et al., 2013). I found increased reported consumption of 
fried and fast foods were associated with reduced bilirubin (Z,Z). A previous study identified 
reported intakes of total fatty acids were correlated with reduced bilirubin in serum (Jenko-




oxidative stress depleting bilirubin. In support of this, increased intakes of fried and fast foods 
were associated with reduced levels of EPA and increased proline (related to collagen 
breakdown (Palka, 1996)) that might suggest higher inflammation and oxidative stress 
(Krishnan et al., 2008). Moreover, vegetable oil frying also lowers polyphenols and was shown 
to increase liver microsomal lipid peroxides when fed to mice (Quiles et al., 2002).  
The primary metabolite connecting diet to VFM was hippurate. Overall, reduced levels 
of hippurate in blood were associated with higher VFM, a finding that I additionally replicated in 
VFM-discordant MZ twins, the VFM dietary score and E. dolichum in the gut. Hippurate is a 
glycine conjugate of benzoic acid formed in the mitochondria of the liver (Gatley and Sherratt, 
1977) and kidneys (Temellini et al., 1993), but is also a is a mammalian-microbial co-metabolite 
formed by gut bacterial metabolism of dietary components, in particular polyphenols (Gonthier 
et al., 2003, Walsh et al., 2007), to produce benzoic acid. I found increased levels of hippurate 
to be independently associated with higher intakes of fruit and whole grain products, which are 
high in polyphenols. Concerning obesity and metabolic diseases animal models which have 
shown reduced hippuric acid urinary excretion in obesity (Shearer et al., 2008, Waldram et al., 
2009, Calvani et al., 2010) and higher levels in Type II diabetes (Williams et al., 2005) 
compared to controls. To my knowledge no human studies to date have extensively evaluated 
the relationship between VFM and blood metabolite biomarkers of dietary polyphenol 
consumption, including hippurate. Although in the previous chapter I found hippurate to be 
positively associated with microbiome diversity as well as inversely associated with MetS risk. 
Interestingly, I also identified higher levels of hippurate in blood to be associated with increased 
expression of neuroglobin in adipose tissue. Neuroglobin, is a globin protein expressed mainly 
in neurons and some endocrine tissues (Burmester et al., 2000), it has roles in protecting cells 
against hypoxia and oxidative stress (Burmester et al., 2007). Hypoxia, which is a lack of 
oxygen reaching tissues, has emerged in recent studies as an important mechanism in the 
progression of adipose tissue dysfunction (Kim et al., 2014). This finding suggests a mechanism 
in which hippurate could protect against adipose tissue dysfunction and resultant VFM 
development.  
E. dolichum is a bacterial species belonging to the family Erysipelotrichaceae, 
increased abundances of E. dolichum were associated with higher dietary VFM scores and 
VFM (independently of diet). This finding suggests this microbe may contribute to VFM 




murine model of Western-style diet induced obesity, abundances of E. dolichum were increased 
(Turnbaugh et al., 2008), additionally further metagenomics analysis showed the E. dolichum 
genome may be enriched for genes that allow this microbe to have an advantage under a 
Western-style diet as it is enriched for phosphotransferase proteins which have roles in the 
import and metabolism of simple sugars. An additional study of Japanese quail strains 
(atherosclerotic-resistant and non-resistant) showed increased E. dolichum abundance in 
atherosclerotic-resistant quails compared to control when fed a high cholesterol diet (Liu et al., 
2015). I believe this is the first human study to find a connection between E. dolichum and a diet 
high in fat and low in fibre and micronutrients however I do not believe there to be literature on 
the mechanisms of the effect of this species on VFM development. It may be that the 
relationship between E. dolichum and VFM is primarily an artefact of poor diet and not 
specifically contributing to VFM, however the association was unaffected when adjusted for the 
diet score. Within TwinsUK higher abundances of E. dolichum have associated with increased 
scores on the frailty index, a finding that remained strong after adjustment for diet and diversity 
(Jackson et al., 2016b). The association I found between E. dolichum and hippurate is difficult to 
untangle with my limited dataset, though should be assessed in future studies.  
This chapter had many strengths. I believe this to be the first large-scale study applying 
multi-omic methods to explore the effect of diet on VFM. The food intake associations with VFM 
replicate findings from previous studies, this confirms the strength and validity of the dietary 
VFM score. In particular, I replicated associations from previous studies finding higher reported 
intakes of fruit (Romaguera et al., 2011), dairy products (Romaguera et al., 2011), and whole 
grains (Caron-Jobin et al., 2011) with reduced VFM or WC, while higher intakes of fried and 
fatty foods (Mollard et al., 2014, Romaguera et al., 2011) and red and processed meats 
(Romaguera et al., 2011) with increased VFM or WC. Similar to VFM (Direk et al., 2013), I found 
the dietary risk score determined strongly by genetics (h
2
: 44%) this is in line with previous 
studies suggesting the heritability of an ‘unhealthy’ diet pattern ranges from 33 to 50 % (Pallister 
et al., 2014). I also experienced a number of limitations throughout this chapter. The study 
population was mainly females and my results may not apply to men. Due to the cross-sectional 
nature of the study, I cannot attribute cause and effect to my findings. I adjusted for a large 
number of potential confounders, though I still face possible residual or unmeasured 
confounding due to other unmeasured factors or measurement error. Although, as I did adjust 




would totally account for my results. The measurement of the gut microbiome was further limited 
by using 16S gene sequencing. Subsequent investigations using more accurate metagenomic 
methods may allow for a more thorough examination into microbe-metabolite interactions at the 
functional level. I used a variety of time points for sampling, however it is likely my results may 
be enhanced if the same time point was used throughout. I also did not have repeated 
measurements for individuals and therefore I could not evaluate intra-individual variation. 
Finally, I was not able to replicate my findings in an independent population, despite this I was 
able to replicate top association in MZ VFM-discordant twins that are matched for age, gender 
and the baseline genetic sequence.  
 
Conclusions 
An unhealthy dietary is an important influence on VFM. In this chapter I connected a dietary 
VFM score and VFM to a single gut microbial species and blood metabolites. In particular, I 
found the species E. dolichum seems to link a dietary pattern with low in fruit, whole grains and 
fermented dairy product intakes and high red, processed meat and eggs, and fried and fast 
foods intakes to VFM, which was independent of BMI and total fat mass. Additionally, I found 
hippurate, an important benzoate and microbial co-metabolite, to link these features to the 
microbiome. Finally, I found hippurate to associate with neuroglobin expression in adipose 
tissue, alluding to a potential mechanism of interaction. In the future, studies may aim to verify 
my findings through dietary intervention and establish further how our findings influence long-





Chapter 8 Conclusions and suggested future directions  
 
Metabolomics has emerged from this work as a key application for furthering nutrition research. 
Through examining the metabolome in a bodily system, specific organ, tissue or cell, 
information is provided as to the metabolic state of an individual. Nutrition and the metabolome 
are highly related as nutrients and non-nutrient food constituents supply chemical components 
to the body, although separating these contributions can be challenging (Gibney et al., 2005). In 
spite of this, using self-reported food intakes candidate biomarkers have been identified within 
the metabolome in this study and others (O'Sullivan et al., 2011, Altmaier et al., 2011, Guertin et 
al., 2014b), validating this approach. However, the genetic effect on the metabolite profile is 
highly variable (Suhre et al., 2011), as such application of the co-twin control method can 
provide an excelled way to further metabolomics studies by providing cases and controls 
matched for age, sex and genetics.  
In this thesis, through using metabolomics in collaboration with self-reported dietary 
intakes I have identified a number of candidate biomarkers that can be used and assessed in 
subsequent epidemiology studies. I evaluated the utility of using metabolite scores to assess 
food intakes and applied the scores to study the odds of developing MetS. I used metabolites to 
investigate the metabolomics signature of gut microbiome diversity and connected increased 
levels of hippurate in blood to intakes of foods high in polyphenols, diversity and lower odds of 
developing MetS. Finally, I attempted to untangle the influence of a diet predictive of VFM on 
VFM development and found blood levels of hippurate and E. dolichum in the gut may be 
important links. Throughout each chapter I used discordant MZ twins who are controlled for age, 
sex and the baseline genetic sequence to validate my findings. In the discussion below I have 
highlighted the key findings from each chapter. 
 
Key points/learning from the thesis  
Chapter 4: Metabolite-food intake discovery analysis 
 Self reported food intakes correlate strongly with levels of blood metabolites. 
 Of 601 total metabolites assessed, 128 metabolites (21.3%) were associated with food 
intakes and dietary patterns using stringent cut-offs for multiple testing. 
 Wine intake and seafood/fish intakes yielded the strongest and most abundant results, 




 72 food intake-metabolite associations were novel: including associations between 
mushroom intake and ergothioneine, apples/pear and 3-phenylpropionate, and meat 
intake and trans-4-hydroxyproline. 
 Assessing both dietary patterns and specific food group intakes yielded unique results.  
Chapter 5: Metabolite-food scores 
 Creating metabolite scores provided an advantage over using single metabolites to 
measure food intakes.  
 Differences between each of the methods to create the scores were negligible, though 
the weighted method performed the best. 
 Metabolite scores performed moderately for alcohol (AUC>0.8) and (AUC>0.7) for fruit, 
whole grains, seafood, fried foods, tea and coffee. 
 Metabolite scores for seafood, whole grains, and butter and creams were associated 
with a reduced odds of future MetS, a finding not replicated by intake data. 
Chapter 6: Metabolite markers of gut microbiome diversity 
 Gut microbiome alpha-diversity was associated with five blood metabolites: hippurate, 
p-cresol sulfate, phenylacetylglutamine and 3-phenylpropionate which were associated 
positively; and negatively with hyodeoxycholate 
 Hippurate, a benzoate metabolite derived from polyphenols, was associated with 
intakes of fruit and whole grains cross-sectionally and longitudinally. 
 Hippurate was positively associated with OTUs and collapsed taxa within the family 
Ruminococcacea.  
 Hippurate was negatively associated with OTUs and collapsed taxa within the 
Firmicutes phyla, the family Lachnospiraceae, the class Erysipelotrichi, and the order 
Actinomycetales.  
 Longitudinal hippurate levels were associated with a reduced odds of MetS, which was 
largely mediated by Shannon diversity (61.1%). 
Chapter 7: Dietary VFM score and metabolomic and microbiome profiles 
 Creating a diet score was a robust means to predict VFM 
 The dietary risk score had a strong metabolomics signature: associating with 30 
metabolites  
 Notably, in blood lower hippurate and bilirubin (Z,Z) levels, and higher alpha-
hydroxyisovalerate and butyrlcarnitine levels were associated to increased VFM and the 
VFM diet score.   
 Increased abundances of the collapsed taxonomy assigned to Eubacterium dolichum 
was associated with both increased VFM and the VFM diet score 
 Increased Eubacterium dolichum adbundances were associated with reduced blood 
hippurate and adipose tissue expression of neuroglobin, a protein protective of hypoxia 
and oxidative stress. 
 
Chapter 4: Metabolite-food intake discovery analysis 
I explored all metabolomic associations with reported food intakes and dietary patterns and 
used MZ twins discordant for food intakes to validate the findings. Overall, I identified and 
validated 128 metabolites to be associated between self-reported food intakes and diet 
patterns. To my knowledge, 72 metabolite associations with food intakes were novel (have not 




et al., 2014)). Identifying this many novel associations is encouraging for future dietary 
metabolomics studies suggesting there is much potential within the metabolome. Moreover, that 
I replicated many findings from previous studies further supports the methods used. 
Interestingly, 21 metabolites were associated to dietary patterns not items which may suggest 
that through measuring dietary patterns we are able to capture information not obtained by 
measuring single foods independently. In my analysis, I did not attempt to assess the utility of 
using single food items versus combined biomarkers of dietary patterns when applied to other 
indicators of health such as MetS, fasting blood glucose, waist circumference or BMI, which 
could be an area for future studies. Certainly a larger number of metabolites representing 
diverse metabolic pathways are associated with dietary patterns highlighting this potential area 
of importance. Although, my results with principal components patterns are population-specific 
and therefore cannot be replicated, which is why I chose to analyse the Mediterranean diet 
using an a priori method. This method yielded a lower number of associations than the 
comparable Fruit and Vegetable PC pattern, though this also highlights that the Mediterranean 
diet score has limitations, which have been outlined previously (Hoffman and Gerber, 2013). 
Moreover, I did not find any metabolite-associated SNPs to be related to food intake, though 
more precise food intake data or using combined genetic risk may have a stronger effect. 
Moreover, testing these SNPs or combined genetic risk SNPs to examine gene-diet interactions 
are a potential area for future study.  I used discordant MZ twins as a validation population 
which was very stringent criteria, though this strongly supports the value of the associations I 
identified. Future large-scale feeding studies need to be undertaken to confirm our associations, 
to properly quantify effects and also to determine the origin of the associations (e.g. whether the 
metabolite is derived from a food itself and its quantity in food). Further adding to the complexity 
of associations are intermediate processes such as one’s genetic makeup and the influence of 
gut bacteria metabolism. Finally, 32 metabolites that were associated to food intakes and 29 to 
dietary patterns are currently not identified but in the future may provide useful metabolic 
insights.  
 
Chapter 5: Metabolite-food scores 
For the Chapter 5 analysis, I created metabolite scores (when there were multiple metabolites 
associated to a food) using three methods (quartile ranking, continuous scoring and weighted) 




time this was done before and certainly with such a large dataset. In the training dataset, I was 
able to form metabolite scores for fifteen different food groups (vegetables, fruit, whole grains, 
nuts and legumes, seafood, white meat, red meat, fried foods, sweets and sweet baked 
products, butter and cream, spreads and dressings, milk, tea, coffee and alcohol). To form 
these groups I used highly stringent methods: associations must have passed multiple testing 
cut-offs, been replicated in MZ discordant twins and maintained significance following the data 
reduction steps. Of course, the methods I used may have been too stringent and I may have 
formed more powerful groups if I had used more metabolites, on the other hand, if my results 
were to be replicated this would be easier done with fewer metabolites. Nonetheless, I 
replicated my results in the testing group, therefore at least some of these scores should 
translate as important markers in independent populations. As for the performance of the 
scores, they generally performed better than the top single metabolite and the weighted method 
tended to perform best although differences were negligible. At predicting high and low 
consumers in the test group, metabolite scores performed well (AUC>0.8) for alcohol and 
reasonably (AUC>0.7) for fruit, whole grains, seafood, fried foods, tea and coffee. Moreover, I 
applied a unique method by using food group liking as an alternative way of indicating food 
intakes, I found metabolite scores for all groups but vegetables, white meat and spreads and 
dressings to correlate with reported food liking which also supported the results of the ROC 
analysis. Based on my findings from this analysis, each scoring method appears to be suitable 
for use in biomarker studies, though due to its simplicity, the continuous method (multiplying 
metabolite concentrations according to the association direction and summing) may be ideal, 
especially in studies using multiple populations.  
In the second part of the chapter, I used validated metabolite scores to examine their 
association with MetS and its components in the twins at least 5 years after metabolomics 
profiling. I found high levels of metabolites correlated to consumption of seafood, whole grains 
and butter and cream intakes to associate with a lower risk of MetS. Although reported intakes 
did not reflect these findings in our sample. However, the dataset I used to examine these 
associations was very small and only 25 twins developed MetS in later years. Therefore, further 
analysis could be done on dataset with a larger number of cases. Although, the ability to identify 
an association with MetS with such a small sample size might be encouraging for the usage of 




to be used as pre-disease markers of dietary risk in a personalised medicine setting is an 
exciting area for further development.  
 
Chapter 6: Metabolite markers of gut microbiome diversity 
 I found five blood metabolites correlated with gut microbiome diversity (hippurate, p-cresol 
sulfate, phenylacetylglutamine and 3-phenylpropionate which were associated positively; and 
negatively with hyodeoxycholate) and examined their association with diet and relationship with 
MetS. Figure 8-1 shows a summary of the findings. Overall, higher levels of hippurate in blood 
were the strongest correlate of increased gut microbiome diversity, which was validated in MZ 
twins discordant for diversity. Hippurate was also associated with reported food intakes and I 
therefore examined it more thoroughly. Hippurate is a metabolite derived from benzoic acid 
which is primarily produced by gut bacterial metabolism of dietary phenolic acid (Gonthier et al., 
2003). Supported by previous studies (Gonthier et al., 2003, Walsh et al., 2007), reported 
intakes of high polyphenol-containing foods, whole grains, fruits and coffee, were significantly 
predictive of longitudinal changes in blood hippurate levels. In the faecal microbiome I 
characterised a gut microbiome profile correlated with blood hippurate levels and overall 
identified 46 associations. This included higher hippurate levels being associated with lower 
levels of Firmicutes phyla overall, and lower and higher levels of Lachnospiraceae and 
Ruminococcaceae, respectively. Interestingly, both Lachnospiraceae and Ruminococcaceae 
are butyrate-producing bacteria (Vital et al., 2014), therefore measuring faecal short-chain fatty 
acid production may be an interesting area future investigation. Comparing those OTUs/taxa 
associated with hippurate, I found 5 OTUs and 5 collapsed taxa to be associated to the the 
hippurate diet score as well, suggesting food intake may modify hippurate production through 
enriching these bacteria, though this would need to be confirmed by feeding studies. I had the 
advantage of using longitudinal hippurate data and found an increasing trajectory to be 
associated with a reduced odds of later having MetS, reduced BMI and TG. The longitudinal 
metabolite data certainly provided a strong advantage to this analysis, though Shannon diversity 
accounted for 61.1% of the variance in the association between the hippurate trajectory and 
MetS, suggesting that Shannon diversity was strongly driving this association. Although, the 
dietary factors were not associated with MetS, which may be related to less measurement 
precision. Untangling the dietary influence of hippurate and Shannon diversity on MetS and its 




influencing diversity, the gut microbiome profile and hippurate production though separating the 
effect of diet is a challenge. It is important to consider whether there are diet-microbe 
interactions in the formation of hippurate, I attempted to investigate this but did not find any 
associations, potentially due to the limited precision of the dataset but also the time between 
sample collection and FFQ completion may be of relevance. It is likely some individuals have a 
gut microbiome profile with an increased capacity for hippurate production and therefore 
increased ability to handle oxidative stress, a central component of metabolic diseases. 
However no clear patterns of microbes emerged. Future dietary intervention studies should test 
our findings by feeding individuals high polyphenol-containing foods and testing the changes 
induced on the microbiome, and blood hippurate levels. Longer-term studies should explore the 
influence of hippurate on MetS.  
Figure 8-1. Summary of findings from Chapater 6 
Figure 8-1a represents increased gut microbiome diversity correlates with increased blood 
hippurate. Figure 8-1b represents increased intakes of high polyphenol foods (whole grains, 
coffee and fruits) predict an increasing hippurate trajectory. Moreover, an increasing hippurate 
trajectory correlates with lower risk of MetS (metabolic syndrome) at endpoint. Images have 
been obtained and modified from google search under the usage right option ‘labelled for reuse 
with modification’. 
 
Chapter 7: Dietary VFM score and metabolomic and microbiome profiles 
I identified foods most strongly associated with VFM and developed and validated a predictive 
dietary VFM-risk score. I also characterised the blood metabolomics and gut microbiome 
profiles associated with the dietary VFM-risk score and VFM. Figure 8-2 shows a summary of 




were associated with increased VFM while intakes of fruits, fermented dairy products, and 
whole grain products were associated with lower VFM, moreover the dietary risk score was 
highly predictive of VFM correctly identifying 92.7% of twins in the upper and lower tertiles of 
VFM. The dietary risk score had a strong metabolomics signature, associating with 30 
metabolites, many of which were associated to food intakes in the first and second chapters. 
After data reduction, I found 4 metabolites were associated with both increased VFM and the 
VFM-diet, including reduced hippurate and bilirubin (Z,Z) (involved in hemoglobin and porphyrin 
metabolism), and increased alpha-hydroxyisovalerate (involved in valine, leucine and isoleucine 
metabolism) and butyrylcarnitine (involved in fatty acid and BCAA metabolism). It is 
encouraging that hippurate was found to associate with future MetS in Chapter 6 and also with 
VFM, as waist circumference is a component of MetS.  
The VFM diet score was also associated with 6 collapsed taxa and 8 OTUs, within the 
faecal microbiome, though only 1 Bifidobacterium OTU and 1 taxa, Eubacterium dolichum was 
associated with both VFM and the VFM-diet. Interestingly, increased levels of E. dolichum 
associated with a reduced level of hippurate in blood. Upon further investigation I found 
increased hippurate in blood to be associated with elevated adipose tissue expression of 
neuroglobin (Burmester et al., 2000) a protein which protects cells against hypoxia and 
oxidative stress (Burmester et al., 2007), the importance of hypoxia in the development adipose 
tissue dysfunction has recently emerged (Kim et al., 2014). This may also suggest that 
hippurate protects against adipose tissue dysfunction and VFM development as a result. It 
would be useful if mechanistic studies were performed to confirm if hippurate plays a protective 
role in adipose tissue dysfunction and also, importantly, determine the function of neuroglobin in 
adipose tissue as no studies have outlined this before. Abundance of the species Eubacterium 
dolichum has previously shown to increase in mice fed a Western-style diet high in saturated fat 
and simple carbohydrates and low in plant polysaccharides (Turnbaugh et al., 2008). This study 
on mice found E. dolichum to function in the import and processing of simple sugars 
(Turnbaugh et al., 2008), using metagenomics analysis of the microbiome data from my study 
could be used to confirm their findings (Turnbaugh et al., 2008). To my knowledge this is the 
first time a relationship between Eubacterium dolichum and a poor diet has been made in 
humans and the usefulness of this marker for epidemiology and clinical studies when diet 





Figure 8-2. Summary of findings from Chapter 7 
Figure 8-2 represents the visceral fat mass (VFM) diet which is composed of high intakes of 
fried and fast foods and red processed meat and eggs and low intakes of fruits, whole grains 
and fermented dairy products. The VFM diet and VFM correlate with lower levels of blood 
hipurate and faecal Eubacterium dolichum. The color of the arrows represent direction 
protective of VFM: red, increased VFM; green, lower VFM. Images have been obtained and 
modified from google search under the usage right option ‘labelled for reuse with modification’. 
 
What I learned and challenges  
In general I found using FFQ data throughout the thesis to be problematic. Though I did have 
success in finding associations, to bring the field forward we will need to step away from using 
FFQs and begin to apply intervention studies or use more detailed dietary data (such as food 
records). I also found defining food intake groups to be problematic. Although it is a common 
practice in nutritional epidemiology, statistically intakes of the foods included within these food 
groups are not always correlated and therefore I found providing a logical reasoning for group 
assignment or understanding the biological mechanisms for the metabolite associations was 
challenging. Moreover, the relative importance of a single food as opposed to dietary patterns is 
difficult to ascertain. I did learn how to conduct a principal component dietary pattern analysis, 
though whether these patterns are more reflective of patterns in reporting rather than true 
behaviours is a question that requires asking. I recognise that FFQ data is the best data I had 
access to for the study and for some foods it is better at capturing habitual consumption for (e.g. 
coffee and alcohol).  
I also learned that there are many ways to analyse metabolomics data. In the field of 
metabolomics it is a common practice to perform dimension reduction techniques (such as PCA 




my thesis may have been quite different if I had first undertaken dimension reduction 
techniques. For one, I would have had less risk for false negative associations with fewer 
variables. However, it is likely that not all of the metabolites included in latent variables (e.g. 
PCs) would be directly related to the intake of a food, similar to the issue that not all foods 
included in a food group are likely to explain a metabolite association. Had I undertaken 
dimension reduction it would also have been challenging to unravel the reasoning for 
correlations between certain metabolites.  
Throughout my work I learned and employed the co-twin control method that was a 
unique aspect of the thesis as a whole. One issue I did have was with defining discordance for 
food intake data. As FFQ data is not precise using a 1 SD cut-off for discordance may not have 
been an ideal definition for all foods. The significant food-metabolite associations I found in 
discordant MZ twins may have just been a reflection of improved accuracy of the FFQ to 
measure certain food intakes. It may have been better to define MZ discordance as one twin 
consuming a food while the other does not, though likely there would have been fewer 
instances of these and it would have been food-dependent. The twin model does have potential 
for further exploitation especially in the context of dietary intervention studies, where twin 
studies are few. Despite all of these challenges I encountered, I do believe that metabolomics 
has strong potential for improving our understanding of the relationship between diet and 
disease and we should continue the work being done in this field. 
 
Future directions and conclusion 
Dietary metabolomics research is still very much in its infancy and there are a number of issues 
which need to be overcome before the ideal clinical test panel of dietary biomarkers to measure 
food intake status can be achieved. To take the field forward, I have specific recommendations 
regarding the work I undertook in this thesis (providing Chapter 7 as an example) and general 
recommendations concerning the field as a whole.  
With regards to carrying the work I undertook in this thesis forward, I would recommend the 
following: 
1. Replication of significant results in independent cohorts using similar 
datasets 
2. Repeating the analysis with new metabolomics platforms 
3. Dietary intervention:  





b. To evaluate metabolomics and microbiome findings 
with the metabolic phenotypes studied (VFM and MetS 
[plus components]) 
Due to the very good predictive performance of the VFM dietary risk score, I would 
suggest undertaking a 4- or 5-week dietary intervention modelled after the score. Ideally, this 
could also be done as a cross-over study where for one phase a VFM-risk diet is consumed 
while during the other phase a VFM-protective diet is consumed, separated by a washout 
period.  Therefore, for the VMF-risk phase, the diet would consist of low intakes of fruit, whole 
grains and fermented dairy products and increased intakes of fried and fast foods and red, 
processed meat and eggs, and the opposite for the VFM-protective phase. A challenge may be 
determining the ideal quantities of foods to be consumed and the incorporation of other foods to 
ensure a balanced diet. This could involve collecting subject food records prior to beginning the 
study and personalising the diets to ensure compliance and real-world applicability of the 
findings, though this would utilize more time and resources. Visceral fat mass, faecal 
microbiome and blood metabolomics data would be measured at the beginning and end of each 
phase.  
To analyse the data I would aim to confirm the findings from my analysis in the greater 
twin dataset. Therefore I hypothesize that following a diet high in fried and fast foods and red, 
processed met and eggs, and low in fruit, whole grains and fermented dairy products will 
increase VFM, alpha-hydroxyisoverate, butyrlcarnitine and E. dolichum, and reduce levels of 
hippurate and bilirubin (Z,Z). However, if the same technologies were used it could be 
interesting to confirm if overall results using all metabolites and microbiome phenotypes are 
comparable to my findings in the larger twin dataset. Moreover, twin modelling could be an 
asset, for instance to determine if MZ twins are more alike than DZ twins in their response to the 
intervention, or through using the co-twin control method, which in this case could be confirming 
the hypothesis using MZ twins discordant for feeding (e.g. comparing endpoint phenotypes of 
one twin fed the VFM-risk diet compared to baseline phenotypes of other twin).   
 
General areas to further nutritional metabolomics studies    
For the future of nutritional metabolomics there are a number of issues to be resolved, some of 
which I encountered, and areas of research which require further exploration to strengthen the 
field. For instance, many of the associations I identified were with metabolites endogenous to 




effect of food consumption on levels is complex. The food metabolome potentially contains 
many metabolites that are exogenous to the human body and therefore are less influenced by 
metabolic processes, though it may be more difficult to obtain biological information on these 
metabolites. Delving deeper into the food metabolome therefore may be useful, this would also 
involve compiling more complete metabolomics profiles of foods into databases, which is now 
already taking place (Scalbert et al., 2014), such as the FooDB (www.foodb.ca), Phenol-
Explorer (www.phenol-explorer.eu) and PhytoHub (www.phytohub.eu). Moreover, careful 
intervention studies are needed to evaluate the utility of biomarkers, whether they are applicable 
for short (hours/days) or long-term usage (months/years), as well as the relevance of the type of 
biosample provided (e.g. urine vs blood). Feeding studies evaluating short-term biomarkers 
within exposure are of course the easiest to undertake whereas longer-term studies will be 
more challenging due to difficulties such as participant compliance and cost factors, however 
these will be more valuable.  
The generalisability of my findings to both males and females and determining racial 
effects have also not been thoroughly explored here nor in many other studies. One study found 
one third of metabolites were influenced by sex, with network analysis revealing sex-specific 
metabolic pathways (Krumsiek et al., 2015). Racial effects have not been well characterised, 
though one study found distinct differences between the metabolomics profiles of Caucasians 
versus African Americans in response to atenolol treatment (Wikoff et al., 2013), I did however 
confirm some of the top findings from two food metabolomics studies on African Americans 
(Zheng et al., 2014).  
Longitudinal data of metabolite levels, which I was able to have access to for hippurate, 
will likely provide stronger correlations with intakes and power for outcome prediction, improving 
studies more still. In additions, repeating the findings of my study with more advanced platforms 
measuring more metabolites and with increased quantitative accuracy (such as NMR-based 
metabolomics) will likely generate further novel findings. Applications of food intake biomarkers 
to study disease outcomes is one of the primary aims of the research and future studies should 
begin to apply these methods, for which longitudinal data will be a particular asset.   
Interactions between the human gut microbiome and diet and the subsequent influence 
on metabolism are not well characterised at this time therefore future studies are needed. One 
way this could be taken further is through re-analysing the gut microbiome data used in my 




with hippurate or the VFM diet. Analysing the faecal metabolome would add further information. 
Another continuing issue with microbiome data is that methods have not been effectively 
established, for instance studies are quite heterogeneous with regards to quality control 
procedures and referencing panels used making cross-study comparisons difficult. Even within 
my thesis, two different referencing methods were used for chapters 6 and 7. This meant that it 
was difficult to compare results across the thesis, it may have been useful if I had repeated the 
analysis using the same datasets for both chapters. To aid this and other issues collaboration 
between cohorts is essential. 
Conclusion 
In conclusion, I have shown that metabolomics has great promise for furthering nutrition 
research. Using high-throughput omic data and a unique human cohort I have generated a 
number of novel and exciting findings. In particular, I found unique correlations between food 
intakes and metabolites, I evaluated different methods for creating combined metabolite scores, 
I identified hippurate as a useful blood marker of gut microbiome diversity that is also related to 
diet and MetS and VFM. I also characterised the metabolomics and microbiome profile of an 
unhealthy diet associated with VFM. I have shown the broad applications of metabolomics to 
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Appendix A. Chapter 1 Appendices 
Table 1. Selection of twin studies estimating heritability of energy and macronutrient intakes (from Pallister et al., 2014).* 
Author Sex Age 
Dietary 
assessment 







 Macronutrient intake 
 Grams per day  Percent energy 
 Fat Protein CHO Fat Protein CHO 




Male + female 
(n = 3605) 






  11 12 9  10 8 9 
Liu et al. 
(2013) 
Male + female 
(n = 358) 
11-13  
(x̄ = 11.8) 
3-day diet diary USC Twin Study 
(US) 
94 MZ  
85 DZ 
48  44 31 43     




Male + female 
(n = 108) 








33         





(n = 46) 
19-58  
(x̄= 39.2) 
3-day diet diary Toronto Twin 
Register 
(Canada) 
13 MZ  
10 DZ 
    11 ns  -
f
 20 ns 66  48 
ns 
70 67 




Male + female 
(n = 400) 
17-66  
(x̄ = 36) 
4-day food diary Australia 106 MZ 
94 DZ 
    38 ns  24 ns   8 ns 31 ns     
        SFA:  
10 ns  
 SC:  
20 ns  
 
    
        MUFA: 
33 ns       
 CC:  
55  
 
    
        PUFA: 
3 ns  
 
      




Male + female 
(n = 390) 






  51  
(47) 
 57  
(58) 
  61  
 (64) 
    
Hasselbalch 
et al. (2008) 
Male & female 
(n = 1212)  
18-67  
(x̄ = 38) 
247-item FFQ Geminakar 
(Denmark) 
600          
        Males     38      36
g
 28 36 









Male + female 
(n = 335) 
18-77  
(x̄ = 42.4) 
67-item FFQ MSTRA (Multi-
national) 
66 MZ  
51 DZ 
       32      
      (40)
e
 
 35 16 ns 25     
        SFA:  
37 
 
 SC:  
24 ns  
    
        PUFA:  
46  
 CC: 
18 ns  
    
FFQ, food frequency questionnaire; USC, University of Southern California; MSTRA, Minnesota Study of Twins Reared Apart; MZ, monozygotic; DZ, dizygotic; ns, not significant (confidence interval spans 
0); SFA, saturated fat; MUFA, monounsaturated fat; PUFA, polyunsaturated fat; CHO, carbohydrates; SC, simple carbohydrates; CC, complex carbohydrates.  
*Heritability estimates are derived from the additive genetic effect value (a2) calculated using structural equation modelling techniques as outlined by (Neale et al., 1992) unless otherwise specified. Twin pairs 
are same-sex.  Ages are in years, unless otherwise specified. Energy intakes were calculated in kilocalories unless otherwise specified. 
aValues are age- and sex- adjusted. Energy intake calculated in kilojoules.  
bAge and sex-adjusted total caloric intake/meal heritability estimated only. 
cHeritability estimates were calculated via Holzingers’ H [(DZ variance-MZ variance)/DZ variance] or Falconer [2(rMZ-rDZ)] equations.  
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dHeritability estimated using the LISREL method. Heritability per meal is provided in paratheses.  
eTwins reared apart study. Weight-adjusted heritability in parentheses (kilocalories/kg). Values are age- and gender- adjusted. 
fMZ within-pair exceeded between-pair mean square. 
gHeritability estimate derived from non-additive genetic effects (d2) due to correlation coefficient between MZ two times greater than DZ twins. 
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Table 2. Selection of twin studies estimating heritability of empirically derived food intake patterns (from Pallister et al., 2014).*  








count Dietary factor Description h
2
 






(n = 792) 








Peanut butter and jelly 
intake 
Frequent intakes of legumes (peanuts and 
peanut butter), and jam and jelly. 
M: 79 
      Breakfast cereal and milk 
intake 
Frequent intakes of milk and breakfast cereal.       ns 
      Bread and butter intake Frequent intakes of breads, butter and 
margarine. 
M: 18 
F:  20 
      Adjusted fruit intake Frequent intakes of non-citrus fruit, and fruit 
juice, punch and soda (reverse coded). 
M: 26 
      Adjusted red meat and 
pork intake 
Frequent intakes of beef, pork, lamb and 
poultry (reverse coded). 
M: 57 
      Vegetable intake Frequent intakes of deep-coloured vegetables 
and other vegetables. 
      ns 
      Adjusted candy intake Frequent intakes of candy, and sweets (reverse 
coded). 
M: 41 
F:  27 
      Fish and lemon intake Frequent intakes of fish and citrus fruit. M: 12 
F:  56 







(n = 4018) 
22-27  
(x̄ = 24.4) 





“Healthy foods” Frequent intakes of fresh vegetables, fruits, 
cooked vegetables, berries, porridge, muesli, 
cereals, reduced-fat cheeses, rice or pasta, 
chicken yoghurt, and fish. 
M: 49 
F:  54 
      High-fat foods Frequent intakes of fried foods, hamburgers, 
pizza, fried potatoes or French fries, creamy 
foods, and salty snacks. 
M: 44 
F:  47 
      Sweet foods Frequent intakes of other sweets, chocolate, 
and sweet desserts.  
M: 42 
F:  43 
      Meat High intakes of sausage and meat.  M: 39 






(n = 3262) 
18-79  
(x̄ = 48.1) 
131-item FFQ Twins UK 
(UK) 
498 MZ  
1133 DZ 
Fruit and vegetable Frequent intakes of fruit, allium and cruciferous 
vegetables; low intakes of fried potatoes. 
      43 
      High alcohol Frequent intakes of beer, wine and allium 
vegetables; low intakes of high fibre breakfast 
cereals and fruit. 
      48 
      Traditional English Frequent intakes of fried fish and potatoes, 
meats, savoury pies and cruciferous 
vegetables. 
      41 
      Dieting Frequent intakes of low-fat dairy products, low-
sugar soda; low intakes of butter and sweet 
baked products. 
      41 
      Low meat Frequent intakes of baked beans, pizza and 
soy foods; low intakes of meat, other fish and 
seafood, and poultry. 
      43 






(n = 428) 
4-5  









Vegetables High liking of broccoli, cabbage, carrots, 
cauliflower, green beans, mushrooms, onions, 
parsnips, salad greens and tomato.  
      37 
      Desserts High liking of cream, cakes, pastries, fruit pie, 
sponge pudding, custard and dairy desserts. 
      20 
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FFQ, food frequency questionnaire; MZ, monozygotic; DZ, dizygotic; M, male; ns, not significant (confidence interval spans 0); F, female. 
*Heritability estimates are derived from the additive genetic effect value (a
2
) calculated using structural equation modelling techniques as outlined by (Neale et al., 1992) 
unless otherwise specified.  Twin pairs are same-sex. Ages are in years, unless otherwise specified.  
a
Food patterns identified through principal component analysis. 
b
Food patterns identified through factor analysis. 
c
Heritabilities derived from a modified 95-item food frequency questionnaire which asked food ‘liking’ as opposed to intake frequency. 
d
Utilized a twins of mistaken zygosity approach.
      Meat and fish High liking of beef, lamb, pork, chicken, bacon, 
fried fish, white fish and oily fish. 
      78 
      Fruit High liking of apples, bananas, citrus fruits, 
grapes, peaches, strawberries and fruit juice. 







(n = 700) 
30-90  
(x̄ = 50) 






‘Healthy’ dietary pattern Frequent intakes of fish or chicken, carrots, 
tomatoes, salad, green or yellow vegetables, 
fruits, high fibre grains, rice and potatoes.  
      50 
      ‘Unhealthy’ dietary pattern Frequent intakes of beef, pork, hot dogs, eggs, 
cheese, ice cream, butter, margarine, soda, 
and desserts. 
      ns 
van den 
















935 MZ  
713 DZ 
Less healthful Frequent intakes of foods high in fat, salt and 
sugar. 
 
      33 
      Healthful Frequent intakes of a variety of vegetables, 
fruit, rice, yogurt, skim milk and dark bread. 
      33 
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FFQ, food frequency questionnaire; MZ, monozygotic; DZ, dizygotic; ns, not significant (confidence interval spans 0); HF, high fat; LF, low fat; RG, refined grain; WG, whole grain. 
*Heritability estimates are derived from the additive genetic effect value (a
2
) calculated using structural equation modelling techniques as outlined by (Neale et al., 1992) unless otherwise 
specified. Twin pairs are same-sex. ‘ns’ indicates confidence interval spans 0.  ‘-‘ indicates model including additive genetic effects not the best fit. Ages are in years, unless otherwise 
specified. Values presented were derived from single variables, unless otherwise specified.  
a
Heritability analysis performed on age- and sex- adjusted residual scores.  
b
Heritability analysis performed on age- and sex- adjusted residual scores.  
c
Heritability analysis performed on food groups adjusted for total energy intake.  
d
Heritability analysis performed on energy-adjusted residual scores.  
e
Two variables are included in the range.   
f
Five variables are included in the range.  
g




Three variables are included in the range.  
j
Includes eggs. 
Table 3. Selection of twin studies estimating heritability of food group intakes (from Pallister et al., 2014).* 
      Heritability 





count Veg  Potatoes Fruit Meat Fish Dairy  Eggs Cereals 
Legumes 


































  4 ns  5 ns 










































600               





37   
LF: 
39  
- RG: 19 
WG: 24 
















0 ns RG:  
12 ns 
WG: 20 




























              


















   23-55
i























   33-54
i






































29 RG:    8 
WG: 29  
30-32
e




Table 4. Selection of twin studies estimating heritability of fluid intakes (from Pallister et al., 2014).*  
      Heritability 





count Water Alcohol Soda 
Diet 









(n = 3605) 




7  5 ns
h
  8 
 
  1 ns 






(n = 390) 






80 73 ns 61 64 58 
ns 
73  - 






 - 71  - 
Females      - 51 73 65
i








(n = 1212)  
18-67  
(x̄ = 38) 
247-item FFQ Geminakar 
(Denmark) 
600         











(n = 3262) 
18-79  
(x̄ = 48.1) 




 28          41 38 0 ns 






(n = 335) 
18-77  
(x̄ = 42.4) 







 20 ns  33 29 46 25 ns 
FFQ, food frequency questionnaire; MSTRA, Minnesota Study of Twins Reared Apart; MZ, monozygotic; DZ, dizygotic; ns, not significant (confidence interval spans 0). 
*Heritability estimates are derived from the additive genetic effect value (a
2
) calculated using structural equation modelling techniques as outlined by (Neale et al., 1992) unless otherwise 
specified. Twin pairs are same-sex.  ‘-‘ indicates model including additive genetic effects not the best fit. Ages are in years, unless otherwise specified.  
a
Heritability analysis performed on age- and sex- adjusted residual scores.  
b
Heritability estimated using the LISREL method.  
c
Heritability analysis performed on food groups adjusted for total energy intake.  
d
Heritability analysis performed on energy-adjusted residual scores. 
e
Study used twins of mistaken zygosity approach. Heritability analysis performed on age- and gender- adjusted values. 
f
Significant dominant genetic effect 
g
Heritability of alcohol type intake. 
h
Heritability of other beverages group. 
i
Model including additive genetic effects not best fitting model. 
j
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Appendix C. Chapter 4 Appendices 
Table 1. Study population characteristics 
  Whole population (n=3559)  Discordant monozygotic twins 
sample Variable Mean (SD)   Range   n pairs Mean 
(SD) 
  Range 
Age (years) 55.3 (13.4)   18 - 84           
Body mass index (kg/m
2
) 26.1 (4.9)   13.6 - 50.1          
Intakes (servings/week)                 
Allium vegetables 4.5 (4.2)   0 - 84.5   174 7.1 (5.6)   0 - 37 
Apples/pears 4.7 (4.9)   0 - 74   206 7.0 (6.2)   0 - 36 
Avocado 0.4 (0.9)   0 - 18   129 1.6 (2)   0 - 18 
Baked beans 0.9 (1.0)   0 - 7   149 1.8 (1.6)   0 - 7 
Bananas 3.9 (3.7)   0 - 42   210 5.3 (5)   0 - 32 
Beef burgers 0.1 (0.3)   0 - 3   172 0.3 (0.4)   0 - 3 
Beer 0.7 (2.4)   0 - 42   63 3.5 (5.6)   0 - 32 
Berries 0.9 (1.4)   0 - 14   137 2.1 (2.7)   0 - 14 
Black tea 18.9 (13.8)   0 - 42   240 18.4 
(14.1) 
  0 - 42 
Butter 3.5 (6.1)   0 - 50   173 8.5 (8.9)   0 - 42 
Cheese 3.1 (3.1)   0 - 36   198 5.0 (4.8)   0 - 36 
Chocolate 3.8 (6.1)   0 - 84   153 8.9 (10.7)   0 - 84 
Citrus fruit 3.0 (4.3)   0 - 45   167 6.2 (6.6)   0 - 36 
Coffee 12.3 (12.4)   0 - 84   252 17.4 
(14.4) 
  0 - 84 
Cooked potatoes 3.4 (2.6)   0 - 42   207 4.1 (3.3)   0 - 32 
Cream 0.5 (1.3)   0 - 36   70 2.1 (2.1)   0 - 8 
Crispbread 1.2 (3.4)   0 - 42   85 6.1 (8.6)   0 - 42 
Cruciferous vegetables 6.1 (4.7)   0 - 98   219 8.6 (5.7)   0 - 35 
Dairy desserts 0.2 (0.7)   0 - 18   94 0.9 (1.8)   0 - 18 
Eggs 1.4 (1.6)   0 - 18   209 2.6 (2.5)   0 - 18 
Fried fish 0.5 (0.7)   0 - 11   195 0.9 (1)   0 - 7.5 
Fried potatoes 1.4 (1.4)   0 - 32   184 2.2 (1.7)   0 - 12 
Fruit juice 3.4 (4.3)   0 - 42   221 5.8 (6)   0 - 42 
Grapes 2.0 (2.9)   0 - 42   161 4.3 (4.7)   0 - 32 
Green leafy vegetables 4.7 (4.4)   0 - 53   186 8.0 (7)   0 - 43 
Herbal tea 1.6 (5.2)   0 - 64   117 9.5 (10.3)   0 - 50 
High fat milk 1.0 (4.0)   0 - 45.5   59 7.4 (10.4)   0 - 45.5 
High fibre breakfast 
cereals 
2.7 (3.5)   0 - 42   220 4.1 (4.1)   0 - 32.5 
High sugar d ink  2.5 (5.6)   0 - 60   109 9.1 (10.2)   0 - 49 
Ice cream 0.7 (1.2)   0 - 18   132 2.0 (1.8)   0 - 7 
Lasagne 0.3 (0.4)   0 - 3   307 0.4 (0.4)   0 - 3 
Legumes 4.3 (3.3)   0 - 43   230 5.8 (4.2)   0 - 32 
Low fat milk 3.3 (2.4)   0 - 10.5   228 3.6 (3)   0 - 10.5 
Low fibre breakfast cereals 1.6 (2.9)   0 - 42   224 3.4 (3.9)   0 - 42 
Low fat spread 1.4 (4.5)   0 - 74   90 6.8 (8.5)   0 - 42 
Malt drinks 0.3 (1.4)   0 - 32   66 2.9 (3.1)   0 - 18 
Margarine 2.3 (4.9)   0 - 64   186 6.5 (7.8)   0 - 42.5 
Marrow 0.7 (1.3)   0 - 32   130 2.1 (1.8)   0 - 7 
Meat 2.4 (2.0)   0 - 16.5   222 3.3 (2.4)   0 - 11 
Melon 0.9 (1.7)   0 - 32   150 2.8 (3.4)   0 - 32 
Mushrooms 1.5 (1.7)   0 - 32   258 2.4 (1.8)   0 - 7 
Nuts 1.7 (3.2)   0 - 43.5   144 5.0 (5.3)   0 - 41.5 
Oily fish 1.1 (1.2)   0 - 18   217 2.1 (1.7)   0 - 18 
Other fish/seafood 1.2 (1.2)   0 - 16.5   171 2.1 (1.7)   0 - 9.5 
Peaches 0.7 (1.3)   0 - 14   141 1.8 (2.2)   0 - 14 
Pizza 0.5 (0.7)   0 - 8   199 0.8 (0.9)   0 - 5.5 
Polyunsaturated margarine 3.1 (6.0)   0 - 42   143 9.3 (10)   0 - 42 
Porridge 1.4 (2.4)   0 - 32   215 3.0 (2.7)   0 - 7 
Poultry 1.9 (1.3)   0 - 7   344 2.2 (1.4)   0 - 7 
Processed meats 1.8 (3.1)   0 - 60   190 4.3 (4.2)   0 - 32 
Processed fruit 2.8 (2.3)   0 - 18   228 3.9 (2.8)   0 - 15.5 
Root vegetables 4.6 (3.7)   0 - 96   202 6.3 (4.5)   0 - 28 
High fat salad dressing 1.6 (2.2)   0 - 25   201 3.1 (3.3)   0 - 25 
Low fat salad dressing 0.7 (1.4)   0 - 18   140 2.3 (2.4)   0 - 18 
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Table 1. Study population characteristics 
  Whole population (n=3559)  Discordant monozygotic twins 
sample Variable Mean (SD)   Range   n pairs Mean 
(SD) 
  Range 
Savoury pies 0.3 (0.5)   0 - 7   163 0.5 (0.8)   0 - 7 
Savoury snacks 2.1 (3.0)   0 - 35   170 4.5 (5.3)   0 - 35 
Seasonings 3.6 (3.7)   0 - 84.5   195 5.6 (6.6)   0 - 84.5 
Low sugar soda 1.8 (4.8)   0 - 42   92 7.9 (9.2)   0 - 42 
Soup 1.1 (1.9)   0 - 64   149 2.9 (2.6)   0 - 14 
Soy/other milk 0.1 (0.8)   0 - 10.5   68 1.7 (1.9)   0 - 10.5 
Soy foods 0.2 (1.0)   0 - 18   60 2.2 (3.2)   0 - 18 
Spirits/liquor 1.2 (3.2)   0 - 50   97 5.1 (7)   0 - 42.5 
Sweet baked products 7.9 (8.9)   0 - 85   155 15.5 
(14.2) 
  0 - 76.5 
Sweetcorn 0.9 (1.3)   0 - 18   187 2.1 (1.9)   0 - 18 
Sweet peppers 1.4 (1.8)   0 - 32   245 2.5 (2.1)   0 - 18 
Confectionary/jam 8.1 (11.9)   0 - 84.5   149 18.2 
(16.3) 
  0 - 84 
Tomatoes 4.0 (3.6)   0 - 42   175 6.5 (6.2)   0 - 42 
White/brown bread, refined 
grains 
8.3 (8.5)   0 - 70   206 12.8 
(10.7) 
  0 - 43.5 
Wholemeal bread/ i  4.9 (6.7)   0 - 44   179 10.3 (9.2)   0 - 43 
Wine 3.9 (6.1)   0 - 64   111 12.2 
(10.5) 
  0 - 43 





Table 2. Food frequency questionnaire variables included in each food group and 
descriptions 





Allium vegetables Garlic Garlic (clove) TRUE TRUE 
Allium vegetables Leeks Leeks TRUE TRUE 
Allium vegetables Onions Onions TRUE TRUE 
Apples/pears Apples Apples (1 fruit) TRUE TRUE 
Apples/pears Pears Pears (1 fruit) TRUE TRUE 
Avocado Avocado Avocado TRUE TRUE 
Baked beans BakedBeans Baked beans TRUE TRUE 
Bananas Bananas Bananas (1fruit) TRUE TRUE 
Beef burgers MFburgers Beefburgers TRUE TRUE 
Beer Beer Beer, lager or cider (half pint) TRUE TRUE 
Berries Strawberries Strawberries, raspberries, other 
berries, kiwi fruit (one fruit or 
handful) 
TRUE TRUE 
Black tea Tea Tea (cup) TRUE TRUE 
Butter RedFatButter Reduced fat butter (teaspoon) FALSE TRUE 
Butter Butter Butter (teaspoon) TRUE TRUE 
Cheese DairyLFcheese Low fat cheese e.g. reduced fat 
cheddar  (matchbox size) 
FALSE TRUE 
Cheese Dairycheese Cheese, e.g. cheddar, brie, 
edam  (matchbox size) 
TRUE TRUE 
Cheese DairyCottageCheese Cottage cheese, low fat soft 
cheese  (2 tablespoons) 
TRUE TRUE 
Chocolate ChocsDark Dark chocolates, single or 
squares (one) 
FALSE TRUE 
Chocolate ChocsMilk White or milk chocolates, single 
or squares (one) 
FALSE TRUE 
Chocolate LowFatHotChoc Low fat hot chocolate (cup) FALSE TRUE 
Chocolate Cocoa Cocoa, hot chocolate (cup) TRUE TRUE 
Chocolate Chocolatebar Chocolate snack bars e.g. Mars, 
Crunchie (one) 
TRUE TRUE 
Chocolate Chocolates Chocolate, fancy and filled TRUE FALSE 
Citrus fruit Grapefruit Grapefruit (half) TRUE TRUE 
Citrus fruit Oranges Oranges, satsumas, mandarins 
(1 fruit) 
TRUE TRUE 
Coffee Coffee Coffee, instant or ground (cup) TRUE TRUE 
Coffee CoffeeDecaffeinated Coffee, decaffeinated (cup) TRUE TRUE 
Confectionary/ja
m 










SweetsToffees Sweets, toffees, mints (small 
packet) 
TRUE TRUE 
Cooked potatoes Boiledpotato Boiled, mashed, instant or one 
jacket potato 
TRUE TRUE 
Cream Dairydouble Double or clotted cream 
(tablespoon) 
TRUE TRUE 
Cream Dairysingle Single or sour cream 
(tablespoon) 
TRUE TRUE 
Crispbread Crispbread Crispbread, e.g. Ryvita TRUE TRUE 
Cruciferous 
vegetables 
Broccoli Broccoli, spring green, kale TRUE TRUE 
Cruciferous 
vegetables 
BrusselsSprouts Brussel sprouts TRUE TRUE 
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Table 2. Food frequency questionnaire variables included in each food group and 
descriptions 







Cabbage Cabbage TRUE TRUE 
Cruciferous 
vegetables 
Cauliflower Cauliflower TRUE TRUE 
Cruciferous 
vegetables 
Coleslaw Coleslaw TRUE TRUE 
Dairy desserts DairyDesserts Dairy desserts (small pot) e.g. 
chocolate mousse, cream 
caramels 
TRUE TRUE 
Eggs Eggs Eggs as boiled, fried, scrambled, 
etc. (one) 
TRUE TRUE 
Fried fish MFFishFingers Fish fingers, fish cakes & 
breaded fish 
TRUE TRUE 
Fried fish MFFriedfish Fried fish in batter, as in fish and 
chips 
TRUE TRUE 
Fried potatoes ChipsRoastPots Chips, roast potatoes FALSE TRUE 
Fried potatoes Chips Chips, retail, fried in vegetable oil TRUE FALSE 
Fried potatoes PotatoSalad Potato salad TRUE TRUE 
Fried potatoes RoastPotatoes Old potatoes, roast in blended oil TRUE FALSE 
Fruit juice Smoothies Smoothies (cup) FALSE TRUE 
Fruit juice PureFruitJuice Pure fruit juice (100%) e.g. 
orange, apple juice (cup) 
TRUE TRUE 
Grapes Grapes Grapes (handful) TRUE TRUE 
Green leafy 
vegetables 





Spinach Spinach TRUE TRUE 
Green leafy 
vegetables 
Watercress Watercress TRUE TRUE 
Herbal tea FruitTea Fruit tea (cup) FALSE TRUE 
Herbal tea GreenTea Green tea (cup) FALSE TRUE 
High fat milk ChannelIslandMilk Channel Islands milk TRUE TRUE 
High fat milk EvaporatedMilk Evaporated milk TRUE TRUE 
High fat milk FullMilk Full cream milk TRUE TRUE 
High fat milk CoffeeWhitener Coffee whitener, e.g. Coffee-
mate (teaspoon) 
TRUE TRUE 
High fat salad 
dressing 
FrenchDressing French dressing (tablespoon) TRUE TRUE 
High fat salad 
dressing 
Mayo Full fat salad cream, mayonnaise 
(tablespoon) 
TRUE TRUE 
High fat salad 
dressing 





HighFibreCereal High Fibre cereals e.g. 





AllBran All Bran TRUE FALSE 
High fibre 
breakfast cereals 
Branflakes Branflakes TRUE FALSE 
High fibre 
breakfast cereals 
Cheerios Cheerios TRUE FALSE 
High fibre 
breakfast cereals 
FruitnFibre Fruit n' fibre TRUE FALSE 
High fibre 
breakfast cereals 
Grapenuts Grape nuts TRUE FALSE 
High fibre 
breakfast cereals 
Muesli Muesli TRUE TRUE 
High fibre 
breakfast cereals 
OatBasedCereal Oat based TRUE FALSE 
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Table 2. Food frequency questionnaire variables included in each food group and 
descriptions 







OtherCereal Cereal, other TRUE FALSE 
High fibre 
breakfast cereals 
ShreddedWheat Shredded wheat TRUE FALSE 
High fibre 
breakfast cereals 
Shreddies Shreddies TRUE FALSE 
High fibre 
breakfast cereals 
Start Start TRUE FALSE 
High fibre 
breakfast cereals 
SultanaBran Sultana Bran TRUE FALSE 
High fibre 
breakfast cereals 
WeetabixType Weetabix type TRUE FALSE 
High fibre 
breakfast cereals 
WheatFlakes Wheat flakes TRUE FALSE 
High sugar drinks FruitSquash Fruit squash or cordial (cup) TRUE TRUE 
High sugar drinks FizzySoftDrinks Fizzy soft drinks, e.g. Coca Cola, 
lemonade (cup) 
TRUE TRUE 
Ice cream IceCream Ice cream, choc ices TRUE TRUE 
Lasagne Lasagne Lasagne, moussaka TRUE TRUE 
Legumes Beansprouts Beansprouts TRUE TRUE 
Legumes DriedLentils Pulses e.g. lentils, beans, peas TRUE TRUE 
Legumes GreenBeans Green beans, broad beans, 
runner beans 
TRUE TRUE 
Legumes Peas Peas TRUE TRUE 
Low fat milk DriedMilk Dried milk TRUE TRUE 
Low fat milk SemiSkimmedMilk Semi-skimmed milk TRUE TRUE 
Low fat milk SkimmedMilk Skimmed milk TRUE TRUE 
Low fat salad 
dressing 
Lowcalsaladcream Low calorie, low fat salad cream 
(tablespoon) 
TRUE TRUE 
Low fat spread LowFatSpread Low fat spread, e.g. Outline, 
Gold (teaspoon) 
TRUE TRUE 
Low fat spread VLowFatSpread Very low fat spread (teaspoon) 









CocoPops Coco pops TRUE FALSE 
Low fibre 
breakfast cereals 





Crunchynut cornflakes TRUE FALSE 
Low fibre 
breakfast cereals 





JustRightType Just right type TRUE FALSE 
Low fibre 
breakfast cereals 
RiceKrispies Rice Krispies TRUE FALSE 
Low fibre 
breakfast cereals 
SpecialK Special K TRUE FALSE 
Low fibre 
breakfast cereals 
SugarPuffType Sugar puffs TRUE FALSE 
Low sugar soda Dietfizzy Low calorie or diet fizzy soft 
drinks (cup) 
TRUE TRUE 
Malt drinks Horlicks Horlicks, Ovaltine (cup) TRUE TRUE 
Margarine CholLowerSpread Cholesterol lowering fat spreads 
e.g. Benecol (teaspoon) 
FALSE TRUE 
Margarine OliveOilSpread Olive oil spread (teaspoon) FALSE TRUE 





Table 2. Food frequency questionnaire variables included in each food group and 
descriptions 





Margarine OtherSoftMarg Other soft margarine, dairy 
spreads, e.g. Blue Band, Clover 
(teaspoon) 
TRUE TRUE 
Marrow Marrow Marrow, courgettes TRUE TRUE 
Meat MFBeef Beef: roast, steak, mince, stew or 
casserole 
TRUE TRUE 
Meat MFLamb Lamb: roast, chops or stew TRUE TRUE 
Meat MFPork Pork: roast, chops or stew TRUE TRUE 
Melon Melon Melon (1 slice) TRUE TRUE 
Mushrooms Mushrooms Mushrooms TRUE TRUE 
Nuts NutsSalted Salted nuts e.g. peanuts, 
cashews (handful) 
FALSE TRUE 
Nuts NutsUnsalted Unsalted nuts, e.g. brazil, 
walnuts (handful) 
FALSE TRUE 
Nuts Seeds Seeds e.g. Sunflower, pumpkin 
(tablespoon) 
FALSE TRUE 
Nuts Nuts Mixed nuts TRUE FALSE 
Nuts PeanutButter Peanut butter (teaspoon) TRUE TRUE 
Oily fish MFOilyfish Oily fish, fresh or canned, e.g. 





MFFishroe Fish roe, taramasalata TRUE TRUE 
Other 
fish/seafood 





MFWhitefish Other white fish, fresh or frozen, 
e.g. cod, plaice, sole, haddock, 
halibut 
TRUE TRUE 
Peaches Peaches Peaches, plums, apricots (1 fruit) TRUE TRUE 
Pizza Pizza Pizza (one slice) TRUE TRUE 
Pizza Quiche Quiche (slice) TRUE TRUE 
Polyunsaturated 
margarine 
PufaMarg Polyunsaturated margarine, e.g. 
Flora, sunflower (teaspoon) 
TRUE TRUE 
Porridge Porridge Porridge, Readybreak, oats TRUE TRUE 
Poultry MFPoultry Chicken or other poultry e.g. 
turkey 
TRUE TRUE 
Processed fruit DriedFruit Dried fruit, e.g. raisins, prunes 
(heaped tablespoon) 
TRUE TRUE 
Processed fruit TinnedFruit Tinned fruit (handful) TRUE TRUE 
Processed meats MFBacon Bacon or gammon TRUE TRUE 
Processed meats MFCornedBeef Corned Beef, Spam, luncheon 
meats 
TRUE TRUE 
Processed meats MFHam Ham, cured meats & chorizo TRUE TRUE 
Processed meats MFLiver Liver, liver pate, liver sausage TRUE TRUE 
Processed meats MFSausages Sausages TRUE TRUE 
Root vegetables Beetroot Beetroot TRUE TRUE 
Root vegetables Parsnips Parsnips, turnips, swedes TRUE TRUE 
Root vegetables Carrots Carrots TRUE TRUE 
Savoury pies MFPies Savoury pies, e.g. meat pie, pork 
pie, pasties, steak & kidney pie, 
sausage rolls 
TRUE TRUE 
Savoury snacks CreamCrackers Cream crackers, savoury biscuits TRUE TRUE 
Savoury snacks Crisps Crisps or other packet snacks, 




Table 2. Food frequency questionnaire variables included in each food group and 
descriptions 





Seasonings Marmite Marmite, Bovril (teaspoon) TRUE TRUE 
Seasonings PicklesChutney Pickles, chutney (tablespoon) TRUE TRUE 
Seasonings Sauces Sauces, e.g. white sauce, 
cheese sauce, gravy 
(tablespoon) 
TRUE TRUE 
Seasonings TomatoKetchup Tomato ketchup (tablespoon) TRUE TRUE 
Soup MeatSoup Meat soups (bowl) (to include 
meat and vegetable soups) 
TRUE TRUE 
Soup VegSoup Vegetable soups (bowl) TRUE TRUE 
Soy foods Tofu Meat substitutes e.g. tofu, 
soyameat, textured vegetable 
protein, vegeburger 
TRUE TRUE 
Soy/other milk GoatsMilk Goats' milk TRUE TRUE 
Soy/other milk RiceMilk Rice milk TRUE TRUE 
Soy/other milk SoyaMilk Soya milk TRUE TRUE 
Spirits/liquor Liqueurs Port, sherry, vermouth, liqueurs 
(pub measure) 
TRUE TRUE 
Spirits/liquor Spirits Spirits, e.g. gin, brandy, whisky, 




BiscuitsRedFat Reduced fat biscuits e.g. Go 
Ahead, Highlights (one small 














Bunshome Buns, pastries e.g. scones, 






























SpongePudhome Sponge puddings, home baked TRUE TRUE 
Sweet baked 
products 
SpongePudready Sponge puddings, ready made TRUE TRUE 
Sweet peppers SweetPeppers Sweet peppers TRUE TRUE 
Sweetcorn Sweetcorn Sweetcorn TRUE TRUE 
















Whitepasta White or green pasta, e.g. 




Table 2. Food frequency questionnaire variables included in each food group and 
descriptions 








WhiteRice White rice TRUE TRUE 
Wholemeal 
bread/grains 
BrownRice Brown rice TRUE TRUE 
Wholemeal 
bread/grains 
WholemealBread Wholemeal & granary bread/rolls TRUE TRUE 
Wholemeal 
bread/grains 
WholemealPasta Wholemeal pasta TRUE TRUE 
Wine RedWine Red wine (small glass) FALSE TRUE 
Wine WhiteWine White wine (small glass) FALSE TRUE 
Wine Wine White wine, red wine TRUE FALSE 
Wine Wine White wine, red wine TRUE FALSE 
Yoghurt DairyFFYog Full fat or Greek yoghurt (small 
pot) 
TRUE TRUE 
Yoghurt DairyLFYog Low fat yoghurt, fromage frais 
(small pot) 
TRUE TRUE 
Notes: Details of each food frequency questionnaire (FFQ) variables included in each food 
group analysis are shown. FFQs completed before 2007 (FFQ1) included slightly different 
variables than FFQs completed during 2007 (FFQ2), therefore the right hand columns indicate if 
a particular variable was included in the final (TRUE) or not (FALSE). 
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Figure 1. Scree plot for the first 20 principal components, adapted from 











Vegetable High Alcohol 
Traditional 
English Dieting Low Meat 
Baked beans –.01 (–.04,.01) –.07 (–.18,.10) .17 (–.01,.25) .10 (–.19,.36) .31 (–.16,.37) 
Beefburgers –.14 (–.16,–.13) .13 (–.11,.23) .18 (–.02,.25) .15 (–.02,.23) .08 (–.18,.19) 
Beer –.03 (–.05,–.01) .22 (.07,.26) .00 (–.18,.17) .09 (–.03,.16) .04 (–.12,.14) 
Berries .16 (.14,.19) –.05 (–.11,.04) –.05 (–.11,.04) .00 (–.10,.09) –.05 (–.13,.06) 
Butter –.07 (–.09,–.05) .11 (.00,.19) –.03 (–.16,.13) –.35 (–.40,–.03) –.20 (–.40,.37) 
Citrus fruit .19 (.16,.21) –.11 (–.16,–.01) –.01 (–.12,.09) .08 (–.11,.16) –.07 (–.15,.06) 
Coffee –.01 (–.04,.01) .17 (.04,.21) –.01 (–.17,.14) .13 (–.20,.23) –.16 (–.25,.06) 
Cooked potatoes .03 (.00,.05) –.19 (–.27,.00) .19 (–.02,.28) –.08 (–.17,.08) –.02 (–.15,.15) 
Crisp bread .11 (.09,.14) –.06 (–.11,.02) –.03 (–.10,.05) .03 (–.07,.10) .02 (–.08,.11) 
Dairy products; 
high fat 
–.07 (–.09,–.06) .14 (.00,.20) –.13 (–.21,.02) –.12 (–.20,.02) –.07 (–.18,.16) 
Dairy products; 
low fat 
.15 (.13,.17) –.29 (–.33,–.06) –.05 (–.24,.21) .25 (–.09,.29) –.02 (–.27,.22) 
Drinks; other .04 (.02,.06) –.07 (–.14,.07) –.10 (–.17,.02) .17 (–.01,.23) .11 (–.19,.23) 
Eggs .00 (–.02,.02) .04 (–.08,.12) .11 (.01,.17) –.05 (–.14,.07) –.06 (–.16,.11) 
Fried fish –.11 (–.13,–.09) –.02 (–.18,.13) .21 (.08,.24) –.01 (–.11,.10) .03 (–.07,.13) 
Fried potatoes –.21 (–.22,–.19) .09 (–.17,.23) .22 (.04,.27) .01 (–.12,.17) .12 (–.05,.19) 
Fruit juice .09 (.07,.12) .06 (–.03,.12) –.07 (–.14,.03) .08 (–.08,.13) –.04 (–.13,.07) 
High fibre 
breakfast cereals 
.06 (.04,.09) –.23 (–.29,.04) –.14 (–.26,.12) .13 (–.17,.23) –.13 (–.27,.08) 
Lasagne .01 (–.01,.03) .13 (.02,.18) .00 (–.14,.13) .25 (–.00,.31) .13 (–.27,.29) 
Legumes .19 (.16,.21) .03 (–.24,.23) .29 (.10,.33) –.16 (–.27,.18) .13 (–.09,.28) 
Low fibre 
breakfast cereals 
–.07 (–.09,–.05) –.06 (–.11,.01) .05 (–.04,.11) –.05 (–.12,.10) .07 (–.03,.14) 
Low fat spread .02 (–.01,.04) –.10 (–.14,–.01) .02 (–.09,.12) .15 (–.01,.22) .11 (–.18,.22) 
Margarine –.09 (–.11,–.07) –.01 (–.08,.07) .07 (–.01,.12) .00 (–.12,.16) .13 (–.04,.20) 
Meat –.10 (–.12,–.08) –.02 (–.27,.21) .34 (.11,.41) .05 (–.35,.31) –.32 (–.39,.02) 
Nuts .06 (.02,.09) 0.14 (–.02,.24) –.15 (–.25,.01) –.12 (–.20,.11) .07 (–.09,.18) 
Oily fish .15 (.12,.19) 0.01 (–.04,.07) –.01 (–.09,.07) .02 (–.16,.13) –.12 (–.17,.02) 
Other fish and 
seafood 
.18 (.16,.21) 0.07 (–.03,.13) .07 (–.06,.18) –.04 (–.25,.19) –.20 (–.26,.07) 
Other fruit .27 (.25,.29) –.21 (–.26,.00) –.07 (–.21,.13) .09 (–.06,.14) –.01 (–.13,.10) 
Pizza –.06 (–.08,–.04) 0.15 (.02,.22) –.10 (–.21,.07) .18 (–.09,.31) .22 (–.20,.32) 
Polyunsaturated 
margarine 
–.02 (–.04,.00) –.08 (–.14,.03) –.06 (–.15,.06) .07 (–.10,.21) .18 (–.10,.25) 
Porridge .08 (.06,.10) –.13 (–.17,–.03) .05 (–.08,.15) –.14 (–.20,.05) .00 (–.15,.17) 
Poultry .05 (.03,.07) –.02 (–.13,.09) .14 (.01,.25) .17 (–.30,.32) –.25 (–.33,.04) 
Processed meats –.10 (–.12,–.08) .02 (–.25,.24) .32 (.10,.38) .13 (–.23,.28) –.16 (–.27,.06) 
Salad dressing 
high fat 
.12 (.09,.14) .30 (.08,.34) –.11 (–.31,.13) –.02 (–.10,.08) –.03 (–.10,.07) 
Salad dressing 
low fat 
.14 (.10,.17) –.02 (–.13,.11) .10 (–.03,.19) .18 (–.03,.27) .13 (–.20,.25) 
Savoury pies –.19 (–.21,–.17) .03 (–.20,.19) .24 (.09,.27) .00 (–.10,.09) –.01 (–.09,.09) 
Savoury snacks –.10 (–.12,–.08) .12 (.03,.17) –.03 (–.12,.08) .04 (–.07,.13) .09 (–.07,.15) 
Seasonings .02 (.00,.05) .05 (–.05,.11) .07 (–.04,.14) .02 (–.15,.23) .18 (–.06,.25) 
Soda; high sugar –.08 (–.10,–.06) .09 (–.01,.15) .04 (–.07,.12) .08 (–.05,.19) .11 (–.12,.20) 
Soda; low sugar .02 (–.01,.04) .06 (–.05,.14) .04 (–.10,.18) .33 (–.05,.36) .08 (–.34,.33) 
Soup .12 (.10,.14) –.03 (–.10,.03) .03 (–.05,.11) .05 (–.17,.18) –.13 (–.20,.02) 
Soy and other milk .05 (.03,.08) .00 (–.06,.08) –.03 (–.11,.05) –.15 (–.22,.12) .08 (–.10,.21) 
Soy foods .11 (.07,.14) .06 (–.06,.17) –.09 (–.24,.05) –.15 (–.37,.40) .38 (.03,.43) 
Spirits and liquor .00 (–.02,.02) .20 (.06,.23) .01 (–.17,.16) .10 (–.18,.20) –.13 (–.21,.04) 
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Vegetable High Alcohol 
Traditional 
English Dieting Low Meat 
Sweet baked –.16 (–.17,–.14) –.22 (–.26,.00) –.10 (–.25,.14) –.22 (–.27,.10) .00 (–.20,.24) 
Sweets and sweet 
condiments 
–.17 (–.19,–.15) –.02 (–.08,.05) –.01 (–.13,.09) –.26 (–.29,.17) .09 (–.19,.28) 
Tea –.03 (–.05,–.01) –.23 (–.28,–.05) .08 (–.13,.26) –.24 (–.29,.12) .02 (–.22,.27) 
Vegetables; allium .23 (.21,.25) .27 (.04,.30) .06 (–.18,.23) –.13 (–.18,.07) .02 (–.13,.18) 
Vegetables; 
cruciferous 
.21 (.17,.24) –.03 (–.32,.26) .36 (.14,.39) –.08 (–.20,.15) .07 (–.08,.19) 
Vegetables; green 
leafy 
.30 (.28,.32) .12 (–.04,.17) .07 (–.06,.15) –.06 (–.12,.10) .07 (–.04,.13) 
Vegetables; other .32 (.30,.33) .18 (–.09,.26) .15 (–.05,.25) –.13 (–.20,.15) .12 (–.07,.19) 
Vegetables; yellow .30 (.28,.32) –.03 (–.17,.13) .18 (.06,.23) –.09 (–.15,.11) .06 (–.07,.15) 
White and brown 
bread, refined 
grains 
–.11 (–.13,–.09) .04 (–.02,.09) –.03 (–.10,.05) –.02 (–.14,.17) .15 (–.04,.22) 
Wholemeal bread 
and grains 
.15 (.12,.17) –.11 (–.22,.12) –.18 (–.23,.00) –.01 (–.10,.08) –.01 (–.10,.08) 
Wine .08 (.06,.10) .33 (.07,.37) –.14 (–.35,.14) .03 (–.25,.21) –.22 (–.27,.02) 
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Table 4. Items and gram amounts per frequency category for the Mediterranean diet score calculation 
Fruit & nuts  Vegetable  Meat  Fish  Dairy  Cereal
1














Apples 100  Avocado 75  Bacon 25  Shellfish 60  
Channel 
Islands milk 585  Brown bread 36  
Baked 
beans 135 
Bananas 100  Beansprouts 20  Beef 128  Oilyfish 96  
Cottage 
cheese 55  Brown rice 180  Lentils 70 
Dried fruit 30  Beetroot 40  Burgers 78  Fried fish 180  Dairy cheese 40  
Cream 
crackers 7    
Tinned fruit 100  Broccoli 85  
Corned 
beef 30  Fish roe 45  Dairy deserts 125  Crispbread 10    
Grapefruit 80  Cabbage 95  Ham 23  Fish fingers 50  Low fat yogurt 125  Frosties 40    
Grapes 80  Brussel sprouts 90  Lamb 94  Whitefish 120  Double cream 30  Lasagne 420    
Melon 200  Carrots 60  Liver 40     Single cream 15  White pasta 230    
Oranges 120  Cauliflower 90  Meat pies 124     Dried milk 585  Porridge 160    
Peaches 70  Coleslaw 45  Pork 128     Eggs 50  Muesli 60    
Pears 170  Garlic 5  Poultry 125     Full milk 585  
Wholemeal 
pasta 230    
Strawberries 100  Green beans 90  Sausages 40     Goats milk 585  White bread 36    
Mixed nuts
2




 40  Leeks 75        
Semi-
skimmed milk 585  
Wholemeal 
bread 36    
Nuts salted
2
 40  Marrow 90        Skimmed milk 585       
   Mushrooms 56        Soya milk 585       
   Onions 60        
Evaporated 
milk 585       
   Peas 70                
   Spinach 90                
   Sweetcorn 85                
   Sweet peppers 80                
   Tomatoes 85                
   Watercress 20                
   Tofu 50                
   Parsnips 65                
Notes: 
1
The cereal category for FFQ 1 included multiple cereal types which were omitted from FFQ 2, therefore only items which were included in both questionnaires 
were quantified. 
2
’Mixed nuts’ was quantified on only FFQ 1, ‘nuts unsalted’ and ‘nuts salted’ were quantified on FFQ 2. For this analysis, frequencies for these items were 




Table 5. List of metabolites associated with food intake from the Metabolon platform 
        
Discovery Discordant Meta-analysis 
Whole 
sample 
Variable Metabolite name Pathway 
Super-





X-11858     0.040(0.007) 3.65E-08 0.036(0.015) 1.69E-02 0.039(0.007) 1.42E-09 0.030 
Allium 
vegetables 
tryptophan betaine Tryptophan 
metabolism 
Amino acid 0.041(0.007) 3.82E-08 0.023(0.010) 1.57E-02 0.034(0.006) 4.73E-09 0.025 
Allium 
vegetables 
X-02269     0.024(0.005) 2.82E-07 0.019(0.010) 4.75E-02 0.023(0.004) 3.55E-08 0.010 





0.034(0.004) 2.50E-17 0.030(0.007) 4.05E-05 0.033(0.003) 1.69E-21 0.031 
Apples/pears X-11315     0.035(0.004) 9.14E-15 0.036(0.008) 6.10E-06 0.035(0.004) 9.63E-20 0.029 
Apples/pears X-11372     -0.024(0.004) 1.97E-09 -0.021(0.007) 3.40E-03 -0.023(0.003) 2.02E-11 0.014 
Apples/pears indolepropionate Tryptophan 
metabolism 






Amino acid 0.025(0.005) 3.76E-07 0.023(0.009) 1.21E-02 0.024(0.004) 1.24E-08 0.015 
Apples/pears X-09789     0.021(0.004) 2.73E-07 0.016(0.007) 2.58E-02 0.020(0.004) 2.22E-08 0.010 
Avocado X-11469     0.204(0.027) 3.59E-14 0.100(0.027) 3.31E-04 0.153(0.019) 9.36E-16 0.023 












Lysolipid Lipid 0.125(0.024) 2.54E-07 0.094(0.028) 1.06E-03 0.112(0.018) 1.03E-09 0.009 
Avocado eicosapentaenoate 
(EPA; 20:5n3) 
Essential fatty acid Lipid 0.163(0.026) 3.82E-10 0.056(0.025) 2.56E-02 0.108(0.018) 2.01E-09 0.013 
Bananas indolepropionate Tryptophan 
metabolism 






Amino acid 0.428(0.085) 5.90E-07 0.257(0.104) 1.48E-02 0.360(0.066) 5.34E-08 0.009 
Berries X-11315     0.124(0.018) 2.28E-12 0.072(0.021) 8.29E-04 0.103(0.013) 2.70E-14 0.021 
Black tea X-14473     -0.025(0.001) 8.51E-60 -0.020(0.003) 5.16E-09 -0.024(0.001) 1.36E-72 0.110 
Black tea quinate Food component, 
Plant 
Xenobiotics -0.019(0.002) 9.74E-34 -0.019(0.003) 1.61E-09 -0.019(0.001) 5.58E-44 0.066 
Black tea X-12816     -0.019(0.002) 4.68E-23 -0.021(0.004) 2.59E-07 -0.020(0.002) 3.57E-30 0.062 
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Table 5. List of metabolites associated with food intake from the Metabolon platform 
        
Discovery Discordant Meta-analysis 
Whole 
sample 
Variable Metabolite name Pathway 
Super-
pathway Beta(SE) P Beta(SE) P Beta(SE) P R
2
 




Chemical Xenobiotics -0.014(0.002) 2.23E-16 -0.013(0.004) 4.61E-04 -0.014(0.002) 1.60E-19 0.035 
Black tea X-05426     -0.010(0.002) 8.54E-12 -0.008(0.003) 1.66E-02 -0.010(0.001) 3.62E-13 0.019 
Black tea cyclo(leu-pro) Dipeptide Peptide -0.012(0.002) 5.64E-11 -0.010(0.004) 2.26E-02 -0.012(0.002) 2.89E-12 0.026 
Black tea X-12230     -0.009(0.002) 3.07E-08 -0.010(0.003) 4.67E-03 -0.009(0.001) 3.98E-10 0.015 
Black tea X-13741--3-methyl 
catechol sulfate 1 
Benzoate 
metabolism 





Lipid 0.028(0.004) 9.12E-15 0.020(0.006) 1.97E-03 0.026(0.003) 6.48E-17 0.026 
Butter X-02249     0.027(0.003) 6.97E-15 0.019(0.007) 1.06E-02 0.026(0.003) 2.31E-16 0.023 











Lipid 0.023(0.004) 5.99E-10 0.014(0.005) 4.11E-03 0.020(0.003) 2.35E-11 0.018 
Butter myristate (14:0) Long chain fatty 
acid 
Lipid 0.019(0.004) 5.57E-08 0.019(0.006) 4.34E-03 0.019(0.003) 6.68E-10 0.014 
Butter X-08402     0.018(0.003) 1.85E-08 0.013(0.005) 1.10E-02 0.017(0.003) 7.17E-10 0.012 
Butter 10-nonadecenoate 
(19:1n9) 
Long chain fatty 
acid 
Lipid 0.017(0.004) 9.50E-07 0.019(0.006) 8.91E-04 0.018(0.003) 2.43E-09 0.013 
Butter pentadecanoate 
(15:0) 
Long chain fatty 
acid 
Lipid 0.019(0.004) 8.48E-08 0.015(0.006) 1.03E-02 0.018(0.003) 2.77E-09 0.013 
Chocolate theobromine Xanthine 
metabolism 
Xenobiotics 0.024(0.005) 3.43E-07 0.023(0.005) 1.83E-05 0.024(0.003) 1.34E-11 0.020 
Chocolate 7-methylxanthine Xanthine 
metabolism 
Xenobiotics 0.029(0.005) 2.48E-08 0.012(0.006) 3.31E-02 0.022(0.004) 2.00E-08 0.020 
Citrus fruit stachydrine Food component, 
Plant 
Xenobiotics 0.058(0.006) 6.43E-24 0.036(0.008) 4.05E-05 0.051(0.005) 2.07E-27 0.051 






0.027(0.005) 1.15E-07 0.031(0.008) 1.39E-04 0.028(0.004) 4.57E-11 0.014 
Citrus fruit X-11315     0.029(0.005) 4.72E-08 0.021(0.007) 3.30E-03 0.026(0.004) 6.50E-10 0.014 
Coffee X-14473     0.041(0.001) 6.89E-139 0.027(0.003) 1.38E-19 0.038(0.001) 6.12E-187 0.246 
Coffee quinate Food component, 
Plant 
Xenobiotics 0.036(0.001) 6.60E-106 0.024(0.003) 6.84E-15 0.033(0.001) 4.31E-136 0.190 
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Table 5. List of metabolites associated with food intake from the Metabolon platform 
        
Discovery Discordant Meta-analysis 
Whole 
sample 
Variable Metabolite name Pathway 
Super-
pathway Beta(SE) P Beta(SE) P Beta(SE) P R
2
 




Chemical Xenobiotics 0.026(0.002) 6.89E-52 0.020(0.003) 1.72E-09 0.025(0.001) 1.64E-64 0.108 
Coffee X-12816     0.032(0.002) 1.07E-51 0.021(0.004) 7.67E-07 0.030(0.002) 3.22E-61 0.133 
Coffee X-05426     0.019(0.002) 5.06E-34 0.012(0.003) 2.06E-04 0.018(0.001) 6.64E-38 0.058 
Coffee X-12230     0.019(0.002) 1.07E-27 0.015(0.003) 1.99E-06 0.018(0.002) 1.02E-33 0.060 
Coffee X-13741--3-methyl 
catechol sulfate 1 
Benzoate 
metabolism 
Xenobiotics 0.020(0.002) 3.43E-27 0.016(0.004) 1.05E-05 0.019(0.002) 1.25E-32 0.063 
Coffee catechol sulfate Benzoate 
metabolism 
Xenobiotics 0.015(0.002) 5.39E-22 0.011(0.003) 2.24E-04 0.014(0.001) 3.44E-25 0.033 





Xenobiotics 0.012(0.002) 5.43E-12 0.009(0.003) 8.66E-03 0.011(0.002) 1.45E-13 0.022 
Coffee 1-methylxanthine Xanthine 
metabolism 
Xenobiotics 0.010(0.002) 2.82E-07 0.010(0.003) 4.20E-03 0.010(0.002) 3.31E-09 0.016 
Confectionary
/jam 









-0.011(0.002) 4.86E-08 -0.008(0.003) 1.30E-02 -0.010(0.002) 2.02E-09 0.014 
Confectionary
/jam 
pipecolate Lysine metabolism Amino acid -0.009(0.002) 4.07E-07 -0.008(0.004) 3.81E-02 -0.008(0.002) 3.94E-08 0.008 
Fried fish X-11372     0.360(0.051) 2.88E-12 0.165(0.049) 8.66E-04 0.258(0.035) 2.81E-13 0.040 





Amino acid -0.167(0.032) 2.07E-07 -0.184(0.045) 7.67E-05 -0.172(0.026) 4.12E-11 0.012 
Fried fish X-11315     -0.174(0.035) 6.30E-07 -0.149(0.044) 7.69E-04 -0.164(0.027) 1.54E-09 0.013 
Fried fish scyllo-inositol Inositol 
metabolism 
Lipid -0.170(0.031) 6.22E-08 -0.116(0.048) 1.77E-02 -0.154(0.026) 4.44E-09 0.011 
Fruit juice stachydrine Food component, 
Plant 
Xenobiotics 0.064(0.005) 2.87E-30 0.045(0.008) 1.06E-07 0.058(0.005) 3.26E-37 0.064 
Green leafy 
vegetables 
X-11469     0.034(0.005) 9.00E-11 0.025(0.006) 1.24E-04 0.030(0.004) 5.66E-14 0.020 
Green leafy 
vegetables 
X-02269     0.033(0.005) 9.43E-10 0.025(0.006) 6.56E-05 0.030(0.004) 2.39E-13 0.018 
Green leafy 
vegetables 
X-11315     0.038(0.006) 4.37E-10 0.025(0.007) 5.56E-04 0.033(0.005) 1.71E-12 0.023 
Green leafy 
vegetables 
X-11372     -0.028(0.004) 5.23E-10 -0.021(0.009) 1.58E-02 -0.026(0.004) 2.51E-11 0.012 
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Table 5. List of metabolites associated with food intake from the Metabolon platform 
        
Discovery Discordant Meta-analysis 
Whole 
sample 
Variable Metabolite name Pathway 
Super-


















Lysolipid Lipid 0.025(0.005) 9.36E-08 0.017(0.007) 1.87E-02 0.023(0.004) 7.11E-09 0.009 




























X-11315     0.031(0.006) 8.40E-08 0.027(0.010) 1.12E-02 0.030(0.005) 2.75E-09 0.011 




Lipid 0.085(0.008) 3.30E-25 0.045(0.015) 2.55E-03 0.076(0.007) 9.36E-27 0.018 






Amino acid 0.077(0.010) 7.70E-14 0.070(0.017) 6.28E-05 0.075(0.009) 1.08E-17 0.020 
Meat creatine Creatine 
metabolism 
Amino acid 0.070(0.011) 5.01E-11 0.041(0.019) 3.12E-02 0.063(0.009) 8.24E-12 0.016 
Meat pyroglutamine* Glutamate 
metabolism 
Amino acid -0.066(0.011) 4.33E-09 -0.049(0.020) 1.46E-02 -0.062(0.010) 2.10E-10 0.016 
Meat X-09789     -0.052(0.011) 1.11E-06 -0.053(0.020) 7.66E-03 -0.052(0.009) 2.39E-08 0.009 
Mushrooms ergothioneine Food component, 
Plant 
Xenobiotics 0.189(0.023) 6.45E-16 0.165(0.033) 9.28E-07 0.181(0.019) 5.93E-22 0.107 
Nuts X-11315     0.060(0.006) 6.48E-21 0.042(0.009) 1.81E-05 0.054(0.005) 3.75E-25 0.037 
Oily fish docosahexaenoate 
(DHA; 22:6n3) 
Essential fatty acid Lipid 0.244(0.017) 1.72E-45 0.087(0.019) 9.66E-06 0.177(0.013) 2.09E-44 0.064 
Oily fish X-11469     0.214(0.017) 6.59E-34 0.117(0.022) 1.89E-07 0.176(0.013) 5.87E-39 0.062 
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Table 5. List of metabolites associated with food intake from the Metabolon platform 
        
Discovery Discordant Meta-analysis 
Whole 
sample 
Variable Metabolite name Pathway 
Super-









Lipid 0.204(0.016) 3.52E-34 0.112(0.022) 9.22E-07 0.172(0.013) 8.57E-39 0.054 
Oily fish X-02269     0.208(0.017) 1.44E-32 0.122(0.022) 7.36E-08 0.175(0.013) 1.44E-38 0.058 
Oily fish eicosapentaenoate 
(EPA; 20:5n3) 





Lysolipid Lipid 0.145(0.017) 7.40E-17 0.068(0.032) 3.36E-02 0.128(0.015) 3.33E-17 0.025 













Lysolipid Lipid -0.106(0.018) 1.24E-08 -0.081(0.026) 1.97E-03 -0.097(0.015) 9.46E-11 0.013 
Oily fish docosapentaenoate 
(n3 DPA; 22:5n3) 




Lysolipid Lipid -0.106(0.018) 5.45E-09 -0.055(0.025) 3.12E-02 -0.089(0.015) 1.60E-09 0.009 














Essential fatty acid Lipid 0.198(0.017) 5.83E-29 0.141(0.028) 9.10E-07 0.182(0.015) 6.10E-35 0.052 
Other 
fish/seafood 
X-11469     0.189(0.017) 5.51E-27 0.131(0.031) 3.07E-05 0.175(0.015) 2.99E-31 0.052 
Other 
fish/seafood 












Lysolipid Lipid 0.125(0.015) 7.30E-16 0.071(0.029) 1.35E-02 0.113(0.014) 6.70E-17 0.020 
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Table 5. List of metabolites associated with food intake from the Metabolon platform 
        
Discovery Discordant Meta-analysis 
Whole 
sample 
Variable Metabolite name Pathway 
Super-











(n3 DPA; 22:5n3) 



























acid       
-0.084(0.017) 6.20E-07 -0.078(0.036) 2.96E-02 -0.083(0.015) 4.73E-08 0.011 
Peaches X-11315     0.158(0.024) 8.45E-11 0.097(0.024) 6.51E-05 0.127(0.017) 5.92E-14 0.039 




Chemical Xenobiotics 0.053(0.010) 3.85E-08 0.043(0.019) 2.50E-02 0.051(0.009) 2.63E-09 0.016 
Poultry pyroglutamine* Glutamate 
metabolism 
Amino acid -0.102(0.016) 1.87E-10 -0.070(0.022) 1.29E-03 -0.091(0.013) 1.36E-12 0.017 
Poultry creatine Creatine 
metabolism 








Amino acid 0.052(0.009) 4.07E-09 0.035(0.016) 3.14E-02 0.048(0.008) 4.69E-10 0.011 
Processed 
meats 
X-11381     0.052(0.009) 6.89E-09 0.039(0.017) 2.18E-02 0.049(0.008) 4.74E-10 0.011 
Savoury pies X-11315     -0.287(0.044) 5.59E-11 -0.116(0.054) 3.44E-02 -0.221(0.034) 9.08E-11 0.016 





Amino acid -0.264(0.044) 2.06E-09 -0.151(0.068) 2.89E-02 -0.231(0.037) 3.72E-10 0.013 
Savoury pies X-11372     0.290(0.047) 1.14E-09 0.114(0.055) 4.02E-02 0.216(0.036) 2.04E-09 0.015 
Savoury pies ergothioneine Food component, 
Plant 
Xenobiotics -0.320(0.060) 1.31E-07 -0.291(0.105) 6.63E-03 -0.313(0.052) 2.16E-09 0.017 
Savoury 
snacks 
X-11372     0.064(0.008) 8.31E-14 0.029(0.011) 9.73E-03 0.051(0.007) 3.88E-14 0.026 





Xenobiotics 0.299(0.051) 6.10E-09 0.195(0.043) 3.18E-05 0.239(0.033) 6.05E-13 0.061 
Spirits/liquor 4-androsten-
3beta,17beta-diol 
Sterol, Steroid Lipid 0.044(0.008) 2.53E-08 0.028(0.013) 4.24E-02 0.040(0.007) 4.30E-09 0.021 
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Table 5. List of metabolites associated with food intake from the Metabolon platform 
        
Discovery Discordant Meta-analysis 
Whole 
sample 
Variable Metabolite name Pathway 
Super-


















Lipid -0.018(0.003) 8.43E-09 -0.014(0.005) 5.30E-03 -0.017(0.003) 1.44E-10 0.019 
Sweet baked 
products 
X-11799     -0.018(0.003) 1.39E-07 -0.015(0.006) 1.37E-02 -0.017(0.003) 4.88E-09 0.020 
Sweet baked 
products 
X-11315     -0.014(0.003) 3.66E-07 -0.009(0.003) 1.26E-02 -0.012(0.002) 2.90E-08 0.014 










X-11315     -0.017(0.003) 1.00E-08 -0.019(0.005) 6.53E-05 -0.017(0.002) 1.84E-12 0.017 
Wholemeal 
bread/grains 
X-09789     0.017(0.003) 3.91E-07 0.011(0.005) 3.58E-02 0.015(0.003) 6.03E-08 0.010 
Wine scyllo-inositol Inositol 
metabolism 






Amino acid 0.047(0.004) 2.09E-36 0.038(0.006) 2.32E-08 0.045(0.003) 1.23E-45 0.072 




Sterol, Steroid Lipid 0.043(0.004) 1.09E-26 0.034(0.008) 3.31E-05 0.041(0.003) 1.50E-31 0.071 
Wine X-11799     0.035(0.004) 3.49E-22 0.028(0.006) 8.74E-06 0.033(0.003) 1.66E-27 0.052 
Wine X-10395     0.035(0.003) 9.31E-25 0.018(0.006) 3.51E-03 0.031(0.003) 3.45E-26 0.034 




Sterol, Steroid Lipid 0.038(0.004) 6.27E-21 0.030(0.008) 4.21E-04 0.036(0.004) 2.71E-24 0.059 
Wine pipecolate Lysine metabolism Amino acid 0.031(0.003) 1.57E-19 0.024(0.007) 4.94E-04 0.029(0.003) 1.51E-22 0.029 
Wine eicosapentaenoate 
(EPA; 20:5n3) 
Essential fatty acid Lipid 0.030(0.003) 1.66E-20 0.017(0.006) 4.40E-03 0.027(0.003) 6.63E-22 0.027 
Wine docosahexaenoate 
(DHA; 22:6n3) 
Essential fatty acid Lipid 0.029(0.003) 2.42E-17 0.014(0.005) 1.25E-02 0.025(0.003) 6.92E-18 0.022 
Wine myo-inositol Inositol 
metabolism 
Lipid 0.026(0.003) 7.58E-16 0.011(0.005) 4.93E-02 0.022(0.003) 1.36E-15 0.022 
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Table 5. List of metabolites associated with food intake from the Metabolon platform 
        
Discovery Discordant Meta-analysis 
Whole 
sample 
Variable Metabolite name Pathway 
Super-




(n3 DPA; 22:5n3) 
Essential fatty acid Lipid 0.025(0.003) 5.38E-13 0.019(0.006) 3.46E-03 0.024(0.003) 5.28E-15 0.019 
Wine X-12627     0.024(0.003) 4.95E-14 0.014(0.006) 1.55E-02 0.022(0.003) 5.88E-15 0.017 
Wine X-01911     0.029(0.004) 7.11E-11 0.022(0.006) 1.27E-04 0.026(0.003) 2.55E-14 0.031 
Wine 2-aminobutyrate Butanoate 
metabolism 
Amino acid 0.027(0.004) 2.83E-13 0.016(0.007) 2.04E-02 0.025(0.003) 2.73E-14 0.023 
Wine X-05907     0.024(0.003) 4.22E-12 0.017(0.005) 1.85E-03 0.022(0.003) 3.03E-14 0.019 
Wine X-10429     0.025(0.003) 1.88E-12 0.019(0.007) 7.10E-03 0.024(0.003) 3.62E-14 0.019 
Wine caprate (10:0) Medium chain 
fatty acid 
Lipid 0.021(0.003) 1.36E-11 0.023(0.007) 2.09E-03 0.022(0.003) 6.60E-14 0.016 
Wine piperine Food component, 
Plant 
Xenobiotics 0.028(0.004) 1.04E-10 0.022(0.006) 2.34E-04 0.026(0.003) 6.81E-14 0.026 
Wine X-12038     0.020(0.003) 2.27E-09 0.028(0.007) 1.20E-04 0.022(0.003) 9.20E-13 0.014 
Wine X-13215     0.023(0.004) 1.48E-09 0.023(0.006) 3.37E-04 0.023(0.003) 1.07E-12 0.016 












Amino acid 0.021(0.003) 9.19E-11 0.016(0.007) 1.64E-02 0.020(0.003) 4.44E-12 0.009 
Wine X-09026     0.020(0.003) 1.93E-09 0.019(0.006) 2.71E-03 0.020(0.003) 1.30E-11 0.011 
Wine caprylate (8:0) Medium chain 
fatty acid 
Lipid 0.019(0.003) 2.10E-09 0.020(0.007) 4.05E-03 0.019(0.003) 2.13E-11 0.012 
Wine benzoate Benzoate 
metabolism 
Xenobiotics 0.019(0.003) 4.37E-09 0.018(0.006) 2.84E-03 0.019(0.003) 3.20E-11 0.009 
Wine X-11550     0.018(0.003) 1.54E-08 0.020(0.006) 9.97E-04 0.018(0.003) 3.94E-11 0.011 
Wine stearidonate 
(18:4n3) 
Long chain fatty 
acid 




















Amino acid 0.018(0.003) 2.72E-07 0.020(0.007) 3.55E-03 0.018(0.003) 2.61E-09 0.007 
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Table 5. List of metabolites associated with food intake from the Metabolon platform 
        
Discovery Discordant Meta-analysis 
Whole 
sample 
Variable Metabolite name Pathway 
Super-
pathway Beta(SE) P Beta(SE) P Beta(SE) P R
2
 
Wine X-11452     0.023(0.004) 1.18E-07 0.017(0.006) 6.54E-03 0.021(0.003) 2.79E-09 0.015 
Wine epiandrosterone 
sulfate 
Sterol, Steroid Lipid 0.018(0.003) 2.21E-07 0.016(0.006) 1.05E-02 0.018(0.003) 6.29E-09 0.010 
Wine X-13496     0.017(0.003) 1.08E-07 0.015(0.006) 2.23E-02 0.017(0.003) 6.56E-09 0.009 
Wine arachidonate 
(20:4n6) 
Long chain fatty 
acid 
Lipid 0.017(0.004) 1.13E-06 0.018(0.006) 5.04E-03 0.017(0.003) 1.50E-08 0.009 
Wine theophylline Xanthine 
metabolism 





Lysolipid Lipid 0.015(0.003) 8.33E-07 0.017(0.007) 2.16E-02 0.015(0.003) 4.82E-08 0.007 
Notes: Table shows results of the linear regression analysis for the discovery population (excluding monozygotic twins discordant for each food group intake), the MZ 
discordant twin sample and the fixed effects meta-analysis of both groups. Only significant associations are shown which includes those associations passing the 
bonferroni cut-off in the discovery and fixed effects analyses (1.08x10
-6
 = 0.05/[77 food variables x 601 detected metabolites]) and passing the 5% level of significance in 
the discordant twin group. The R-squared was calculated for the relevant metabolite and food group in the study population. The Metabolon platform is a non-targeted 
platform which identified 456 metabolites in blood; data were available for 3559 twins.
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Table 6. List of metabolites associated with food intake from the Biocrates platform 
    
Discovery Discordant Meta-analysis 
Whole 
sample 
Variable Biocrates name Pathway 
Super-





Glycerophsopholipids Lipid 0.029(0.005) 1.36E-07 0.057(0.020) 7.68E-03 0.030(0.005) 3.36E-09 0.013 
Cream Hydroxysphingomyeline 
C14:1 
Sphingolipids Lipid 0.034(0.005) 8.09E-10 0.039(0.016) 2.37E-02 0.035(0.005) 2.22E-11 0.013 
Cream lysoPhosphatidylcholine 
acyl C28:1 
Glycerophsopholipids Lipid 0.025(0.005) 7.57E-07 0.050(0.025) 5.63E-02 0.026(0.005) 1.17E-07 0.012 
Herbal tea Phosphatidylcholine 
acyl-alkyl C38:3 
Glycerophsopholipids Lipid -0.012(0.002) 1.78E-08 -0.001(0.005) 7.75E-01 -0.011(0.002) 9.91E-08 0.017 
Herbal tea Phosphatidylcholine 
acyl-alkyl C40:4 
Glycerophsopholipids Lipid -0.010(0.002) 6.94E-07 -0.003(0.006) 5.44E-01 -0.009(0.002) 8.01E-07 0.014 
Herbal tea Phosphatidylcholine 
acyl-alkyl C40:3 
Glycerophsopholipids Lipid -0.014(0.002) 3.64E-09 -0.004(0.006) 5.40E-01 -0.013(0.002) 5.57E-09 0.013 
Herbal tea Phosphatidylcholine 
acyl-alkyl C38:2 
Glycerophsopholipids Lipid -0.018(0.003) 1.61E-07 -0.002(0.008) 8.05E-01 -0.016(0.003) 6.68E-07 0.012 
Herbal tea Phosphatidylcholine 
diacyl C42:4 
Glycerophsopholipids Lipid -0.014(0.003) 1.51E-07 -0.002(0.008) 7.43E-01 -0.013(0.002) 2.80E-07 0.011 
Herbal tea Phosphatidylcholine 
acyl-alkyl C38:1 
Glycerophsopholipids Lipid -0.020(0.003) 1.65E-08 -0.001(0.010) 9.33E-01 -0.018(0.003) 6.19E-08 0.010 
Oily fish Phosphatidylcholine 
diacyl C40:6 
Glycerophsopholipids Lipid 0.073(0.011) 1.07E-11 0.015(0.021) 4.88E-01 0.061(0.009) 7.34E-11 0.041 
Oily fish Phosphatidylcholine 
diacyl C38:6 




Octenoylcarnitine Acylcarnitines Lipid 0.013(0.002) 1.32E-08 0.008(0.005) 8.23E-02 0.012(0.002) 2.45E-09 0.031 
Wine Phosphatidylcholine 
diacyl C36:5 
Glycerophsopholipids Lipid 0.018(0.003) 1.16E-08 0.011(0.008) 1.73E-01 0.017(0.003) 3.63E-09 0.038 
Wine Phosphatidylcholine 
diacyl C32:1 
Glycerophsopholipids Lipid 0.015(0.003) 2.83E-07 0.013(0.011) 2.25E-01 0.015(0.003) 9.27E-08 0.028 
Notes: Table shows results of the linear regression analysis for the discovery population (excluding monozygotic twins discordant for each food group intake), the MZ 
discordant twin sample and the fixed effects meta-analysis of both groups. Only significant associations are shown which includes those associations passing the 
bonferroni cut-off in the discovery and fixed effects analyses (1.08x10
-6
 = 0.05/[77 food variables x 601 detected metabolites]) and in the same direction in the discordant 
twin group. The R-squared was calculated for the relevant metabolite and food group in the study population. The Biocrates platform is a targeted platform which 




Table 7. Information for metabolites associated to food intakes, including biological role, previous dietary and disease associations 






Lip Essential fatty 
acid 
Docosahexaenoat
e (DHA; 22:6n3) 











Essential fatty acid, derived 
endogenously from α-linolenic 
acid and in high concentrations 
in oily fish. 
↑ Fish (excluding shellfish);  
↑ Other vegetables: Celery, 
green beans, squash, 
cucumbers;  
↑ White rice;  
↓ Chips (Guertin et al., 2014) 
↑ Fish and seafood (Zheng, 
Yu, Alexander, Steffen, & 
Boerwinkle, 2014) 
↓ NASH (Kalhan et al., 
2011) 
↓ Simvastatin treatment 




Lip Essential fatty 
acid 
Docosapentaenoat
e (n3 DPA; 22:5n3) 
↑ Wine ↑ Other 
seafood                                      
↑ Oily fish 
  
  
Essential fatty acid, derived 
endogenously from omega-3 and 
6 fatty acids and in high 
concentrations in oily fish. 
↑ Eggs (Zheng, Yu, 
Alexander, Steffen, & 
Boerwinkle, 2014) 
↑ Alcohol (Zheng, Yu, 
Alexander, Steffen, & 
Boerwinkle, 2014) 
  










↓ Baked goods 
↑ Avocado 
↑ High fat 
salad 
dressings 
Essential fatty acid, derived 
endogenously from α-linolenic 
acid and in high concentrations 
in oily fish. 
↑ Fish and seafood (Zheng, 
Yu, Alexander, Steffen, & 
Boerwinkle, 2014) 










↑ Green leafy 
vegetables 
Downstream product of omega-3 
essential fatty acid metabolism.  
↑ Fish (excluding shellfish), ↑ 
Healthy eating index 






  ↑ Wine Downstream product of omega-3 
essential fatty acid metabolism. 





  ↓ Oily fish  Downstream product of omega-6 
essential fatty acid metabolism. 
Lysolipids form cellular lipid 
bilayer, when cleaved by 
lipoprotein-associated 
phospholipase A2 form free 
lysophosphatidylcholines 
involved in inflammatory 
processes and may influence 
artherosclerotic plaque 
inflammation (Goncalves et al., 
2012). 
↓ HEI (Guertin et al., 2014)   
Lip Lysolipid 1-Eicosatrienoyl 
glycerophosphoch
oline* 
  ↓ Oily fish 
↓ Other 
seafood 
    ↓ Dilated cardiomyopathy 
(Alexander, Lombardi, 
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  ↓ Oily fish   ↓ HEI (Guertin et al., 2014) ↓ Dilated cardiomyopathy 




  ↓ Oily fish     ↓ Dilated cardiomyopathy 
(Alexander et al., 2011) 


















Furan fatty acid, found in 
significant concentrations in fish. 
Thought to be a uremic toxin 
(Miyamoto et al., 2012). Though 
to induce beta cell dysfunction 
(Prentice et al., 2014). 
↑ Fish and shellfish;  
↑ Alliums (garlic and onions);  
↑ Greens: lettuce, spinach, 
green pepper (Guertin et al., 
2014) 
↑ Fish and seafood (Zheng, 
Yu, Alexander, Steffen, & 
Boerwinkle, 2014) 
↓ Dietary choline depletion 
(Sha et al., 2010) 
  




↑ Wine   Derived endogenously from 
essential fatty acid α-linolenic 
acid.  
↑ Alcohol (Zheng, Yu, 
Alexander, Steffen, 
Nettleton, et al., 2014) 
  




  ↑ Butter Monounsaturate of 
nonadecenoate (19:0). 
↓ Sugar-rich foods and 
beverages, dietary sucrose 
and carbohydrate (Zheng, 
Yu, Alexander, Steffen, & 
Boerwinkle, 2014) 
  
Lip Long chain 
fatty acid 
Myristate (14:0)   ↑ Butter Contained in most animal and 
vegetable fats. Higher 
concentrations in plasma 
associated with heart failure 
(Yamagishi, Nettleton, & Folsom, 
2008). 
↑ Alcohol (Zheng, Yu, 
Alexander, Steffen, 
Nettleton, et al., 2014) 
↓ T2D, IFG (Menni et al., 
2013) 




↑ Butter   Produced by ruminal bacteria in 
livestock, found in highest 
concentrations in dairy products, 
butter and meats from ruminant 
animals. 
↑ Butter (Guertin et al., 2014) ↓ T2D, IFG (Menni et al., 
2013) 




↑ Butter   Monounsaturated fatty acid 
found in oils and animal fats and 
produced endogenously. 
↑ Butter (57) ↓ NASH, steatosis (51) 





↑ Butter   Methylated long chain fatty acid, 
found to be anti-inflammatory 
and anti-fibrotic in liver disease 
animal models (Mantawy, 
Tadros, Awad, Hassan, & El-
Demerdash, 2012).  
↑ Butter, ↓ HEI (Guertin et 
al., 2014) 




Table 7. Information for metabolites associated to food intakes, including biological role, previous dietary and disease associations 






Lip Medium chain 
fatty acid 
Caprate (10:0)   ↑ Wine Saturated fatty acid found in oils 
and animal fats and produced 
endogenously. 
    
Lip Medium chain 
fatty acid 
Caprylate (8:0)   ↑ Wine Saturated fatty acid found in oils 
and animal fats and produced 
endogenously. 




oline acyls C17:0 & 
C28:1 






C38:3, C40:3 & 
C40:4 




e diacyls C32:1 & 
C36:5 
  ↑ Wine   ↑ Factor 1: ↑ Fish and 
poultry, ↓ Confectionary, 
cake, cookies, desserts, 
margarine, tea, whole grain 
bread, pasta, rice and high 
fat cheese;  
↑ Factor 2: ↑ sauce and 
butter, ↓ fish, whole grain 
bread, tea, grain flakes, 





e diacyls C38:6 & 
C40:6 
  ↑ Oily fish   ↑ Factor 1: ↑ Fish and 
poultry, ↓ Confectionary, 
cake, cookies, desserts, 
margarine, tea, whole grain 
bread, pasta, rice and high 
fat cheese;  
↓ Factor 2: ↑ sauce and 
butter, ↓ fish, whole grain 
bread, tea, grain flakes, 





e diacyl C42:4 
  ↓ Herbal tea       
Lip Sphingomyelin Hydroxysphingomy
eline C14:1 
  ↑ Cream   ↑ Factor 1: ↑ Butter, garlic 
and coffee, ↓ Margarine, 
fresh fruit and soup; ↓ Factor 
2: ↓ Butter, sweet bread 
spreads, high fat cheese, 
fresh fruit, whole grain 
bread, desserts, cake, 
cookies, high-fat dairy 
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Nonanoylcarnitine*   ↑ Butter Ester of carnitine with pelargonic 
acid (C9). 
    
Lip Carnitine 
metabolism 
Octenoylcarnitine   ↑ White and 
brown bread, 
refined grains 
Acylcarnitines consist of carnitine 
and fatty acid derivatives; formed 
from mitochondrial beta-
oxidation. 
↓ Factor 1: ↑ Butter, ↓ 
Margarine and low fat 
cheese;  
↑ Factor 2: ↑ Cornflakes and 
crisps, ↓ Fish, other 
vegetable fat, whole grain 
bread, cooked vegetables, 
garlic, nuts, tea, cabbage, 
sweet bread spreads, cake, 
cookies, high fat cheese 
(Floegel et al., 2013);  
  




↑ Spirits and 
liquors 
  
  Sex steroid. Found to be a 
testosterone precursor and 
androgen receptor agonist (Chen 
et al., 2004).  
↑ Alcohol (Zheng, Yu, 
Alexander, Steffen, 
Nettleton, et al., 2014) 
↓ Nuts and peanut butter, 
Sugar-rich foods and 
beverages, dietary sucrose 
and carbohydrate (Zheng, 
Yu, Alexander, Steffen, & 
Boerwinkle, 2014) 
↑ Total alcohol (Guertin et 
al., 2014) 
  
Lip Sterol, Steroid 5-Alpha-androstan-
3beta,17beta-diol 
disulfate 
↑ Wine   Sex steroid. Arrests growth of 
prostate cells in mice (Weihua, 
Lathe, Warner, & Gustafsson, 
2002), promotes growth of breast 
cancer cells in vitro (Couture, 
Theriault, Simard, & Labrie, 
1993).  
↑ Alcohol (Zheng, Yu, 
Alexander, Steffen, 
Nettleton, et al., 2014) 
↓ Nuts and peanut butter, 
Sugar-rich foods and 
beverages, dietary sucrose 
and carbohydrate (Zheng, 
Yu, Alexander, Steffen, & 
Boerwinkle, 2014) 
↑ Total alcohol (Guertin et 
al., 2014) 
  
Lip Sterol, Steroid Epiandrosterone 
sulfate 
  ↑ Wine Sex steroid, also known as 
3beta-hydroxy-5alpha-
androstan-17-one sulfate. 
Downstream metabolite of 
dehydroepiandrosterone 
(DHEA).  
    
Lip Inositol 
metabolism 
Myo-inositol   ↑ Wine Contained in citrus fruits (Katz et 
al., 2011), beans, grains and 
nuts (Clements & Darnell, 1980). 
↓ Dietary choline depletion 
(Sha et al., 2010) 
↑ Insulin sensitivity (Gall et 
al., 2010) 
↑ Dilated cardiomyopathy 
(Alexander et al., 2011) 
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Scyllo-inositol ↑ Wine ↓ Baked goods 
↓ Fried fish 
  
Contained in citrus juices and 
grapes; has been used as a 
potential Alzheimer’s treatment 
(Ma, Thomason, & McLaurin, 
2012). 
↑ Citrus fruit: oranges, 
orange juice, grapefruit; 
↑ Wine (Guertin et al., 2014) 
↑ Fruit juice (Zheng, Yu, 





2-Aminobutyrate ↑ Wine   Part of AHB-related pathway. 
AHB is a by-product of hepatic 
glutathione synthesis under 
oxidative stress (Lord & Bralley, 
2008). 
↑ Alcohol (Zheng, Yu, 
Alexander, Steffen, 
Nettleton, et al., 2014) 
↓ Sugar-rich foods and 
beverages, dietary sucrose 
and carbohydrate (Zheng, 









↑ Wine   Part of AHB-related pathway. 
AHB is a by-product of hepatic 
glutathione synthesis under 
oxidative stress (Lord & Bralley, 
2008). 
↑ Alcohol (Zheng, Yu, 
Alexander, Steffen, 
Nettleton, et al., 2014) 
↓ Sugar-rich foods and 
beverages, dietary sucrose 
and carbohydrate (Zheng, 
Yu, Alexander, Steffen, & 
Boerwinkle, 2014) 
  
↑ T2D, IFG (Menni et al., 
2013)                   ↓ Insulin 
sensitivity (Gall et al., 
2010) 
↑ BMI (Moore, 2013)                                   
↑ Dilated cardiomyopathy 
(Alexander et al., 2011) 
  





↑ Wine   Part of AHB-related pathway. 
AHB is a by-product of hepatic 
glutathione synthesis under 
oxidative stress (Lord & Bralley, 
2008). 
↑ Alcohol (Zheng, Yu, 
Alexander, Steffen, 
Nettleton, et al., 2014) 
↓ Sugar-rich foods and 
beverages, dietary sucrose 
and carbohydrate (Zheng, 
Yu, Alexander, Steffen, & 
Boerwinkle, 2014) 
↑ Dilated cardiomyopathy 
(Alexander et al., 2011) 
↑ 28-day mortality in 
critically ill patients 
(Rogers et al., 2014) 





  ↑ Wine Part of AHB-related pathway. 
AHB is a by-product of hepatic 
glutathione synthesis under 
oxidative stress (Lord & Bralley, 
2008). 
    





  ↑ Wine Derived from branched chain 
amino acid, precursor to leucine 
and valine synthesis. 
  ↑ T2D, IFG (Menni et al., 
2013) 
↑ BMI (Moore, 2013) 





  ↑ Wine Derived from branched chain 
amino acid, leucine, metabolism; 
accumulates, and may contribute 
to DNA damage and 
neurotoxicity, in maple-syrup 
urine disease (Mescka et al., 
2014). 
  ↑ T2D, IFG (Menni et al., 
2013)                   ↑ BMI 
(Moore, 2013)   
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Present in citrus fruits (Servillo et 
al., 2012). Thought to be formed 
primarily by gut bacterial lysine 
degradation (Fujita, Fujita, 
Kodama, Hada, & Higashino, 
2003). 







  ↑ Wine The L-form is produced from 
tyrosine metabolism. The 
unusual D-form is of bacterial 
origin (Spaapen, Ketting, 
Wadman, Bruinvis, & Duran, 
1987), particularly by 
Bifidobacteria and lactobacilli, 
from dietary phenolic compounds 
and has shown to reduce 
mitochondrial and neutrophil 
ROS production (Beloborodova 
et al., 2012).  







  ↓ Fried fish 
↓ Savoury pies 
↑ Apples & 
pears 
Formed by gut bacterial 
degradation of tyrosine (Smith & 
Macfarlane, 1996) and phenolic 
compounds (Anson et al., 2009; 
van Dorsten et al., 2012). 
  ↑ NASH vitamin E 








  ↓ Other 
seafood 
      
AA Tryptophan 
metabolism 
Indolepropionate   ↑ Bananas                                                





Formed by gut bacterial 
degradation of tryptophan (Smith 
& Macfarlane, 1996). 
Acts as an antioxidant 
(Karbownik et al., 2001). 
  
  
↓ Eggs, ↓ Red meat (Guertin 
et al., 2014) 
↓ Dietary choline depletion 
(Sha et al., 2010) 
  
  
↑ Insulin sensitivity (Gall et 
al., 2010) 
↑ NASH vitamin E 
responders at baseline 
(Cheng, Joyce, Yates, 
Aouizerat, & Sanyal, 2012) 
↓ Dilated cardiomyopathy 
(Alexander et al., 2011) 
↓ Muscle mass indices in 
elderly (Lustgarten, Price, 






  ↑ Allium 
vegetables 
Indole alkaloid found in legumes 
of Erythrina species, also called 
hypaphorine. Found to induce 
sleep in mice (Ozawa, Honda, 
Nakai, Kishida, & Ohsaki, 2008).  
↑ Peanuts (Guertin et al., 
2014) 
↑ Nuts and peanut butter 
(Zheng, Yu, Alexander, 
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Creatine   ↑ Meat 
↑ Poultry 
  
Red meat a major source; 
vegetarians have lower 
circulating levels (Delanghe et 
al., 1989).  
↓ Sugar-rich foods and 
beverages, dietary sucrose 
and carbohydrate (Zheng, 
Yu, Alexander, Steffen, & 
Boerwinkle, 2014) 
↓ Insulin sensitivity (Gall et 
al., 2010) 
↓ Steatosis vs. NASH 
(Kalhan et al., 2011) 
↑ Dilated cardiomyopathy 
(Alexander et al., 2011) 
AA Glutamate 
metabolism 
Pyroglutamine* ↓ Poultry ↓ Other 
seafood 
↓ Meat 
  ↓ Poultry (chicken) (Guertin 
et al., 2014) 
↑ Dietary choline depletion 
(Sha et al., 2010) 
↑ Active TB (Weiner et al., 
2012) 
↑ Dilated cardiomyopathy 
(Alexander et al., 2011) 






  ↑ Meat                                                    
↑ Processed 
meat                                    
↑ Beef burgers 
Major component of collagen; 
circulating levels increase 
following oral gelatin ingestion 
(Ohara, Matsumoto, Ito, Iwai, & 
Sato, 2007). 
↑ Dietary choline depletion 




1-Methylxanthine ↑ Coffee     ↑ Coffee (Zheng, Yu, 
Alexander, Steffen, & 
Boerwinkle, 2014) (Guertin 
et al., 2015) 
↑ β-carotene 
supplementation in smokers 




7-Methylxanthine   ↑ Chocolate   ↑ Coffee (Zheng, Yu, 
Alexander, Steffen, & 
Boerwinkle, 2014) 





Theobromine ↑ Chocolate   Bitter alkaloid characteristic of 
the cacao plant. 
↑ Sugar-rich foods and 
beverages, dietary sucrose 
and carbohydrate (Zheng, 
Yu, Alexander, Steffen, & 
Boerwinkle, 2014) 





Theophylline   ↑ Wine Theophylline is methylxanthine 
metabolite found in caffeinated 
beverages and foods but also 
administered as a treatment for 
COPD and asthma. Alcohol has 
been shown to delay plasma 
clearance of theophylline 
(Thompson, 1992). 
    
Xeno Benzoate 3-methyl catechol ↑ Coffee ↓ Black tea   ↑ Coffee (Guertin et al.,   
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metabolism sulfate 1 2015) 
Xeno Benzoate 
metabolism 
Catechol sulfate ↑ Coffee   Chlorogenic acid derived 
metabolite (Lang et al., 2013). 
↑ Coffee (Guertin et al., 
2014) 
↑ β-carotene 
supplementation in smokers 
(Mondul et al., 2013) 











  ↑ Soy and 
other milks 
Synthesized by gut bacteria, 
elevated in chronic kidney 
disease (Itoh, Ezawa, Kikuchi, 
Tsuruta, & Niwa, 2013);  
elevated levels may indicate 
intestinal permeability (Hsiao et 
al., 2013). 
↑ Tofu (Guertin et al., 2014)   
Xeno Benzoate 
metabolism 
Benzoate   ↑ Wine Added to foods to prevent mold 
and bacterial growth (often as 
sodium benzoate in wine). 
  ↓ BMI (Moore, 2013) 
Xeno Chemical 3-hydroxypyridine 
sulfate 
↑ Coffee ↓ Black tea   ↑ Coffee (Guertin et al., 
2015) 
  
Xeno Chemical 2-aminophenol 
sulfate 
  ↑ Porridge Benzoxazinoid metabolite 
excreted in urine following whole 
grain rye bread consumption 
(Bondia-Pons et al., 2013). 




Quinate ↑ Coffee ↓ Black tea Phenolic product of chlorogenic 
acid, acts as an antioxidant 
(Lang et al., 2013). 
↑ Coffee (Guertin et al., 
2014; Zheng, Yu, Alexander, 
Steffen, & Boerwinkle, 2014) 
↓ Sugar-sweetened 
beverages: soda, fruit punch 
(Guertin et al., 2014) 




Piperine ↑ Wine   Compound in black pepper with 
antioxidant effects (Srinivasan, 
2014). 
↑ Alcohol (Zheng, Yu, 
Alexander, Steffen, 





Ergothioneine   ↑ Mushroom 
↓ Savoury pies 
Thiol compound which enters 
human cells via the organic 
cation transporter OCTN1. Is 
found in particularly high 
concentrations in specialty 
mushrooms, oat bran and beans 
and demonstrates protection 
against copper(II)-induced 
toxicity (Ey, Schomig, & Taubert, 
2007). 
  ↓ Parkinson’s disease 
patients (Ey et al., 2007) 
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Stachydrine ↑ Fruit juice 
↑ Citrus fruit 
  
  Present in citrus fruits and juices 
(Servillo, Giovane, Balestrieri, 
Cautela, & Castaldo, 2011). 
↑ Citrus fruit: oranges, 
orange juice, grapefruit 
(Guertin et al., 2014) 
↑ Fruit juice (Zheng, Yu, 
Alexander, Steffen, & 
Boerwinkle, 2014) 
↓ Dietary choline depletion 
(Sha et al., 2010) 
↑ Dilated cardiomyopathy 









Contained in citrus fruits (Katz et 
al., 2011) 
↑ Fruits and vegetables;  
↑ Fruit juice (Zheng, Yu, 
Alexander, Steffen, & 
Boerwinkle, 2014) 








  ↑ Other 
seafood 
Marker of glycaemic control and 
of dietary origin (Yamanouchi et 
al., 1989). 
↓ β-carotene 
supplementation in smokers 
(Mondul et al., 2013) 
↓ T2D, IFG (Menni et al., 
2013) 





Threitol   ↑ Apples and 
pears 
Primary end product of D-xylose 
metabolism. Found in the edible 
fungus Armillaria mellea, jute 
and the pigeon pea plant 
FDB002261. 
    
Vit Vitamin B6 
metabolism 
Pyridoxate   ↑ High fibre 
breakfast 
cereals 
Essential nutrient, coenzyme for 
synthesis of amino acids, 
neurotransmitters (serotonin, 
norepinephrine), sphingolipids, 
and aminolevulinic acid. 
↑ Vitamins/supplements;  
↑ Healthy eating index;  
↑ Other fruits: plums, 
apricots, peaches, prunes, 
raisins, grapes, pineapple 
(Guertin et al., 2014) 
↓ Dietary choline depletion 
(Sha et al., 2010) 
  
Pep Dipeptide Cyclo(leu-pro)   ↑ Coffee  
↓ Black tea 
Cyclo(leu-pro) is a 
diketopiperazine which 
contributes to the bitter flavor of 
roasted coffee beans (Ginz & 
Engelhardt, 2000). 
↓ Starchy vegetables: white 
potatoes, corn, and peas, ↑ 
Total alcohol (Guertin et al., 
2014) 
↑ Alcohol (Zheng, Yu, 
Alexander, Steffen, 
Nettleton, et al., 2014) 
  
Notes: Associations are reported which replicate previous findings from food intake and blood metabolite association studies and those which 
associations which we believe to be novel. Biological roles of most metabolites are defined and some previous disease associations with the 
appropriate metabolite in blood are included. 
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Table 8. List of metabolites associated with dietary patterns from the Metabolon platform 
        
Discovery Discordant Meta-analysis Unique 
to 
pattern Variable Metabolite name Pathway 
Super-
pathway Beta(SE) P Beta(SE) P Beta(SE) P 
Mediterranean 
Diet Score 
X-11315     0.117(0.010) 3.22E-28 0.085(0.018) 2.01E-06 0.109(0.009) 7.94E-34 No 
Mediterranean 
Diet Score 
X-11469     0.104(0.010) 3.86E-23 0.091(0.016) 3.08E-08 0.100(0.009) 9.16E-31 No 
Mediterranean 
Diet Score 



































    -0.076(0.011) 1.60E-12 -0.064(0.018) 3.20E-04 -0.073(0.009) 1.48E-15 No 
Mediterranean 
Diet Score 
tryptophan betaine Tryptophan 
metabolism 
Amino acid 0.089(0.012) 2.36E-13 0.068(0.022) 2.53E-03 0.084(0.011) 1.65E-15 No 
Mediterranean 
Diet Score 
X-11847     0.091(0.013) 9.97E-13 0.074(0.024) 2.38E-03 0.088(0.011) 6.32E-15 Yes 
Mediterranean 
Diet Score 
X-11381     -0.075(0.011) 5.75E-12 -0.052(0.018) 3.27E-03 -0.069(0.009) 8.27E-14 No 
Mediterranean 
Diet Score 
X-11849     0.094(0.014) 3.05E-11 0.067(0.023) 3.69E-03 0.086(0.012) 4.15E-13 Yes 
Mediterranean 
Diet Score 
X-12798     -0.067(0.011) 2.68E-09 -0.076(0.019) 8.03E-05 -0.069(0.010) 6.80E-13 No 
Mediterranean 
Diet Score 
ergothioneine Food component, 
Plant 
Xenobiotics 0.083(0.016) 1.08E-07 0.107(0.026) 4.21E-05 0.090(0.013) 1.56E-11 No 
Mediterranean 
Diet Score 





Lipid 0.067(0.012) 1.52E-08 0.061(0.022) 5.19E-03 0.066(0.010) 2.25E-10 No 
Mediterranean 
Diet Score 
piperine Food component, 
Plant 
Xenobiotics 0.060(0.012) 4.12E-07 0.050(0.020) 1.39E-02 0.057(0.010) 1.73E-08 No 
Fruit & 
Vegetable 
X-11315     0.145(0.009) 5.48E-52 0.130(0.022) 1.20E-08 0.142(0.008) 3.87E-63 No 
Fruit & 
Vegetable 
X-11469     0.112(0.010) 3.63E-29 0.083(0.018) 1.16E-05 0.106(0.009) 3.39E-34 No 
Fruit & 
Vegetable 
X-11372     -0.109(0.009) 6.97E-32 -0.061(0.021) 4.25E-03 -0.102(0.008) 5.27E-34 No 
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Table 8. List of metabolites associated with dietary patterns from the Metabolon platform 
        
Discovery Discordant Meta-analysis Unique 
to 
pattern Variable Metabolite name Pathway 
Super-
pathway Beta(SE) P Beta(SE) P Beta(SE) P 
Fruit & 
Vegetable 



















Lipid 0.093(0.010) 1.08E-20 0.068(0.021) 1.08E-03 0.088(0.009) 2.22E-23 No 
Fruit & 
Vegetable 
ergothioneine Food component, 
Plant 





Essential fatty acid Lipid 0.102(0.012) 5.49E-18 0.067(0.018) 1.91E-04 0.091(0.010) 6.05E-21 No 
Fruit & 
Vegetable 

























Lipid 0.082(0.010) 9.19E-17 0.053(0.020) 7.55E-03 0.076(0.009) 2.74E-18 No 
Fruit & 
Vegetable 
tryptophan betaine Tryptophan 
metabolism 
Amino acid 0.083(0.010) 9.57E-16 0.064(0.025) 1.06E-02 0.080(0.009) 1.94E-17 No 
Fruit & 
Vegetable 
X-14056     -0.071(0.010) 2.40E-13 -0.081(0.021) 1.29E-04 -0.073(0.009) 6.78E-17 Yes 
Fruit & 
Vegetable 



















Amino acid 0.077(0.011) 4.84E-12 0.089(0.020) 1.72E-05 0.080(0.010) 1.73E-16 No 
Fruit & 
Vegetable 
X-11847     0.077(0.011) 2.85E-11 0.092(0.025) 3.65E-04 0.080(0.010) 2.68E-14 Yes 
Fruit & 
Vegetable 
X-11849     0.085(0.013) 1.96E-11 0.083(0.027) 2.38E-03 0.085(0.011) 9.86E-14 Yes 
Fruit & 
Vegetable 





Xenobiotics 0.061(0.009) 2.42E-11 0.042(0.021) 4.86E-02 0.058(0.008) 3.29E-12 Yes 
 263 
 
Table 8. List of metabolites associated with dietary patterns from the Metabolon platform 
        
Discovery Discordant Meta-analysis Unique 
to 
pattern Variable Metabolite name Pathway 
Super-
pathway Beta(SE) P Beta(SE) P Beta(SE) P 
Fruit & 
Vegetable 
X-09789     0.062(0.010) 7.79E-10 0.059(0.025) 1.84E-02 0.061(0.009) 3.50E-11 No 
Fruit & 
Vegetable 
catechol sulfate Benzoate 
metabolism 





Lipid 0.051(0.009) 5.14E-09 0.056(0.019) 3.08E-03 0.052(0.008) 4.43E-11 No 
Fruit & 
Vegetable 





0.056(0.010) 6.64E-09 0.058(0.021) 6.08E-03 0.056(0.009) 1.07E-10 No 
Fruit & 
Vegetable 
X-11261     -0.062(0.011) 2.39E-08 -0.057(0.019) 3.08E-03 -0.061(0.010) 2.08E-10 Yes 
Fruit & 
Vegetable 
X-12063     -0.047(0.009) 1.73E-07 -0.052(0.018) 4.69E-03 -0.048(0.008) 2.31E-09 Yes 
Fruit & 
Vegetable 
X-11858     0.080(0.015) 9.59E-08 0.077(0.034) 2.48E-02 0.080(0.014) 5.28E-09 No 
Fruit & 
Vegetable 
proline Urea cycle; 
arginine-, proline-, 
metabolism 
Amino acid -0.053(0.010) 2.60E-07 -0.060(0.027) 2.87E-02 -0.054(0.010) 1.95E-08 Yes 
Fruit & 
Vegetable 
N-acetylornithine Urea cycle; 
arginine-, proline-, 
metabolism 
Amino acid 0.049(0.010) 3.45E-07 0.052(0.024) 2.92E-02 0.050(0.009) 2.57E-08 Yes 
Fruit & 
Vegetable 






Amino acid 0.165(0.014) 1.32E-32 0.108(0.036) 3.05E-03 0.158(0.013) 2.20E-35 No 
High Alcohol X-11795     0.150(0.013) 1.93E-28 0.118(0.026) 1.02E-05 0.143(0.012) 1.19E-33 No 
High Alcohol scyllo-inositol Inositol 
metabolism 
Lipid 0.146(0.015) 2.89E-22 0.128(0.033) 1.54E-04 0.143(0.014) 4.20E-26 No 
High Alcohol piperine Food component, 
Plant 




Sterol, Steroid Lipid 0.113(0.015) 9.34E-14 0.157(0.031) 1.35E-06 0.122(0.014) 3.27E-19 No 
High Alcohol X-09789     -0.118(0.014) 6.15E-16 -0.107(0.030) 4.23E-04 -0.116(0.013) 4.99E-19 No 
High Alcohol ergothioneine Food component, 
Plant 
Xenobiotics 0.147(0.019) 1.65E-14 0.147(0.037) 1.21E-04 0.147(0.017) 2.44E-18 No 
High Alcohol X-11799     0.116(0.015) 9.27E-14 0.137(0.032) 4.04E-05 0.120(0.014) 6.07E-18 No 
High Alcohol X-01911     0.129(0.016) 7.26E-16 0.074(0.027) 7.15E-03 0.115(0.014) 3.77E-17 No 
High Alcohol tryptophan betaine Tryptophan 
metabolism 
Amino acid 0.129(0.016) 6.70E-16 0.069(0.030) 2.27E-02 0.116(0.014) 1.08E-16 No 
High Alcohol X-12798     -0.103(0.014) 8.77E-13 -0.086(0.025) 6.77E-04 -0.099(0.012) 1.58E-15 No 
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Discovery Discordant Meta-analysis Unique 
to 
pattern Variable Metabolite name Pathway 
Super-




Sterol, Steroid Lipid 0.109(0.015) 1.02E-12 0.130(0.038) 7.44E-04 0.112(0.014) 1.73E-15 No 
High Alcohol X-21365 [trimethyl-N-
aminovalerate] 
    -0.083(0.013) 1.72E-10 -0.123(0.026) 4.64E-06 -0.091(0.012) 3.91E-15 No 




0.107(0.015) 4.11E-13 0.062(0.029) 3.39E-02 0.098(0.013) 6.75E-14 Yes 
High Alcohol 2-aminobutyrate Butanoate 
metabolism 
Amino acid 0.088(0.014) 1.23E-10 0.109(0.030) 2.85E-04 0.092(0.012) 1.08E-13 No 
High Alcohol X-10395     0.097(0.014) 3.99E-12 0.066(0.030) 2.90E-02 0.091(0.013) 3.80E-13 No 
High Alcohol X-04495     0.090(0.014) 4.83E-11 0.079(0.026) 3.16E-03 0.088(0.012) 4.06E-13 No 
High Alcohol X-11381     -0.073(0.013) 2.04E-08 -0.096(0.028) 6.04E-04 -0.077(0.012) 4.54E-11 No 
High Alcohol X-11847     0.087(0.015) 1.42E-08 0.075(0.035) 3.16E-02 0.085(0.014) 1.11E-09 Yes 
High Alcohol 4-vinylphenol sulfate Benzoate 
metabolism 
Xenobiotics 0.078(0.014) 7.28E-08 0.074(0.027) 7.55E-03 0.077(0.013) 1.50E-09 Yes 
High Alcohol 10-undecenoate 
(11:1n1) 
Medium chain fatty 
acid 
Lipid 0.072(0.014) 4.15E-07 0.075(0.028) 7.09E-03 0.073(0.013) 8.17E-09 No 
High Alcohol X-12816     0.093(0.017) 1.19E-07 0.075(0.036) 3.97E-02 0.089(0.016) 1.22E-08 No 
High Alcohol X-12038     0.065(0.013) 9.44E-07 0.057(0.028) 4.23E-02 0.064(0.012) 1.02E-07 No 
Traditional 
English 
stachydrine Food component, 
Plant 
Xenobiotics -0.100(0.013) 1.17E-13 -0.076(0.025) 2.74E-03 -0.094(0.012) 9.94E-16 No 
Traditional 
English 








Amino acid -0.083(0.016) 4.19E-07 -0.089(0.025) 4.17E-04 -0.084(0.014) 5.18E-10 No 
Traditional 
English 





Amino acid 0.089(0.015) 6.26E-09 0.050(0.022) 2.63E-02 0.076(0.013) 1.19E-09 No 
Traditional 
English 
X-11381     0.072(0.014) 1.84E-07 0.070(0.026) 7.14E-03 0.072(0.012) 3.71E-09 No 
Dieting X-14473     -0.143(0.017) 3.69E-17 -0.161(0.028) 2.78E-08 -0.148(0.014) 8.46E-25 No 
Dieting X-02249     0.097(0.016) 8.79E-10 0.072(0.029) 1.35E-02 0.091(0.014) 4.01E-11 No 
Dieting quinate Food component, 
Plant 
Xenobiotics -0.098(0.017) 1.70E-08 -0.088(0.029) 2.86E-03 -0.095(0.015) 1.40E-10 No 
Dieting 4-ethylphenylsulfate Benzoate 
metabolism 
Xenobiotics 0.104(0.019) 1.01E-07 0.093(0.039) 1.84E-02 0.102(0.017) 4.89E-09 No 
Dieting X-14374     -0.088(0.017) 1.27E-07 -0.065(0.031) 3.85E-02 -0.083(0.015) 1.48E-08 No 
Low Meat 3-carboxy-4-methyl-5- Fatty acid, Lipid -0.145(0.017) 4.24E-17 -0.139(0.034) 5.26E-05 -0.144(0.015) 3.63E-21 No 
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Discovery Discordant Meta-analysis Unique 
to 
pattern Variable Metabolite name Pathway 
Super-





Low Meat pyroglutamine* Glutamate 
metabolism 
Amino acid 0.102(0.016) 1.62E-10 0.162(0.024) 1.28E-10 0.120(0.013) 8.99E-20 No 
Low Meat docosahexaenoate 
(DHA; 22:6n3) 
Essential fatty acid Lipid -0.134(0.017) 4.71E-15 -0.128(0.030) 2.97E-05 -0.133(0.015) 2.65E-19 No 
Low Meat eicosapentaenoate 
(EPA; 20:5n3) 
Essential fatty acid Lipid -0.131(0.016) 2.89E-15 -0.102(0.026) 9.59E-05 -0.123(0.014) 8.44E-19 No 
Low Meat 2-aminobutyrate Butanoate 
metabolism 
Amino acid -0.114(0.017) 1.57E-11 -0.108(0.028) 1.89E-04 -0.113(0.015) 7.47E-15 No 
Low Meat X-11261     0.111(0.016) 1.30E-11 0.089(0.027) 9.83E-04 0.105(0.014) 4.20E-14 Yes 
Low Meat X-11469     -0.111(0.017) 2.74E-11 -0.106(0.035) 2.73E-03 -0.110(0.015) 1.88E-13 No 
Low Meat X-02269     -0.112(0.017) 2.97E-11 -0.097(0.032) 3.24E-03 -0.109(0.015) 2.61E-13 No 
Low Meat creatine Creatine 
metabolism 
Amino acid -0.092(0.015) 2.80E-09 -0.117(0.028) 4.24E-05 -0.098(0.014) 4.12E-13 No 
Low Meat X-02249     -0.122(0.018) 6.73E-12 -0.073(0.031) 1.99E-02 -0.110(0.015) 7.70E-13 No 






Amino acid -0.106(0.016) 1.24E-10 -0.078(0.027) 4.42E-03 -0.099(0.014) 2.09E-12 No 





Lipid -0.109(0.019) 5.20E-09 -0.091(0.029) 2.06E-03 -0.104(0.016) 3.23E-11 No 
Low Meat X-11478     0.103(0.017) 3.48E-09 0.073(0.027) 6.92E-03 0.094(0.015) 9.86E-11 Yes 






Amino acid -0.081(0.016) 1.70E-07 -0.095(0.028) 7.53E-04 -0.085(0.014) 4.08E-10 No 
Low Meat betaine Glycine, serine 
and threonine 
metabolism 
Amino acid 0.087(0.017) 1.90E-07 0.078(0.029) 7.05E-03 0.085(0.014) 3.87E-09 Yes 
Low Meat C-glycosyltryptophan* Tryptophan 
metabolism 
Amino acid 0.072(0.014) 3.27E-07 0.056(0.024) 1.77E-02 0.068(0.012) 1.80E-08 Yes 
Low Meat X-11521     0.086(0.017) 2.79E-07 0.064(0.028) 2.32E-02 0.080(0.014) 2.12E-08 Yes 
Low Meat X-11204     -0.081(0.016) 6.79E-07 -0.063(0.025) 1.12E-02 -0.076(0.014) 2.52E-08 Yes 
Notes: Table shows results of the linear regression analysis for the discovery population (excluding monozygotic twins discordant for each diet pattern), the MZ 
discordant twin sample and the fixed effects meta-analysis of both groups. Only significant associations are shown which includes those associations passing the 
bonferroni cut-off in the discovery and fixed effects analyses (1.08x10
-6
 = 0.05/[77 diet phenotypes x 601 detected metabolites]) and passing the 5% level of significance 
in the discordant twin group. The Metabolon platform is a non-targeted platform which identified 456 metabolites in blood for which data were available for 3559 twins. 
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Table 9. List of metabolites associated with dietary patterns from the Metabolon platform. 
Notes: Table shows results of the linear regression analysis for the discovery population (excluding monozygotic twins discordant for each diet pattern), the MZ 
discordant twin sample and the fixed effects meta-analysis of both groups. Only significant associations are shown which includes those associations passing the 
bonferroni cut-off in the discovery and fixed effects analyses (1.08x10
-6
 = 0.05/[77 diet phenotypes x 601 detected metabolites]) and in the same direction in the 
discordant twin group. The Biocrates platform is a targeted platform which measures 163 metabolites in blood for which data were available for 858 twins.   
 
 
    
Discovery Discordant Meta-analysis Unique 
to 
patterns Variable Metabolite Pathway 
Super-
pathway Beta(SE) P Beta(SE) P Beta(SE) P 
Fruit & 
Vegetable 
Octenoylcarnitine Acylcarnitines Lipid -0.052(0.009) 1.96E-08 -0.021(0.018) 0.261 -0.045(0.008) 2.09E-08 No 
Low Meat Phosphatidylcholine 
diacyl C36:5 
Glycerophospholipids Lipid -0.115(0.016) 8.26E-12 -0.028(0.032) 0.380 -0.096(0.015) 3.96E-11 No 
Low Meat Phosphatidylcholine 
diacyl C36:6 
Glycerophospholipids Lipid -0.094(0.016) 3.81E-09 -0.024(0.036) 0.510 -0.083(0.014) 8.53E-09 Yes 
Low Meat Phosphatidylcholine 
acyl-alkyl C38:6 
Glycerophospholipids Lipid -0.061(0.011) 9.29E-08 -0.016(0.023) 0.481 -0.053(0.010) 2.33E-07 Yes 
Low Meat Phosphatidylcholine 
diacyl C38:6 




Table 10. SNP associations with diet-associated metabolites from previous genome-wide association study (Shin et al., Nat Genet. 2014 Jun;46(6):543-50) 
  
  
Diet variable-Metabolite  
(Meta-analysis result) 
   
  
SNP-Metabolite  
(Shin et al., 2014) 
Metabolite Diet variable 
Diet 
pattern 
or food Beta(SE) P 
Gene 
symbol SNP EA/OA EAF Beta(SE) P 
2-Aminobutyrate Low Meat Pattern -0.113(0.015) 7.47E-15 PPM1K rs10022462 T/C 0.45 -0.012(0.002) 4.55E-11 
2-Aminobutyrate Wine Food 0.025(0.003) 2.73E-14 SLC1A4 rs10211524 A/G 0.42 0.019(0.002) 5.59E-16 
2-Aminobutyrate Wine Food 0.025(0.003) 2.73E-14 PPM1K rs10022462 T/C 0.45 -0.012(0.002) 4.55E-11 
2-Aminobutyrate High Alcohol Pattern 0.092(0.012) 1.08E-13 SLC1A4 rs10211524 A/G 0.42 0.019(0.002) 5.59E-16 
3-(4-
Hydroxyphenyl)lactate 
Wine Food 0.018(0.003) 1.08E-09 CCDC57 rs4625783 T/C 0.43 -0.019(0.003) 3.90E-13 
3-Phenylpropionate 
(hydrocinnamate) 
Fruit & Vegetable Pattern 0.080(0.010) 1.73E-16 ACSM5 rs11647589 A/G 0.72 0.030(0.005) 2.85E-11 
3-Phenylpropionate 
(hydrocinnamate) 
Fried fish Food -0.172(0.026) 4.12E-11 ACSM5 rs11647589 A/G 0.72 0.030(0.005) 2.85E-11 
3-Phenylpropionate 
(hydrocinnamate) 





Pattern -0.084(0.014) 5.18E-10 ACSM5 rs11647589 A/G 0.72 0.030(0.005) 2.85E-11 
3-Phenylpropionate 
(hydrocinnamate) 
Apples & pears Food 0.024(0.004) 1.24E-08 ACSM5 rs11647589 A/G 0.72 0.030(0.005) 2.85E-11 
alpha-
Hydroxyisovalerate 
Wine Food 0.045(0.003) 1.23E-45 HAO2 rs12141041 T/C 0.47 -0.025(0.004) 1.77E-12 
alpha-
Hydroxyisovalerate 
High Alcohol Pattern 0.158(0.013) 2.20E-35 HAO2 rs12141041 T/C 0.47 -0.025(0.004) 1.77E-12 
alpha-
Hydroxyisovalerate 
Low Meat Pattern -0.099(0.014) 2.09E-12 HAO2 rs12141041 T/C 0.47 -0.025(0.004) 1.77E-12 
Betaine Low Meat Pattern 0.085(0.014) 3.87E-09 CBS rs2851391 T/C 0.46 -0.012(0.002) 1.15E-11 
Creatine Low Meat Pattern -0.098(0.014) 4.12E-13 CPS1 rs715 T/C 0.71 -0.045(0.004) 9.63E-25 
Creatine Meat Food 0.063(0.009) 8.24E-12 CPS1 rs715 T/C 0.71 -0.045(0.004) 9.63E-25 
Creatine Poultry Food 0.083(0.013) 3.17E-11 CPS1 rs715 T/C 0.71 -0.045(0.004) 9.63E-25 
Creatine Traditional 
English 
Pattern 0.076(0.013) 1.19E-09 CPS1 rs715 T/C 0.71 -0.045(0.004) 9.63E-25 
Indolepropionate Fruit & Vegetable Pattern 0.082(0.009) 8.42E-21 ACSM2A rs1394678 T/C 0.28 -0.035(0.004) 1.70E-20 
Indolepropionate Mediterranean 
Diet Score 
Pattern 0.078(0.009) 1.60E-17 ACSM2A rs1394678 T/C 0.28 -0.035(0.004) 1.70E-20 
Indolepropionate Bananas Food 0.034(0.005) 1.05E-11 ACSM2A rs1394678 T/C 0.28 -0.035(0.004) 1.70E-20 
Indolepropionate Apples & pears Food 0.026(0.004) 2.39E-09 ACSM2A rs1394678 T/C 0.28 -0.035(0.004) 1.70E-20 
N-acetylornithine Fruit & Vegetable Pattern 0.050(0.009) 2.57E-08 NAT8 rs10206899 T/C 0.78 0.221(0.005) 4.66E-481 
proline Fruit & Vegetable Pattern -0.054(0.010) 1.95E-08 PRODH rs2540641 A/C 0.08 0.063(0.004) 2.98E-59 
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Table 10. SNP associations with diet-associated metabolites from previous genome-wide association study (Shin et al., Nat Genet. 2014 Jun;46(6):543-50) 
  
  
Diet variable-Metabolite  
(Meta-analysis result) 
   
  
SNP-Metabolite  
(Shin et al., 2014) 
Metabolite Diet variable 
Diet 
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symbol SNP EA/OA EAF Beta(SE) P 
Pyroglutamine* Low Meat Pattern 0.120(0.013) 8.99E-20 SLC6A13 rs11613331 A/G 0.55 0.037(0.004) 2.23E-25 
Pyroglutamine* Low Meat Pattern 0.120(0.013) 8.99E-20 SLC6A20 rs17279437 A/G 0.10 0.059(0.006) 1.25E-20 
Pyroglutamine* Poultry Food -0.091(0.013) 1.36E-12 SLC6A13 rs11613331 A/G 0.55 0.037(0.004) 2.23E-25 
Pyroglutamine* Poultry Food -0.091(0.013) 1.36E-12 SLC6A20 rs17279437 A/G 0.10 0.059(0.006) 1.25E-20 
Pyroglutamine* Other seafood Food -0.099(0.014) 5.22E-12 SLC6A13 rs11613331 A/G 0.55 0.037(0.004) 2.23E-25 
Pyroglutamine* Other seafood Food -0.099(0.014) 5.22E-12 SLC6A20 rs17279437 A/G 0.10 0.059(0.006) 1.25E-20 
Pyroglutamine* Meat Food -0.062(0.010) 2.10E-10 SLC6A13 rs11613331 A/G 0.55 0.037(0.004) 2.23E-25 
Pyroglutamine* Meat Food -0.062(0.010) 2.10E-10 SLC6A20 rs17279437 A/G 0.10 0.059(0.006) 1.25E-20 
Tryptophan betaine Fruit & Vegetable Pattern 0.080(0.009) 1.94E-17 SLC22A4 rs2405522 A/G 0.17 -0.126(0.011) 4.49E-29 
Tryptophan betaine High Alcohol Pattern 0.116(0.014) 1.08E-16 SLC22A4 rs2405522 A/G 0.17 -0.126(0.011) 4.49E-29 
Tryptophan betaine Mediterranean 
Diet Score 
Pattern 0.084(0.011) 1.65E-15 SLC22A4 rs2405522 A/G 0.17 -0.126(0.011) 4.49E-29 
Tryptophan betaine  Allium vegetables Food 0.034(0.006) 4.73E-09 SLC22A4 rs2405522 A/G 0.17 -0.126(0.011) 4.49E-29 
1,5-anhydroglucitol 
(1,5-AG) 
Fruit & Vegetable Pattern -0.071(0.009) 1.02E-16 RAB3GA
P1 
rs7570971 A/C 0.33 -0.037(0.003) 7.86E-45 
1,5-Anhydroglucitol 
(1,5-AG) 
Fruit & Vegetable Pattern -0.071(0.009) 1.02E-16 MGAM rs3800993 T/C 0.17 0.029(0.004) 1.53E-15 
1,5-Anhydroglucitol 
(1,5-AG) 
Other seafood Food -0.081(0.014) 1.80E-08 RAB3GA
P1 
rs7570971 A/C 0.33 -0.037(0.003) 7.86E-45 
1,5-Anhydroglucitol 
(1,5-AG) 








Oily fish Food -0.097(0.015) 9.46E-11 SLCO1B
1 












Oily fish Food -0.089(0.015) 1.60E-09 FADS1 rs174535 T/C 0.67 -0.044(0.004) 2.82E-36 
10-Undecenoate 
(11:1n1) 
Butter Food 0.020(0.003) 2.35E-11 CYP4A11 rs9333029 A/G 0.87 -0.070(0.004) 1.52E-61 
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10-Undecenoate 
(11:1n1) 




































High Alcohol Pattern 0.112(0.014) 1.73E-15 ZCWPW1 rs13222543 T/C 0.02 -0.263(0.028) 1.18E-20 
Docosapentaenoate 
(n3 DPA; 22:5n3) 
Wine Food 0.024(0.003) 5.28E-15 FADS1 rs174538 A/G 0.30 -0.026(0.004) 8.90E-14 
Docosapentaenoate 
(n3 DPA; 22:5n3) 
Other seafood Food 0.089(0.013) 3.44E-11 FADS1 rs174538 A/G 0.30 -0.026(0.004) 8.90E-14 
Docosapentaenoate 
(n3 DPA; 22:5n3) 
Oily fish Food 0.080(0.013) 2.22E-10 FADS1 rs174538 A/G 0.30 -0.026(0.004) 8.90E-14 
Eicosapentaenoate 
(EPA; 20:5n3) 
Oily fish Food 0.169(0.014) 1.57E-33 FADS1 rs174556 T/C 0.30 -0.036(0.004) 1.97E-22 
Eicosapentaenoate 
(EPA; 20:5n3) 
Fruit & Vegetable Pattern 0.095(0.009) 1.86E-25 FADS1 rs174556 T/C 0.30 -0.036(0.004) 1.97E-22 
Eicosapentaenoate 
(EPA; 20:5n3) 
Other seafood Food 0.154(0.015) 2.66E-24 FADS1 rs174556 T/C 0.30 -0.036(0.004) 1.97E-22 
Eicosapentaenoate 
(EPA; 20:5n3) 
Wine Food 0.027(0.003) 6.63E-22 FADS1 rs174556 T/C 0.30 -0.036(0.004) 1.97E-22 
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Pattern 0.083(0.009) 9.54E-21 FADS1 rs174556 T/C 0.30 -0.036(0.004) 1.97E-22 
Eicosapentaenoate 
(EPA; 20:5n3) 
Low Meat Pattern -0.123(0.014) 8.44E-19 FADS1 rs174556 T/C 0.30 -0.036(0.004) 1.97E-22 
Eicosapentaenoate 
(EPA; 20:5n3) 
Baked goods Food -0.014(0.002) 1.08E-12 FADS1 rs174556 T/C 0.30 -0.036(0.004) 1.97E-22 
Eicosapentaenoate 
(EPA; 20:5n3) 
Avocado Food 0.108(0.018) 2.01E-09 FADS1 rs174556 T/C 0.30 -0.036(0.004) 1.97E-22 
Eicosapentaenoate 
(EPA; 20:5n3) 
High fat salad 
dressings 
Food 0.044(0.008) 5.48E-08 FADS1 rs174556 T/C 0.30 -0.036(0.004) 1.97E-22 
Epiandrosterone 
sulfate 
Wine Food 0.018(0.003) 6.29E-09 CYP3A5 rs11974702 A/G 0.91 0.184(0.010) 2.80E-75 
Epiandrosterone 
sulfate 
Wine Food 0.018(0.003) 6.29E-09 ZCWPW1 rs13222543 T/C 0.02 -0.347(0.024) 3.31E-47 
Myo-inositol Wine Food 0.022(0.003) 1.36E-15 SLC5A11 rs4788439 T/C 0.08 -0.027(0.004) 6.59E-13 
Myo-inositol Fruit & Vegetable Pattern 0.052(0.008) 4.43E-11 SLC5A11 rs4788439 T/C 0.08 -0.027(0.004) 6.59E-13 
Nonanoylcarnitine* Butter Food 0.026(0.003) 6.48E-17 ACADL rs3738934 T/C 0.62 -0.106(0.004) 1.21E-134 
Nonanoylcarnitine* Butter Food 0.026(0.003) 6.48E-17 THEM4 rs12566232 A/C 0.71 -0.045(0.005) 5.69E-19 
Scyllo-inositol Wine Food 0.052(0.003) 1.47E-49 SLC5A11 rs4787294 A/T 0.93 0.075(0.008) 9.64E-21 
Scyllo-inositol High Alcohol Pattern 0.143(0.014) 4.20E-26 SLC5A11 rs4787294 A/T 0.93 0.075(0.008) 9.64E-21 
Scyllo-inositol Fruit & Vegetable Pattern 0.088(0.009) 2.22E-23 SLC5A11 rs4787294 A/T 0.93 0.075(0.008) 9.64E-21 
Scyllo-inositol Baked goods Food -0.017(0.003) 1.44E-10 SLC5A11 rs4787294 A/T 0.93 0.075(0.008) 9.64E-21 
Scyllo-inositol Mediterranean 
Diet Score 
Pattern 0.066(0.010) 2.25E-10 SLC5A11 rs4787294 A/T 0.93 0.075(0.008) 9.64E-21 
Scyllo-inositol Fried fish Food -0.154(0.026) 4.44E-09 SLC5A11 rs4787294 A/T 0.93 0.075(0.008) 9.64E-21 
Stearidonate (18:4n3) Wine Food 0.019(0.003) 3.17E-10 FADS1 rs174601 T/C 0.34 -0.034(0.004) 7.93E-16 
1-Methylxanthine Coffee Food 0.010(0.002) 3.31E-09 NAT2 rs4921914 T/C 0.78 0.088(0.005) 1.09E-60 
X-01911 High Alcohol Pattern 0.115(0.014) 3.77E-17 COMT rs4680 A/G 0.51 -0.044(0.006) 1.31E-13 
X-01911 Wine Food 0.026(0.003) 2.55E-14 COMT rs4680 A/G 0.51 -0.044(0.006) 1.31E-13 
X-02249 Butter Food 0.026(0.003) 2.31E-16 CYP2C8 rs1934955 A/G 0.71 -0.030(0.004) 3.33E-16 
X-02249 Low Meat Pattern -0.110(0.015) 7.70E-13 CYP2C8 rs1934955 A/G 0.71 -0.030(0.004) 3.33E-16 
X-02249 Dieting Pattern 0.091(0.014) 4.01E-11 CYP2C8 rs1934955 A/G 0.71 -0.030(0.004) 3.33E-16 
X-02269 Oily fish Food 0.175(0.013) 1.44E-38 CYP2C8 rs2071426 T/C 0.71 0.055(0.007) 6.87E-14 
X-02269 Fruit & Vegetable Pattern 0.102(0.009) 7.46E-31 CYP2C8 rs2071426 T/C 0.71 0.055(0.007) 6.87E-14 
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X-02269 Other fish and 
seafood 
Food 0.174(0.015) 9.25E-31 CYP2C8 rs2071426 T/C 0.71 0.055(0.007) 6.87E-14 
X-02269 Mediterranean 
Diet Score 
Pattern 0.099(0.009) 1.70E-29 CYP2C8 rs2071426 T/C 0.71 0.055(0.007) 6.87E-14 
X-02269 Avocado Food 0.147(0.019) 6.33E-15 CYP2C8 rs2071426 T/C 0.71 0.055(0.007) 6.87E-14 
X-02269 Green leafy 
vegetables 
Food 0.030(0.004) 2.39E-13 CYP2C8 rs2071426 T/C 0.71 0.055(0.007) 6.87E-14 
X-02269 Low Meat Pattern -0.109(0.015) 2.61E-13 CYP2C8 rs2071426 T/C 0.71 0.055(0.007) 6.87E-14 
X-02269 High fibre 
breakfast cereals 
Food 0.030(0.004) 3.63E-12 CYP2C8 rs2071426 T/C 0.71 0.055(0.007) 6.87E-14 
X-02269 Allium vegetables Food 0.023(0.004) 3.55E-08 CYP2C8 rs2071426 T/C 0.71 0.055(0.007) 6.87E-14 
X-08402 Butter Food 0.017(0.003) 7.17E-10 SGPP1 rs7157785 T/G 0.16 0.068(0.003) 7.23E-87 
X-08402 Butter Food 0.017(0.003) 7.17E-10 SPTLC3 rs4814176 T/C 0.39 0.022(0.003) 2.97E-17 
X-09789 Porridge Food 0.094(0.008) 4.96E-33 SLC51A rs7642243 C/G 0.39 0.048(0.006) 7.5E-16 
X-09789 High Alcohol Pattern -0.116(0.013) 4.99E-19 SLC51A rs7642243 C/G 0.39 0.048(0.006) 7.50E-16 
X-09789 High fibre 
breakfast cereals 
Food 0.038(0.005) 7.28E-14 SLC51A rs7642243 C/G 0.39 0.048(0.006) 7.5E-16 
X-09789 Fruit & Vegetable Pattern 0.061(0.009) 3.50E-11 SLC51A rs7642243 C/G 0.39 0.048(0.006) 7.50E-16 
X-09789 Apples & pears Food 0.020(0.004) 2.22E-08 SLC51A rs7642243 C/G 0.39 0.048(0.006) 7.5E-16 
X-09789 Wholemeal 
bread, grains 
Food 0.015(0.003) 6.03E-08 SLC51A rs7642243 C/G 0.39 0.048(0.006) 7.5E-16 
X-10395 Wine Food 0.031(0.003) 3.45E-26 NR1I3 rs4073054 A/C 0.63 0.016(0.002) 4.42E-19 
X-10395 High Alcohol Pattern 0.091(0.013) 3.80E-13 NR1I3 rs4073054 A/C 0.63 0.016(0.002) 4.42E-19 
X-10510 Butter Food 0.022(0.003) 8.28E-15 SGPP1 rs7157785 T/G 0.86 -0.044(0.004) 3.41E-37 
X-11261 Low Meat Pattern 0.105(0.014) 4.20E-14 SLC22A1 rs662138 C/G 0.83 0.063(0.006) 9.38E-25 
X-11261 Low Meat Pattern 0.105(0.014) 4.20E-14 SLC16A9 rs1171614 T/C 0.22 -0.042(0.006) 6.68E-14 
X-11261 Fruit & Vegetable Pattern -0.061(0.010) 2.08E-10 SLC22A1 rs662138 C/G 0.83 0.063(0.006) 9.38E-25 
X-11261 Fruit & Vegetable Pattern -0.061(0.010) 2.08E-10 SLC16A9 rs1171614 T/C 0.22 -0.042(0.006) 6.68E-14 
X-11315 Fruit & Vegetable Pattern 0.142(0.008) 3.87E-63 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Mediterranean 
Diet Score 
Pattern 0.109(0.009) 7.94E-34 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Nuts Food 0.054(0.005) 3.75E-25 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Apples & pears Food 0.035(0.004) 9.63E-20 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
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X-11315 Oily fish Food 0.106(0.014) 1.62E-14 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Berries Food 0.103(0.013) 2.70E-14 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Peaches Food 0.127(0.017) 5.92E-14 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Green leafy 
vegetables 
Food 0.033(0.005) 1.71E-12 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 White and brown 
bread, refined 
grains 
Food -0.017(0.002) 1.84E-12 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Confectionary & 
jams 
Food -0.010(0.001) 1.53E-11 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Traditional 
English 
Pattern -0.093(0.014) 1.68E-11 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Savoury pies Food -0.221(0.034) 9.08E-11 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Citrus fruit Food 0.026(0.004) 6.50E-10 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Fried fish Food -0.164(0.027) 1.54E-09 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 High fibre 
breakfast cereals 
Food 0.030(0.005) 2.75E-09 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11315 Baked goods Food -0.012(0.002) 2.90E-08 SLC6A20 rs4327428 A/C 0.11 -0.031(0.004) 2.81E-12 
X-11381 Mediterranean 
Diet Score 
Pattern -0.069(0.009) 8.27E-14 SLC16A9 rs12356193 A/G 0.84 0.024(0.003) 8.36E-20 
X-11381 High Alcohol Pattern -0.077(0.012) 4.54E-11 SLC16A9 rs12356193 A/G 0.84 0.024(0.003) 8.36E-20 
X-11381 Processed meats Food 0.049(0.008) 4.74E-10 SLC16A9 rs12356193 A/G 0.84 0.024(0.003) 8.36E-20 
X-11381 Traditional 
English 
Pattern 0.072(0.012) 3.71E-09 SLC16A9 rs12356193 A/G 0.84 0.024(0.003) 8.36E-20 
X-11381 Soy foods Food -0.108(0.020) 5.80E-08 SLC16A9 rs12356193 A/G 0.84 0.024(0.003) 8.36E-20 
X-11469 Oily fish Food 0.176(0.013) 5.87E-39 CYP2C8 rs2071426 T/C 0.71 0.052(0.007) 3.97E-14 
X-11469 Oily fish Food 0.176(0.013) 5.87E-39 SLC17A3 rs11754288 A/G 0.44 0.043(0.006) 1.88E-12 
X-11469 Fruit & Vegetable Pattern 0.106(0.009) 3.39E-34 CYP2C8 rs2071426 T/C 0.71 0.052(0.007) 3.97E-14 
X-11469 Other fish and 
seafood 
Food 0.175(0.015) 2.99E-31 CYP2C8 rs2071426 T/C 0.71 0.052(0.007) 3.97E-14 
X-11469 Other fish and 
seafood 
Food 0.175(0.015) 2.99E-31 SLC17A3 rs11754288 A/G 0.44 0.043(0.006) 1.88E-12 
X-11469 Mediterranean 
Diet Score 
Pattern 0.100(0.009) 9.16E-31 CYP2C8 rs2071426 T/C 0.71 0.052(0.007) 3.97E-14 
X-11469 Avocado Food 0.153(0.019) 9.36E-16 CYP2C8 rs2071426 T/C 0.71 0.052(0.007) 3.97E-14 
X-11469 Avocado Food 0.153(0.019) 9.36E-16 SLC17A3 rs11754288 A/G 0.44 0.043(0.006) 1.88E-12 
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X-11469 Green leafy 
vegetables 
Food 0.030(0.004) 5.66E-14 CYP2C8 rs2071426 T/C 0.71 0.052(0.007) 3.97E-14 
X-11469 Green leafy 
vegetables 
Food 0.030(0.004) 5.66E-14 SLC17A3 rs11754288 A/G 0.44 0.043(0.006) 1.88E-12 
X-11469 Low Meat Pattern -0.110(0.015) 1.88E-13 SLC17A3 rs11754288 A/G 0.44 0.043(0.006) 1.88E-12 
X-11469 High fibre 
breakfast cereals 
Food 0.031(0.004) 5.40E-13 CYP2C8 rs2071426 T/C 0.71 0.052(0.007) 3.97E-14 
X-11469 High fibre 
breakfast cereals 
Food 0.031(0.004) 5.40E-13 SLC17A3 rs11754288 A/G 0.44 0.043(0.006) 1.88E-12 
X-11478 Low Meat Pattern 0.094(0.015) 9.86E-11 ACSM2A rs6497490 T/G 0.88 -0.082(0.008) 4.95E-27 
X-11550 Wine Food 0.018(0.003) 3.94E-11 CETP rs247616 T/C 0.32 0.010(0.001) 1.11E-11 
X-11799 Wine Food 0.033(0.003) 1.66E-27 GBA3 rs3099557 A/G 0.85 -0.148(0.011) 1.83E-39 
X-11799 High Alcohol Pattern 0.120(0.014) 6.07E-18 GBA3 rs3099557 A/G 0.85 -0.148(0.011) 1.83E-39 
X-11799 Baked goods Food -0.017(0.003) 4.88E-09 GBA3 rs3099557 A/G 0.85 -0.148(0.011) 1.83E-39 
X-12038 Wine Food 0.022(0.003) 9.20E-13 CETP rs1800775 A/C 0.50 0.013(0.002) 1.02E-11 
X-12038 High Alcohol Pattern 0.064(0.012) 1.02E-07 CETP rs1800775 A/C 0.50 0.013(0.002) 1.02E-11 
X-12063 Fruit & Vegetable Pattern -0.048(0.008) 2.31E-09 CYP3A5 rs10242455 A/G 0.93 0.221(0.010) 1.67E-109 
X-12063 Fruit & Vegetable Pattern -0.048(0.008) 2.31E-09 SLCO1B
1 
rs4149056 T/C 0.84 -0.118(0.007) 1.26E-73 
X-12627 Wine Food 0.022(0.003) 5.88E-15 ELOVL2 rs4713169 C/G 0.42 -0.032(0.004) 2.87E-14 
X-12627 Oily fish Food 0.073(0.012) 5.74E-09 ELOVL2 rs4713169 C/G 0.42 -0.032(0.004) 2.87E-14 
X-12798 Low fat milk Food 0.062(0.008) 1.24E-15 SLC22A1 rs316019 A/C 0.09 -0.181(0.005) 1.56E-259 
X-12798 Low fat milk Food 0.062(0.008) 1.24E-15 SLC16A9 rs1171615 T/C 0.78 -0.048(0.004) 3.19E-34 
X-12798 High Alcohol Pattern -0.099(0.012) 1.58E-15 SLC22A1 rs316019 A/C 0.09 -0.181(0.005) 1.56E-259 
X-12798 Mediterranean 
Diet Score 
Pattern -0.069(0.010) 6.80E-13 SLC16A9 rs1171615 T/C 0.78 -0.048(0.004) 3.19E-34 
X-13477 Mediterranean 
Diet Score 
Pattern 0.067(0.010) 1.56E-10 NAT8 rs10206899 T/C 0.78 0.025(0.003) 1.73E-14 
X-14473 Coffee Food 0.038(0.001) 6.12E-
187 
CYP2C9 rs4986894 T/C 0.84 -0.042(0.006) 5.55E-12 
X-14473 Black tea Food -0.024(0.001) 1.36E-72 CYP2C9 rs4986894 T/C 0.84 -0.042(0.006) 5.55E-12 
X-14473 Dieting Pattern -0.148(0.014) 8.46E-25 CYP2C9 rs4986894 T/C 0.84 -0.042(0.006) 5.55E-12 
X-21365 [trimethyl-N-
aminovalerate] 
Low fat milk Food 0.076(0.007) 9.36E-27 SLC22A4 rs273913 T/C 0.38 0.026(0.003) 1.08E-25 
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Diet 
pattern 
or food Beta(SE) P 
Gene 
symbol SNP EA/OA EAF Beta(SE) P 
X-21365 [trimethyl-N-
aminovalerate] 










Pattern -0.073(0.009) 1.48E-15 MARCH8 rs2291429 A/C 0.76 0.017(0.003) 8.69E-11 
X-21365 [trimethyl-N-
aminovalerate] 
High Alcohol Pattern -0.091(0.012) 3.91E-15 SLC22A4 rs273913 T/C 0.38 0.026(0.003) 1.08E-25 
X-21365 [trimethyl-N-
aminovalerate] 
High Alcohol Pattern -0.091(0.012) 3.91E-15 MARCH8 rs2291429 A/C 0.76 0.017(0.003) 8.69E-11 
Notes: Statistics are reported for the most associated metabolite at each single nucleotide polymorphism (SNP) for those metabolites associated with food intakes and 
diet patterns. The genome-wide association study was previously performed on the TwinsUK and KORA blood metabolite datasets (Shin et al., Nat Genet. 2014 
Jun;46(6):543-50). EA/OA = effect/other allele; EAF = effect allele frequency.
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Table 11. Diet-SNP associations with SNPs associated with metabolites from a previous genome-wide association study (Shin et al., Nat 
Genet. 2014 Jun;46(6):543-50) 
   
Food Group-Metabolite  
(Meta-analysis result) 
 
SNP-Metabolite         
(Shin et al., 2014) Food variable-SNP 
 
Metabolite Diet variable 
Diet 
pattern 







Pattern 0.080(0.010) 1.73E-16 rs11647589 0.030(0.005) 2.85E-11 0.140(0.059) 1.80E-02 ACSM5 
3-Phenylpropionate 
(hydrocinnamate) 
Savoury pies Food -0.231(0.037) 3.72E-10 rs11647589 0.030(0.005) 2.85E-11 -0.023(0.012) 4.76E-02 ACSM5 
Indolepropionate Fruid & 
Vegetable 
Pattern 0.082(0.009) 8.42E-21 rs1394678 -0.035(0.004) 1.70E-20 0.163(0.065) 1.20E-02 ACSM2A 
Indolepropionate Mediterranean 
Diet Score 
Pattern 0.078(0.009) 1.60E-17 rs1394678 -0.035(0.004) 1.70E-20 0.125(0.053) 1.80E-02 ACSM2A 
Pyroglutamine* Meat Food -0.062(0.010) 2.10E-10 rs17279437 0.059(0.006) 1.25E-20 -0.142(0.069) 3.95E-02 SLC6A20 
1,5-Anhydroglucitol 
(1,5-AG) 








High Alcohol Pattern 0.112(0.014) 1.73E-15 rs13222543 -0.263(0.028) 1.18E-20 0.301(0.129) 2.00E-02 ZCWPW1 
Myo-inositol Wine Food 0.022(0.003) 1.36E-15 rs4788439 -0.027(0.004) 6.59E-13 -0.654(0.236) 5.59E-03 SLC5A11 
Scyllo-inositol Fried fish Food -0.154(0.026) 4.44E-09 rs4787294 0.075(0.008) 9.64E-21 0.088(0.035) 1.25E-02 SLC5A11 
Scyllo-inositol Wine Food 0.052(0.003) 1.47E-49 rs4787294 0.075(0.008) 9.64E-21 -0.586(0.243) 1.60E-02 SLC5A11 
X-02269 Green leafy 
vegetables 
Food 0.030(0.004) 2.39E-13 rs2071426 0.055(0.007) 6.87E-14 0.228(0.110) 3.76E-02 CYP2C8 
X-08402 Butter Food 0.017(0.003) 7.17E-10 rs7157785 0.068(0.003) 7.23E-87 0.004(0.001) 2.95E-03 SGPP1 
X-10395 High Alcohol Pattern 0.091(0.013) 3.80E-13 rs4073054 0.016(0.002) 4.42E-19 -0.071(0.034) 4.10E-02 NR1I3 
X-10510 Butter Food 0.022(0.003) 8.28E-15 rs7157785 -0.044(0.004) 3.41E-37 0.004(0.001) 2.95E-03 SGPP1 
X-11315 Citrus fruit Food 0.026(0.004) 6.50E-10 rs4327428 -0.031(0.004) 2.81E-12 0.473(0.209) 2.37E-02 SLC6A20 
X-11315 Traditional 
English 
Pattern -0.093(0.014) 1.68E-11 rs4327428 -0.031(0.004) 2.81E-12 -0.114(0.057) 4.80E-02 SLC6A20 
X-11469 Green leafy 
vegetables 
Food 0.030(0.004) 5.66E-14 rs2071426 0.052(0.007) 3.97E-14 0.228(0.110) 3.76E-02 CYP2C8 
X-11469 Avocado Food 0.153(0.019) 9.36E-16 rs11754288 0.043(0.006) 1.88E-12 0.043(0.022) 4.75E-02 SLC17A3 
Notes: Statistics are reported for associations between food intake at metabolite-SNPs which meet the 5% level of significance. A linear regression was performed using 
the applicable metabolite-associated SNP as a predictor of reported food group intake or dietary pattern score adjusted for age, energy intake and family relatedness; an 
additive genetic model was performed for each. No associations met statistical significance of 4.76x10
-4
 (0.05/105 tests). The genome-wide association study was 
previously performed on the TwinsUK and KORA blood metabolite datasets (Shin et al., Nat Genet. 2014 Jun;46(6):543-50).  
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Discovery  Discordant  Meta-analysis 
Food 
group Metabolite Sub-pathway Beta (SE) P  Beta (SE) P  Beta (SE) P 
Vegetables X-11315   0.009 (0.002) 1.06E-08  0.007 (0.005) 1.51E-01  0.009 (0.002) 2.94E-09 
X-11372   -0.007 (0.001) 1.09E-06  -0.004 (0.004) 3.06E-01  -0.007 (0.001) 6.20E-07 
X-12063   -0.006 (0.001) 2.36E-06  -0.002 (0.003) 4.28E-01  -0.005 (0.001) 2.33E-06 
Fruit stachydrine Xenobiotics Food component, 
Plant 
0.021 (0.002) 3.65E-17  0.012 (0.004) 6.86E-03  0.019 (0.002) 8.71E-19 
glycerate Carbohydrate Glycolysis, 
gluconeogenesis, 
pyruvate metabolism 
0.017 (0.002) 7.92E-13  0.017 (0.004) 2.33E-04  0.017 (0.002) 2.08E-16 




0.012 (0.002) 2.47E-08  0.015 (0.004) 3.38E-04  0.013 (0.002) 1.89E-11 
threitol Carbohydrate Nucleotide sugars, 
pentose metabolism 
0.012 (0.002) 5.18E-10  0.005 (0.003) 1.19E-01  0.010 (0.002) 7.27E-10 
docosahexaenoate 
(DHA; 22:6n3) 
Lipid Essential fatty acid 0.011 (0.002) 6.54E-06  0.010 (0.004) 2.13E-02  0.011 (0.002) 3.42E-07 
scyllo-inositol Lipid Inositol metabolism 0.012 (0.002) 1.03E-06  0.007 (0.004) 1.11E-01  0.011 (0.002) 3.68E-07 
proline Amino acid Urea cycle; arginine-, 
proline-, metabolism 
-0.010 (0.002) 1.70E-06  -0.005 (0.005) 3.33E-01  -0.009 (0.002) 1.30E-06 
hippurate Xenobiotics Benzoate metabolism 0.011 (0.002) 7.86E-07  0.003 (0.004) 4.69E-01  0.009 (0.002) 2.12E-06 
X-11315   0.021 (0.002) 1.08E-16  0.014 (0.004) 1.43E-03  0.019 (0.002) 2.52E-19 





Amino acid Phenylalanine & 
tyrosine metabolism 
0.017 (0.003) 1.90E-07  0.003 (0.007) 6.79E-01  0.015 (0.003) 7.90E-07 
eicosapentaenoate 
(EPA; 20:5n3) 
Lipid Essential fatty acid 0.015 (0.003) 2.30E-07  0.001 (0.006) 9.09E-01  0.013 (0.003) 1.67E-06 
X-09789   0.021 (0.003) 1.19E-12  0.015 (0.006) 1.00E-02  0.020 (0.003) 2.65E-14 
X-11372   -0.022 (0.003) 7.00E-13  -0.005 (0.006) 3.43E-01  -0.018 (0.003) 6.97E-12 
X-11469   0.019 (0.003) 4.72E-11  0.003 (0.007) 6.77E-01  0.017 (0.003) 2.64E-10 
X-02269   0.019 (0.003) 1.09E-10  0.001 (0.007) 8.54E-01  0.017 (0.003) 7.75E-10 
X-11315   0.015 (0.003) 3.95E-06  0.014 (0.005) 1.42E-02  0.014 (0.003) 1.37E-07 
Nuts and 
legumes 
tryptophan betaine Amino acid Tryptophan 
metabolism 
0.048 (0.007) 9.22E-12  0.017 (0.011) 1.49E-01  0.040 (0.006) 2.52E-11 





Lipid Fatty acid, 
dicarboxylate 
0.149 (0.014) 7.86E-24  0.112 (0.026) 2.84E-05  0.140 (0.012) 4.47E-29 
docosahexaenoate 
(DHA; 22:6n3) 
Lipid Essential fatty acid 0.167 (0.016) 5.32E-25  0.085 (0.022) 1.96E-04  0.139 (0.013) 1.03E-27 
eicosapentaenoate 
(EPA; 20:5n3) 
Lipid Essential fatty acid 0.133 (0.015) 4.36E-19  0.100 (0.027) 3.97E-04  0.126 (0.013) 1.25E-22 
1-
docosahexaenoylglyc
Lipid Lysolipid 0.103 (0.013) 4.42E-14  0.050 (0.030) 9.59E-02  0.094 (0.012) 1.47E-14 
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Discovery  Discordant  Meta-analysis 
Food 
group Metabolite Sub-pathway Beta (SE) P  Beta (SE) P  Beta (SE) P 
ero-phosphocholine* 
docosapentaenoate 
(n3 DPA; 22:5n3) 






Lipid Lysolipid -0.068 (0.013) 4.51E-07  -0.117 (0.028) 7.99E-05  -0.077 (0.012) 1.99E-10 




Lipid Lysolipid -0.076 (0.013) 2.99E-09  -0.052 (0.027) 5.66E-02  -0.072 (0.012) 4.28E-10 
pseudouridine Nucleotide Pyrimidine 
metabolism, uracil 
containing 








Lipid Lysolipid -0.064 (0.014) 4.08E-06  -0.058 (0.028) 4.26E-02  -0.063 (0.012) 4.01E-07 
X-11469   0.140 (0.014) 2.17E-21  0.120 (0.028) 4.19E-05  0.136 (0.013) 2.04E-26 
X-02269   0.139 (0.015) 2.27E-20  0.121 (0.027) 2.49E-05  0.135 (0.013) 1.45E-25 
X-11315   0.078 (0.014) 1.82E-08  0.044 (0.025) 7.47E-02  0.070 (0.012) 5.35E-09 
X-12627   0.076 (0.013) 1.61E-08  0.026 (0.023) 2.53E-01  0.064 (0.012) 3.62E-08 
X-12644   0.087 (0.015) 9.74E-09  0.008 (0.019) 6.84E-01  0.057 (0.012) 1.39E-06 
X-11437   0.076 (0.015) 3.97E-07  0.009 (0.027) 7.53E-01  0.061 (0.013) 3.41E-06 
X-12798   -0.061 (0.013) 6.13E-06  -0.035 (0.035) 3.18E-01  -0.058 (0.013) 4.15E-06 







Amino acid Urea cycle; arginine-, 
proline-, metabolism 
0.039 (0.007) 5.30E-08  0.014 (0.015) 3.57E-01  0.034 (0.006) 8.32E-08 
creatine Amino acid Creatine metabolism 0.037 (0.007) 6.84E-07  0.016 (0.014) 2.62E-01  0.032 (0.006) 7.36E-07 
X-11381   0.034 (0.007) 6.10E-07  0.023 (0.013) 8.56E-02  0.032 (0.006) 1.44E-07 
X-09789   -0.033 (0.007) 1.65E-06  -0.012 (0.014) 4.01E-01  -0.029 (0.006) 2.65E-06 
Fermented 
dairy 





Amino acid Phenylalanine & 
tyrosine metabolism 
-0.037 (0.008) 2.82E-06  -0.027 (0.014) 4.79E-02  -0.035 (0.007) 3.59E-07 
X-11372   0.071 (0.009) 2.09E-15  0.045 (0.010) 3.66E-05  0.060 (0.007) 2.93E-19 
X-11469   -0.035 (0.006) 5.23E-08  -0.009 (0.019) 6.36E-01  -0.032 (0.006) 8.19E-08 
X-02269   -0.035 (0.006) 9.23E-08  -0.008 (0.020) 6.80E-01  -0.032 (0.006) 1.52E-07 





Lipid Essential fatty acid -0.010 (0.002) 7.56E-09  -0.016 (0.002) 3.97E-09  -0.012 (0.001) 1.07E-17 
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Discovery  Discordant  Meta-analysis 
Food 





Lipid Essential fatty acid -0.009 (0.002) 2.20E-08  -0.013 (0.003) 2.14E-06  -0.010 (0.001) 7.29E-14 
pipecolate Amino acid Lysine metabolism -0.010 (0.002) 1.05E-08  -0.011 (0.004) 4.30E-03  -0.010 (0.002) 9.37E-11 
scyllo-inositol Lipid Inositol metabolism -0.012 (0.002) 7.77E-09  -0.011 (0.005) 3.49E-02  -0.012 (0.002) 5.14E-10 
C-
glycosyltryptophan* 
Amino acid Tryptophan 
metabolism 
0.008 (0.002) 3.73E-07  0.008 (0.003) 1.09E-02  0.008 (0.001) 9.24E-09 
glycerate Carbohydrate Glycolysis, 
gluconeogenesis, 
pyruvate metabolism 




Lipid Lysolipid -0.008 (0.002) 3.37E-07  -0.005 (0.004) 1.89E-01  -0.008 (0.001) 1.70E-07 
pyroglutamine* Amino acid Glutamate metabolism 0.008 (0.002) 3.05E-06  0.007 (0.004) 9.02E-02  0.007 (0.001) 5.91E-07 
piperine Xenobiotics Food component, 
Plant 
-0.009 (0.002) 4.26E-06  -0.007 (0.004) 6.64E-02  -0.008 (0.002) 7.19E-07 
X-11315   -0.013 (0.002) 2.16E-13  -0.004 (0.003) 1.61E-01  -0.011 (0.001) 1.99E-12 
X-11437   -0.010 (0.002) 3.42E-08  -0.002 (0.006) 7.89E-01  -0.009 (0.002) 6.75E-08 





Lipid Carnitine metabolism 0.034 (0.005) 1.61E-12  0.028 (0.009) 2.67E-03  0.033 (0.004) 6.30E-15 
myristate (14:0) Lipid Long chain fatty acid 0.024 (0.005) 1.04E-06  0.015 (0.011) 1.99E-01  0.022 (0.004) 4.99E-07 
caprate (10:0) Lipid Medium chain fatty 
acid 
0.020 (0.004) 4.99E-06  0.017 (0.010) 8.37E-02  0.020 (0.004) 9.38E-07 
X-02249   0.028 (0.005) 1.98E-09  0.025 (0.009) 5.53E-03  0.027 (0.004) 2.22E-11 




X-11478   0.020 (0.003) 1.69E-08  0.012 (0.005) 1.40E-02  0.017 (0.003) 1.22E-09 
X-11521   0.017 (0.003) 8.82E-08  0.013 (0.005) 5.17E-03  0.015 (0.003) 1.22E-09 
X-11261   0.020 (0.004) 1.16E-07  0.015 (0.006) 1.15E-02  0.019 (0.003) 3.94E-09 
Milk alpha-
hydroxyisovalerate 
Amino acid Valine, leucine and 
isoleucine metabolism 
-0.055 (0.012) 3.85E-06  -0.048 (0.026) 6.36E-02  -0.054 (0.011) 5.48E-07 
X-21365 [trimethyl-N-
aminovalerate] 
  0.107 (0.012) 6.14E-18  0.076 (0.025) 3.08E-03  0.101 (0.011) 2.04E-20 
X-12798   0.093 (0.012) 3.21E-14  0.047 (0.026) 6.94E-02  0.084 (0.011) 7.72E-15 
X-11381   0.076 (0.011) 2.58E-11  0.024 (0.026) 3.54E-01  0.068 (0.010) 5.01E-11 
X-11795   -0.060 (0.012) 3.58E-07  -0.005 (0.021) 8.03E-01  -0.048 (0.010) 3.93E-06 
Soy and 
other milks 
glycerate Carbohydrate Glycolysis, 
gluconeogenesis, 
pyruvate metabolism 
0.150 (0.031) 1.14E-06  0.238 (0.048) 2.75E-04  0.175 (0.026) 1.24E-11 
Soda X-11469   -0.020 (0.004) 1.85E-06  -0.001 (0.012) 9.58E-01  -0.018 (0.004) 5.32E-06 
Tea quinate Xenobiotics Food component, 
Plant 
-0.019 (0.002) 6.87E-18  -0.025 (0.005) 1.08E-06  -0.020 (0.002) 1.95E-24 
N-acetylornithine Amino acid Urea cycle; arginine-, 
proline-, metabolism 
0.009 (0.002) 2.55E-06  0.008 (0.004) 5.49E-02  0.009 (0.002) 3.14E-07 
pseudouridine Nucleotide Pyrimidine 0.008 (0.002) 4.01E-06  0.003 (0.005) 5.02E-01  0.008 (0.002) 4.53E-06 
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Discovery  Discordant  Meta-analysis 
Food 
group Metabolite Sub-pathway Beta (SE) P  Beta (SE) P  Beta (SE) P 
metabolism, uracil 
containing 
X-14473   -0.026 (0.002) 6.70E-34  -0.021 (0.005) 1.29E-04  -0.025 (0.002) 2.82E-40 
X-12734   0.019 (0.002) 1.32E-20  0.002 (0.006) 7.34E-01  0.018 (0.002) 2.90E-20 
X-09789   0.014 (0.002) 3.40E-13  0.006 (0.005) 2.05E-01  0.013 (0.002) 2.01E-13 
X-14374   -0.012 (0.002) 2.59E-10  -0.008 (0.006) 1.88E-01  -0.012 (0.002) 9.06E-11 
Coffee quinate Xenobiotics Food component, 
Plant 
0.035 (0.002) 1.08E-43  0.027 (0.005) 4.30E-08  0.033 (0.002) 1.77E-56 
catechol sulfate Xenobiotics Benzoate metabolism 0.017 (0.002) 1.43E-12  0.013 (0.005) 1.84E-02  0.016 (0.002) 4.57E-14 
paraxanthine Xenobiotics Xanthine metabolism 0.013 (0.003) 8.63E-07  0.008 (0.005) 1.11E-01  0.012 (0.002) 2.77E-07 
theophylline Xenobiotics Xanthine metabolism 0.012 (0.003) 3.88E-06  0.007 (0.005) 1.09E-01  0.011 (0.002) 1.26E-06 
X-14473   0.040 (0.002) 1.53E-77  0.028 (0.005) 6.27E-08  0.039 (0.002) 6.41E-102 
X-14374   0.024 (0.002) 1.98E-28  0.021 (0.006) 1.84E-04  0.023 (0.002) 1.08E-33 
X-05426   0.018 (0.002) 4.64E-13  0.008 (0.005) 9.86E-02  0.016 (0.002) 2.01E-13 
X-12217   0.014 (0.003) 1.64E-07  0.010 (0.006) 1.03E-01  0.013 (0.002) 3.82E-08 
X-09789   -0.014 (0.002) 6.43E-08  -0.004 (0.005) 4.04E-01  -0.012 (0.002) 1.43E-07 
X-12734   -0.014 (0.003) 1.20E-06  -0.007 (0.006) 2.41E-01  -0.013 (0.003) 8.02E-07 
Alcohol scyllo-inositol Lipid Inositol metabolism 0.042 (0.005) 2.16E-18  0.037 (0.011) 1.83E-03  0.041 (0.004) 1.57E-21 
alpha-
hydroxyisovalerate 
Amino acid Valine, leucine and 
isoleucine metabolism 




Lipid Sterol, Steroid 0.032 (0.004) 1.25E-12  0.037 (0.011) 1.64E-03  0.032 (0.004) 1.89E-15 
eicosapentaenoate 
(EPA; 20:5n3) 
Lipid Essential fatty acid 0.019 (0.004) 2.26E-07  0.024 (0.005) 7.77E-05  0.021 (0.003) 1.57E-11 
docosahexaenoate 
(DHA; 22:6n3) 
Lipid Essential fatty acid 0.020 (0.004) 4.03E-08  0.024 (0.007) 1.57E-03  0.020 (0.003) 1.09E-10 
2-oleoylglycero-
phosphocholine* 
Lipid Lysolipid 0.016 (0.003) 2.32E-07  0.030 (0.008) 6.93E-04  0.018 (0.003) 6.90E-10 
docosapentaenoate 
(n3 DPA; 22:5n3) 
Lipid Essential fatty acid 0.019 (0.004) 2.58E-07  0.025 (0.009) 1.15E-02  0.020 (0.003) 7.10E-09 




Lipid Lysolipid 0.015 (0.003) 1.39E-06  0.012 (0.009) 1.65E-01  0.015 (0.003) 4.40E-07 
X-11795   0.030 (0.004) 1.11E-11  0.036 (0.009) 1.36E-04  0.031 (0.004) 1.15E-15 
X-10395   0.026 (0.004) 6.35E-11  0.019 (0.010) 6.55E-02  0.025 (0.004) 7.70E-12 
X-14473   0.020 (0.003) 1.06E-09  0.023 (0.009) 1.06E-02  0.020 (0.003) 1.98E-11 
X-12627   0.019 (0.003) 2.06E-08  0.016 (0.008) 5.24E-02  0.018 (0.003) 2.13E-09 
X-11204   0.017 (0.003) 2.34E-07  0.015 (0.008) 5.40E-02  0.017 (0.003) 2.61E-08 
X-11444   -0.018 (0.003) 9.08E-08  -0.012 (0.008) 1.43E-01  -0.017 (0.003) 3.13E-08 
X-12644   0.014 (0.003) 6.55E-06  0.017 (0.008) 2.86E-02  0.014 (0.003) 4.46E-07 
X-11787   -0.014 (0.003) 2.67E-06  -0.007 (0.009) 4.12E-01  -0.014 (0.003) 2.22E-06 
 297 
 
Notes: Table shows results of the linear regression analysis for the discovery population (excluding monozygotic twins discordant for each food group), the MZ 
discordant twin sample and the fixed effects meta-analysis of both groups. Only significant associations are shown which includes those associations passing the 
bonferroni cut-off in the discovery and fixed effects analyses (7.60x10
-6
 = 0.05/[20 food groups x 329 detected metabolites]) and passing the 5% level of significance in 




Table 2. Multivariate regression results for metabolites associated with multiple food groups  
Superpathway Metabolite Food group beta (SE) P 
Amino acid 
 
3-phenylpropionate (hydrocinnamate) Fried foods -0.028 (0.007) 2.44E-05 
Whole grains 0.012 (0.003) 6.98E-05 
alpha-hydroxyisovalerate Alcohol  0.033 (0.004) 1.37E-14* 
Milk  -0.038 (0.011) 3.60E-04 
pipecolate Sweets and sweet baked products -0.008 (0.002) 1.78E-06* 
Alcohol  0.016 (0.004) 2.77E-05 
pyroglutamine* Seafood  -0.064 (0.012) 2.31E-07* 
Sweets and sweet baked products 0.006 (0.002) 2.35E-04 
Carbohydrate 
 
glycerate Fruit  0.013 (0.002) 2.38E-11* 
Soy and other milk 0.132 (0.030) 9.40E-06 





Seafood  0.083 (0.012) 3.08E-12* 
Alcohol  0.010 (0.003) 1.09E-03 
Sweets and sweet baked products -0.004 (0.002) 7.12E-03 
docosahexaenoate (DHA; 22:6n3) 
 
Seafood  0.127 (0.012) 1.79E-24* 
Alcohol  0.015 (0.003) 7.79E-08* 
Sweets and sweet baked products -0.005 (0.002) 1.71E-03 
Fruit  0.005 (0.002) 8.25E-03 
docosapentaenoate (n3 DPA; 22:5n3) 
 
Seafood  0.070 (0.011) 2.94E-10* 
Alcohol  0.017 (0.003) 1.39E-07* 
eicosapentaenoate (EPA; 20:5n3) 
 
Seafood  0.112 (0.012) 2.24E-19* 
Alcohol  0.015 (0.003) 7.21E-08* 
Whole grains 0.010 (0.003) 7.59E-05 
Sweets and sweet baked products -0.004 (0.001) 1.96E-03 
scyllo-inositol 
 
Alcohol  0.042 (0.004) 3.03E-22* 
Fruit  0.013 (0.002) 7.22E-10* 





Seafood  -0.065 (0.011) 1.76E-09* 





Coffee  0.029 (0.002) 4.90E-35* 
Tea   -0.012 (0.002) 1.66E-09* 
Unknown X-02269 
 
Seafood  0.127 (0.012) 6.27E-24* 
Whole grains 0.012 (0.003) 3.52E-06* 
Fried foods -0.014 (0.007) 3.75E-02 
X-09789 
 
Whole grains 0.017 (0.003) 3.95E-11* 
Tea   0.011 (0.002) 9.24E-10* 
Red, processed meat and eggs -0.022 (0.006) 3.20E-04 
Coffee  -0.007 (0.002) 2.48E-03 
X-11315 
 
Fruit  0.014 (0.002) 1.21E-10* 
Fermented dairy 0.017 (0.005) 1.17E-03 
Seafood  0.037 (0.012) 2.03E-03 
Sweets and sweet baked products -0.005 (0.002) 2.61E-03 
Whole grains 0.007 (0.003) 1.23E-02 
Nuts and legumes 0.012 (0.006) 3.39E-02 
Fried foods  5.16E-02 
Vegetable   2.60E-01 
X-11372 Fried foods 0.052 (0.007) 9.20E-15* 
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Table 2. Multivariate regression results for metabolites associated with multiple food groups  
Superpathway Metabolite Food group beta (SE) P 
 Whole grains -0.012 (0.003) 1.03E-05 
Fruit  -0.004 (0.002) 4.39E-02 
Vegetable  -0.003 (0.001) 4.85E-02 
X-11381 
 
Milk  0.070 (0.010) 9.83E-12* 
Red, processed meat and eggs 0.035 (0.006) 1.39E-08* 
X-11437 
 
Seafood  0.047 (0.013) 5.05E-04 
Sweets and sweet baked products -0.006 (0.002) 6.14E-04 
X-11469 
 
Seafood  0.127 (0.012) 2.13E-24* 
Whole grains 0.012 (0.003) 2.89E-06* 
Soda -0.012 (0.004) 1.74E-03 
Fried foods -0.014 (0.007) 4.25E-02 
X-11795 
 
Alcohol  0.029 (0.004) 1.48E-13* 
Milk  -0.035 (0.010) 6.93E-04 
X-12627 
 
Alcohol  0.017 (0.003) 9.29E-09* 
Seafood  0.057 (0.011) 1.70E-07* 
X-12644 
 
Seafood  0.067 (0.012) 2.25E-08* 
Alcohol  0.012 (0.003) 3.48E-05 
X-12734 
 
Tea   0.016 (0.002) 2.55E-14* 
Coffee  -0.006 (0.003) 2.38E-02 
X-12798 
 
Milk  0.080 (0.011) 8.80E-13* 
Seafood  -0.042 (0.013) 1.43E-03 
X-14374 
 
Coffee  0.020 (0.002) 2.54E-22* 
Tea   -0.007 (0.002) 3.88E-04 
X-14473 
 
Coffee  0.032 (0.002) 4.05E-57* 
Tea   -0.016 (0.002) 1.47E-17* 
Alcohol  0.011 (0.003) 1.41E-04 
Notes: Table shows results of a multivariate backwards stepwise linear regression including all food groups associated to a metabolite from the discovery analysis using 
P<0.05 as the cut-off threshold. Metabolites and foods in bold, and with an asterisk (*) beside the P-value passed the Bonferroni cut-off for multiple testing from the 
discovery analysis (7.60x10
-6




Table 3. Backward stepwise linear regression results for foods associated with multiple metabolites and foods associated with single 
metabolites 
  Model 1  Model 2 Standardized 
betas Food group Metabolite R
2
 Beta(SE) P  R
2
 Beta(SE) P 
Vegetables X-12063 0.0094 -1.798 (0.627) 4.23E-03     -0.101 
Fruit  stachydrine 0.1195 2.327 (0.345) 2.59E-11      0.194 
X-11315  2.586 (0.391) 6.16E-11      0.207 
proline  -1.506 (0.346) 1.48E-05     -0.119 
threitol  1.614 (0.409) 8.63E-05      0.097 
hippurate   5.46E-02      
glycerate   6.20E-02      
scyllo-inositol   0.454      
threonate   0.798      
Whole grains X-09789 0.0508 1.552 (0.229) 2.08E-11      0.173 
X-11469  1.337 (0.235) 1.79E-08      0.142 
X-02269   0.650      0.173 
Nuts and legumes tryptophan betaine 0.0384 0.905 (0.132) 1.32E-11      0.181 
Seafood  docosahexaenoate (DHA; 22:6n3) 0.1514 0.563 (0.090) 7.03E-10  0.1535 0.399 (0.056) 2.09E-12  0.192 
X-11469  0.246 (0.063) 9.44E-05   0.281 (0.061) 3.89E-06  0.130 
pseudouridine  -0.165 (0.047) 5.13E-04   -0.164 (0.046) 4.31E-04 -0.079 
1-eicosatrienoylglycerophosphocholine*  -0.182 (0.067) 6.71E-03   -0.205 (0.063) 1.29E-03 -0.105 
pyroglutamine*  -0.133 (0.050) 8.34E-03   -0.130 (0.049) 8.44E-03 -0.065 









 0.162 (0.081) 4.52E-02   0.169 (0.078) 3.01E-02 
 0.084 
eicosapentaenoate (EPA; 20:5n3)   6.37E-02      
1-
linoleoylglycerophosphoethanolamine* 
  7.63E-02      
1-oleoylglycerophosphoethanolamine   8.13E-02      
X-02269   0.255      
3-carboxy-4-methyl-5-propyl-2-
furanpropanoate (CMPF) 
  0.271      
X-12627   0.450      
X-12644   0.580      
White meat 3-methylhistidine 0.0291 0.219 (0.034) 1.62E-10      0.170 
Red meat  trans-4-hydroxyproline 0.0403 0.449 (0.101) 9.20E-06      0.113 
X-11381  0.393 (0.093) 2.83E-05      0.102 
creatine  0.401 (0.099) 5.40E-05      0.102 
Fried foods X-11372 0.0668 1.058 (0.100) 9.39E-25      0.279 
Sweets and sweet baked C-glycosyltryptophan* 0.0588 2.233 (0.500) 8.93E-06      0.129 
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Table 3. Backward stepwise linear regression results for foods associated with multiple metabolites and foods associated with single 
metabolites 
  Model 1  Model 2 Standardized 
betas Food group Metabolite R
2
 Beta(SE) P  R
2
 Beta(SE) P 
products pipecolate  -1.719 (0.439) 9.77E-05     
-0.117 
X-12696  1.582 (0.435) 2.94E-04      0.102 
piperine  -1.406 (0.405) 5.40E-04     -0.093 
Butter and cream nonanoylcarnitine* 0.0754 1.030 (0.188) 5.95E-08      0.164 
X-02249  0.615 (0.185) 8.99E-04      0.093 
myristate (14:0)  0.511 (0.175) 3.52E-03      0.083 
caprate (10:0)  0.363 (0.168) 3.05E-02      0.058 
X-10510  0.349 (0.161) 3.09E-02      0.053 
Spreads and dressings X-11261 0.0331 1.103 (0.355) 1.94E-03      0.101 
X-11478  0.774 (0.291) 8.00E-03      0.093 
Milk  X-21365 [trimethyl-N-aminovalerate] 0.0735 0.401 (0.065) 1.31E-09      0.175 
X-11381  0.206 (0.059) 4.88E-04      0.091 
X-12798  0.238 (0.069) 6.52E-04      0.102 
Tea   X-14473 0.2113 -3.959 (0.503) 1.33E-14     -0.282 
N-acetylornithine  1.710 (0.376) 6.26E-06      0.122 
X-12734  1.675 (0.390) 2.01E-05      0.121 
X-09789  1.461 (0.430) 7.15E-04      0.102 
quinate  -1.253 (0.495) 1.16E-02     -0.090 
Coffee   X-14473 0.1963 3.756 (0.404) 2.02E-19      0.344 
quinate  2.197 (0.439) 7.27E-07      0.204 
X-14374   5.46E-02      
X-05426   0.115      
catechol sulfate   0.313      
X-12217   0.715      
theophylline   0.887      
paraxanthine   0.964      
Alcohol  scyllo-inositol 0.2537 1.813 (0.213) 1.04E-16  0.2493 1.776 (0.209) 1.16E-16  0.231 
4-androsten-3beta,17beta-diol disulfate 
1* 
 1.692 (0.272) 8.18E-10   1.623 (0.271) 3.21E-09  0.188 
X-11795  1.107 (0.209) 1.57E-07   1.141 (0.206) 4.39E-08  0.143 
X-11444  -1.130 (0.224) 5.74E-07   -1.075 (0.221) 1.33E-06 -0.131 
alpha-hydroxyisovalerate  1.066 (0.224) 2.28E-06   1.010 (0.213) 2.54E-06  0.127 
eicosapentaenoate (EPA; 20:5n3)  1.042 (0.281) 2.23E-04   0.827 (0.222) 2.06E-04  0.098 
2-oleoylglycerophosphocholine*  0.630 (0.206) 2.30E-03   0.626 (0.203) 2.11E-03  0.080 
X-11787  -0.491 (0.217) 2.42E-02   -0.442 (0.217) 4.18E-02 -0.053 
X-12627  -0.484 (0.241) 4.51E-02      
X-10395   0.112      
docosapentaenoate (n3 DPA; 22:5n3)   0.489      
docosahexaenoate (DHA; 22:6n3)   0.502      
X-11204   0.928      
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Notes: Table shows the results of a multivariate backwards stepwise linear regression including all associated metabolites used to predict food group intakes using 
P<0.05 as the cut-off threshold. Metabolites highlighted in red indicate the association was in the opposite direction to the discovery analysis for model 1 and therefore, 
for the corresponding food group a second multivariate regression was undertaken. The rightmost column shows the final standardized betas used for the weighted 




Table 4. Associations between reported food intakes and the final scores in the training and test groups 
   Training group  Test group 
Food group No. metabolites in score Score Beta (SE) P   Beta (SE) P 
Vegetables 1 Top: X-12063 -0.005 (0.001) 2.96E-06  -0.006 (0.002) 3.62E-04* 
  Quartiles 0.004 (0.001) 8.59E-03  0.005 (0.002) 6.88E-03* 
Fruit 4 Top: X-11315  0.019 (0.002) 7.14E-20  0.016 (0.002) 1.81E-18 
  Quartiles 0.064 (0.005) 4.06E-34  0.062 (0.005) 1.28E-36 
  Continuous 0.060 (0.005) 2.68E-36  0.055 (0.004) 3.76E-37 
  Weighted 0.010 (0.001) 3.03E-36  0.009 (0.001) 4.48E-40 
Whole grains 3 Top: X-09789  0.020 (0.003) 1.33E-13  0.031 (0.003) 4.35E-22 
  Quartiles 0.038 (0.005) 6.99E-16  0.049 (0.005) 5.42E-23 
  Continuous 0.036 (0.004) 1.40E-18  0.046 (0.005) 6.98E-22 
  Weighted 0.006 (0.001) 8.78E-19  0.008 (0.001) 9.51E-23 
Nuts and legumes 1 Top: tryptophan betaine 0.044 (0.006) 1.45E-13  0.037 (0.005) 3.38E-13 
  Quartiles 0.041 (0.005) 2.78E-14  0.037 (0.005) 1.29E-13 
Seafood 7 Top: DHA 0.147 (0.013) 6.98E-30  0.141 (0.011) 1.76E-34 
  Quartiles 0.711 (0.048) 1.24E-45  0.599 (0.049) 7.85E-32 
  Continuous 0.662 (0.046) 1.30E-42  0.575 (0.045) 3.43E-34 
  Weighted 0.076 (0.005) 6.01E-44  0.069 (0.005) 1.63E-41 
White meat 1 Top: 3-methylhistidine 0.135 (0.021) 1.52E-10  0.077 (0.023) 7.78E-04 
  Quartiles 0.176 (0.021) 2.11E-16  0.134 (0.022) 1.03E-09 
Red meat 3 Top: trans-4-hydroxyproline 0.035 (0.006) 9.27E-08  0.036 (0.007) 3.66E-08 
  Quartiles 0.108 (0.013) 9.64E-16  0.124 (0.014) 9.23E-19 
  Continuous 0.100 (0.012) 2.96E-16  0.114 (0.012) 3.43E-19 
  Weighted 0.011 (0.001) 3.40E-16  0.012 (0.001) 3.79E-19 
Fried foods 1 Top: X-11372 0.067 (0.007) 3.28E-20  0.080 (0.009) 2.55E-17 
  Quartiles 0.068 (0.008) 2.30E-18  0.084 (0.010) 1.31E-16 
Sweets and sweet baked products 4 Top: C-glycosyltryptophan*  0.136 (0.034) 8.54E-05  0.008 (0.001) 1.78E-09 
  Quartiles 0.457 (0.095) 2.00E-06  0.032 (0.004) 6.44E-17 
  Continuous 0.427 (0.082) 2.27E-07  0.031 (0.003) 8.93E-21 
  Weighted 0.047 (0.009) 1.73E-07  0.003 (0.000) 3.28E-21 
Butter and creams 5 Top: nonanoylcarnitine* 0.034 (0.004) 2.69E-16  0.022 (0.004) 8.92E-08 
  Quartiles 0.122 (0.013) 2.53E-21  0.107 (0.013) 4.89E-16 
  Continuous 0.120 (0.013) 1.90E-18  0.094 (0.012) 8.66E-15 
  Weighted 0.011 (0.001) 8.09E-21  0.009 (0.001) 2.30E-15 
Spreads and dressings 2 Top: X-11261 0.019 (0.003) 2.77E-09  0.014 (0.003) 6.34E-06 
  Quartiles 0.041 (0.006) 4.21E-12  0.034 (0.007) 4.86E-07 
  Continuous 0.036 (0.005) 5.47E-11  0.026 (0.006) 1.83E-05* 
  Weighted 0.003 (0.001) 5.89E-11  0.002 (0.001) 1.68E-05* 
Milk 3 Top: X-21365 0.102 (0.011) 2.58E-20  0.094 (0.010) 6.20E-19 
  Quartiles 0.264 (0.026) 3.02E-23  0.247 (0.028) 1.60E-18 
  Continuous 0.250 (0.023) 1.23E-25  0.204 (0.024) 4.95E-17 
  Weighted 0.032 (0.003) 2.90E-26  0.027 (0.003) 1.49E-19 
Tea 5 Top: X-14473  -0.025 (0.002) 2.56E-37  -0.024 (0.002) 2.83E-36 
  Quartiles 0.078 (0.005) 3.98E-42  0.050 (0.005) 3.32E-22 
  Continuous 0.073 (0.005) 2.96E-50  0.051 (0.004) 2.08E-32 
  Weighted 0.012 (0.001) 1.15E-52  0.009 (0.001) 7.64E-38 
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Table 4. Associations between reported food intakes and the final scores in the training and test groups 
   Training group  Test group 
Food group No. metabolites in score Score Beta (SE) P   Beta (SE) P 
Coffee 2 Top: X-14473 0.038 (0.002) 3.47E-83  0.036 (0.002) 3.00E-61 
  Quartiles 0.090 (0.003) 8.56E-115  0.091 (0.004) 1.06E-104 
  Continuous 0.064 (0.003) 2.63E-82  0.057 (0.003) 1.66E-71 
  Weighted 0.018 (0.001) 4.83E-87  0.016 (0.001) 5.92E-72 
Alcohol 8 Top: scyllo-inositol 0.041 (0.004) 8.22E-22  0.039 (0.004) 2.48E-24 
  Quartiles 0.212 (0.018) 7.53E-31  0.191 (0.013) 1.21E-42 
  Continuous 0.197 (0.018) 1.06E-27  0.180 (0.013) 2.51E-41 
   Weighted 0.029 (0.003) 5.47E-27   0.027 (0.002) 7.79E-45 
Notes: A linear regression was performed in the training (n=1780) and test groups (n=1779) using each food group intake as a predictor of the top 







Table 5. Average (SD) energy-adjusted intakes (servings/week) for the top and bottom tertiles for 







Vegetables 19.5 (5.4) 51.0 (13.4) 
Fruit 9.7 (4.4) 35.6 (10.3) 
Whole grains 2.7 (2.4) 19.2 (7.4) 
Nuts and legumes 3.0 (1.5) 12.9 (5.4) 
Seafood 0.7 (0.5) 4.5 (1.8) 
White meat 0.6 (0.4) 3.4 (0.8) 
Red meat 2.9 (1.5) 10.8 (3.0) 
Fried foods 1.6 (1.1) 8.0 (3.3) 
Sweets and sweet baked products 4.2 (3.6) 30.4 (14.5) 
Butter and cream -0.4 (1.0) 10.6 (7.4) 
Spreads and dressings 1.7 (2.1) 17.3 (10.8) 
Milk 1.1 (0.9) 5.8 (1.5) 
Tea 3.2 (3.7) 35.5 (5.6) 
Coffee 0.0 (0.5) 22.1 (7.9) 
Alcohol 0.4 (1.0) 14.3 (8.8) 
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Table 6. Results of ROC analysis 
      Versus top metabolite 
Food group Score Sensitivity Specificity Correctly classified ROC area χ² P 
Vegetables Top: X-12063 59.74% 55.47% 57.60% 0.6136 [0.5802, 0.6470]   
Quartiles 59.22% 54.50% 56.85% 0.6136 [0.5802, 0.6470] 0.00 1.0000 
Fruit Top: X-11315  65.59% 60.34% 62.98% 0.6783 [0.6479, 0.7087]   
Quartiles 68.54% 67.06% 67.80% 0.7305 [0.7020, 0.7590] 18.14 <0.0001 
Continuous 67.52% 66.55% 67.04% 0.7339 [0.7057, 0.7622] 19.99 <0.0001 
Weighted 66.84% 67.24% 67.04% 0.7411 [0.7131, 0.7690] 29.77 <0.0001 
Whole grains Top: X-09789  65.25% 67.07% 66.15% 0.7134 [0.6841, 0.7428]   
Quartiles 66.61% 65.47% 66.04% 0.7063 [0.6768, 0.7359] 0.60 0.4394 
Continuous 67.46% 66.32% 66.89% 0.7186 [0.6895, 0.7478] 0.36 0.5500 
Weighted 67.63% 65.81% 66.72% 0.7224 [0.6934, 0.7514] 1.37 0.2425 
Nuts and legumes Top: tryptophan betaine 64.25% 60.70% 62.47% 0.6723 [0.6366, 0.7080]   
Quartiles 65.82% 57.68% 61.77% 0.6629 [0.6268, 0.6991] 2.42 0.1197 
Seafood Top: DHA 64.79% 67.46% 66.13% 0.7230 [0.6943, 0.7516]   
Quartiles 65.81% 67.12% 66.47% 0.7307 [0.7023, 0.7592] 0.42 0.5172 
Continuous 66.15% 67.12% 66.64% 0.7356 [0.7075, 0.7637] 1.12 0.2893 
Weighted 69.57% 70.68% 70.13% 0.7547 [0.7274, 0.7821] 11.88 0.0006 
White meat Top: 3-methylhistidine 77.78% 32.44% 56.86% 0.5733 [0.5371, 0.6096]   
Quartiles 54.31% 62.39% 58.40% 0.5536 [0.5172, 0.5901] 4.74 0.0295 
Red meat Top: trans-4-hydroxyproline 58.94% 65.37% 62.16% 0.6697 [0.6390, 0.7003]   
Quartiles 61.73% 63.50% 62.62% 0.6920 [0.6622, 0.7218] 5.36 0.0207 
Continuous 63.10% 65.70% 64.40% 0.6963 [0.6666, 0.7260] 8.63 0.0033 
Weighted 63.61% 65.53% 64.57% 0.6963 [0.6666, 0.7260] 9.36 0.0022 
Fried foods Top: X-11372 65.30% 66.32% 65.81% 0.7322 [0.7038, 0.7606]   
Quartiles 65.98% 65.93% 65.96% 0.7217 [0.6928, 0.7506] 6.70 0.0096 
Sweets and sweet baked products Top: C-glycosyltryptophan*  58.67% 56.51% 57.59% 0.6002 [0.5679, 0.6325]   
Quartiles 58.57% 57.78% 58.18% 0.6235 [0.5917, 0.6552] 3.29 0.0697 
Continuous 60.27% 59.32% 59.80% 0.6249 [0.5932, 0.6566] 4.29 0.0384 
Weighted 60.10% 58.97% 59.54% 0.6254 [0.5937, 0.6571] 5.07 0.0243 
Butter and cream Top: nonanoylcarnitine* 71.88% 39.55% 56.84% 0.5889 [0.5529, 0.6249]   
Quartiles 61.02% 58.87% 59.95% 0.6386 [0.6037, 0.6735] 7.45 0.0064 
Continuous 58.31% 60.75% 59.52% 0.6383 [0.6034, 0.6732] 7.38 0.0066 
Weighted 59.15% 59.90% 59.52% 0.6385 [0.6036, 0.6734] 11.39 0.0007 
Spreads and dressings Top: X-11261 59.08% 57.48% 58.28% 0.6199 [0.5880, 0.6518]   
Quartiles 60.27% 60.10% 60.19% 0.6374 [0.6059, 0.6689] 5.42 0.0199 
Continuous 59.25% 60.61% 59.93% 0.6319 [0.6003, 0.6636] 3.07 0.0799 
Weighted 58.90% 60.27% 59.59% 0.6316 [0.5999, 0.6633] 3.14 0.0762 
Milk Top: X-21365 60.17% 60.65% 60.41% 0.6409 [0.6096, 0.6723]   
quartiles 60.51% 61.33% 60.92% 0.6403 [0.6089, 0.6717] 0.00 0.9575 
Continuous 60.68% 61.33% 61.00% 0.6355 [0.6040, 0.6669] 0.22 0.6402 
Weighted 60.68% 60.48% 60.58% 0.6442 [0.6130, 0.6755] 0.14 0.7122 
Tea Top: X-14473  59.28% 73.51% 67.04% 0.7384 [0.7078, 0.7691]   
Quartiles 61.63% 64.63% 63.13% 0.7121 [0.6803, 0.7439] 2.68 0.1016 
Continuous 66.04% 66.16% 66.10% 0.7257 [0.6943, 0.7572] 0.80 0.3705 
Weighted 67.40% 65.65% 66.53% 0.7443 [0.7139, 0.7747] 0.40 0.5276 
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Table 6. Results of ROC analysis 
      Versus top metabolite 
Food group Score Sensitivity Specificity Correctly classified ROC area χ² P 
Coffee Top: X-14473 78.21% 65.38% 72.42% 0.7779 [0.7483, 0.8074]   
Quartiles 72.06% 76.36% 74.21% 0.7917 [0.7627, 0.8208] 3.08 0.0790 
Continuous 66.78% 70.92% 68.85% 0.7803 [0.7510, 0.8096] 0.11 0.7388 
Weighted 67.63% 70.75% 69.19% 0.7856 [0.7565, 0.8148] 2.06 0.1511 
Alcohol Top: scyllo-inositol 75.75% 63.32% 70.02% 0.7531 [0.7230, 0.7832]   
Quartiles 71.48% 70.97% 71.22% 0.7914 [0.7638, 0.8191] 5.52 0.0188 
Continuous 70.80% 74.02% 72.41% 0.8067 [0.7800, 0.8333] 11.05 0.0009 
Weighted 74.70% 76.40% 75.55% 0.8351 [0.8104, 0.8598] 38.99 <0.0001 
Notes: Table shows the results of the receiver operating characteristic analysis testing the ability of each top metabolite or metabolite score to predict 
the top (1, positive outcome) and bottom (0, negative outcome) tertiles of food group intake. The area under the receiver operating characteristic curve 
(AUC) was compared for each metabolite score against the top performing metabolite. Metabolite scores which performed the best and better than the 





Table 7. Top metabolite and score associations with food preferences in the test group 




score Score Beta (SE) P 
Vegetables 1 Top: X-12063 -0.062 (0.059) NS 
  Quartiles 0.036 (0.067) NS 
Fruit 4 Top: X-11315  0.203 (0.045) 7.40E-06 
  Quartiles 0.490 (0.122) 6.62E-05 
  Continuous 0.448 (0.108) 3.51E-05 
  Weighted 0.077 (0.017) 1.12E-05 
Whole grains 3 Top: X-09789  0.287 (0.054) 1.37E-07 
  Quartiles 0.226 (0.083) 6.62E-03* 
  Continuous 0.258 (0.075) 6.29E-04 
  Weighted 0.045 (0.012) 1.70E-04 
Nuts and legumes 1 Top: tryptophan betaine 0.271 (0.045) 3.04E-09 
  Quartiles 0.293 (0.042) 9.87E-12 
Seafood 7 Top: DHA 0.333 (0.035) 6.85E-20 
  Quartiles 1.538 (0.139) 2.12E-26 
  Continuous 1.464 (0.129) 1.01E-27 
  Weighted 0.173 (0.014) 1.51E-30 
White meat 1 Top: 3-methylhistidine 0.083 (0.037) 2.45E-02* 
  Quartiles 0.118 (0.035) 8.28E-04 
Red meat 3 Top: trans-4-hydroxyproline 0.221 (0.046) 2.29E-06 
  Quartiles 0.854 (0.093) 4.01E-19 
  Continuous 0.766 (0.083) 3.54E-19 
  Weighted 0.081 (0.009) 7.71E-19 
Fried foods 1 Top: X-11372 0.344 (0.046) 2.69E-13 
  Quartiles 0.355 (0.051) 1.12E-11 
Sweets and sweet baked 
products 
4 Top: C-glycosyltryptophan*  0.004 (0.002) 1.09E-02* 
  Quartiles 0.021 (0.004) 5.24E-07 
  Continuous 0.020 (0.004) 2.07E-07 
  Weighted 0.002 (0.000) 2.24E-07 
Butter and creams 5 Top: nonanoylcarnitine* 0.023 (0.033) 4.79E-01* 
  Quartiles 0.294 (0.094) 1.78E-03 
  Continuous 0.262 (0.080) 1.11E-03 
  Weighted 0.022 (0.007) 2.61E-03 
Spreads and dressings 2 Top: X-11261 0.105 (0.041) 1.15E-02* 
  Quartiles 0.207 (0.089) 2.06E-02* 
  Continuous 0.203 (0.073) 5.71E-03* 
  Weighted 0.020 (0.007) 5.67E-03* 
Milk 3 Top: X-21365 0.167 (0.041) 5.71E-05 
  Quartiles 0.384 (0.116) 9.55E-04 
  Continuous 0.352 (0.097) 3.15E-04 
  Weighted 0.047 (0.012) 9.71E-05 
Tea 5 Top: X-14473  -0.217 (0.031) 7.83E-12 
  Quartiles 0.624 (0.082) 8.88E-14 
  Continuous 0.549 (0.068) 3.19E-15 
  Weighted 0.089 (0.011) 2.53E-16 
Coffee 2 Top: X-14473 0.241 (0.055) 1.36E-05 
  Quartiles 0.689 (0.101) 1.98E-11 
  Continuous 0.379 (0.073) 2.50E-07 
  Weighted 0.104 (0.020) 4.38E-07 
Alcohol 8 Top: scyllo-inositol 0.322 (0.042) 1.01E-13 
  Quartiles 1.559 (0.144) 1.22E-25 
  Continuous 1.299 (0.125) 6.46E-24 
   Weighted 0.197 (0.018) 4.08E-27 
NS, not significant; *, not statistically significant (P<3.33x10
-3
). 
Notes: Table shows the results of the linear regression using each food group liking score used 
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 Assigned taxonomy 
Hippurate Diet score Foods 
(3)
 
(P<0.05) Beta (SE) P Beta (SE) P 
denovo467  k__Bacteria; p__Actinobacteria; c__Actinobacteria; o__Actinomycetales; 
f__Actinomycetaceae; g__Actinomyces; s__ 
-0.099 (0.022) 5.14E-06 -0.051 (0.011) 2.81E-06 Fruit: -0.005(0.002) 
WG: -0.009(0.003) 
denovo44  k__Bacteria; p__Bacteroidetes; c__Bacteroidia; o__Bacteroidales; f__Rikenellaceae; 
g__; s__ 
0.094 (0.023) 6.55E-05    
denovo299  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__; g__; s__ 0.113 (0.024) 2.21E-06 0.044 (0.010) 9.76E-06 Coffee: 0.013(0.002)* 
denovo346  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__; g__; s__ 0.129 (0.025) 2.07E-07    
denovo197  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Clostridiaceae; g__; 
s__ 
0.126 (0.026) 1.44E-06    
denovo52  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Clostridiaceae; 
g__Clostridium; s__ 
0.117 (0.024) 1.50E-06    
denovo1263  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae -0.097 (0.022) 1.38E-05    
denovo272  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__; s__ 
-0.094 (0.022) 1.29E-05    
denovo20  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__; s__ 
-0.117 (0.022) 1.29E-07    
denovo100  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__; s__ 
-0.107 (0.022) 1.92E-06    
denovo55  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__[Ruminococcus]; s__ 
-0.123 (0.021) 1.17E-08 -0.054 (0.011) 2.79E-06 Fruit: -0.006(0.002)* 
WG: -0.009(0.003) 
denovo27  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__[Ruminococcus]; s__gnavus 
-0.107 (0.023) 3.04E-06 -0.064 (0.011) 1.99E-08 Fruit: -0.006(0.002)* 
WG: -0.009(0.003) 
denovo25  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__Blautia; s__ 
-0.135 (0.024) 1.28E-08    
denovo35  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__Blautia; s__ 
-0.137 (0.022) 4.94E-10    
denovo13  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__Blautia; s__ 
-0.177 (0.021) 5.56E-17    
denovo144  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__Blautia; s__ 
-0.165 (0.022) 4.83E-14    
denovo237  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__Blautia; s__producta 
-0.102 (0.022) 4.78E-06    
denovo329  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__Dorea; s__ 
-0.130 (0.023) 1.73E-08    
denovo97  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__Dorea; s__formicigenerans 
-0.114 (0.022) 2.46E-07    
denovo414  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; 
g__Roseburia; s__ 
-0.091 (0.022) 3.67E-05    
denovo79  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Ruminococcaceae; 
g__; s__ 
0.097 (0.022) 8.32E-06    
denovo123  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Ruminococcaceae; 
g__; s__ 
0.103 (0.024) 2.83E-05    
denovo12  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Ruminococcaceae; 
g__; s__ 
0.167 (0.025) 8.61E-11    
denovo1380  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Ruminococcaceae; 
g__; s__ 
0.095 (0.022) 1.10E-05    
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 Assigned taxonomy 
Hippurate Diet score Foods 
(3)
 
(P<0.05) Beta (SE) P Beta (SE) P 
denovo438  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Ruminococcaceae; 
g__; s__ 
0.100 (0.025) 5.01E-05    
denovo33  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Ruminococcaceae; 
g__; s__ 
0.098 (0.024) 4.87E-05    
denovo469  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Ruminococcaceae; 
g__Faecalibacterium; s__prausnitzii 
0.100 (0.023) 1.66E-05 0.034 (0.010) 9.24E-04 WG: 0.007(0.003) 
denovo276  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Ruminococcaceae; 
g__Oscillospira; s__ 
0.110 (0.026) 2.53E-05    
denovo59  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Ruminococcaceae; 
g__Oscillospira; s__ 
0.170 (0.026) 2.17E-10    
denovo424  k__Bacteria; p__Firmicutes; c__Clostridia; o__Clostridiales; f__Ruminococcaceae; 
g__Ruminococcus; s__ 
0.107 (0.026) 3.36E-05    
*= statistically significant: P<0.0017; WG: whole grain products; OTUs, operational taxonomic units 
(4) Microbiome OTUs significantly associated with both hippurate and the hippurate diet score are shown. Associations were adjusted for covariates (age, 
Shannon Index, metabolite batch, BMI, sex and family relatedness) and multiple testing using Bonferroni correction. Hippurate diet score associations 
were also adjusted for hippurate. 
(5) OTU ID assignment is specific to the TwinsUK cohort.  
(6) All foods included in the hippurate diet score were fitted into a backwards stepwise linear regression using P<0.05 as the cut-off threshold with each 
collapsed taxa/OTU associated to both hippurate and the diet score. Results displayed are the betas with standard errors of foods at least nominally 




Table 2. List of collapsed taxa associated with hippurate, the hippurate diet score and foods 
(1)
 
     Hippurate Diet score Foods 
P<0.05 
(2)
 Phylum Class Order Family Genus Beta (SE) P Beta (SE) P 












Firmicutes     -0.102 (0.024) 1.94E-05    
Firmicutes Clostridia    -0.088 (0.024) 2.44E-04    
Firmicutes Clostridia Clostridiales   -0.088 (0.024) 2.40E-04    
Firmicutes Clostridia Clostridiales Lachnospiraceae  -0.125 (0.022) 1.72E-08    




Firmicutes Clostridia Clostridiales Lachnospiraceae Blautia -0.146 (0.021) 5.68E-12    
Firmicutes Clostridia Clostridiales Lachnospiraceae Dorea -0.116 (0.021) 6.13E-08    
Firmicutes Clostridia Clostridiales Lachnospiraceae Roseburia -0.089 (0.022) 4.18E-05    
Firmicutes Erysipelotrichi    -0.111 (0.021) 1.64E-07    
Firmicutes Erysipelotrichi Erysipelotrichales   -0.111 (0.021) 1.64E-07    
Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae  -0.111 (0.021) 1.64E-07    




Proteobacteria Betaproteobacteria Burkholderiales Oxalobacteraceae Ralstonia -0.084 (0.021) 7.85E-05    
*= statistically significant: P<0.0017; WG: whole grain products 
(1) Microbiome collapsed taxa significantly associated with both hippurate and the hippurate diet score are shown. Associations were adjusted for 
covariates (age, Shannon Index, metabolite batch, BMI, sex and family relatedness) and multiple testing using Bonferroni correction. Hippurate diet 
score associations were also adjusted for hippurate. 
(2) All foods included in the hippurate diet score were fitted into a backwards stepwise linear regression using P<0.05 as the cut-off threshold with each 
collapsed taxa associated to both hippurate and the diet score. Results displayed are the betas with standard errors of foods at least nominally 
associated (P<0.05). Statistical significance was defined as P<0.0017 (Bonferronil: 0.05/[10 taxa/OTUs x 3 foods]) 
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 Table 3. Associations between MetS status and criteria categories with Shannon 
diversity, the hippurate gradient, the hippurate diet score and associated OTUs and taxa 
MetS, metabolic syndrome; HDL, high density lipoprotein; OTU, operational taxonomic unit; OR, odds ratio 
Notes: A linear regression was performed using Shannon diversity, the hippurate trajectory, the hippurate 
diet and hippurate and diet associated taxa/OTUs as predictors of MetS status (adjusting for age, sex, and 
family relatedness) and each component adjusting for age, BMI (except for BMI), sex, and family 








(0, no; 1, yes) 
Shannon diversity OR: 0.744 (0.064) 6.35E-04 0.0105 
Hippurate trajectory OR: 0.795 (0.082) 0.026 0.0054 
Actinomycetaceae family OR: 1.397 (0.145) 0.001 0.0110 
Actinomycetales order OR: 1.373 (0.140) 0.002 0.0100 
Actinomyces genus OR: 1.310 (0.134) 0.009 0.0072 
Eubacterium genus OR: 1.215 (0.111) 0.034 0.0038 
Ruminococcus genus OR: 1.308 (0.128) 0.006 0.0075 
Ruminococcus genus OTU 
denovo55 
OR: 1.373 (0.145) 0.003 0.0099 
Clostridiales order OTU 
denovo299 
OR: 0.703 (0.063) 9.47E-05 0.0122 
Faecalibacterium prausnitzii OTU 
denovo469 
OR: 0.732 (0.065) 4.33E-04 0.0095 
BMI Shannon diversity -0.770 (0.151) 4.63E-07 0.0288 
Hippurate trajectory -0.700 (0.149) 3.25E-06 0.0240 
Hippurate diet -0.332 (0.154) 0.032 0.0053 
Actinomycetaceae family 0.393 (0.152) 0.010 0.0075 
Actinomycetales order 0.420 (0.153) 0.006 0.0085 
Actinomyces genus 0.431 (0.155) 0.005 0.0089 
Ruminococcus genus 0.407 (0.149) 0.006 0.0081 
Ruminococcus genus OTU 
denovo55 
0.430 (0.151) 0.005 0.0091 
Clostridiales order OTU 
denovo299 
-0.317 (0.147) 0.031 0.0048 
Faecalibacterium prausnitzii OTU 
denovo469 
-0.487 (0.143) 7.26E-04 0.0115 
HDL-
cholesterol 
Shannon diversity 0.096 (0.027) 4.42E-04 0.0126 
Hippurate diet 0.081 (0.027) 0.003 0.0095 
Ruminococcus genus OTU 
denovo55 
0.092 (0.027) 8.46E-04 0.0123 
Clostridiales order OTU 
denovo299 
0.073 (0.027) 0.007 0.0076 
Faecalibacterium prausnitzii OTU 
denovo469 
0.056 (0.026) 0.035 0.0044 
Triglycerides Shannon -0.122 (0.027) 4.97E-06 0.0213 
Hippurate -0.077 (0.026) 0.003 0.0087 
Diet -0.094 (0.027) 5.72E-04 0.0130 
Actinomycetaceae family 0.055 (0.025) 0.029 0.0045 
Eubacterium genus 0.061 (0.026) 0.019 0.0056 
Ruminococcus genus 0.072 (0.026) 0.005 0.0077 
Ruminococcus genus OTU 
denovo55 
0.109 (0.026) 3.56E-05 0.0178 
Clostridiales order OTU 
denovo299 
-0.115 (0.024) 2.38E-06 0.0194 
Faecalibacterium prausnitzii OTU 
denovo469 
-0.079 (0.025) 0.002 0.0092 
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Table 4. Percent variance in the association between the hippurate trajectory and MetS, 
BMI and triglycerides accounted for through each associated variable 
MetS, metabolic syndrome; OTU, operational taxonomic unit 
(5) All variables were significantly (P<0.05) associated with each listed MetS phenotype. 
(6) The proportion of the variance in each MetS phenotype explained by the hippurate trajectory after 
taking into account all covariates (age, sex, family relatedness and BMI [for triglycerides]). 
(7) The proportion of the variance in each MetS phenotype explained by the hippurate trajectory after 






















MetS status  
(0, no; 1, yes) 
Hippurate trajectory 0.0054   
Shannon diversity  0.0021 61.1 
Actinomycetaceae family  0.0040 25.9 
Actinomycetales order  0.0042 22.2 
Actinomyces genus  0.0042 22.2 
Eubacterium genus  0.0052 3.7 
Ruminococcus genus  0.0046 14.8 
Ruminococcus genus OTU denovo55  0.0038 29.6 
Clostridiales order OTU denovo299  0.0026 51.9 
Faecalibacterium prausnitzii OTU denovo469  0.0031 42.6 
BMI Hippurate trajectory 0.0288   
Hippurate diet  0.0203 29.5 
Shannon diversity  0.0122 57.6 
Actinomycetaceae family  0.0215 25.3 
Actinomycetales order  0.0217 24.7 
Actinomyces genus  0.0211 26.7 
Ruminococcus genus  0.0223 22.6 
Ruminococcus genus OTU denovo55  0.0207 28.1 
Clostridiales order OTU denovo299  0.0199 30.9 
Faecalibacterium prausnitzii OTU denovo469  0.0186 35.4 
Triglycerides Hippurate trajectory 0.0087   
Hippurate diet  0.0055 36.8 
Shannon diversity  0.0032 63.2 
Actinomycetaceae family  0.0077 11.5 
Eubacterium genus  0.0084   3.4 
Ruminococcus genus  0.0079   9.2 
Ruminococcus genus OTU denovo55  0.0063 27.6 
Clostridiales order OUT denovo299  0.0045 48.3 
Faecalibacterium prausnitzii OTU denovo469  0.0060 31.0 
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Table 5. Percent variance in the association between the hippurate diet score and BMI, 
HDL cholesterol and triglycerides accounted for through each associated variable 
















BMI Hippurate diet 0.0053   
Shannon diversity  0.0029 45.3 
Hippurate trajectory  0.0021 60.4 
Actinomycetaceae family  0.0042 20.8 
Actinomycetales order  0.0042 20.8 
Actinomyces genus  0.0039 26.4 
Ruminococcus genus  0.0045 15.1 
Ruminococcus genus OTU denovo55  0.0038 28.3 
Clostridiales order OTU denovo299  0.0038 28.3 
Faecalibacterium prausnitzii OTU denovo469  0.0034 35.8 
HDL Hippurate diet 0.0095   
Shannon diversity  0.0074 22.1 
Ruminococcus genus OTU denovo55  0.0073 23.2 
Clostridiales order OTU denovo299  0.0070 26.3 
Faecalibacterium prausnitzii OTU denovo469  0.0079 16.8 
Triglycerides Hippurate diet 0.0130   
Shannon diversity  0.0100 23.1 
Hippurate trajectory  0.0097 25.4 
Actinomycetaceae family  0.0118   9.2 
Eubacterium genus  0.0118   9.2 
Ruminococcus genus  0.0120   7.7 
Ruminococcus genus OTU denovo55  0.0100 23.1 
Clostridiales order OUT denovo299  0.0087 33.1 
Faecalibacterium prausnitzii OTU denovo469  0.0104 20.0 
MetS, metabolic syndrome; HDL, high density lipoprotein; OTU, operational taxonomic unit 
(1) All variables were significantly (P<0.05) associated with each listed MetS phenotype. 
(2) The proportion of the variance in each MetS phenotype explained by the hippurate diet score 
after taking into account all covariates (age, sex, family relatedness and BMI [for triglycerides]). 
(3) The proportion of the variance in each MetS phenotype explained by the hippurate diet score 






Appendix F. Chapter 7 Appendices 
Table 1. Nutrient profile and linear trends of the visceral fat mass diet score according to score tertile 
NS= not significant: P>0.05. FA: fatty acid, MUFAS: monounsaturated fatty acids, PUFAS: polyunsaturated fatty acids, 
NSP: non-starch polysaccharides 
Tertile 1: score 0-6; tertile 2: score 7-9; tertile 3: scores 10-15. Linear trend determined by using the tertile of the VFM 
diet score as a predictor of the energy-adjusted nutrient intake. 
 
 Tertile 1  Tertile 2  Tertile 3  Trend 
Nutrient Mean (SD) Mean (SD) Mean (SD) Beta (SE) P 
Energy (kcal) 1892.1 (510.9) 1804.2 (522.9) 1870.4 (552.2) -15.61 (14.56) NS 
Fat (g/d) 61.5 (10.4) 68.6 (9.5) 72.4 (10.3) 5.53 (0.28) 1.62x10
-75
 
   Saturated FAs (g/d) 21.3 (5.4) 24.5 (5.2) 26.6 (5.1) 2.65 (0.14) 1.90x10
-67
 
   MUFAs (g/d) 19.7 (3.7) 22.7 (3.4) 24.7 (3.8) 2.54 (0.1) 2.33x10
-113
 
   PUFAs (g/d) 15.2 (4.4) 15.9 (4.4) 15.7 (4.5) 0.3 (0.12) 1.21x10
-2
 
   trans-FAs (g/d) 1.3 (0.6) 1.6 (0.6) 1.8 (0.6) 0.25 (0.02) 2.55x10
-51
 
   Cholesterol (mg/d) 202.5 (69.1) 234.8 (74.2) 251.5 (78.2) 24.98 (2.06) 4.04x10
-32
 
Protein (g/d) 79.5 (12.2) 81 (12.3) 79.6 (12.5) 0.15 (0.34) NS 
Carbohydrate (g/d) 248.1 (29.6) 229 (29.1) 217.2 (31.1) -15.66 (0.84) 1.13x10
-69
 
   Starch (g/d) 107.7 (26.3) 107.9 (25.1) 111.2 (26.1) 1.65 (0.71) 2.05x10
-2
 
   Total sugars (g/d) 137.5 (28.1) 118.3 (24.4) 103.4 (24.1) -17.22 (0.71) 5.34x10
-108
 
   Glucose (g/d) 28 (9.2) 22.4 (7.8) 18 (6.5) -5.05 (0.22) 8.20x10
-101
 
   Fructose (g/d) 33.7 (11.4) 26 (9.2) 19.9 (7.5) -6.99 (0.26) 1.29x10
-125
 
   Sucrose (g/d) 48 (14.1) 44.2 (14.4) 42.7 (15.6) -2.73 (0.41) 6.34x10
-11
 
   Maltose (g/d) 3.3 (1.5) 3 (1.6) 3.3 (1.8) -0.02 (0.05) NS 
   Lactose (g/d) 18.7 (9.9) 18.3 (8.9) 17 (9.8) -0.82 (0.26) 1.82x10
-3
 
NSP (g/d) 22.9 (5.5) 19.6 (4.5) 16.4 (4.2) -3.22 (0.13) 2.27x10
-110
 
Alcohol (g/d) 8.4 (11.1) 8.8 (11.3) 10.9 (14.9) 1.24 (0.38) 9.45x10
-4
 
Water (g/d) 2754.6 (662) 2593.7 (598.9) 2478.5 (598.1) -139.45 (16.71) 1.80x10
-16
 
Sodium (mg/d) 2308.6 (498.6) 2262.8 (471.7) 2162.2 (453.5) -71.5 (12.87) 3.33x10
-8
 
Potassium (mg/d) 4080.4 (624.4) 3833 (569.2) 3550.3 (524.2) -263.97 (15.56) 1.48x10
-58
 
Chloride (mg/d) 3705.3 (764.9) 3598.8 (728.6) 3411.9 (694.5) -144.23 (19.7) 4.30x10
-13
 
Calcium (mg/d) 1095.7 (286.9) 1039.4 (260.8) 949.3 (264.1) -72.17 (7.31) 3.18x10
-22
 
Magnesium (mg/d) 369.1 (52.3) 336.3 (49.2) 296.7 (42.4) -36.01 (1.27) 3.72x10
-138
 
Phosphorous (mg/d) 1534.9 (218.8) 1474.9 (202.7) 1357 (211.8) -87.14 (5.81) 4.40x10
-47
 
Iron (mg/d) 13.5 (3.1) 12.5 (2.4) 11.5 (2.3) -0.99 (0.07) 2.43x10
-39
 
Copper (mg/d) 1.6 (0.4) 1.6 (0.5) 1.5 (0.5) -0.07 (0.01) 1.90x10
-8
 
Zinc (mg/d) 10.1 (1.5) 10.1 (1.6) 9.8 (1.7) -0.13 (0.04) 2.60x10
-3
 
Manganese (mg/d) 4.4 (1.1) 4 (1) 3.6 (0.9) -0.43 (0.03) 9.54x10
-52
 
Iodine (ug/d) 212.9 (73) 207 (68.7) 196.5 (68.7) -8.03 (1.89) 2.25x10
-5
 
Retinol (ug/d) 407.1 (403.2) 533.9 (586.6) 617.4 (772.6) 106.49 (16.78) 3.05x10
-10
 
Carotene (ug/d) 6060.1 (4193.3) 5399.6 (3002.5) 4729.8 (2742.7) -664.87 (94.64) 3.41x10
-12
 
Vitamin D (ug/d) 2.5 (1.1) 2.5 (1) 2.4 (0.9) -0.05 (0.03) 5.36x10
-2
 
Vitamin E (mg/d) 11.7 (3.4) 10.9 (2.9) 9.9 (2.8) -0.92 (0.08) 1.02x10
-26
 
Thiamin (mg/d) 1.8 (0.4) 1.7 (0.3) 1.6 (0.3) -0.12 (0.01) 3.38x10
-31
 
Riboflavin (mg/d) 2.3 (0.7) 2.2 (0.6) 2.1 (0.6) -0.09 (0.02) 2.03x10
-7
 
Niacin (mg/d) 21.7 (5) 21.1 (4.5) 20.5 (4.5) -0.59 (0.13) 4.09x10
-6
 
Tryptophan (mg/d) 16.6 (2.5) 16.9 (2.5) 16.6 (2.5) 0.02 (0.07) NS 
Vitamin B6 (mg/d) 2.6 (0.6) 2.5 (0.5) 2.3 (0.5) -0.15 (0.01) 2.63x10
-23
 
Vitamin B12 (mg/d) 5.8 (2.2) 6.3 (2.5) 6.4 (2.9) 0.31 (0.07) 6.65x10
-6
 
Folate (ug/d) 416 (116) 378.8 (103.5) 341.8 (91.7) -37.1 (2.79) 5.95x10
-38
 
Pantothenate (mg/d) 6.1 (1.6) 6 (2.8) 5.6 (1.3) -0.23 (0.04) 1.43x10
-8
 
Biotin (ug/d) 46.9 (10.1) 45.5 (9.4) 42.3 (9.5) -2.27 (0.26) 1.50x10
-17
 





Table 2. Associations between visceral fat mass (VFM) and the VFM diet score, Shannon 
Index and top microbiome and metabolite associations in the MZ discordant twin sample 
Notes: A linear regression was conducted using the VFM diet score, Shannon Index and top 
microbiome and metabolite associations to predict VFM in the MZ discordant (1 SD apart in 
VFM) twin sample.  Variables standardized to have mean=0, SD=1. 
 
     Regression 




twins   VFM 
Variable N pairs Mean(SE) Mean(SE)   Beta(SE) P R
2
 
VFM diet score 80 -0.141(0.122) -0.047(0.115) 
  
0.281(0.091) 0.002 0.057 
Alpha-
hydroxyisovalerate 
80 -0.239(0.120) 0.064(0.111) 
  
0.141(0.094) 0.136 0.014 
Bilirubin (Z,Z) 68 0.093(0.102) -0.110(0.134) 
  
-0.187(0.102) 0.068 0.023 
Butyrylcarnitine  80 -0.168(0.126) 0.096(0.124) 
  
0.199(0.087) 0.023 0.032 
Hippurate 80 0.062(0.112) -0.162(0.114) 
  
-0.297(0.095) 0.002 0.058 
Shannon Index 27 -0.019(0.182) -0.268(0.224) 
  
-0.287(0.176) 0.110 0.048 
Bifidobacterium 
OTU (4426298) 
27 0.140(0.718) 0.175(1.098) 
 
-0.064(0.197) 0.749 0.002 
Eubacterium 
dolichum 
27 -0.108(0.155) -0.013(0.171) 
  
0.131(0.227) 0.566 0.006 
 317 
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